data_1wia_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wia _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 17.0 pt -104.91 143.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -92.68 138.64 31.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.31 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -99.97 118.44 36.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.475 HD11 ' CZ ' ' A' ' 193' ' ' PHE . 42.3 mt -87.02 112.0 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -99.31 130.3 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.8 m-85 -107.72 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.1 mt -59.6 -10.76 3.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.51 15.51 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 62.87 31.63 16.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -123.59 174.31 7.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -142.77 157.39 44.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.07 132.29 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.9 tp -75.74 118.48 18.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.67 125.62 17.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.93 121.83 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.187 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -123.06 157.59 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -112.11 153.17 44.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.85 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.54 -29.77 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -54.91 172.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.0 p -116.59 158.08 24.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.118 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.88 -43.72 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.01 -41.64 94.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.22 -45.56 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.48 -47.12 76.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 193' ' ' PHE . 24.9 mtpt -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -70.74 -28.1 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.58 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.98 -47.82 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.58 ' CZ ' ' CE ' ' A' ' 191' ' ' LYS . 51.6 m-85 -99.93 -44.42 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.9 m-85 -109.71 79.52 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.5 28.12 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.46 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 74.74 -45.25 1.58 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.46 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -82.47 39.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 38.5 mp0 -85.53 -28.98 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 15.9 m -72.19 -13.59 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -110.83 -47.69 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.04 85.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.458 ' NZ ' ' CD2' ' A' ' 208' ' ' LEU . 11.7 mmtp -89.81 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.26 141.25 37.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.561 HD12 ' CD2' ' A' ' 230' ' ' HIS . 54.7 mt -129.16 122.82 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -119.93 112.39 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 62.24 44.05 7.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.15 1.0 55.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -101.97 140.3 36.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.458 ' CD2' ' NZ ' ' A' ' 201' ' ' LYS . 15.0 tp -86.21 125.3 33.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 210' ' ' GLN . 6.4 mt -83.25 20.79 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -34.62 -53.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.456 ' HB3' ' CG ' ' A' ' 214' ' ' ARG . 12.6 t0 -48.49 105.73 0.53 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.714 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -4.04 13.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.691 2.26 . . . . 0.0 112.384 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.13 -28.73 10.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.456 ' CG ' ' HB3' ' A' ' 211' ' ' ASP . 15.5 mmt180 -46.21 109.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.59 148.87 44.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -63.03 -31.5 72.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 t -64.59 -44.26 91.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 52.4 m -66.46 -35.99 81.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.86 1.97 13.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 10.6 m120 67.05 25.04 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 32.8 mt -77.97 103.65 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.2 p -103.52 -177.85 3.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 224' ' ' ASN . 1.0 OUTLIER -72.29 170.95 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 223' ' ' ASN . 4.4 p-10 47.71 30.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.9 t -107.97 159.57 16.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.0 p -119.2 138.72 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.8 mt -119.1 119.59 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -70.53 133.37 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 91.7 m -107.96 148.35 29.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.561 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.3 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 21.0 pt -110.33 138.84 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.34 137.13 32.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.459 HG23 ' CB ' ' A' ' 179' ' ' ALA . 13.3 t -126.63 133.28 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -95.91 115.55 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.489 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 40.6 mt -86.48 106.55 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -98.78 133.96 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.853 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 6.0 m-85 -107.61 164.57 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.95 -11.79 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 32.9 t30 -85.36 16.32 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 62.41 30.17 17.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.416 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 7.6 t -113.2 169.96 8.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -142.82 149.21 38.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -135.65 137.32 41.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.21 118.77 20.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.509 ' HB3' ' CE2' ' A' ' 192' ' ' TYR . . . -142.77 113.9 7.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.1 t -83.9 121.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.459 ' CB ' HG23 ' A' ' 165' ' ' VAL . . . -122.04 158.09 29.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -109.25 151.09 41.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.622 0.725 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -1.67 8.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.298 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 17.1 pm0 -112.67 -17.07 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.89 -177.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.9 p -127.14 149.48 49.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 88.4 t -57.22 -39.57 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -63.19 -42.01 99.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.37 -44.79 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.57 -47.04 77.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.4 mtpt -58.38 -48.38 80.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 t -70.78 -27.99 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.579 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.7 tmmm? -65.05 -47.8 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.579 ' CZ ' ' CE ' ' A' ' 191' ' ' LYS . 51.4 m-85 -99.82 -44.29 6.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' LYS . 16.4 m-85 -108.64 75.99 0.65 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.641 0.734 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.68 28.5 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 0.0 112.33 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.456 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.51 -41.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -90.67 42.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 27.8 mp0 -88.11 -32.5 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.5 t -67.43 -24.91 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -98.57 -38.18 9.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -71.41 85.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -91.02 134.79 34.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.469 HD11 ' N ' ' A' ' 202' ' ' LEU . 7.4 mp -109.55 141.65 41.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.14 122.89 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.469 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.5 t80 -115.42 113.0 23.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 68.3 mt-30 62.99 44.08 6.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.53 -0.27 43.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -102.68 131.29 49.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 33.5 tp -79.98 127.6 32.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 209' ' ' LEU . 4.4 mt -80.5 46.02 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -44.2 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -45.08 104.09 0.37 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.584 0.707 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 0.0 112.312 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.93 -17.73 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -54.3 117.98 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.1 p -65.71 147.01 54.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.49 -32.14 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 p -64.98 -46.9 79.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 p -61.59 -35.95 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.82 5.0 10.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 220' ' ' ASN . 1.8 m-80 62.2 34.22 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 58.5 mt -87.29 93.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -98.21 -178.31 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.8 52.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.9 t30 73.59 37.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . 0.446 ' HG ' ' N ' ' A' ' 226' ' ' VAL . 1.1 t -119.0 145.86 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 225' ' ' CYS . 5.6 p -110.54 141.36 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.429 HG22 ' CD2' ' A' ' 202' ' ' LEU . 23.0 mt -119.92 120.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -70.89 134.24 47.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 84.2 m -111.36 141.58 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.0 pt -101.29 143.99 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.61 136.26 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.49 136.62 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -99.79 123.09 43.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 36.5 mt -91.49 107.4 19.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.72 133.29 43.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 6.0 m-85 -107.13 164.47 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.22 -7.68 14.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -84.89 9.47 14.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.39 26.39 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -119.14 160.0 22.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.183 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.01 154.2 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -133.98 128.97 35.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.0 tp -73.43 118.62 16.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.73 132.37 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.8 p -93.45 121.9 44.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.417 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.61 157.25 35.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -110.4 154.97 42.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -12.09 32.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.319 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.66 -36.62 10.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -47.38 168.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 24.0 p -110.76 159.57 17.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.434 ' CG2' ' CD1' ' A' ' 219' ' ' LEU . 68.6 t -61.5 -35.78 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.9 -40.85 89.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -68.36 -38.49 81.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 111.123 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -55.59 -46.6 77.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 193' ' ' PHE . 6.2 mtpp -65.11 -42.05 94.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.8 t -71.02 -28.17 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.565 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.09 -48.14 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.565 ' CE1' ' HD2' ' A' ' 191' ' ' LYS . 7.7 m-85 -100.04 -43.65 6.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 189' ' ' LYS . 24.3 m-85 -107.47 80.74 0.95 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.665 0.745 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 127.07 14.07 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.321 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.454 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.1 -41.96 1.83 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.55 39.43 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 37.8 mp0 -85.22 -36.55 20.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.3 t -64.06 -22.96 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.29 -34.61 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -79.35 85.24 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -88.24 134.45 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.469 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 13.5 mt -104.11 141.27 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.13 122.78 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 62.0 t80 -117.32 122.43 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.551 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.2 mm-40 53.46 48.61 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.15 33.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.55 142.15 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.439 HD23 ' CG ' ' A' ' 210' ' ' GLN . 35.1 tp -87.68 121.94 30.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -75.75 50.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.439 ' CG ' HD23 ' A' ' 208' ' ' LEU . 73.6 mt-30 -53.1 -71.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 16.5 t0 -42.23 102.57 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.846 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.5 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.11 -33.15 7.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -39.98 114.27 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.9 p -61.5 143.37 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -57.56 -31.84 66.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.6 p -64.74 -46.93 80.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.8 t -65.05 -32.32 73.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 185' ' ' VAL . 48.5 mt -77.14 4.97 9.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.88 30.36 16.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.53 95.84 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.7 p -99.75 -175.13 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -74.79 159.79 31.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 62.27 28.88 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.85 157.1 20.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.68 133.68 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 35.2 mt -112.6 116.03 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.93 139.38 57.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.59 144.04 44.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 8.2 m170 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 26.5 pt -93.75 145.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 111.124 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -89.49 129.76 35.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.423 HG21 ' CB ' ' A' ' 179' ' ' ALA . 22.0 t -123.58 138.5 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -103.14 117.68 35.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.21 108.1 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -99.03 129.5 45.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.2 m-85 -107.65 157.17 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.9 mt -63.55 -7.78 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -83.21 17.09 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 62.18 29.03 17.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.5 t -123.79 167.12 14.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -139.65 153.23 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.25 131.0 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.8 tp -77.42 117.92 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -139.12 135.55 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.9 p -94.8 123.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 165' ' ' VAL . . . -124.08 157.65 34.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -111.46 152.09 43.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.879 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -2.55 10.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.341 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.54 -38.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.14 172.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.6 p -114.45 164.57 13.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 43.2 t -64.72 -40.41 88.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.89 -42.18 99.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.15 -47.01 82.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 193' ' ' PHE . 21.1 mtpt -63.66 -44.06 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.418 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 39.7 t -70.87 -28.21 64.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.567 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.12 -48.2 74.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.919 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.567 ' CE1' ' HD2' ' A' ' 191' ' ' LYS . 8.6 m-85 -99.94 -43.91 6.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.66 78.63 2.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 131.7 21.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.46 -42.27 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -71.6 1.91 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 9.7 mt-10 -55.19 -14.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -64.41 -58.28 6.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 201' ' ' LYS . 6.1 pt20 -84.28 -37.2 21.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.45 ' SD ' ' CG ' ' A' ' 199' ' ' GLN . 0.0 OUTLIER -52.6 85.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 199' ' ' GLN . 19.5 mttp -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 17.4 mt -93.67 137.07 33.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.94 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -129.08 122.89 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.7 t80 -114.86 119.75 37.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.558 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.4 mm100 54.39 48.45 20.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.73 41.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -102.61 139.08 38.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.41 ' CD2' ' HG3' ' A' ' 210' ' ' GLN . 41.0 tp -87.39 123.17 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 209' ' ' LEU . 5.5 mt -79.09 47.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.41 ' HG3' ' CD2' ' A' ' 208' ' ' LEU . 12.3 mt-30 -50.38 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.79 103.29 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.597 0.713 . . . . 0.0 110.842 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.34 6.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.58 22.52 14.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -94.32 105.09 17.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.9 p -50.64 142.95 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.6 mt -62.26 -32.67 73.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.7 t -64.57 -45.94 84.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.1 m -65.08 -31.32 72.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.64 4.48 18.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.0 34.22 11.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 57.5 mt -90.83 93.56 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 76.2 p -98.76 -176.66 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -69.39 150.64 47.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 72.44 33.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.2 t -113.39 149.88 33.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.12 134.51 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.0 mt -114.47 122.14 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -79.08 135.74 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -115.82 127.55 55.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -97.99 151.53 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -101.12 139.12 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 179' ' ' ALA . 16.6 t -129.29 132.31 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -94.38 117.58 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.528 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 38.6 mt -85.14 107.34 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -98.73 128.61 45.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 5.3 m-85 -107.32 157.26 18.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.08 -9.97 5.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -81.23 14.59 2.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 62.33 34.05 16.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -130.53 157.43 42.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -128.16 153.5 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -134.32 136.25 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.51 116.69 18.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.65 116.56 10.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.9 t -82.4 121.86 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.079 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -122.36 158.13 30.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.5 mtm-85 -110.54 152.85 43.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.56 0.695 . . . . 0.0 110.924 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -105.02 -36.82 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -49.59 169.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -111.65 160.1 17.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.1 -44.11 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.59 88.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.53 -43.22 66.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 11.4 tp -55.36 -47.18 76.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.4 mtpt -58.63 -48.24 81.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.7 p -70.76 -27.97 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.581 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -65.19 -47.87 75.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.581 ' CZ ' ' CE ' ' A' ' 191' ' ' LYS . 48.0 m-85 -99.95 -44.31 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.528 ' CZ ' HD12 ' A' ' 167' ' ' LEU . 7.7 m-85 -111.84 77.44 1.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.689 0.757 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 196' ' ' GLN . 53.2 Cg_endo -69.82 128.02 15.38 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.316 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.24 -14.95 4.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 194' ' ' PRO . 17.0 mm100 -94.52 -12.49 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.727 0.299 . . . . 0.0 110.835 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -48.56 -20.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m -61.54 -49.79 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 201' ' ' LYS . 29.3 mt-30 -91.97 -45.24 8.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -52.14 85.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 199' ' ' GLN . 5.9 ttmm -91.55 120.52 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 15.0 mt -93.06 134.89 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.3 mt -129.13 123.46 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.9 t80 -115.45 116.5 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.1 mt-30 58.13 38.1 26.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.68 7.29 87.27 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -107.05 135.17 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.458 ' CD2' ' HG3' ' A' ' 210' ' ' GLN . 10.1 tp -80.15 127.03 31.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.4 mt -84.16 26.2 0.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.458 ' HG3' ' CD2' ' A' ' 208' ' ' LEU . 21.1 mt-30 -34.33 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.58 100.12 0.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 0.79 5.09 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.288 . . . . 0.0 112.36 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.88 16.01 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -89.5 112.83 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -57.92 137.19 56.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.7 mt -57.07 -34.7 68.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.3 t -61.37 -44.31 97.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.5 m -67.05 -35.94 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 mt -75.62 4.37 7.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.64 38.86 11.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.5 mt -94.04 90.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.7 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.8 157.6 7.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 61.96 37.76 14.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 t -114.46 143.74 44.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.7 p -109.44 134.75 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 41.5 mt -115.45 129.93 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -83.66 127.36 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 1.8 t -111.14 122.42 47.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 19.2 pt -100.97 144.99 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.16 134.32 34.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.21 135.43 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -100.68 118.19 36.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 mt -85.15 110.73 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -98.77 128.56 45.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.7 m-85 -107.69 158.5 17.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.41 -7.81 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -85.31 23.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 55.81 27.54 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -123.75 164.23 19.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.03 153.95 51.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -132.83 133.41 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.71 124.74 28.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -141.58 142.74 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.19 121.76 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -128.01 158.21 38.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -115.86 154.18 48.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.85 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -4.86 14.85 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.05 -37.93 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.77 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.0 p -115.01 164.29 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.143 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 50.0 t -57.06 -44.02 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.71 -36.62 90.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.36 -39.58 71.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.1 tp -55.52 -47.17 76.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 29.4 mttt -58.99 -47.92 83.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -70.12 -28.05 65.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.906 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.517 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -64.53 -48.14 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 177' ' ' ALA . 4.0 m-85 -100.32 -44.58 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.9 m-85 -111.51 83.13 4.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.17 7.0 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.444 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.74 -26.88 2.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -79.84 -3.88 49.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 2.8 mp0 -52.11 -21.06 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.8 m -60.47 -51.66 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -93.3 -44.09 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.97 95.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -103.77 134.3 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.06 138.94 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.561 HD11 ' CD2' ' A' ' 230' ' ' HIS . 45.1 mt -129.24 122.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.547 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 68.1 t80 -115.21 125.68 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.547 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 12.4 mm-40 52.72 46.09 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.3 2.23 40.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 5.2 ttp-105 -102.78 144.94 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 25.6 tp -88.28 124.47 33.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.464 ' N ' HD21 ' A' ' 209' ' ' LEU . 5.7 mt -75.71 48.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -51.44 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m-20 -42.31 102.48 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.615 0.722 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.2 Cg_endo -69.82 3.09 3.0 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -118.31 19.42 13.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -86.76 101.16 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 p -48.36 135.42 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -58.97 -37.6 77.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.4 t -59.59 -43.48 93.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -36.04 81.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.67 5.12 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 63.02 32.94 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.411 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 48.4 mt -85.54 89.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.5 p -95.73 179.66 5.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 157.96 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 63.6 39.53 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.2 149.49 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 226' ' ' VAL . 1.7 p -114.85 123.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 30.9 mt -105.99 124.02 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -74.4 130.77 40.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 88.6 m -103.81 149.41 25.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.561 ' CD2' HD11 ' A' ' 203' ' ' ILE . 4.0 m170 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.7 pt -95.97 138.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.168 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -87.31 143.62 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.27 138.64 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -97.75 116.59 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.7 mt -85.18 109.19 18.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' CYS . 1.6 tmtm? -98.95 133.67 42.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.463 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 1.9 m-85 -108.57 162.89 13.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.478 HD12 ' CG ' ' A' ' 230' ' ' HIS . 19.0 mt -61.61 -22.74 65.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 173' ' ' THR . 11.2 p-10 -82.96 34.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 43.19 54.82 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.464 ' HB ' ' ND2' ' A' ' 171' ' ' ASN . 0.8 OUTLIER -128.33 171.59 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.62 147.4 31.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.98 129.48 25.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 tp -77.39 117.82 19.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -140.96 140.31 34.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.05 121.84 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.41 ' CB ' HD13 ' A' ' 188' ' ' LEU . . . -125.01 157.65 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 76.7 mtm-85 -110.83 152.08 43.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 0.22 6.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.59 -43.85 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.63 161.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.0 p -103.28 164.25 11.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.89 -42.39 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.98 98.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -66.17 -38.01 87.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 111.198 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.441 HD12 ' CE2' ' A' ' 192' ' ' TYR . 14.9 tp -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.7 mtpt -66.67 -42.05 87.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -70.83 -28.2 64.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.557 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.02 -48.35 74.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.557 ' CE1' ' HD2' ' A' ' 191' ' ' LYS . 6.7 m-85 -99.98 -44.01 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.0 m-85 -109.98 78.89 1.38 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 131.33 20.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.455 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.79 -41.59 1.72 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.455 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -84.57 35.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.455 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 32.7 mp0 -83.42 -31.4 26.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.5 m -64.7 -19.73 65.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 230' ' ' HIS . 34.5 mt-30 -104.17 -45.02 4.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.77 85.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -88.51 122.21 31.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.95 137.54 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.449 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.3 mt -129.15 122.68 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.561 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 64.0 t80 -116.1 113.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.561 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.9 mt-30 62.93 43.55 6.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.32 4.61 60.72 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -106.83 131.62 53.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.95 125.27 29.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.0 46.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -45.49 -67.84 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 19.6 t0 -44.61 103.93 0.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 52.9 Cg_endo -69.84 2.55 3.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.659 2.239 . . . . 0.0 112.286 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.92 -30.53 8.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -41.47 123.3 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.3 p -70.29 150.39 46.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -64.45 -35.63 81.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.0 p -63.55 -46.07 87.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -63.72 -34.45 77.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 59.3 mt -77.84 4.49 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 67.0 29.34 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 84.8 mt -87.02 92.05 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.0 p -101.77 -175.73 2.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -70.24 154.46 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 62.45 38.3 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.92 146.29 47.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.2 p -107.32 142.22 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.68 119.56 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -66.18 137.66 57.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 168' ' ' LYS . 83.1 m -120.26 146.72 45.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.478 ' CG ' HD12 ' A' ' 170' ' ' LEU . 4.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.4 pt -120.07 138.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.806 0.336 . . . . 0.0 111.144 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -87.96 143.2 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.458 HG23 ' CB ' ' A' ' 179' ' ' ALA . 16.3 t -131.7 137.47 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -100.59 117.55 34.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.408 HD13 ' CB ' ' A' ' 177' ' ' ALA . 37.0 mt -86.67 107.88 18.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -98.88 128.32 45.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.6 m-85 -107.5 160.23 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.71 -6.24 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -84.83 16.37 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 63.0 26.93 15.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.404 HG21 ' CD1' ' A' ' 169' ' ' PHE . 6.1 t -120.84 168.26 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -144.48 149.9 36.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -135.77 129.18 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.27 120.29 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.566 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -137.14 125.96 24.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.451 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 6.2 p -86.57 123.07 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.458 ' CB ' HG23 ' A' ' 165' ' ' VAL . . . -126.31 157.97 37.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -111.96 153.49 44.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -5.61 16.61 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.375 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.76 -38.41 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -51.36 173.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 41.5 p -118.91 164.36 15.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.37 -43.99 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.78 83.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -44.59 63.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.167 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.14 -47.12 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 33.6 mtpt -57.98 -48.57 79.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.422 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 94.0 p -70.93 -27.92 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.571 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.66 -47.55 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.571 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 86.4 m-85 -98.7 -44.44 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LYS . 10.3 m-85 -113.65 79.14 4.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 134.31 27.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.04 -44.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -68.77 -1.46 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.738 0.304 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 13.2 mt-10 -51.56 -20.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.7 t -58.83 -59.29 5.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 201' ' ' LYS . 0.0 OUTLIER -82.92 -42.2 17.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.441 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -45.14 91.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 199' ' ' GLN . 17.8 ttmt -105.29 117.94 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.0 mt -93.72 137.12 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.27 122.9 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -116.14 111.9 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 57.97 51.51 8.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.59 5.87 39.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.73 136.55 43.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.444 ' CD1' ' HG2' ' A' ' 201' ' ' LYS . 12.1 tp -85.32 121.07 27.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.46 44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.959 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.416 ' CG ' HD23 ' A' ' 208' ' ' LEU . 16.8 mt-30 -52.14 -72.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 214' ' ' ARG . 9.2 t70 -42.24 102.5 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.698 . . . . 0.0 110.896 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.02 3.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.51 8.66 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.455 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 8.4 mmm-85 -82.33 105.81 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 17.6 p -51.36 142.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.2 mt -62.09 -31.74 72.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 85.8 p -63.3 -44.35 95.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -35.4 79.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.97 5.0 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.65 26.07 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.18 93.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.3 p -96.31 -175.58 3.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.5 OUTLIER -74.95 158.18 33.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 56.4 m-20 62.91 29.18 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.9 t -110.22 154.82 22.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.11 138.98 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.7 mt -116.15 122.78 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -73.53 134.09 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 60.3 m -120.14 133.9 55.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.6 m170 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.6 pt -95.96 144.81 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.28 134.63 34.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -96.79 117.06 30.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.4 mt -85.67 107.14 17.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -99.06 127.87 45.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 4.0 m-85 -105.42 161.48 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 230' ' ' HIS . 5.3 mp -67.47 -7.71 27.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.11 16.23 2.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.8 t70 63.29 30.15 15.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.7 t -125.15 174.91 7.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -148.22 150.14 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -130.23 134.13 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.6 tp -80.87 122.5 27.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.561 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -141.69 141.24 33.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.88 121.91 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -126.48 157.91 37.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -113.95 154.51 45.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.72 8.95 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.363 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.26 -39.21 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.11 170.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.7 p -112.76 161.99 16.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.24 -40.18 88.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.12 97.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.8 m -67.04 -36.28 81.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.12 -46.69 79.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 17.6 mttp -64.76 -41.79 95.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.4 p -70.6 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.567 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.69 -48.69 73.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.567 ' CD1' ' HD3' ' A' ' 191' ' ' LYS . 10.3 m-85 -100.33 -43.58 6.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 20.2 m-85 -110.83 80.47 2.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.18 14.18 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.78 -39.99 1.81 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -84.11 28.68 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -18.72 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.8 t -75.71 -24.15 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.67 -44.3 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.65 86.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.89 121.15 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 202' ' ' LEU . 6.8 mp -96.88 139.13 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.1 mt -129.05 122.97 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 74.4 t80 -114.06 111.78 22.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.525 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 26.5 mt-30 63.31 42.36 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.77 0.77 64.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.04 131.99 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 tp -81.5 122.36 27.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -76.21 53.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.46 -71.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -42.03 102.3 0.27 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.72 . . . . 0.0 110.929 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.74 2.43 3.53 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.385 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.47 14.25 19.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -89.1 101.2 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.1 p -47.8 143.22 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -59.59 -39.99 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.3 p -58.72 -44.77 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -63.92 -34.05 77.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.848 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 78.9 mt -77.91 4.69 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 62.52 36.44 13.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.8 mt -90.88 94.48 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.2 p -100.32 173.75 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.1 153.42 37.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.4 t30 69.37 38.44 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 t -120.55 151.42 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.11 136.29 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 28.9 mt -115.37 130.04 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -83.4 127.08 33.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 170' ' ' LEU . 58.0 m -109.02 136.13 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.537 ' CD2' HD12 ' A' ' 170' ' ' LEU . 5.8 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 223' ' ' ASN . 13.0 pt -108.19 145.38 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.91 138.84 32.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.43 137.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -98.07 125.23 42.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.1 mt -92.53 104.52 16.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.73 133.69 42.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 3.9 m-85 -107.27 166.33 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 230' ' ' HIS . 14.4 mt -70.6 -14.21 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.498 ' OD1' ' CG2' ' A' ' 173' ' ' THR . 3.0 p30 -78.15 4.12 13.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.2 t70 73.97 47.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.498 ' CG2' ' OD1' ' A' ' 171' ' ' ASN . 1.3 t -135.46 171.82 13.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -142.96 153.94 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.55 130.44 23.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.79 117.82 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.1 123.48 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.57 123.76 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB1' ' CD1' ' A' ' 188' ' ' LEU . . . -127.18 157.67 39.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -107.99 153.6 41.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.889 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -1.15 7.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.26 -33.22 6.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -50.18 173.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 2.6 p -117.21 159.09 23.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.96 -40.19 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.58 -37.32 94.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -70.44 -42.5 71.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.168 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.448 ' CD1' ' HB1' ' A' ' 179' ' ' ALA . 13.2 tp -55.34 -47.27 75.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 26.4 mtpt -58.87 -48.11 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.447 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.7 t -70.57 -27.99 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.557 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.5 tmmm? -65.02 -48.06 75.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.602 ' CZ ' ' CB ' ' A' ' 177' ' ' ALA . 54.9 m-85 -100.01 -44.48 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.07 77.23 2.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 134.72 28.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.349 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.08 -42.42 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.29 -9.87 50.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.447 ' OE2' ' CB ' ' A' ' 190' ' ' SER . 13.1 mt-10 -45.51 -22.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.6 t -55.92 -61.24 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -84.19 -42.61 15.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -44.83 113.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -126.3 122.28 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.83 141.21 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.9 mt -129.13 122.81 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.451 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 61.2 t80 -116.33 110.94 19.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.451 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 67.2 mt-30 62.38 53.37 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.92 3.74 11.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -104.88 136.47 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.8 tp -84.42 125.39 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -79.99 54.43 1.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -54.96 -73.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -43.34 103.15 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.88 7.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.3 23.13 13.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -91.94 108.33 19.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.5 p -52.8 138.41 29.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.8 mt -57.8 -32.22 67.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.4 t -64.75 -42.6 95.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 34.5 t -67.67 -35.41 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.6 mt -76.47 1.77 15.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.2 m120 67.17 28.87 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.5 mt -84.45 96.08 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.5 p -100.46 -175.71 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.458 ' HB3' ' CG2' ' A' ' 163' ' ' ILE . 7.0 p30 -76.04 148.6 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 74.2 27.15 1.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.65 158.87 17.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.67 131.69 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.42 124.14 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.75 138.98 39.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 39.3 m -120.68 138.55 53.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.428 ' CE1' HD12 ' A' ' 170' ' ' LEU . 9.3 m170 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 19.6 pt -99.87 152.39 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.367 . . . . 0.0 111.081 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.07 141.94 30.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.97 137.12 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -101.6 115.79 31.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 35.6 mt -85.74 106.05 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 229' ' ' CYS . 2.4 tmmm? -98.77 134.23 41.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.66 165.55 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.57 -6.98 28.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -87.05 13.34 9.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.67 35.91 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -128.66 156.57 43.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -129.62 149.9 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -130.54 132.42 45.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.77 118.95 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 192' ' ' TYR . . . -143.27 120.35 11.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.6 p -88.36 121.85 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.25 158.16 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -111.45 152.6 44.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.11 3.82 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.701 2.267 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 14.2 pm0 -113.32 -23.94 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.82 179.66 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.2 p -119.75 158.65 26.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.57 -43.42 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.77 96.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -69.68 -31.72 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 111.122 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.91 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 193' ' ' PHE . 7.4 mtpp -70.02 -38.6 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.9 t -72.28 -29.89 64.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.492 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.86 -47.09 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 177' ' ' ALA . 65.1 m-85 -94.72 -21.26 18.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 189' ' ' LYS . 5.1 m-85 -135.02 74.55 62.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 125.06 11.7 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.42 3.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' SER . 27.6 mt-30 -86.59 -15.69 39.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -42.61 -23.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLN . 75.1 p -59.38 -52.54 65.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -88.89 -36.41 15.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -62.15 100.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -107.93 121.62 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.413 ' HG ' ' NZ ' ' A' ' 189' ' ' LYS . 23.9 mt -94.01 136.98 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.2 122.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.6 t80 -113.48 119.98 39.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.545 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 4.9 mm100 55.45 44.2 27.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.24 2.45 59.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 32.3 ttm-85 -102.27 137.69 40.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.838 0.351 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.88 120.54 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 209' ' ' LEU . 5.4 mt -75.98 53.87 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -53.34 -73.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -46.23 104.59 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 1.74 4.15 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.707 2.272 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.08 20.81 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -90.42 107.16 18.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 p -52.39 141.49 19.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -62.01 -31.96 72.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 p -65.34 -43.11 91.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.8 t -67.65 -34.71 77.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.92 5.0 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 63.27 37.0 11.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.56 95.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.0 p -96.75 -174.98 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.19 142.43 52.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 73.72 24.98 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.54 140.02 30.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -105.16 133.37 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.8 mt -116.35 122.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -72.49 139.43 47.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' LYS . 60.6 m -116.3 145.25 43.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.4 m170 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.938 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.4 pt -95.19 144.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 111.183 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.508 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 2.5 m-20 -93.47 139.48 30.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.9 t -129.41 134.63 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.55 118.72 36.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 177' ' ' ALA . 28.3 mt -85.12 107.07 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -98.72 128.26 44.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.0 m-85 -107.24 161.49 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.29 -5.01 12.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -82.38 7.28 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.9 t0 70.86 31.23 2.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -129.64 170.57 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.85 155.71 46.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -136.39 137.68 40.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 14.9 tp -75.48 120.62 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.98 115.55 8.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.44 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 90.4 t -87.73 122.12 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.448 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -125.05 158.12 34.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -108.9 153.4 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 0.42 5.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.47 -33.17 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.63 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.6 p -124.43 157.39 35.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.53 -41.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.32 93.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.4 m -71.61 -40.15 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.42 -47.09 76.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' PHE . 31.3 mttt -58.66 -48.06 82.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.4 p -70.71 -28.11 64.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.514 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.2 tmmm? -65.44 -47.73 75.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.514 ' CZ ' ' HE3' ' A' ' 191' ' ' LYS . 73.0 m-85 -99.8 -44.46 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.2 m-85 -113.32 79.23 3.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 110.843 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 126.03 12.87 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 2.25 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.403 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.57 -20.94 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -87.59 -13.5 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 5.4 mp0 -46.0 -22.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.9 m -60.89 -52.08 66.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -92.43 -38.51 11.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.27 89.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -96.65 133.86 40.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.28 137.15 40.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 230' ' ' HIS . 19.8 mt -129.22 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.454 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 67.3 t80 -114.08 113.93 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.454 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 22.0 mt-30 62.45 44.62 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.01 0.31 50.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -102.23 133.13 47.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.7 tp -80.52 126.15 30.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.86 48.19 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -47.81 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.31 105.24 0.47 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.705 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 2.97 3.09 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.628 2.219 . . . . 0.0 112.366 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.61 -27.64 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.9 mmt-85 -44.87 102.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 48.2 p -54.18 150.65 8.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.67 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.2 p -64.93 -43.55 92.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.0 m -68.59 -35.26 77.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.4 mt -75.76 4.76 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.3 37.87 10.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.6 mt -92.61 102.54 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -106.65 -174.3 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.508 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 20.4 t-20 -69.45 152.15 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.8 m120 64.18 31.99 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.62 143.83 32.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 p -110.95 134.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.8 mt -116.02 126.98 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -78.46 130.89 36.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 98.7 m -103.21 152.21 21.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.548 ' CD2' ' CD1' ' A' ' 203' ' ' ILE . 3.8 m170 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.4 pt -96.36 140.16 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.28 138.78 31.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.466 HG21 ' CB ' ' A' ' 179' ' ' ALA . 9.4 t -128.59 138.04 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -97.59 122.7 40.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 65.0 mt -93.14 104.84 17.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -98.66 130.17 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.5 m-85 -107.6 158.35 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 230' ' ' HIS . 52.1 mt -63.41 -7.87 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.27 19.8 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.67 35.0 24.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.9 t -129.91 175.15 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -144.89 154.69 42.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -136.29 129.01 30.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.31 121.32 21.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.91 138.75 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 p -99.91 121.93 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 165' ' ' VAL . . . -124.28 157.76 34.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.083 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -113.4 152.89 45.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -0.9 7.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -109.59 -38.98 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.69 173.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.8 p -116.78 162.29 17.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 26.1 t -60.16 -42.48 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.181 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.36 -41.91 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 m -66.95 -41.68 86.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.2 tp -57.68 -45.54 85.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.3 mtpt -65.39 -44.61 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.8 t -70.67 -28.03 64.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.565 ' CD ' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.43 -48.74 74.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.607 ' CZ ' ' CB ' ' A' ' 177' ' ' ALA . 14.6 m-85 -100.48 -43.41 6.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.8 m-85 -110.67 80.59 2.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 128.04 15.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.67 -40.36 1.81 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -83.81 31.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.936 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.425 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 5.9 mt-10 -83.04 -20.73 34.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 5.3 t -74.57 -26.1 59.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.82 -41.82 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.64 97.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.447 ' HG2' ' CD1' ' A' ' 208' ' ' LEU . 0.8 OUTLIER -97.89 118.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 5.1 mp -93.75 137.89 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mt -129.0 122.74 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 84.6 t80 -114.81 118.65 34.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.509 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 11.3 mm-40 53.14 32.95 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.968 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.88 82.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -106.12 131.15 53.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.447 ' CD1' ' HG2' ' A' ' 201' ' ' LYS . 9.5 tp -80.95 121.9 26.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.46 ' N ' HD21 ' A' ' 209' ' ' LEU . 4.5 mt -81.56 40.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -47.58 -67.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 0.9 OUTLIER -44.35 104.32 0.38 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.77 2.77 3.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.618 2.212 . . . . 0.0 112.378 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.6 -10.22 14.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -61.22 117.13 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.5 p -67.08 141.14 57.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.12 -33.98 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -64.02 -44.85 91.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 m -65.3 -33.1 75.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.3 mt -77.78 3.46 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 30.7 t30 65.95 28.44 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.93 104.84 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.2 p -105.7 -174.76 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.41 150.04 43.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t30 69.27 26.32 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -102.32 140.47 36.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 p -105.45 140.37 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.6 mt -121.54 129.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -83.07 126.47 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 55.8 m -112.06 127.58 55.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.472 ' CE1' HD11 ' A' ' 170' ' ' LEU . 4.1 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 9.8 pt -108.5 143.18 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 165' ' ' VAL . 9.6 m120 -86.68 141.77 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.406 HG23 ' C ' ' A' ' 164' ' ' ASN . 20.8 t -134.39 137.39 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -101.97 110.68 22.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.28 108.69 17.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 0.7 OUTLIER -98.78 131.6 44.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -107.62 166.04 10.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.65 -2.47 11.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.53 14.35 13.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t0 64.37 28.14 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.431 ' C ' ' OE2' ' A' ' 174' ' ' GLU . 9.0 t -117.11 174.76 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 173' ' ' THR . 5.2 mp0 -147.98 147.78 30.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -138.29 128.99 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 177' ' ' ALA . 2.1 tm? -77.01 131.1 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 132.01 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.446 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 96.9 t -82.23 121.76 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -129.84 158.18 40.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.404 ' O ' ' CD1' ' A' ' 216' ' ' LEU . 27.9 mtm180 -117.11 152.47 48.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 0.0 110.847 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.79 9.04 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -108.5 -33.71 6.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.4 168.61 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 p -110.38 161.35 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.097 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.56 -44.11 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.82 78.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -72.1 -43.7 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.3 -47.35 75.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 9.3 mtpp -60.48 -46.99 88.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.42 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 27.7 t -70.56 -27.75 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.84 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.516 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.4 tmmm? -66.02 -47.62 73.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 177' ' ' ALA . 63.3 m-85 -99.59 -44.46 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 7.9 m-85 -111.91 81.97 3.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 130.41 19.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.238 . . . . 0.0 112.343 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.74 -44.31 1.75 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -63.22 -6.87 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.944 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.3 mt-10 -49.6 -18.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 48.0 t -68.9 -46.54 68.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 201' ' ' LYS . 40.1 mt-30 -92.51 -46.11 7.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.71 85.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' GLN . 6.0 mtmp? -95.64 123.14 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 9.1 mt -93.32 138.36 31.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.439 HD13 ' CD2' ' A' ' 230' ' ' HIS . 29.0 mt -129.46 122.68 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.563 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 82.6 t80 -115.78 121.65 43.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 14.0 mm-40 55.87 47.52 19.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.58 57.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.433 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 16.4 ttm105 -111.05 134.19 52.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.455 HD23 ' CG ' ' A' ' 210' ' ' GLN . 24.9 tp -81.36 124.67 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 209' ' ' LEU . 6.9 mt -78.33 45.35 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.455 ' CG ' HD23 ' A' ' 208' ' ' LEU . 61.6 mt-30 -47.15 -73.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -49.07 105.98 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.643 0.735 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 1.3 4.57 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.86 31.9 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -104.64 101.63 11.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 40.5 p -48.83 141.73 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.3 mt -60.48 -36.09 77.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.8 t -60.47 -41.24 93.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.7 t -70.7 -30.44 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . 0.493 ' O ' ' CE2' ' A' ' 204' ' ' TYR . 36.5 mt -81.42 5.02 18.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 62.03 32.46 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.15 92.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.4 p -103.23 160.71 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -47.96 149.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 9.2 t30 72.49 32.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.3 t -113.69 145.26 41.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 p -110.35 130.78 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 10.0 mt -111.55 125.8 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -80.93 133.82 35.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.42 128.72 56.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.439 ' CD2' HD13 ' A' ' 203' ' ' ILE . 4.1 m-70 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.461 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 16.7 pt -112.84 143.47 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 111.175 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.417 ' C ' HG22 ' A' ' 165' ' ' VAL . 15.4 m120 -85.37 143.67 28.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 164' ' ' ASN . 7.1 t -134.12 137.88 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -100.51 108.85 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 mt -85.15 109.69 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -98.82 133.49 43.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.0 m-85 -107.65 166.26 10.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.1 mt -70.92 -11.59 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -85.16 18.08 2.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 63.47 25.01 14.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 4.0 t -113.46 162.46 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -138.32 148.12 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.6 128.76 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.51 125.26 28.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.524 ' HB3' ' CE2' ' A' ' 192' ' ' TYR . . . -138.73 120.86 15.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.99 121.44 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.461 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -129.91 158.66 38.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -107.94 154.05 41.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.845 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.93 2.51 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.02 -25.78 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.534 ' OD2' ' CD1' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -58.25 159.65 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 71.4 p -103.33 151.35 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 88.5 t -57.02 -42.55 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.71 86.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -72.08 -42.9 65.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.115 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.2 tp -55.0 -47.29 74.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 193' ' ' PHE . 30.5 mttt -58.86 -47.87 83.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.42 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 45.2 t -70.73 -27.94 64.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.568 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.3 tmmm? -65.51 -47.63 75.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.568 ' CE1' ' HE3' ' A' ' 191' ' ' LYS . 50.0 m-85 -99.74 -44.47 6.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' LYS . 12.0 m-85 -110.46 82.07 2.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 123.71 10.37 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.09 -36.1 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.93 5.76 4.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 7.9 mt-10 -60.68 -9.58 4.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.5 t -75.89 -45.03 37.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' LYS . 36.1 mm-40 -92.07 -43.87 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.24 88.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 199' ' ' GLN . 39.6 mttp -99.28 121.49 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -93.9 139.06 31.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 230' ' ' HIS . 17.8 mt -129.42 123.07 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.497 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.2 t80 -117.23 113.78 22.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.497 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 29.1 mt-30 62.14 49.68 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.26 1.36 13.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -103.37 134.38 46.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.431 ' CD2' ' HG2' ' A' ' 210' ' ' GLN . 34.1 tp -80.8 124.89 29.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.7 mt -75.87 50.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.431 ' HG2' ' CD2' ' A' ' 208' ' ' LEU . 11.3 mm-40 -54.51 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 44.9 m-20 -44.68 103.91 0.36 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.76 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.36 14.48 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.083 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -82.94 98.09 9.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 p -47.24 139.92 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.534 ' CD1' ' OD2' ' A' ' 183' ' ' ASP . 2.2 mt -57.52 -36.21 71.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.7 t -58.01 -42.58 85.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 t -71.73 -29.19 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.52 5.07 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.13 25.12 15.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.71 96.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.3 p -102.92 -176.72 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.8 OUTLIER -72.72 154.23 40.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 25.7 m-20 63.52 36.2 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 2.0 t -116.51 151.5 35.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.84 136.27 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 mt -115.33 118.29 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.31 136.3 53.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 168' ' ' LYS . 5.8 m -117.24 143.32 46.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.482 ' CD2' HD11 ' A' ' 203' ' ' ILE . 4.4 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 38.4 pt -97.12 140.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -86.68 141.7 28.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.2 t -133.74 137.51 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -98.63 118.58 35.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.426 HD11 ' CB ' ' A' ' 177' ' ' ALA . 51.1 mt -87.76 107.09 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -98.67 128.6 45.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 2.1 m-85 -107.76 158.91 16.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 230' ' ' HIS . 12.3 mt -62.01 -9.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -85.46 23.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 54.3 29.61 11.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 169' ' ' PHE . 9.4 t -121.91 160.15 25.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -134.32 150.96 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -133.3 133.95 43.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp -77.37 117.57 18.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.604 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.75 125.69 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.434 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 93.9 t -91.66 123.68 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.4 158.18 33.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.418 ' HB3' ' CD ' ' A' ' 182' ' ' GLU . 6.5 mpt_? -106.96 152.66 41.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -10.34 28.33 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.727 2.285 . . . . 0.0 112.324 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 180' ' ' ARG . 17.0 pm0 -99.78 -33.49 10.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.95 166.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 32.0 p -107.82 162.33 14.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.82 -43.75 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -57.84 -34.89 72.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.5 m -72.18 -43.11 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.7 -47.3 77.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.9 mtpp -59.91 -47.1 87.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.444 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.4 t -70.79 -27.95 64.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.563 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.44 -48.09 71.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.604 ' CZ ' ' CB ' ' A' ' 177' ' ' ALA . 80.2 m-85 -97.99 -44.07 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.1 m-85 -111.78 83.22 4.44 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 125.51 12.24 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.685 2.256 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.72 -41.17 1.89 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -66.54 -3.88 7.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.932 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.456 ' HG2' ' CB ' ' A' ' 189' ' ' LYS . 18.2 mt-10 -52.24 -16.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 17.9 m -70.04 -46.5 64.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.63 -47.21 8.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.447 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -50.26 97.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.431 ' HG2' ' CD1' ' A' ' 208' ' ' LEU . 5.4 ttmt -104.63 119.03 38.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.57 135.15 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.38 123.01 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.4 t80 -117.0 120.86 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 86.2 mt-30 54.71 35.24 23.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.76 4.51 90.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -102.55 134.37 46.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.431 ' CD1' ' HG2' ' A' ' 201' ' ' LYS . 11.3 tp -80.06 119.65 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.68 45.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -52.75 -69.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -43.64 103.31 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.65 2.66 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.57 9.05 16.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -79.27 101.48 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.8 p -47.23 135.06 10.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.21 -31.35 65.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.4 t -64.11 -42.2 96.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 66.7 m -69.1 -35.6 76.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 76.2 mt -75.05 4.98 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.44 34.99 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.2 mt -92.08 96.76 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 p -104.14 -177.83 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 224' ' ' ASN . 33.8 t-20 -67.87 153.16 44.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 223' ' ' ASN . 4.4 m120 64.1 46.9 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.65 148.21 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.1 p -110.33 141.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.19 121.06 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -68.11 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 14.4 m -118.25 131.21 56.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.499 ' CG ' HD11 ' A' ' 170' ' ' LEU . 6.1 m170 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -117.96 138.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.099 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.78 143.39 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.91 137.46 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -101.66 113.51 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.419 HD13 ' CB ' ' A' ' 177' ' ' ALA . 31.3 mt -85.18 111.19 19.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.86 131.67 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -106.6 163.01 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 mt -66.29 -9.44 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.71 21.76 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 56.24 44.03 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.5 t -131.98 165.29 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -139.56 144.54 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -131.14 128.92 41.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.96 118.42 16.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' A' ' 167' ' ' LEU . . . -137.07 121.3 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.576 ' N ' ' HH ' ' A' ' 192' ' ' TYR . 92.6 t -83.7 123.39 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.44 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -128.66 158.13 39.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -112.51 154.23 44.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 2.92 3.08 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.354 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -109.25 -38.63 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -48.04 170.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.3 p -110.96 158.32 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.183 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.52 -43.96 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.116 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.6 94.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.7 -32.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.5 tp -64.77 -47.08 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 193' ' ' PHE . 2.6 mtpm? -70.73 -39.84 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.424 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 9.5 t -72.43 -29.4 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.558 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.77 -47.41 59.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.576 ' HH ' ' N ' ' A' ' 178' ' ' VAL . 80.5 m-85 -94.64 -22.47 18.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.6 m-85 -135.05 84.22 37.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.652 0.739 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 123.99 10.63 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.58 -42.31 1.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -9.68 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.424 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.0 mt-10 -49.29 -18.64 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -67.75 -48.29 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 230' ' ' HIS . 26.2 mt-30 -92.62 -45.13 8.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.887 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -57.04 90.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -101.14 120.73 40.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.469 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 28.1 mt -93.26 135.22 34.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.9 mt -129.02 122.88 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.091 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 73.4 t80 -112.9 111.32 21.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 53.4 mt-30 64.15 50.14 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.7 3.19 26.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -105.72 131.75 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 32.2 tp -80.8 126.9 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.408 ' N ' HD22 ' A' ' 209' ' ' LEU . 6.7 mt -78.08 46.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -48.36 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.33 103.06 0.3 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 2.55 3.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.721 2.28 . . . . 0.0 112.334 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.59 -27.94 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 214' ' ' ARG . 8.2 mmp_? -49.03 114.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.1 p -63.06 149.33 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.42 -31.81 71.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -65.38 -45.22 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 m -63.2 -33.45 75.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.6 mt -79.99 3.81 18.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.65 33.89 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.7 mt -86.55 92.1 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.7 p -97.08 -176.01 3.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 224' ' ' ASN . 1.7 t30 -70.91 150.71 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.43 ' HB2' ' ND2' ' A' ' 223' ' ' ASN . 10.9 t-20 69.64 32.89 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.4 t -110.7 143.99 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.1 132.25 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 23.9 mt -111.04 125.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -79.76 132.57 36.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -113.13 127.64 56.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 199' ' ' GLN . 3.8 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 14.8 pt -107.85 141.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.04 143.14 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.429 HG22 ' CB ' ' A' ' 179' ' ' ALA . 24.5 t -131.57 134.1 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -100.82 115.35 30.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.421 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 37.4 mt -85.18 105.06 15.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -98.56 127.35 44.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.2 m-85 -106.53 163.46 12.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.42 -10.38 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 51.8 t30 -84.86 30.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 2.1 p30 49.85 25.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 169' ' ' PHE . 6.9 t -118.51 161.11 20.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -141.09 149.15 41.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -132.42 128.73 38.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.66 125.1 27.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.82 128.29 20.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.453 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 11.2 p -90.5 122.14 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.454 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -125.61 158.0 35.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.47 ' CZ ' ' OD2' ' A' ' 183' ' ' ASP . 11.9 mtm105 -112.84 154.52 44.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.641 0.734 . . . . 0.0 110.809 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -4.94 15.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.75 -41.17 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.47 ' OD2' ' CZ ' ' A' ' 180' ' ' ARG . 1.4 m-20 -50.34 160.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.7 p -103.3 156.33 17.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.73 -41.65 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.165 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.05 93.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -69.02 -42.98 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.341 . . . . 0.0 111.18 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.32 -47.22 75.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.3 mtpt -57.79 -49.13 77.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 t -70.5 -28.06 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.515 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.78 -47.67 77.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.515 ' CZ ' ' HE3' ' A' ' 191' ' ' LYS . 83.2 m-85 -100.25 -44.46 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' LYS . 11.9 m-85 -107.77 80.96 1.06 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 123.63 10.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.48 ' CA ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.2 -30.83 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.487 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -82.96 19.74 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.743 0.306 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.48 ' OE1' ' CA ' ' A' ' 195' ' ' GLY . 28.3 mp0 -74.1 2.47 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 91.1 p -86.34 -48.48 8.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 201' ' ' LYS . 2.8 pt20 -89.52 -34.0 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.461 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -55.29 85.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.453 ' HE2' ' CD2' ' A' ' 208' ' ' LEU . 10.2 tttt -97.78 113.18 24.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 1.0 OUTLIER -95.12 137.66 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.1 mt -129.31 122.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 57.74 50.56 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.08 3.0 9.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -104.03 132.44 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.475 ' CD2' ' HG2' ' A' ' 210' ' ' GLN . 14.9 tp -79.76 128.84 33.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 209' ' ' LEU . 3.3 mt -84.72 35.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.475 ' HG2' ' CD2' ' A' ' 208' ' ' LEU . 7.6 mm100 -39.68 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -40.14 101.23 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.826 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 3.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.89 21.45 12.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -92.6 107.57 19.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 p -48.97 135.12 16.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.151 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.33 -31.71 65.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 92.7 p -63.17 -46.0 89.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.5 t -65.1 -33.66 76.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 26.6 mt -77.47 4.92 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 65.12 27.31 12.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.9 mt -83.55 104.2 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 56.1 p -108.73 -177.26 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.51 151.99 36.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.1 t30 74.01 25.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.81 162.77 13.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -123.62 133.6 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.7 mt -112.43 119.59 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -72.22 126.15 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.43 127.03 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 20.5 pt -111.61 141.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.06 139.51 30.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.93 132.16 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -94.27 112.07 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' A' ' 177' ' ' ALA . 77.7 mt -85.32 104.57 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 2.4 tmmm? -98.57 134.73 41.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.429 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 44.3 m-85 -107.6 165.14 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.0 mt -67.42 -12.3 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.59 18.76 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.52 27.06 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 174' ' ' GLU . 5.0 t -115.55 160.51 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.45 ' N ' ' HG1' ' A' ' 173' ' ' THR . 37.9 mt-10 -130.7 150.59 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.79 129.09 34.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.77 119.56 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.571 ' HB2' ' CE1' ' A' ' 192' ' ' TYR . . . -141.54 119.66 12.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.445 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 84.7 t -89.59 121.74 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -123.98 158.12 32.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -110.94 154.84 43.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 217' ' ' SER . 53.7 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.363 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 183' ' ' ASP . 14.8 pt-20 -111.24 -41.36 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -44.96 170.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 77.7 p -113.85 160.18 19.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.36 -44.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.09 -42.2 96.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -70.25 -31.18 68.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.45 -47.35 76.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 193' ' ' PHE . 11.5 mtpt -67.3 -39.15 85.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 21.4 t -72.33 -31.92 66.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.559 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -70.71 -47.83 57.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 177' ' ' ALA . 90.5 m-85 -91.23 -25.27 19.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 189' ' ' LYS . 23.5 m-85 -135.01 85.75 33.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.359 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 -39.15 2.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -65.57 -4.98 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.426 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 19.1 mt-10 -49.89 -18.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 11.4 m -63.03 -53.72 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 201' ' ' LYS . 11.0 mm-40 -86.91 -45.72 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.442 ' HG2' ' CG ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -49.26 87.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 199' ' ' GLN . 1.8 ttmp? -103.94 116.56 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.47 ' CD1' ' HG2' ' A' ' 189' ' ' LYS . 6.6 mp -93.48 137.51 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mt -129.29 122.45 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 70.9 t80 -114.98 113.8 24.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.545 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.3 mt-30 60.17 42.13 15.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.05 5.56 62.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -105.11 134.09 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.365 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 7.7 tp -79.8 130.39 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.461 ' N ' HD21 ' A' ' 209' ' ' LEU . 5.5 mt -84.04 26.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 209' ' ' LEU . 19.4 mt-30 -34.69 -73.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' GLN . 7.7 m-20 -37.05 99.36 0.18 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.46 -15.98 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -57.26 118.16 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 p -67.89 142.29 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -59.57 -31.54 69.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 181' ' ' PRO . 5.6 t -62.04 -47.05 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.3 t -67.49 -31.63 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.91 4.54 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.82 40.61 15.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.6 mt -96.41 98.4 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -102.01 179.18 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -68.5 150.52 47.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.74 34.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.88 143.41 45.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.06 136.98 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 14.5 mt -117.83 120.49 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -72.11 128.8 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.82 132.5 56.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.4 pt -108.25 138.34 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.55 138.41 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 179' ' ' ALA . 9.5 t -127.72 133.51 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -96.43 116.83 29.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.531 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 51.8 mt -85.07 106.99 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 226' ' ' VAL . 3.1 tmtm? -98.6 128.55 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.78 158.98 16.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.18 -7.56 6.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 25.9 t30 -83.52 17.99 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 60.15 27.41 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.9 t -121.17 172.71 7.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -143.58 152.39 41.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -133.85 135.23 43.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.93 119.6 20.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.535 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -143.27 120.0 11.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.45 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 94.1 t -89.52 121.93 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -120.68 158.16 28.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -110.48 153.44 43.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.4 23.51 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -98.81 -39.9 8.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.19 165.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.6 p -108.36 162.35 14.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.77 -41.12 91.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.98 -36.58 93.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -70.71 -41.33 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.152 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.2 -47.26 75.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 193' ' ' PHE . 23.1 mttp -58.29 -48.41 80.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -70.7 -27.89 64.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.573 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.06 -47.75 73.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.903 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' TYR . . . . . 0.573 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 83.1 m-85 -99.16 -44.55 6.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 189' ' ' LYS . 10.8 m-85 -112.88 76.06 2.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 196' ' ' GLN . 53.6 Cg_endo -69.77 128.07 15.49 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.58 -21.24 3.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 194' ' ' PRO . 71.4 mm-40 -92.04 -5.21 53.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.938 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 13.2 mp0 -51.26 -18.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.3 m -62.87 -58.19 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -86.36 -36.56 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -59.94 90.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -103.54 125.05 49.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 5.6 mp -100.53 139.94 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.416 HG21 ' C ' ' A' ' 207' ' ' ARG . 19.4 mt -129.17 123.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 77.4 t80 -111.42 114.39 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.429 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 35.9 mt-30 62.2 48.52 4.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.8 2.43 29.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ARG . . . . . 0.416 ' C ' HG21 ' A' ' 203' ' ' ILE . 9.1 ttt180 -105.55 134.83 48.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 210' ' ' GLN . 37.3 tp -82.07 125.92 31.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 209' ' ' LEU . 5.8 mt -76.56 47.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.464 ' CG ' HD22 ' A' ' 208' ' ' LEU . 21.0 mt-30 -50.13 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 12.3 m-20 -41.36 101.9 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.6 0.715 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.0 Cg_endo -69.75 -0.49 6.99 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 0.0 112.353 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.03 -24.45 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.5 mmt-85 -51.7 115.24 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 9.4 p -63.52 151.06 42.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.175 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.37 -34.61 78.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.1 t -63.97 -46.65 83.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.4 m -62.72 -35.71 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.9 mt -76.81 4.54 9.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 m120 62.94 39.08 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.416 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 45.2 mt -92.68 89.0 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 62.6 p -95.15 170.23 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.77 157.65 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.89 38.89 8.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 144.52 48.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.5 p -109.63 141.3 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 28.4 mt -119.21 127.29 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -77.4 131.33 37.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 54.6 m -113.17 138.81 49.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -134.48 158.62 43.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 110.878 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.9 p -172.57 151.32 2.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.24 77.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.7 m -102.33 99.04 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.3 t -134.26 143.28 47.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.59 17.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 17.0 pt -104.91 143.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -92.68 138.64 31.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.0 t -128.31 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -99.97 118.44 36.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.475 HD11 ' CZ ' ' A' ' 193' ' ' PHE . 42.3 mt -87.02 112.0 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -99.31 130.3 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.8 m-85 -107.72 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.1 mt -59.6 -10.76 3.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.51 15.51 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 62.87 31.63 16.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -123.59 174.31 7.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -142.77 157.39 44.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.07 132.29 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.9 tp -75.74 118.48 18.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.518 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.67 125.62 17.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.93 121.83 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.187 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -123.06 157.59 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -112.11 153.17 44.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.85 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.54 -29.77 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -54.91 172.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.0 p -116.59 158.08 24.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.118 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.88 -43.72 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.01 -41.64 94.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.22 -45.56 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.0 tp -55.48 -47.12 76.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 193' ' ' PHE . 24.9 mtpt -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -70.74 -28.1 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.58 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.98 -47.82 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.58 ' CZ ' ' CE ' ' A' ' 191' ' ' LYS . 51.6 m-85 -99.93 -44.42 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.9 m-85 -109.71 79.52 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.5 28.12 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.46 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 74.74 -45.25 1.58 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.46 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -82.47 39.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 38.5 mp0 -85.53 -28.98 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 15.9 m -72.19 -13.59 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -110.83 -47.69 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.04 85.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.458 ' NZ ' ' CD2' ' A' ' 208' ' ' LEU . 11.7 mmtp -89.81 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.26 141.25 37.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.561 HD12 ' CD2' ' A' ' 230' ' ' HIS . 54.7 mt -129.16 122.82 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -119.93 112.39 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 62.24 44.05 7.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.15 1.0 55.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -101.97 140.3 36.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.458 ' CD2' ' NZ ' ' A' ' 201' ' ' LYS . 15.0 tp -86.21 125.3 33.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 210' ' ' GLN . 6.4 mt -83.25 20.79 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -34.62 -53.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.456 ' HB3' ' CG ' ' A' ' 214' ' ' ARG . 12.6 t0 -48.49 105.73 0.53 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.714 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -4.04 13.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.691 2.26 . . . . 0.0 112.384 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.13 -28.73 10.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.456 ' CG ' ' HB3' ' A' ' 211' ' ' ASP . 15.5 mmt180 -46.21 109.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.59 148.87 44.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.553 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -63.03 -31.5 72.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 t -64.59 -44.26 91.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 52.4 m -66.46 -35.99 81.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.86 1.97 13.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 10.6 m120 67.05 25.04 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 32.8 mt -77.97 103.65 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.2 p -103.52 -177.85 3.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 224' ' ' ASN . 1.0 OUTLIER -72.29 170.95 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 223' ' ' ASN . 4.4 p-10 47.71 30.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.9 t -107.97 159.57 16.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.0 p -119.2 138.72 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.8 mt -119.1 119.59 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -70.53 133.37 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 91.7 m -107.96 148.35 29.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.561 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.3 m-70 -129.54 138.41 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 231' ' ' ARG . 21.3 ttm105 -113.21 126.7 55.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 154.44 40.3 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.682 0.754 . . . . 0.0 110.873 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 148.92 66.13 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.754 2.302 . . . . 0.0 112.318 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 99.83 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.341 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -97.91 31.89 7.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.12 148.99 43.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -119.16 37.22 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.01 140.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.3 t -151.63 127.35 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.831 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -169.98 146.08 9.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.22 8.39 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.329 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.9 m -62.15 126.74 28.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -102.08 142.27 33.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 61.4 p -117.28 102.59 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.9 p -147.03 134.05 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 106.02 85.49 1.82 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 165.5 30.69 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.364 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.5 m -151.54 113.23 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 55.4 m -127.74 110.54 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.53 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.6 m -82.47 141.22 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.813 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.8 m -122.27 101.67 7.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.856 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 44.56 88.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.2 m -102.06 101.31 11.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.824 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 t -110.82 90.88 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.24 -170.34 43.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.463 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 21.0 pt -110.33 138.84 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.34 137.13 32.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.459 HG23 ' CB ' ' A' ' 179' ' ' ALA . 13.3 t -126.63 133.28 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -95.91 115.55 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.489 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 40.6 mt -86.48 106.55 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -98.78 133.96 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.853 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 6.0 m-85 -107.61 164.57 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.95 -11.79 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 32.9 t30 -85.36 16.32 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 62.41 30.17 17.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.416 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 7.6 t -113.2 169.96 8.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -142.82 149.21 38.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -135.65 137.32 41.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.21 118.77 20.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.509 ' HB3' ' CE2' ' A' ' 192' ' ' TYR . . . -142.77 113.9 7.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.1 t -83.9 121.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.459 ' CB ' HG23 ' A' ' 165' ' ' VAL . . . -122.04 158.09 29.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -109.25 151.09 41.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.622 0.725 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -1.67 8.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.298 . . . . 0.0 112.319 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 17.1 pm0 -112.67 -17.07 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.89 -177.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.9 p -127.14 149.48 49.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 88.4 t -57.22 -39.57 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -63.19 -42.01 99.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.37 -44.79 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.57 -47.04 77.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.4 mtpt -58.38 -48.38 80.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 t -70.78 -27.99 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.579 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.7 tmmm? -65.05 -47.8 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.579 ' CZ ' ' CE ' ' A' ' 191' ' ' LYS . 51.4 m-85 -99.82 -44.29 6.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' LYS . 16.4 m-85 -108.64 75.99 0.65 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.641 0.734 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.68 28.5 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 0.0 112.33 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.456 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.51 -41.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -90.67 42.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 27.8 mp0 -88.11 -32.5 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.5 t -67.43 -24.91 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -98.57 -38.18 9.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -71.41 85.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -91.02 134.79 34.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.469 HD11 ' N ' ' A' ' 202' ' ' LEU . 7.4 mp -109.55 141.65 41.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.14 122.89 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.469 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.5 t80 -115.42 113.0 23.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.469 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 68.3 mt-30 62.99 44.08 6.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.53 -0.27 43.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -102.68 131.29 49.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 33.5 tp -79.98 127.6 32.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 209' ' ' LEU . 4.4 mt -80.5 46.02 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -44.2 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -45.08 104.09 0.37 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.584 0.707 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 0.0 112.312 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.93 -17.73 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -54.3 117.98 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.1 p -65.71 147.01 54.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.49 -32.14 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 p -64.98 -46.9 79.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 p -61.59 -35.95 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.82 5.0 10.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.421 ' N ' HD21 ' A' ' 220' ' ' ASN . 1.8 m-80 62.2 34.22 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.419 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 58.5 mt -87.29 93.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -98.21 -178.31 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.8 52.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.9 t30 73.59 37.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . 0.446 ' HG ' ' N ' ' A' ' 226' ' ' VAL . 1.1 t -119.0 145.86 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.446 ' N ' ' HG ' ' A' ' 225' ' ' CYS . 5.6 p -110.54 141.36 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.429 HG22 ' CD2' ' A' ' 202' ' ' LEU . 23.0 mt -119.92 120.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -70.89 134.24 47.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 84.2 m -111.36 141.58 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -121.77 130.84 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -107.02 119.92 40.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.0 t -96.89 144.5 27.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.682 0.753 . . . . 0.0 110.831 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.54 63.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.726 2.284 . . . . 0.0 112.351 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 154.35 67.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.629 2.22 . . . . 0.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -112.96 -35.99 1.58 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.87 173.41 11.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 238' ' ' VAL . . . -115.15 127.87 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 237' ' ' ALA . 14.5 m 35.93 54.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 t -126.34 138.9 53.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 127.56 145.21 6.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 129.38 17.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.324 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.1 m -143.83 123.38 13.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -154.81 131.04 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.7 t -145.5 108.63 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.1 t -155.23 148.77 25.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.53 83.41 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 166.58 27.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 2.242 . . . . 0.0 112.349 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.0 t 68.43 35.64 3.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.6 m -117.92 -47.47 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.9 p -86.46 107.66 18.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.3 p -85.74 135.1 33.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.822 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -76.55 -125.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.6 m -145.34 163.19 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.4 p -55.41 154.69 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.97 -178.95 38.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.0 pt -101.29 143.99 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.61 136.26 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.49 136.62 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -99.79 123.09 43.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 36.5 mt -91.49 107.4 19.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.72 133.29 43.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 6.0 m-85 -107.13 164.47 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.22 -7.68 14.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -84.89 9.47 14.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.39 26.39 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -119.14 160.0 22.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.183 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.01 154.2 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -133.98 128.97 35.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.0 tp -73.43 118.62 16.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.73 132.37 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.8 p -93.45 121.9 44.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.417 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.61 157.25 35.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 -110.4 154.97 42.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -12.09 32.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.319 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.66 -36.62 10.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -47.38 168.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 24.0 p -110.76 159.57 17.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.434 ' CG2' ' CD1' ' A' ' 219' ' ' LEU . 68.6 t -61.5 -35.78 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.9 -40.85 89.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -68.36 -38.49 81.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 111.123 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -55.59 -46.6 77.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 193' ' ' PHE . 6.2 mtpp -65.11 -42.05 94.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.8 t -71.02 -28.17 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.565 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.09 -48.14 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.565 ' CE1' ' HD2' ' A' ' 191' ' ' LYS . 7.7 m-85 -100.04 -43.65 6.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 189' ' ' LYS . 24.3 m-85 -107.47 80.74 0.95 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.665 0.745 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 127.07 14.07 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.321 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.454 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.1 -41.96 1.83 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.55 39.43 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 37.8 mp0 -85.22 -36.55 20.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.3 t -64.06 -22.96 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.29 -34.61 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -79.35 85.24 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -88.24 134.45 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.469 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 13.5 mt -104.11 141.27 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.13 122.78 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 62.0 t80 -117.32 122.43 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.551 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.2 mm-40 53.46 48.61 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.15 33.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.55 142.15 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.439 HD23 ' CG ' ' A' ' 210' ' ' GLN . 35.1 tp -87.68 121.94 30.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -75.75 50.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.439 ' CG ' HD23 ' A' ' 208' ' ' LEU . 73.6 mt-30 -53.1 -71.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 16.5 t0 -42.23 102.57 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.846 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.5 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.11 -33.15 7.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -39.98 114.27 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.9 p -61.5 143.37 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -57.56 -31.84 66.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.6 p -64.74 -46.93 80.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.8 t -65.05 -32.32 73.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.434 ' CD1' ' CG2' ' A' ' 185' ' ' VAL . 48.5 mt -77.14 4.97 9.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.88 30.36 16.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.53 95.84 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.7 p -99.75 -175.13 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -74.79 159.79 31.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 62.27 28.88 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.85 157.1 20.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.68 133.68 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 35.2 mt -112.6 116.03 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.93 139.38 57.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.59 144.04 44.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -131.7 128.38 38.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -102.5 125.46 49.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.2 m -97.69 154.33 37.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 0.0 110.832 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 142.48 48.12 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 143.54 51.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.252 . . . . 0.0 112.37 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.89 -52.22 3.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -147.84 155.9 42.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.48 144.35 53.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.071 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.13 123.88 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.2 t -164.24 -179.59 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.85 147.21 4.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.538 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -45.0 1.72 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.661 2.241 . . . . 0.0 112.309 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.9 m 63.7 35.19 11.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -142.76 112.62 6.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 m -131.33 178.8 6.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.6 p -67.71 152.72 45.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.74 148.15 17.5 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 151.8 69.35 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.349 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 m -145.82 174.85 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 75.4 p -110.5 135.62 50.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.461 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.2 t -68.42 -61.38 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.0 t -77.42 108.03 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.63 71.72 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 t -69.91 -52.31 25.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.86 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 26.0 p -53.75 128.4 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.15 154.08 10.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 26.5 pt -93.75 145.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 111.124 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -89.49 129.76 35.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.423 HG21 ' CB ' ' A' ' 179' ' ' ALA . 22.0 t -123.58 138.5 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -103.14 117.68 35.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.837 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 46.1 mt -85.21 108.1 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -99.03 129.5 45.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.2 m-85 -107.65 157.17 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.9 mt -63.55 -7.78 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -83.21 17.09 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 62.18 29.03 17.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 11.5 t -123.79 167.12 14.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -139.65 153.23 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.25 131.0 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.8 tp -77.42 117.92 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.523 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -139.12 135.55 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.9 p -94.8 123.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 165' ' ' VAL . . . -124.08 157.65 34.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -111.46 152.09 43.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.879 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -2.55 10.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.341 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.54 -38.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.14 172.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.6 p -114.45 164.57 13.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 43.2 t -64.72 -40.41 88.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.121 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.89 -42.18 99.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.15 -47.01 82.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 193' ' ' PHE . 21.1 mtpt -63.66 -44.06 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.418 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 39.7 t -70.87 -28.21 64.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.567 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.12 -48.2 74.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.919 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.567 ' CE1' ' HD2' ' A' ' 191' ' ' LYS . 8.6 m-85 -99.94 -43.91 6.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.66 78.63 2.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 131.7 21.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.46 -42.27 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -71.6 1.91 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 9.7 mt-10 -55.19 -14.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -64.41 -58.28 6.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 201' ' ' LYS . 6.1 pt20 -84.28 -37.2 21.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.45 ' SD ' ' CG ' ' A' ' 199' ' ' GLN . 0.0 OUTLIER -52.6 85.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 199' ' ' GLN . 19.5 mttp -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.464 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 17.4 mt -93.67 137.07 33.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.94 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -129.08 122.89 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.558 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.7 t80 -114.86 119.75 37.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.558 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.4 mm100 54.39 48.45 20.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.73 41.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -102.61 139.08 38.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.41 ' CD2' ' HG3' ' A' ' 210' ' ' GLN . 41.0 tp -87.39 123.17 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.456 ' N ' HD21 ' A' ' 209' ' ' LEU . 5.5 mt -79.09 47.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.41 ' HG3' ' CD2' ' A' ' 208' ' ' LEU . 12.3 mt-30 -50.38 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.79 103.29 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.597 0.713 . . . . 0.0 110.842 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.34 6.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.58 22.52 14.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -94.32 105.09 17.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.9 p -50.64 142.95 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.6 mt -62.26 -32.67 73.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.7 t -64.57 -45.94 84.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.1 m -65.08 -31.32 72.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.64 4.48 18.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.0 34.22 11.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 57.5 mt -90.83 93.56 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 76.2 p -98.76 -176.66 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -69.39 150.64 47.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 72.44 33.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.2 t -113.39 149.88 33.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.12 134.51 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.0 mt -114.47 122.14 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -79.08 135.74 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -115.82 127.55 55.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -100.45 123.15 44.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -108.58 113.28 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -89.15 143.81 31.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 0.0 110.84 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 148.83 65.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 157.71 59.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.727 2.284 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -147.27 37.78 1.13 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.445 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.97 162.47 35.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 238' ' ' VAL . . . -115.12 99.57 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 237' ' ' ALA . 12.5 m 34.49 50.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.3 t -156.29 134.4 11.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -153.47 148.26 18.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.446 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -23.93 30.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 2.1 t 43.45 40.1 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -117.09 145.89 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.077 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t -153.05 174.27 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.3 p -130.94 174.24 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.47 16.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 150.62 68.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 72.7 m -78.77 82.74 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 47.3 p -118.59 84.5 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -85.71 141.81 29.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 t -60.45 115.14 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 77.95 77.08 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.4 m -69.81 170.62 10.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 110.883 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.6 m 50.4 38.23 17.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.52 173.26 22.39 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -97.99 151.53 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -101.12 139.12 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.454 HG22 ' CB ' ' A' ' 179' ' ' ALA . 16.6 t -129.29 132.31 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.8 mtm180 -94.38 117.58 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.528 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 38.6 mt -85.14 107.34 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -98.73 128.61 45.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 5.3 m-85 -107.32 157.26 18.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.08 -9.97 5.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -81.23 14.59 2.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 62.33 34.05 16.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.1 t -130.53 157.43 42.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -128.16 153.5 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -134.32 136.25 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.51 116.69 18.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.65 116.56 10.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.9 t -82.4 121.86 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.079 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.454 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -122.36 158.13 30.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.5 mtm-85 -110.54 152.85 43.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.56 0.695 . . . . 0.0 110.924 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -105.02 -36.82 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -49.59 169.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -111.65 160.1 17.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.1 -44.11 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.59 88.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.53 -43.22 66.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 11.4 tp -55.36 -47.18 76.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.4 mtpt -58.63 -48.24 81.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.7 p -70.76 -27.97 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.581 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -65.19 -47.87 75.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.581 ' CZ ' ' CE ' ' A' ' 191' ' ' LYS . 48.0 m-85 -99.95 -44.31 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.528 ' CZ ' HD12 ' A' ' 167' ' ' LEU . 7.7 m-85 -111.84 77.44 1.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.689 0.757 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 196' ' ' GLN . 53.2 Cg_endo -69.82 128.02 15.38 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.316 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.24 -14.95 4.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 194' ' ' PRO . 17.0 mm100 -94.52 -12.49 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.727 0.299 . . . . 0.0 110.835 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -48.56 -20.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m -61.54 -49.79 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 201' ' ' LYS . 29.3 mt-30 -91.97 -45.24 8.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.434 ' CE ' ' HG3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -52.14 85.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 199' ' ' GLN . 5.9 ttmm -91.55 120.52 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 15.0 mt -93.06 134.89 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.3 mt -129.13 123.46 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.439 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.9 t80 -115.45 116.5 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.1 mt-30 58.13 38.1 26.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.68 7.29 87.27 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -107.05 135.17 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.458 ' CD2' ' HG3' ' A' ' 210' ' ' GLN . 10.1 tp -80.15 127.03 31.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.454 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.4 mt -84.16 26.2 0.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.458 ' HG3' ' CD2' ' A' ' 208' ' ' LEU . 21.1 mt-30 -34.33 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.58 100.12 0.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 0.79 5.09 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.288 . . . . 0.0 112.36 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.88 16.01 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -89.5 112.83 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -57.92 137.19 56.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.7 mt -57.07 -34.7 68.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.3 t -61.37 -44.31 97.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.5 m -67.05 -35.94 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 mt -75.62 4.37 7.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.64 38.86 11.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 52.5 mt -94.04 90.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.7 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.8 157.6 7.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 61.96 37.76 14.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 t -114.46 143.74 44.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.7 p -109.44 134.75 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.426 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 41.5 mt -115.45 129.93 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -83.66 127.36 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 1.8 t -111.14 122.42 47.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -99.83 130.26 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.434 ' HG3' ' CE ' ' A' ' 200' ' ' MET . 16.3 ttm180 -113.01 112.93 24.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 41.4 t -81.95 144.12 50.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.676 0.751 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 145.41 56.84 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 235' ' ' GLY . 53.9 Cg_endo -69.73 102.86 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.381 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -34.51 -59.23 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -141.68 155.24 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.14 90.5 6.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.02 -8.52 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 36.4 m -115.76 166.31 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -101.73 -164.88 27.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -17.46 37.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.8 p -42.84 156.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -126.9 118.5 24.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.086 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.0 t -97.73 137.47 36.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.4 t -170.56 151.15 3.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.8 67.51 0.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 142.1 46.92 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.324 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 249' ' ' SER . 12.1 t -63.95 152.36 40.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 248' ' ' SER . 52.6 p -36.54 147.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -47.55 142.68 4.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.818 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.4 t -89.14 151.26 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -179.14 47.24 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.502 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.7 t -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 p -73.16 167.05 21.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.817 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 138.09 167.05 10.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.507 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 19.2 pt -100.97 144.99 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.16 134.32 34.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.21 135.43 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -100.68 118.19 36.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 mt -85.15 110.73 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -98.77 128.56 45.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.7 m-85 -107.69 158.5 17.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.41 -7.81 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -85.31 23.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 55.81 27.54 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -123.75 164.23 19.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.03 153.95 51.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -132.83 133.41 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.71 124.74 28.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -141.58 142.74 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.19 121.76 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -128.01 158.21 38.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -115.86 154.18 48.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.85 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -4.86 14.85 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.05 -37.93 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.77 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.0 p -115.01 164.29 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.143 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 50.0 t -57.06 -44.02 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.71 -36.62 90.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.36 -39.58 71.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.1 tp -55.52 -47.17 76.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 29.4 mttt -58.99 -47.92 83.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -70.12 -28.05 65.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.906 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.517 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -64.53 -48.14 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 177' ' ' ALA . 4.0 m-85 -100.32 -44.58 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.9 m-85 -111.51 83.13 4.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.17 7.0 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.444 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.74 -26.88 2.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -79.84 -3.88 49.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 2.8 mp0 -52.11 -21.06 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.8 m -60.47 -51.66 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -93.3 -44.09 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.97 95.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -103.77 134.3 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.5 mt -101.06 138.94 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.561 HD11 ' CD2' ' A' ' 230' ' ' HIS . 45.1 mt -129.24 122.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.547 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 68.1 t80 -115.21 125.68 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.547 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 12.4 mm-40 52.72 46.09 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.3 2.23 40.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 5.2 ttp-105 -102.78 144.94 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 25.6 tp -88.28 124.47 33.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.464 ' N ' HD21 ' A' ' 209' ' ' LEU . 5.7 mt -75.71 48.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -51.44 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m-20 -42.31 102.48 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.615 0.722 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.2 Cg_endo -69.82 3.09 3.0 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -118.31 19.42 13.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -86.76 101.16 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 p -48.36 135.42 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -58.97 -37.6 77.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.4 t -59.59 -43.48 93.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -36.04 81.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.67 5.12 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 63.02 32.94 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.411 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 48.4 mt -85.54 89.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.5 p -95.73 179.66 5.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 157.96 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 63.6 39.53 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.2 149.49 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 226' ' ' VAL . 1.7 p -114.85 123.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 30.9 mt -105.99 124.02 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -74.4 130.77 40.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 88.6 m -103.81 149.41 25.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.561 ' CD2' HD11 ' A' ' 203' ' ' ILE . 4.0 m170 -127.24 127.1 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -113.2 112.75 24.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -90.36 143.05 28.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 147.27 62.28 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 0.0 112.359 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 157.51 60.13 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -105.01 -33.88 3.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.45 162.38 35.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.318 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.58 42.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.95 -15.44 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.4 t -56.11 100.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.888 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 84.78 146.92 8.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.493 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -29.81 23.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 23.7 m -140.7 178.86 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -106.97 94.09 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.0 m -64.6 108.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.0 m -96.7 103.31 15.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 165.47 167.98 26.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 151.73 69.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.252 . . . . 0.0 112.382 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 60.0 p -157.51 127.55 6.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 61.0 p -53.45 166.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.5 m -139.79 144.55 37.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.383 . . . . 0.0 110.85 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -134.17 131.54 38.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.879 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.39 162.18 11.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.0 m -165.29 154.75 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 0.0 110.872 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.7 p -97.79 142.96 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.28 164.37 14.31 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.7 pt -95.97 138.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.168 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -87.31 143.62 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.27 138.64 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.5 mtm180 -97.75 116.59 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 58.7 mt -85.18 109.19 18.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' CYS . 1.6 tmtm? -98.95 133.67 42.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.463 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 1.9 m-85 -108.57 162.89 13.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.478 HD12 ' CG ' ' A' ' 230' ' ' HIS . 19.0 mt -61.61 -22.74 65.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 173' ' ' THR . 11.2 p-10 -82.96 34.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 43.19 54.82 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.464 ' HB ' ' ND2' ' A' ' 171' ' ' ASN . 0.8 OUTLIER -128.33 171.59 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.62 147.4 31.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.98 129.48 25.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 tp -77.39 117.82 19.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -140.96 140.31 34.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.05 121.84 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.41 ' CB ' HD13 ' A' ' 188' ' ' LEU . . . -125.01 157.65 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 76.7 mtm-85 -110.83 152.08 43.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 0.22 6.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.59 -43.85 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.63 161.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.0 p -103.28 164.25 11.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.89 -42.39 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.98 98.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -66.17 -38.01 87.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 111.198 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.441 HD12 ' CE2' ' A' ' 192' ' ' TYR . 14.9 tp -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.7 mtpt -66.67 -42.05 87.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -70.83 -28.2 64.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.557 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.02 -48.35 74.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.557 ' CE1' ' HD2' ' A' ' 191' ' ' LYS . 6.7 m-85 -99.98 -44.01 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.0 m-85 -109.98 78.89 1.38 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 131.33 20.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.455 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.79 -41.59 1.72 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.455 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -84.57 35.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.455 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 32.7 mp0 -83.42 -31.4 26.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.5 m -64.7 -19.73 65.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 230' ' ' HIS . 34.5 mt-30 -104.17 -45.02 4.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.77 85.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -88.51 122.21 31.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.95 137.54 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.449 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.3 mt -129.15 122.68 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.561 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 64.0 t80 -116.1 113.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.561 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.9 mt-30 62.93 43.55 6.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.32 4.61 60.72 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -106.83 131.62 53.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.8 tp -79.95 125.27 29.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.0 46.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -45.49 -67.84 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 19.6 t0 -44.61 103.93 0.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 52.9 Cg_endo -69.84 2.55 3.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.659 2.239 . . . . 0.0 112.286 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.92 -30.53 8.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -41.47 123.3 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.3 p -70.29 150.39 46.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -64.45 -35.63 81.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.0 p -63.55 -46.07 87.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -63.72 -34.45 77.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 59.3 mt -77.84 4.49 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 67.0 29.34 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 84.8 mt -87.02 92.05 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.0 p -101.77 -175.73 2.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -70.24 154.46 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 62.45 38.3 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.92 146.29 47.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.2 p -107.32 142.22 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.68 119.56 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -66.18 137.66 57.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 168' ' ' LYS . 83.1 m -120.26 146.72 45.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.478 ' CG ' HD12 ' A' ' 170' ' ' LEU . 4.2 m-70 -127.28 141.57 51.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 231' ' ' ARG . 2.7 tmm_? -112.3 123.78 51.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 72.1 m -92.19 143.37 27.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.655 0.74 . . . . 0.0 110.824 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 146.55 60.54 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 235' ' ' GLY . 53.9 Cg_endo -69.72 98.19 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.702 2.268 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -34.82 -46.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.75 155.25 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.1 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.26 141.47 35.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.05 170.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 52.1 p -127.08 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 75.36 141.63 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 242' ' ' SER . 53.5 Cg_endo -69.77 170.92 15.45 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.737 2.291 . . . . 0.0 112.301 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' PRO . 26.0 p -37.11 137.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.7 151.96 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.2 t -94.49 -47.9 6.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.5 t 56.6 42.59 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.4 73.1 0.26 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 98.41 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.6 t -92.19 153.86 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 2.3 t -161.67 137.25 7.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 85.4 p -95.6 176.62 6.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.898 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.0 m -84.4 132.72 34.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.68 55.6 2.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.0 m -49.79 -48.15 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.877 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.6 t -124.07 103.04 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.83 30.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.4 pt -120.07 138.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.806 0.336 . . . . 0.0 111.144 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -87.96 143.2 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.458 HG23 ' CB ' ' A' ' 179' ' ' ALA . 16.3 t -131.7 137.47 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -100.59 117.55 34.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.408 HD13 ' CB ' ' A' ' 177' ' ' ALA . 37.0 mt -86.67 107.88 18.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -98.88 128.32 45.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.6 m-85 -107.5 160.23 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt -66.71 -6.24 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -84.83 16.37 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 63.0 26.93 15.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.404 HG21 ' CD1' ' A' ' 169' ' ' PHE . 6.1 t -120.84 168.26 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -144.48 149.9 36.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -135.77 129.18 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.27 120.29 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.566 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -137.14 125.96 24.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.451 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 6.2 p -86.57 123.07 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.458 ' CB ' HG23 ' A' ' 165' ' ' VAL . . . -126.31 157.97 37.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -111.96 153.49 44.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -5.61 16.61 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.375 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.76 -38.41 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -51.36 173.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 41.5 p -118.91 164.36 15.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 54.2 t -64.37 -43.99 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.78 83.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -44.59 63.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.167 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.14 -47.12 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 33.6 mtpt -57.98 -48.57 79.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.422 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 94.0 p -70.93 -27.92 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.571 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.66 -47.55 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.571 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 86.4 m-85 -98.7 -44.44 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LYS . 10.3 m-85 -113.65 79.14 4.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 134.31 27.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.04 -44.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -68.77 -1.46 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.738 0.304 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.422 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 13.2 mt-10 -51.56 -20.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.7 t -58.83 -59.29 5.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 201' ' ' LYS . 0.0 OUTLIER -82.92 -42.2 17.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.441 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -45.14 91.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 199' ' ' GLN . 17.8 ttmt -105.29 117.94 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.0 mt -93.72 137.12 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.27 122.9 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -116.14 111.9 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 57.97 51.51 8.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.59 5.87 39.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.73 136.55 43.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.444 ' CD1' ' HG2' ' A' ' 201' ' ' LYS . 12.1 tp -85.32 121.07 27.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.46 44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.959 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.416 ' CG ' HD23 ' A' ' 208' ' ' LEU . 16.8 mt-30 -52.14 -72.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 214' ' ' ARG . 9.2 t70 -42.24 102.5 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.698 . . . . 0.0 110.896 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.02 3.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.51 8.66 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.455 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 8.4 mmm-85 -82.33 105.81 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 17.6 p -51.36 142.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.2 mt -62.09 -31.74 72.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 85.8 p -63.3 -44.35 95.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -35.4 79.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.97 5.0 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.65 26.07 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.6 mt -81.18 93.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.3 p -96.31 -175.58 3.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.5 OUTLIER -74.95 158.18 33.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 56.4 m-20 62.91 29.18 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.9 t -110.22 154.82 22.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 4.9 p -117.11 138.98 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.7 mt -116.15 122.78 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -73.53 134.09 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 60.3 m -120.14 133.9 55.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -111.07 127.3 55.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -113.32 112.95 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.3 t -102.33 143.13 25.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 138.25 37.36 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.317 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 128.16 15.6 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -42.71 -75.4 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.488 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.4 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -40.12 114.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.5 m -40.1 140.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -152.7 119.1 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.36 95.94 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.474 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 80.34 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 88.0 p -160.64 150.26 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -165.43 169.13 15.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 77.8 p -62.2 177.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 35.0 t -53.17 96.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 150.2 146.71 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.452 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -177.42 1.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.731 2.287 . . . . 0.0 112.32 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.9 m -148.73 144.92 27.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 42.9 m -65.02 -49.77 68.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.0 t -50.86 -44.15 59.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.827 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.0 m -64.15 -60.12 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.12 153.7 41.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.5 m -60.09 -50.99 71.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.835 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.4 m -153.73 129.56 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.39 -179.6 9.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.6 pt -95.96 144.81 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.28 134.63 34.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -96.79 117.06 30.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.4 mt -85.67 107.14 17.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -99.06 127.87 45.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.422 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 4.0 m-85 -105.42 161.48 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.537 HD12 ' CD2' ' A' ' 230' ' ' HIS . 5.3 mp -67.47 -7.71 27.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.11 16.23 2.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.8 t70 63.29 30.15 15.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.7 t -125.15 174.91 7.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -148.22 150.14 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -130.23 134.13 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.6 tp -80.87 122.5 27.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.561 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -141.69 141.24 33.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.88 121.91 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.414 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -126.48 157.91 37.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -113.95 154.51 45.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.72 8.95 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.363 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.26 -39.21 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.11 170.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.7 p -112.76 161.99 16.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.9 t -64.24 -40.18 88.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.12 97.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.8 m -67.04 -36.28 81.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.12 -46.69 79.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 17.6 mttp -64.76 -41.79 95.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 74.4 p -70.6 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.567 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.69 -48.69 73.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.567 ' CD1' ' HD3' ' A' ' 191' ' ' LYS . 10.3 m-85 -100.33 -43.58 6.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 20.2 m-85 -110.83 80.47 2.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.18 14.18 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.78 -39.99 1.81 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -84.11 28.68 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -18.72 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.8 t -75.71 -24.15 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.67 -44.3 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.65 86.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.89 121.15 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 202' ' ' LEU . 6.8 mp -96.88 139.13 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.1 mt -129.05 122.97 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 74.4 t80 -114.06 111.78 22.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.525 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 26.5 mt-30 63.31 42.36 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.77 0.77 64.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.04 131.99 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 tp -81.5 122.36 27.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -76.21 53.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.46 -71.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -42.03 102.3 0.27 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.72 . . . . 0.0 110.929 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.74 2.43 3.53 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.385 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.47 14.25 19.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -89.1 101.2 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.1 p -47.8 143.22 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -59.59 -39.99 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.3 p -58.72 -44.77 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -63.92 -34.05 77.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.848 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 78.9 mt -77.91 4.69 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 62.52 36.44 13.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.8 mt -90.88 94.48 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.2 p -100.32 173.75 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.1 153.42 37.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.4 t30 69.37 38.44 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 t -120.55 151.42 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.5 p -115.11 136.29 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 28.9 mt -115.37 130.04 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -83.4 127.08 33.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . 0.416 ' O ' ' CD1' ' A' ' 170' ' ' LEU . 58.0 m -109.02 136.13 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.537 ' CD2' HD12 ' A' ' 170' ' ' LEU . 5.8 m-70 -112.66 131.72 55.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.86 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.412 ' NH1' ' HE3' ' A' ' 200' ' ' MET . 49.6 ttm-85 -110.16 128.67 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.0 t -115.65 139.44 24.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 0.0 110.859 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 126.71 13.65 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.682 2.255 . . . . 0.0 112.404 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 79.96 0.91 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.718 2.279 . . . . 0.0 112.345 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.24 -90.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -174.87 122.75 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.074 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.87 165.34 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.92 144.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.19 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 44.6 t -51.1 115.75 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -171.59 153.31 19.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 163.83 36.8 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.312 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.0 t -124.25 -59.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -148.36 141.22 24.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.073 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 t -95.57 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 29.0 p -107.03 41.65 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.24 -75.94 0.49 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 1.75 4.16 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.312 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.7 t -67.35 109.67 3.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 96.3 p -98.59 152.73 19.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 m -55.11 125.29 19.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.0 p -127.22 146.37 50.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.8 42.04 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 42.0 t -157.41 147.12 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.6 m -59.56 169.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.14 179.15 30.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 223' ' ' ASN . 13.0 pt -108.19 145.38 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.91 138.84 32.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.43 137.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 -98.07 125.23 42.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 40.1 mt -92.53 104.52 16.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.73 133.69 42.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 3.9 m-85 -107.27 166.33 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.428 HD12 ' CE1' ' A' ' 230' ' ' HIS . 14.4 mt -70.6 -14.21 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.498 ' OD1' ' CG2' ' A' ' 173' ' ' THR . 3.0 p30 -78.15 4.12 13.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.2 t70 73.97 47.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.498 ' CG2' ' OD1' ' A' ' 171' ' ' ASN . 1.3 t -135.46 171.82 13.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -142.96 153.94 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.55 130.44 23.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.79 117.82 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.1 123.48 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.57 123.76 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.448 ' HB1' ' CD1' ' A' ' 188' ' ' LEU . . . -127.18 157.67 39.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 73.7 mtm-85 -107.99 153.6 41.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.889 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -1.15 7.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.26 -33.22 6.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -50.18 173.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 2.6 p -117.21 159.09 23.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.96 -40.19 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.58 -37.32 94.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -70.44 -42.5 71.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.168 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.448 ' CD1' ' HB1' ' A' ' 179' ' ' ALA . 13.2 tp -55.34 -47.27 75.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 26.4 mtpt -58.87 -48.11 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.447 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.7 t -70.57 -27.99 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.557 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.5 tmmm? -65.02 -48.06 75.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.602 ' CZ ' ' CB ' ' A' ' 177' ' ' ALA . 54.9 m-85 -100.01 -44.48 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.07 77.23 2.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 134.72 28.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.349 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.08 -42.42 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.29 -9.87 50.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.447 ' OE2' ' CB ' ' A' ' 190' ' ' SER . 13.1 mt-10 -45.51 -22.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.6 t -55.92 -61.24 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -84.19 -42.61 15.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -44.83 113.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -126.3 122.28 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.83 141.21 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.9 mt -129.13 122.81 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.451 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 61.2 t80 -116.33 110.94 19.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.451 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 67.2 mt-30 62.38 53.37 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.92 3.74 11.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -104.88 136.47 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.8 tp -84.42 125.39 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -79.99 54.43 1.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -54.96 -73.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -43.34 103.15 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.88 7.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.3 23.13 13.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -91.94 108.33 19.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.5 p -52.8 138.41 29.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.431 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.8 mt -57.8 -32.22 67.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.4 t -64.75 -42.6 95.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 34.5 t -67.67 -35.41 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.6 mt -76.47 1.77 15.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.2 m120 67.17 28.87 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.5 mt -84.45 96.08 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.5 p -100.46 -175.71 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.458 ' HB3' ' CG2' ' A' ' 163' ' ' ILE . 7.0 p30 -76.04 148.6 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 74.2 27.15 1.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.65 158.87 17.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.67 131.69 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.42 124.14 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.75 138.98 39.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 39.3 m -120.68 138.55 53.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.428 ' CE1' HD12 ' A' ' 170' ' ' LEU . 9.3 m170 -119.68 122.78 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -99.67 113.88 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.6 m -78.68 149.81 75.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.19 62.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.07 34.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -129.39 76.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . 44.79 45.54 8.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.079 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.1 122.38 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.071 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.8 p -133.64 155.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 78.3 p -151.42 138.35 19.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -97.35 -121.42 4.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 107.0 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.711 2.274 . . . . 0.0 112.311 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 8.1 t -101.74 92.08 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 60.71 38.2 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 94.0 p -124.63 142.87 51.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.0 m 44.78 47.44 8.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.53 84.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.72 68.36 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.693 2.262 . . . . 0.0 112.312 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.1 t -126.24 -41.59 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 77.5 p -117.77 42.24 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 t -171.76 137.69 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.824 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.9 p -76.29 164.86 25.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.66 -122.03 28.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.5 m -164.7 164.85 21.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 t -56.05 -62.07 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.815 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.88 20.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 19.6 pt -99.87 152.39 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.367 . . . . 0.0 111.081 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.07 141.94 30.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.97 137.12 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -101.6 115.79 31.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.415 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 35.6 mt -85.74 106.05 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 229' ' ' CYS . 2.4 tmmm? -98.77 134.23 41.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.66 165.55 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.57 -6.98 28.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -87.05 13.34 9.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.67 35.91 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -128.66 156.57 43.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -129.62 149.9 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -130.54 132.42 45.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.77 118.95 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 192' ' ' TYR . . . -143.27 120.35 11.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.6 p -88.36 121.85 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.422 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.25 158.16 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -111.45 152.6 44.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.11 3.82 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.701 2.267 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 14.2 pm0 -113.32 -23.94 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.82 179.66 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.2 p -119.75 158.65 26.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.57 -43.42 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.77 96.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -69.68 -31.72 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 111.122 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.5 tp -66.91 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 193' ' ' PHE . 7.4 mtpp -70.02 -38.6 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.9 t -72.28 -29.89 64.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.492 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.86 -47.09 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 177' ' ' ALA . 65.1 m-85 -94.72 -21.26 18.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.548 ' N ' ' O ' ' A' ' 189' ' ' LYS . 5.1 m-85 -135.02 74.55 62.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 125.06 11.7 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.42 3.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' SER . 27.6 mt-30 -86.59 -15.69 39.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -42.61 -23.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLN . 75.1 p -59.38 -52.54 65.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -88.89 -36.41 15.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -62.15 100.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -107.93 121.62 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.413 ' HG ' ' NZ ' ' A' ' 189' ' ' LYS . 23.9 mt -94.01 136.98 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.2 122.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.6 t80 -113.48 119.98 39.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.545 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 4.9 mm100 55.45 44.2 27.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.24 2.45 59.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 32.3 ttm-85 -102.27 137.69 40.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.838 0.351 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.88 120.54 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 209' ' ' LEU . 5.4 mt -75.98 53.87 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -53.34 -73.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -46.23 104.59 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 1.74 4.15 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.707 2.272 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.08 20.81 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -90.42 107.16 18.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.927 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 p -52.39 141.49 19.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -62.01 -31.96 72.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 p -65.34 -43.11 91.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.8 t -67.65 -34.71 77.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.92 5.0 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 63.27 37.0 11.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.56 95.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.0 p -96.75 -174.98 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.19 142.43 52.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 73.72 24.98 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.54 140.02 30.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -105.16 133.37 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.8 mt -116.35 122.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -72.49 139.43 47.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' LYS . 60.6 m -116.3 145.25 43.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -123.32 123.88 41.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.419 ' HD2' ' C ' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -109.14 120.76 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.843 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.3 t -98.23 148.23 34.22 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.704 0.764 . . . . 0.0 110.866 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 148.55 65.18 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.636 2.224 . . . . 0.0 112.377 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 119.93 6.8 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.634 2.222 . . . . 0.0 112.344 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.53 -42.17 99.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -137.96 119.75 15.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.92 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.18 134.55 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 m -61.61 136.66 58.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -151.3 150.32 22.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -8.9 24.78 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.7 m -68.07 71.43 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 244' ' ' SER . . . -119.41 140.67 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 243' ' ' ALA . 4.3 m -35.21 145.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 26.3 t -122.89 105.18 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.72 82.82 1.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 93.51 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.686 2.258 . . . . 0.0 112.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 t 62.64 38.51 12.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 6.8 t -162.94 143.57 9.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.9 m -110.16 124.49 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -99.26 137.69 37.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.85 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.32 -61.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.1 m -89.4 106.13 18.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.865 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.2 p -97.41 161.63 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.08 173.99 37.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.4 pt -95.19 144.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 111.183 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.508 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 2.5 m-20 -93.47 139.48 30.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.9 t -129.41 134.63 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -99.55 118.72 36.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 177' ' ' ALA . 28.3 mt -85.12 107.07 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -98.72 128.26 44.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.0 m-85 -107.24 161.49 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.29 -5.01 12.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -82.38 7.28 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.9 t0 70.86 31.23 2.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -129.64 170.57 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.85 155.71 46.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -136.39 137.68 40.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 14.9 tp -75.48 120.62 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.51 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.98 115.55 8.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.44 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 90.4 t -87.73 122.12 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.448 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -125.05 158.12 34.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -108.9 153.4 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 0.42 5.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.47 -33.17 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.63 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.6 p -124.43 157.39 35.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 70.8 t -61.53 -41.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.32 93.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.4 m -71.61 -40.15 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.42 -47.09 76.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' PHE . 31.3 mttt -58.66 -48.06 82.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.4 p -70.71 -28.11 64.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.514 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.2 tmmm? -65.44 -47.73 75.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.514 ' CZ ' ' HE3' ' A' ' 191' ' ' LYS . 73.0 m-85 -99.8 -44.46 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.2 m-85 -113.32 79.23 3.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 110.843 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 126.03 12.87 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 2.25 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.403 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.57 -20.94 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -87.59 -13.5 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.403 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 5.4 mp0 -46.0 -22.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.9 m -60.89 -52.08 66.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -92.43 -38.51 11.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.27 89.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -96.65 133.86 40.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.28 137.15 40.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.548 ' CD1' ' CD2' ' A' ' 230' ' ' HIS . 19.8 mt -129.22 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.454 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 67.3 t80 -114.08 113.93 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.454 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 22.0 mt-30 62.45 44.62 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.01 0.31 50.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -102.23 133.13 47.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.7 tp -80.52 126.15 30.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.1 mt -76.86 48.19 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -47.81 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.31 105.24 0.47 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.705 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 2.97 3.09 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.628 2.219 . . . . 0.0 112.366 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.61 -27.64 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.9 mmt-85 -44.87 102.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 48.2 p -54.18 150.65 8.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.67 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.2 p -64.93 -43.55 92.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.0 m -68.59 -35.26 77.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.4 mt -75.76 4.76 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.3 37.87 10.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 50.6 mt -92.61 102.54 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -106.65 -174.3 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.508 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 20.4 t-20 -69.45 152.15 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.8 m120 64.18 31.99 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.62 143.83 32.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.3 p -110.95 134.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.8 mt -116.02 126.98 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -78.46 130.89 36.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 98.7 m -103.21 152.21 21.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.548 ' CD2' ' CD1' ' A' ' 203' ' ' ILE . 3.8 m170 -128.54 124.92 37.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -108.01 123.85 49.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.1 t -108.67 143.66 27.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.682 0.753 . . . . 0.0 110.852 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 147.83 64.06 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.1 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.722 2.282 . . . . 0.0 112.312 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 140.81 48.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -152.01 158.86 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.82 -179.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.47 136.86 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.2 t -142.12 150.8 41.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -178.47 155.22 16.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 167.02 25.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.9 p -76.31 155.29 34.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.76 51.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 66.1 m -155.43 124.8 6.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 246' ' ' GLY . 58.1 m -129.77 139.15 51.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 245' ' ' SER . . . -32.05 95.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.443 ' N ' ' O ' ' A' ' 245' ' ' SER . 53.4 Cg_endo -69.74 119.73 6.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 94.1 p -150.95 135.21 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 36.3 m -40.77 -62.45 0.8 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.869 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 m -86.77 161.97 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.4 t -112.87 98.38 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.78 -153.4 6.96 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.9 t 62.59 42.61 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 110.867 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 m -140.17 152.37 45.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.23 159.24 10.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.4 pt -96.36 140.16 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.28 138.78 31.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.466 HG21 ' CB ' ' A' ' 179' ' ' ALA . 9.4 t -128.59 138.04 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 26.4 mtm-85 -97.59 122.7 40.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 65.0 mt -93.14 104.84 17.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -98.66 130.17 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.5 m-85 -107.6 158.35 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 230' ' ' HIS . 52.1 mt -63.41 -7.87 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.27 19.8 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.67 35.0 24.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.9 t -129.91 175.15 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -144.89 154.69 42.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -136.29 129.01 30.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.31 121.32 21.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.607 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.91 138.75 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.2 p -99.91 121.93 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 165' ' ' VAL . . . -124.28 157.76 34.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.083 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -113.4 152.89 45.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -0.9 7.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -109.59 -38.98 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.69 173.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.8 p -116.78 162.29 17.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 26.1 t -60.16 -42.48 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.181 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.36 -41.91 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 m -66.95 -41.68 86.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.2 tp -57.68 -45.54 85.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.3 mtpt -65.39 -44.61 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.8 t -70.67 -28.03 64.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.565 ' CD ' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.43 -48.74 74.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.607 ' CZ ' ' CB ' ' A' ' 177' ' ' ALA . 14.6 m-85 -100.48 -43.41 6.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.8 m-85 -110.67 80.59 2.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 128.04 15.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.67 -40.36 1.81 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -83.81 31.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.936 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.425 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 5.9 mt-10 -83.04 -20.73 34.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 5.3 t -74.57 -26.1 59.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.82 -41.82 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.64 97.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.447 ' HG2' ' CD1' ' A' ' 208' ' ' LEU . 0.8 OUTLIER -97.89 118.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 5.1 mp -93.75 137.89 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mt -129.0 122.74 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.509 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 84.6 t80 -114.81 118.65 34.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.509 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 11.3 mm-40 53.14 32.95 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.968 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.88 82.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -106.12 131.15 53.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.447 ' CD1' ' HG2' ' A' ' 201' ' ' LYS . 9.5 tp -80.95 121.9 26.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.46 ' N ' HD21 ' A' ' 209' ' ' LEU . 4.5 mt -81.56 40.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -47.58 -67.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 0.9 OUTLIER -44.35 104.32 0.38 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.77 2.77 3.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.618 2.212 . . . . 0.0 112.378 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.6 -10.22 14.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -61.22 117.13 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.5 p -67.08 141.14 57.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.12 -33.98 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -64.02 -44.85 91.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 m -65.3 -33.1 75.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.3 mt -77.78 3.46 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 30.7 t30 65.95 28.44 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.93 104.84 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.2 p -105.7 -174.76 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.41 150.04 43.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t30 69.27 26.32 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -102.32 140.47 36.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.1 p -105.45 140.37 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.6 mt -121.54 129.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -83.07 126.47 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 55.8 m -112.06 127.58 55.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.472 ' CE1' HD11 ' A' ' 170' ' ' LEU . 4.1 m170 -105.91 136.97 44.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -106.15 128.84 54.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.6 143.72 30.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.688 0.756 . . . . 0.0 110.864 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.85 52.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.694 2.263 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 139.03 39.37 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.373 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -89.22 -38.38 6.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -169.15 155.59 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.86 123.18 26.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.5 m -69.47 157.4 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 42.9 p -164.22 156.2 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 168.59 147.58 5.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 150.04 67.95 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.1 t -131.06 143.74 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -157.47 120.15 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 44.9 t -90.89 155.32 18.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 60.1 p -174.15 163.4 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -68.76 173.26 34.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -48.35 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.714 2.276 . . . . 0.0 112.338 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 249' ' ' SER . 7.3 t -66.28 146.85 54.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 248' ' ' SER . 27.7 t -36.92 -46.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.818 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.492 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.3 m -90.87 121.87 33.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.875 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.1 m -48.74 -54.33 15.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.2 128.22 7.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.7 p -135.79 119.97 17.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 110.836 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.6 p -113.11 106.71 14.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.16 -177.32 43.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 9.8 pt -108.5 143.18 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.406 ' C ' HG23 ' A' ' 165' ' ' VAL . 9.6 m120 -86.68 141.77 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.88 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.406 HG23 ' C ' ' A' ' 164' ' ' ASN . 20.8 t -134.39 137.39 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -101.97 110.68 22.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.28 108.69 17.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 0.7 OUTLIER -98.78 131.6 44.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -107.62 166.04 10.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.65 -2.47 11.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.53 14.35 13.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t0 64.37 28.14 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.431 ' C ' ' OE2' ' A' ' 174' ' ' GLU . 9.0 t -117.11 174.76 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 173' ' ' THR . 5.2 mp0 -147.98 147.78 30.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -138.29 128.99 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 177' ' ' ALA . 2.1 tm? -77.01 131.1 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 132.01 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.446 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 96.9 t -82.23 121.76 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -129.84 158.18 40.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.404 ' O ' ' CD1' ' A' ' 216' ' ' LEU . 27.9 mtm180 -117.11 152.47 48.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 0.0 110.847 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.79 9.04 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -108.5 -33.71 6.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.4 168.61 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 p -110.38 161.35 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.097 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.56 -44.11 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.82 78.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -72.1 -43.7 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.3 -47.35 75.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 9.3 mtpp -60.48 -46.99 88.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.42 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 27.7 t -70.56 -27.75 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.84 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.516 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.4 tmmm? -66.02 -47.62 73.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 177' ' ' ALA . 63.3 m-85 -99.59 -44.46 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 7.9 m-85 -111.91 81.97 3.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 130.41 19.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.238 . . . . 0.0 112.343 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.74 -44.31 1.75 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -63.22 -6.87 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.944 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.3 mt-10 -49.6 -18.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 48.0 t -68.9 -46.54 68.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 201' ' ' LYS . 40.1 mt-30 -92.51 -46.11 7.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.71 85.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' GLN . 6.0 mtmp? -95.64 123.14 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 9.1 mt -93.32 138.36 31.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.439 HD13 ' CD2' ' A' ' 230' ' ' HIS . 29.0 mt -129.46 122.68 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.563 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 82.6 t80 -115.78 121.65 43.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 14.0 mm-40 55.87 47.52 19.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.58 57.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.433 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 16.4 ttm105 -111.05 134.19 52.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.455 HD23 ' CG ' ' A' ' 210' ' ' GLN . 24.9 tp -81.36 124.67 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.4 ' N ' HD23 ' A' ' 209' ' ' LEU . 6.9 mt -78.33 45.35 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.455 ' CG ' HD23 ' A' ' 208' ' ' LEU . 61.6 mt-30 -47.15 -73.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -49.07 105.98 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.643 0.735 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 1.3 4.57 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.86 31.9 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -104.64 101.63 11.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 40.5 p -48.83 141.73 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.3 mt -60.48 -36.09 77.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.8 t -60.47 -41.24 93.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.7 t -70.7 -30.44 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . 0.493 ' O ' ' CE2' ' A' ' 204' ' ' TYR . 36.5 mt -81.42 5.02 18.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 62.03 32.46 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 43.1 mt -86.15 92.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.4 p -103.23 160.71 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -47.96 149.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 9.2 t30 72.49 32.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.3 t -113.69 145.26 41.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.8 p -110.35 130.78 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 10.0 mt -111.55 125.8 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -80.93 133.82 35.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.42 128.72 56.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.439 ' CD2' HD13 ' A' ' 203' ' ' ILE . 4.1 m-70 -99.73 127.86 45.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -113.33 124.97 53.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 17.2 t -102.54 145.33 30.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.674 0.749 . . . . 0.0 110.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 154.93 67.27 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 81.76 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -45.14 -44.33 9.58 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -137.93 176.78 8.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -125.36 91.66 3.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.44 164.29 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 70.0 m -59.8 122.31 13.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.825 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.84 -173.37 48.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 137.6 35.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.2 m -145.35 117.88 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -163.62 167.23 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 74.5 m -107.16 84.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.5 p -117.74 81.66 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.55 67.41 0.49 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.82 29.67 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.381 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 m -160.98 162.8 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.9 t -55.38 150.06 12.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.2 p -114.09 -44.67 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.8 t -110.09 156.02 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -88.32 140.84 16.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 m -88.22 39.09 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -131.29 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.55 175.96 14.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.463 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.461 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 16.7 pt -112.84 143.47 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 111.175 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.417 ' C ' HG22 ' A' ' 165' ' ' VAL . 15.4 m120 -85.37 143.67 28.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 164' ' ' ASN . 7.1 t -134.12 137.88 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.2 mtm180 -100.51 108.85 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 mt -85.15 109.69 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -98.82 133.49 43.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.0 m-85 -107.65 166.26 10.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.1 mt -70.92 -11.59 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -85.16 18.08 2.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 63.47 25.01 14.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 4.0 t -113.46 162.46 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -138.32 148.12 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.6 128.76 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.51 125.26 28.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.524 ' HB3' ' CE2' ' A' ' 192' ' ' TYR . . . -138.73 120.86 15.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.9 p -81.99 121.44 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.461 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -129.91 158.66 38.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -107.94 154.05 41.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.845 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 3.93 2.51 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.02 -25.78 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.534 ' OD2' ' CD1' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -58.25 159.65 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 71.4 p -103.33 151.35 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 88.5 t -57.02 -42.55 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.71 86.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -72.08 -42.9 65.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.115 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.2 tp -55.0 -47.29 74.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 193' ' ' PHE . 30.5 mttt -58.86 -47.87 83.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.42 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 45.2 t -70.73 -27.94 64.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.568 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.3 tmmm? -65.51 -47.63 75.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.568 ' CE1' ' HE3' ' A' ' 191' ' ' LYS . 50.0 m-85 -99.74 -44.47 6.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' LYS . 12.0 m-85 -110.46 82.07 2.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 123.71 10.37 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.09 -36.1 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.93 5.76 4.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 7.9 mt-10 -60.68 -9.58 4.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.5 t -75.89 -45.03 37.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' LYS . 36.1 mm-40 -92.07 -43.87 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.24 88.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 199' ' ' GLN . 39.6 mttp -99.28 121.49 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -93.9 139.06 31.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 230' ' ' HIS . 17.8 mt -129.42 123.07 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.497 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.2 t80 -117.23 113.78 22.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.497 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 29.1 mt-30 62.14 49.68 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.26 1.36 13.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -103.37 134.38 46.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.431 ' CD2' ' HG2' ' A' ' 210' ' ' GLN . 34.1 tp -80.8 124.89 29.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.7 mt -75.87 50.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.431 ' HG2' ' CD2' ' A' ' 208' ' ' LEU . 11.3 mm-40 -54.51 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 44.9 m-20 -44.68 103.91 0.36 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.76 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.36 14.48 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.083 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -82.94 98.09 9.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 p -47.24 139.92 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.534 ' CD1' ' OD2' ' A' ' 183' ' ' ASP . 2.2 mt -57.52 -36.21 71.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.7 t -58.01 -42.58 85.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 t -71.73 -29.19 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.52 5.07 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.13 25.12 15.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 28.7 mt -78.71 96.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.3 p -102.92 -176.72 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.8 OUTLIER -72.72 154.23 40.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 25.7 m-20 63.52 36.2 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 2.0 t -116.51 151.5 35.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 2.0 p -111.84 136.27 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 mt -115.33 118.29 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.31 136.3 53.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 168' ' ' LYS . 5.8 m -117.24 143.32 46.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.482 ' CD2' HD11 ' A' ' 203' ' ' ILE . 4.4 m-70 -121.15 122.46 40.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -113.14 119.32 37.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 3.8 t -108.67 140.49 21.87 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 0.0 110.879 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 148.29 64.83 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.665 2.243 . . . . 0.0 112.328 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 156.93 62.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 0.0 112.361 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -74.15 -71.33 1.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -122.0 116.55 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -43.16 113.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 92.9 t -78.6 116.1 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 33.9 t -137.27 135.27 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -156.37 152.41 23.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 129.63 17.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.9 t -151.04 159.06 44.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -139.62 124.95 19.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -90.16 117.2 28.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.7 p -51.13 -57.7 8.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 139.39 83.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 248' ' ' SER . 53.1 Cg_endo -69.82 -32.07 19.01 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 247' ' ' PRO . 9.1 t -37.89 121.0 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 17.6 t -101.3 101.43 12.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.7 p -127.81 154.89 44.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 0.0 110.855 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.0 m -89.96 126.19 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.2 -100.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 m -120.48 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 0.0 110.825 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.5 m -122.48 141.29 51.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.4 159.4 29.39 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 38.4 pt -97.12 140.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -86.68 141.7 28.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.2 t -133.74 137.51 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 mtm180 -98.63 118.58 35.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.426 HD11 ' CB ' ' A' ' 177' ' ' ALA . 51.1 mt -87.76 107.09 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -98.67 128.6 45.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 2.1 m-85 -107.76 158.91 16.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 230' ' ' HIS . 12.3 mt -62.01 -9.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -85.46 23.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 54.3 29.61 11.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 169' ' ' PHE . 9.4 t -121.91 160.15 25.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -134.32 150.96 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -133.3 133.95 43.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp -77.37 117.57 18.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.604 ' CB ' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.75 125.69 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.434 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 93.9 t -91.66 123.68 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.4 158.18 33.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.418 ' HB3' ' CD ' ' A' ' 182' ' ' GLU . 6.5 mpt_? -106.96 152.66 41.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -10.34 28.33 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.727 2.285 . . . . 0.0 112.324 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.418 ' CD ' ' HB3' ' A' ' 180' ' ' ARG . 17.0 pm0 -99.78 -33.49 10.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.95 166.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 32.0 p -107.82 162.33 14.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.82 -43.75 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -57.84 -34.89 72.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.5 m -72.18 -43.11 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.7 -47.3 77.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.9 mtpp -59.91 -47.1 87.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.444 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.4 t -70.79 -27.95 64.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.563 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.44 -48.09 71.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.604 ' CZ ' ' CB ' ' A' ' 177' ' ' ALA . 80.2 m-85 -97.99 -44.07 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.1 m-85 -111.78 83.22 4.44 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 125.51 12.24 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.685 2.256 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.72 -41.17 1.89 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -66.54 -3.88 7.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.932 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.456 ' HG2' ' CB ' ' A' ' 189' ' ' LYS . 18.2 mt-10 -52.24 -16.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 17.9 m -70.04 -46.5 64.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.63 -47.21 8.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.447 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -50.26 97.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.431 ' HG2' ' CD1' ' A' ' 208' ' ' LEU . 5.4 ttmt -104.63 119.03 38.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.3 mt -93.57 135.15 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.38 123.01 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.4 t80 -117.0 120.86 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 86.2 mt-30 54.71 35.24 23.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.76 4.51 90.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -102.55 134.37 46.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.431 ' CD1' ' HG2' ' A' ' 201' ' ' LYS . 11.3 tp -80.06 119.65 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.68 45.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -52.75 -69.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -43.64 103.31 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.65 2.66 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.57 9.05 16.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -79.27 101.48 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.8 p -47.23 135.06 10.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.21 -31.35 65.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.4 t -64.11 -42.2 96.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 66.7 m -69.1 -35.6 76.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 76.2 mt -75.05 4.98 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.44 34.99 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 54.2 mt -92.08 96.76 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 p -104.14 -177.83 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 224' ' ' ASN . 33.8 t-20 -67.87 153.16 44.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 223' ' ' ASN . 4.4 m120 64.1 46.9 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.65 148.21 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 5.1 p -110.33 141.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.19 121.06 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -68.11 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 14.4 m -118.25 131.21 56.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.499 ' CG ' HD11 ' A' ' 170' ' ' LEU . 6.1 m170 -117.66 146.92 43.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -112.85 112.59 24.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -80.61 135.17 53.13 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.649 0.738 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.74 66.05 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.742 2.294 . . . . 0.0 112.362 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 176.56 6.58 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.695 2.264 . . . . 0.0 112.374 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -130.78 -28.57 0.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.3 32.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 111.083 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.75 97.34 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.68 145.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.8 p -110.3 159.36 17.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 77.58 149.58 3.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 152.64 69.57 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.734 2.289 . . . . 0.0 112.319 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 78.2 p -104.92 85.78 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 58.49 44.86 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -106.57 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 59.9 p -92.92 175.03 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.865 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -68.57 146.38 45.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 169.75 18.18 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.2 m -131.08 -44.85 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.8 p -103.96 97.56 7.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.5 m -147.45 146.72 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -129.45 161.0 31.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.92 177.72 1.44 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 96.3 p -78.37 -46.79 19.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.892 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -61.83 152.67 30.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 133.49 -169.57 22.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -117.96 138.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.099 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.78 143.39 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.91 137.46 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -101.66 113.51 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.419 HD13 ' CB ' ' A' ' 177' ' ' ALA . 31.3 mt -85.18 111.19 19.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.86 131.67 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -106.6 163.01 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 mt -66.29 -9.44 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.71 21.76 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 56.24 44.03 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 14.5 t -131.98 165.29 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -139.56 144.54 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -131.14 128.92 41.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.96 118.42 16.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' A' ' 167' ' ' LEU . . . -137.07 121.3 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.576 ' N ' ' HH ' ' A' ' 192' ' ' TYR . 92.6 t -83.7 123.39 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.44 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -128.66 158.13 39.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -112.51 154.23 44.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 2.92 3.08 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.354 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -109.25 -38.63 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -48.04 170.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.3 p -110.96 158.32 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.183 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.52 -43.96 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.116 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.6 94.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.7 -32.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.5 tp -64.77 -47.08 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 193' ' ' PHE . 2.6 mtpm? -70.73 -39.84 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.424 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 9.5 t -72.43 -29.4 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.558 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.77 -47.41 59.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.576 ' HH ' ' N ' ' A' ' 178' ' ' VAL . 80.5 m-85 -94.64 -22.47 18.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.6 m-85 -135.05 84.22 37.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.652 0.739 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 123.99 10.63 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.58 -42.31 1.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -9.68 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.424 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.0 mt-10 -49.29 -18.64 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -67.75 -48.29 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 230' ' ' HIS . 26.2 mt-30 -92.62 -45.13 8.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.887 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -57.04 90.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -101.14 120.73 40.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.469 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 28.1 mt -93.26 135.22 34.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.9 mt -129.02 122.88 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.091 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 73.4 t80 -112.9 111.32 21.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 53.4 mt-30 64.15 50.14 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.7 3.19 26.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -105.72 131.75 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 32.2 tp -80.8 126.9 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.408 ' N ' HD22 ' A' ' 209' ' ' LEU . 6.7 mt -78.08 46.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -48.36 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.33 103.06 0.3 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 2.55 3.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.721 2.28 . . . . 0.0 112.334 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.59 -27.94 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.459 ' HA ' ' NE ' ' A' ' 214' ' ' ARG . 8.2 mmp_? -49.03 114.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.1 p -63.06 149.33 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.42 -31.81 71.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -65.38 -45.22 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 m -63.2 -33.45 75.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 64.6 mt -79.99 3.81 18.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.65 33.89 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 55.7 mt -86.55 92.1 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.7 p -97.08 -176.01 3.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' A' ' 224' ' ' ASN . 1.7 t30 -70.91 150.71 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.43 ' HB2' ' ND2' ' A' ' 223' ' ' ASN . 10.9 t-20 69.64 32.89 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.4 t -110.7 143.99 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.4 p -109.1 132.25 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 23.9 mt -111.04 125.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -79.76 132.57 36.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -113.13 127.64 56.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 199' ' ' GLN . 3.8 m-70 -100.06 129.05 46.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.9 ttp85 -113.05 119.98 39.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 5.5 t -116.87 124.54 29.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 147.88 63.71 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.667 2.245 . . . . 0.0 112.324 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 140.72 43.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.695 2.263 . . . . 0.0 112.339 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -95.82 -41.46 3.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -108.29 37.56 2.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 41.28 40.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.5 t -74.93 -20.77 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.8 t -91.28 74.49 6.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -66.27 -155.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.491 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.11 59.25 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.366 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 52.4 p -98.81 -47.9 5.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 55.61 42.27 29.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 m -94.06 -55.83 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t 66.25 41.11 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -112.58 86.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 127.31 14.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.314 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 60.0 p -67.78 105.59 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 73.3 m -89.22 -55.14 3.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.1 p -69.33 168.89 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.852 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 m -163.6 143.86 8.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 -179.85 2.38 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.449 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.0 m -108.41 97.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.1 m -127.0 168.36 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.0 175.46 29.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 14.8 pt -107.85 141.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.04 143.14 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.429 HG22 ' CB ' ' A' ' 179' ' ' ALA . 24.5 t -131.57 134.1 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -100.82 115.35 30.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.421 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 37.4 mt -85.18 105.06 15.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -98.56 127.35 44.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.2 m-85 -106.53 163.46 12.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.42 -10.38 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 51.8 t30 -84.86 30.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 2.1 p30 49.85 25.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.404 HG22 ' CD1' ' A' ' 169' ' ' PHE . 6.9 t -118.51 161.11 20.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -141.09 149.15 41.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -132.42 128.73 38.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.66 125.1 27.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.82 128.29 20.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.453 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 11.2 p -90.5 122.14 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.454 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -125.61 158.0 35.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.47 ' CZ ' ' OD2' ' A' ' 183' ' ' ASP . 11.9 mtm105 -112.84 154.52 44.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.641 0.734 . . . . 0.0 110.809 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -4.94 15.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.75 -41.17 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.47 ' OD2' ' CZ ' ' A' ' 180' ' ' ARG . 1.4 m-20 -50.34 160.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.7 p -103.3 156.33 17.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -58.73 -41.65 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.165 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.05 93.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -69.02 -42.98 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.341 . . . . 0.0 111.18 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.32 -47.22 75.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.3 mtpt -57.79 -49.13 77.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 t -70.5 -28.06 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.515 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.78 -47.67 77.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.515 ' CZ ' ' HE3' ' A' ' 191' ' ' LYS . 83.2 m-85 -100.25 -44.46 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' LYS . 11.9 m-85 -107.77 80.96 1.06 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 123.63 10.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.48 ' CA ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.2 -30.83 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.487 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -82.96 19.74 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.743 0.306 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.48 ' OE1' ' CA ' ' A' ' 195' ' ' GLY . 28.3 mp0 -74.1 2.47 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 91.1 p -86.34 -48.48 8.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 201' ' ' LYS . 2.8 pt20 -89.52 -34.0 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.461 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -55.29 85.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.453 ' HE2' ' CD2' ' A' ' 208' ' ' LEU . 10.2 tttt -97.78 113.18 24.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 1.0 OUTLIER -95.12 137.66 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.1 mt -129.31 122.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 57.74 50.56 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.08 3.0 9.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -104.03 132.44 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.475 ' CD2' ' HG2' ' A' ' 210' ' ' GLN . 14.9 tp -79.76 128.84 33.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 209' ' ' LEU . 3.3 mt -84.72 35.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.475 ' HG2' ' CD2' ' A' ' 208' ' ' LEU . 7.6 mm100 -39.68 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -40.14 101.23 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.826 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 3.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.89 21.45 12.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -92.6 107.57 19.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 p -48.97 135.12 16.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.151 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.33 -31.71 65.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 92.7 p -63.17 -46.0 89.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.5 t -65.1 -33.66 76.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 26.6 mt -77.47 4.92 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 65.12 27.31 12.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.9 mt -83.55 104.2 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 56.1 p -108.73 -177.26 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -76.51 151.99 36.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.1 t30 74.01 25.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.81 162.77 13.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -123.62 133.6 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.7 mt -112.43 119.59 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -72.22 126.15 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.43 127.03 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -101.89 123.83 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -112.26 128.84 56.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -117.51 143.7 32.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 0.0 110.902 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -175.49 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.83 -53.87 3.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -117.65 96.65 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.49 53.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.91 -10.04 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.2 t -163.58 176.07 10.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -153.82 146.58 14.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 242' ' ' SER . 53.5 Cg_endo -69.8 -8.75 24.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 243' ' ' ALA . 31.0 p -37.9 -41.59 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 242' ' ' SER . . . -34.56 -62.73 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 245' ' ' SER . 24.3 p -45.98 -47.62 16.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 244' ' ' SER . 3.6 t -35.43 131.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -104.64 -158.34 23.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 102.91 1.08 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -84.23 -38.19 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 37.0 m -59.66 104.34 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.476 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.9 t -89.8 -59.85 2.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 t -112.27 153.41 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.05 -46.01 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.6 p -53.93 -46.53 71.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 6.9 p -62.32 -11.98 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -126.78 -173.5 13.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.435 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 20.5 pt -111.61 141.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.06 139.51 30.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.93 132.16 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -94.27 112.07 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' A' ' 177' ' ' ALA . 77.7 mt -85.32 104.57 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 2.4 tmmm? -98.57 134.73 41.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.429 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 44.3 m-85 -107.6 165.14 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.0 mt -67.42 -12.3 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -83.59 18.76 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.52 27.06 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.45 ' HG1' ' N ' ' A' ' 174' ' ' GLU . 5.0 t -115.55 160.51 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.45 ' N ' ' HG1' ' A' ' 173' ' ' THR . 37.9 mt-10 -130.7 150.59 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.79 129.09 34.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.77 119.56 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.571 ' HB2' ' CE1' ' A' ' 192' ' ' TYR . . . -141.54 119.66 12.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.445 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 84.7 t -89.59 121.74 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.435 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -123.98 158.12 32.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -110.94 154.84 43.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 217' ' ' SER . 53.7 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.363 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 183' ' ' ASP . 14.8 pt-20 -111.24 -41.36 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -44.96 170.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 77.7 p -113.85 160.18 19.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.36 -44.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.09 -42.2 96.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -70.25 -31.18 68.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.45 -47.35 76.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 193' ' ' PHE . 11.5 mtpt -67.3 -39.15 85.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.426 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 21.4 t -72.33 -31.92 66.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.559 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -70.71 -47.83 57.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 177' ' ' ALA . 90.5 m-85 -91.23 -25.27 19.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 189' ' ' LYS . 23.5 m-85 -135.01 85.75 33.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.359 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 -39.15 2.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -65.57 -4.98 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.426 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 19.1 mt-10 -49.89 -18.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 11.4 m -63.03 -53.72 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 201' ' ' LYS . 11.0 mm-40 -86.91 -45.72 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.442 ' HG2' ' CG ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -49.26 87.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 199' ' ' GLN . 1.8 ttmp? -103.94 116.56 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.47 ' CD1' ' HG2' ' A' ' 189' ' ' LYS . 6.6 mp -93.48 137.51 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mt -129.29 122.45 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.545 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 70.9 t80 -114.98 113.8 24.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.545 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.3 mt-30 60.17 42.13 15.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.05 5.56 62.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -105.11 134.09 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.365 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 7.7 tp -79.8 130.39 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.461 ' N ' HD21 ' A' ' 209' ' ' LEU . 5.5 mt -84.04 26.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 209' ' ' LEU . 19.4 mt-30 -34.69 -73.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 210' ' ' GLN . 7.7 m-20 -37.05 99.36 0.18 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.46 -15.98 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -57.26 118.16 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 p -67.89 142.29 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.515 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -59.57 -31.54 69.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 181' ' ' PRO . 5.6 t -62.04 -47.05 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.3 t -67.49 -31.63 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.91 4.54 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.82 40.61 15.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.6 mt -96.41 98.4 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -102.01 179.18 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -68.5 150.52 47.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.74 34.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.88 143.41 45.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.06 136.98 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 14.5 mt -117.83 120.49 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -72.11 128.8 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.82 132.5 56.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -99.76 124.58 45.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -112.24 127.45 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.2 t -127.91 143.6 48.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.827 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 144.32 53.77 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.653 2.236 . . . . 0.0 112.326 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.43 40.15 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -137.08 80.44 0.3 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.487 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -135.53 168.74 18.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.2 40.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.27 143.73 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.2 t -167.84 125.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.6 146.82 4.42 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 174.54 9.37 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.3 m -165.82 123.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -119.32 152.97 35.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -165.24 153.63 11.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.3 t -122.37 173.98 7.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.06 82.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 105.9 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.6 t -77.76 -43.95 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 34.7 t -68.32 -48.86 63.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.463 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.1 p -81.43 135.11 35.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.842 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -58.53 -63.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 139.94 -69.41 0.47 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.1 m -146.32 132.36 19.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.805 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -167.95 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.51 -175.17 15.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.4 pt -108.25 138.34 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.55 138.41 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.467 HG22 ' CB ' ' A' ' 179' ' ' ALA . 9.5 t -127.72 133.51 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -96.43 116.83 29.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.531 HD12 ' CZ ' ' A' ' 193' ' ' PHE . 51.8 mt -85.07 106.99 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.46 ' HB2' ' CG2' ' A' ' 226' ' ' VAL . 3.1 tmtm? -98.6 128.55 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -107.78 158.98 16.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.18 -7.56 6.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 25.9 t30 -83.52 17.99 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 60.15 27.41 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 13.9 t -121.17 172.71 7.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -143.58 152.39 41.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -133.85 135.23 43.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.93 119.6 20.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.535 ' HB3' ' CE1' ' A' ' 192' ' ' TYR . . . -143.27 120.0 11.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.45 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 94.1 t -89.52 121.93 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 165' ' ' VAL . . . -120.68 158.16 28.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -110.48 153.44 43.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.4 23.51 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -98.81 -39.9 8.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.19 165.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.6 p -108.36 162.35 14.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.77 -41.12 91.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.98 -36.58 93.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -70.71 -41.33 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.152 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.2 -47.26 75.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 193' ' ' PHE . 23.1 mttp -58.29 -48.41 80.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -70.7 -27.89 64.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.573 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.06 -47.75 73.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.903 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' TYR . . . . . 0.573 ' CE2' ' HE3' ' A' ' 191' ' ' LYS . 83.1 m-85 -99.16 -44.55 6.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 189' ' ' LYS . 10.8 m-85 -112.88 76.06 2.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 196' ' ' GLN . 53.6 Cg_endo -69.77 128.07 15.49 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.58 -21.24 3.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 194' ' ' PRO . 71.4 mm-40 -92.04 -5.21 53.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.938 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 13.2 mp0 -51.26 -18.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.3 m -62.87 -58.19 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -86.36 -36.56 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -59.94 90.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -103.54 125.05 49.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 5.6 mp -100.53 139.94 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.416 HG21 ' C ' ' A' ' 207' ' ' ARG . 19.4 mt -129.17 123.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 77.4 t80 -111.42 114.39 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.429 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 35.9 mt-30 62.2 48.52 4.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.8 2.43 29.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . 0.416 ' C ' HG21 ' A' ' 203' ' ' ILE . 9.1 ttt180 -105.55 134.83 48.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 210' ' ' GLN . 37.3 tp -82.07 125.92 31.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 209' ' ' LEU . 5.8 mt -76.56 47.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.464 ' CG ' HD22 ' A' ' 208' ' ' LEU . 21.0 mt-30 -50.13 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 12.3 m-20 -41.36 101.9 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.6 0.715 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.0 Cg_endo -69.75 -0.49 6.99 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 0.0 112.353 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -103.03 -24.45 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 20.5 mmt-85 -51.7 115.24 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 9.4 p -63.52 151.06 42.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.175 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.37 -34.61 78.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.1 t -63.97 -46.65 83.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.4 m -62.72 -35.71 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.9 mt -76.81 4.54 9.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 m120 62.94 39.08 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.416 ' O ' ' CD1' ' A' ' 163' ' ' ILE . 45.2 mt -92.68 89.0 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 62.6 p -95.15 170.23 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.77 157.65 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.89 38.89 8.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 144.52 48.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.5 p -109.63 141.3 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.463 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 28.4 mt -119.21 127.29 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -77.4 131.33 37.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 54.6 m -113.17 138.81 49.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -111.78 122.48 47.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 -100.83 124.35 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.8 m -113.82 141.39 26.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.643 0.735 . . . . 0.0 110.848 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 126.73 13.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.73 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -99.1 -76.51 1.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -145.28 135.05 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -121.41 119.72 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.98 -11.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.8 t -91.13 -53.33 4.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 84.33 -114.25 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.443 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.681 2.254 . . . . 0.0 112.355 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.83 141.59 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -91.43 167.58 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.6 m -116.46 -59.01 2.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 t -46.85 148.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.822 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -155.55 -93.43 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 150.88 69.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.338 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 54.1 p -117.51 139.0 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 31.2 t -120.72 135.5 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 17.0 pt -104.91 143.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -92.68 138.64 31.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 179' ' ' ALA . 5.0 t -128.31 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HB2' HG23 ' A' ' 226' ' ' VAL . 31.7 mtm180 -99.97 118.44 36.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 42.3 mt -87.02 112.0 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -99.31 130.3 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.8 m-85 -107.72 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.1 mt -59.6 -10.76 3.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.51 15.51 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 62.87 31.63 16.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -123.59 174.31 7.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -142.77 157.39 44.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.07 132.29 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.9 tp -75.74 118.48 18.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.949 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.67 125.62 17.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 178' ' ' VAL . 12.1 p -91.93 121.83 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.06 157.59 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -112.11 153.17 44.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.85 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.54 -29.77 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -54.91 172.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.0 p -116.59 158.08 24.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.118 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.533 HG12 ' HD2' ' A' ' 189' ' ' LYS . 86.5 t -61.88 -43.72 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.01 -41.64 94.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.22 -45.56 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.0 tp -55.48 -47.12 76.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.533 ' HD2' HG12 ' A' ' 185' ' ' VAL . 24.9 mtpt -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -70.74 -28.1 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.98 -47.82 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.949 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 51.6 m-85 -99.93 -44.42 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 9.9 m-85 -109.71 79.52 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.5 28.12 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.46 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 74.74 -45.25 1.58 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.46 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -82.47 39.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 38.5 mp0 -85.53 -28.98 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 15.9 m -72.19 -13.59 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -110.83 -47.69 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.04 85.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.78 ' NZ ' HD21 ' A' ' 208' ' ' LEU . 11.7 mmtp -89.81 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.608 ' HB2' HD12 ' A' ' 209' ' ' LEU . 12.4 mt -106.26 141.25 37.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.7 mt -129.16 122.82 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.498 ' CB ' HD21 ' A' ' 209' ' ' LEU . 57.8 t80 -119.93 112.39 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 62.24 44.05 7.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.15 1.0 55.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -101.97 140.3 36.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.78 HD21 ' NZ ' ' A' ' 201' ' ' LYS . 15.0 tp -86.21 125.3 33.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.755 HD22 HD13 ' A' ' 219' ' ' LEU . 6.4 mt -83.25 20.79 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -34.62 -53.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.46 ' HB3' ' CG ' ' A' ' 214' ' ' ARG . 12.6 t0 -48.49 105.73 0.53 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.714 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -4.04 13.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.691 2.26 . . . . 0.0 112.384 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.13 -28.73 10.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.5 mmt180 -46.21 109.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.59 148.87 44.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -63.03 -31.5 72.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 t -64.59 -44.26 91.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 52.4 m -66.46 -35.99 81.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.755 HD13 HD22 ' A' ' 209' ' ' LEU . 95.4 mt -75.86 1.97 13.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 10.6 m120 67.05 25.04 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 216' ' ' LEU . 32.8 mt -77.97 103.65 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.2 p -103.52 -177.85 3.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 224' ' ' ASN . 1.0 OUTLIER -72.29 170.95 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 223' ' ' ASN . 4.4 p-10 47.71 30.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.9 t -107.97 159.57 16.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -119.2 138.72 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.8 mt -119.1 119.59 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -70.53 133.37 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 91.7 m -107.96 148.35 29.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 21.0 pt -110.33 138.84 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.34 137.13 32.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 179' ' ' ALA . 13.3 t -126.63 133.28 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.432 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.5 mtm180 -95.91 115.55 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.6 mt -86.48 106.55 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -98.78 133.96 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.853 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' THR . 6.0 m-85 -107.61 164.57 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.95 -11.79 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 32.9 t30 -85.36 16.32 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 62.41 30.17 17.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 169' ' ' PHE . 7.6 t -113.2 169.96 8.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -142.82 149.21 38.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -135.65 137.32 41.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.21 118.77 20.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.744 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -142.77 113.9 7.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.1 t -83.9 121.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.653 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -122.04 158.09 29.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -109.25 151.09 41.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.622 0.725 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.5 Cg_endo -69.75 -1.67 8.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.298 . . . . 0.0 112.319 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 17.1 pm0 -112.67 -17.07 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.89 -177.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.9 p -127.14 149.48 49.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.465 HG12 ' HD2' ' A' ' 189' ' ' LYS . 88.4 t -57.22 -39.57 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -63.19 -42.01 99.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.37 -44.79 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.57 -47.04 77.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.4 mtpt -58.38 -48.38 80.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 t -70.78 -27.99 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.7 tmmm? -65.05 -47.8 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.744 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 51.4 m-85 -99.82 -44.29 6.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 16.4 m-85 -108.64 75.99 0.65 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.641 0.734 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.68 28.5 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 0.0 112.33 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.456 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.51 -41.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -90.67 42.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 27.8 mp0 -88.11 -32.5 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.5 t -67.43 -24.91 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -98.57 -38.18 9.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -71.41 85.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -91.02 134.79 34.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.896 HD23 HG21 ' A' ' 227' ' ' ILE . 7.4 mp -109.55 141.65 41.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.14 122.89 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.5 t80 -115.42 113.0 23.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.461 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 68.3 mt-30 62.99 44.08 6.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.53 -0.27 43.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -102.68 131.29 49.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 33.5 tp -79.98 127.6 32.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 209' ' ' LEU . 4.4 mt -80.5 46.02 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -44.2 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -45.08 104.09 0.37 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.584 0.707 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 0.0 112.312 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.93 -17.73 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -54.3 117.98 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.1 p -65.71 147.01 54.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.49 -32.14 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 p -64.98 -46.9 79.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 p -61.59 -35.95 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.82 5.0 10.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.2 34.22 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 221' ' ' ILE . 58.5 mt -87.29 93.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -98.21 -178.31 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.8 52.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.9 t30 73.59 37.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.1 t -119.0 145.86 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.6 p -110.54 141.36 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.896 HG21 HD23 ' A' ' 202' ' ' LEU . 23.0 mt -119.92 120.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -70.89 134.24 47.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 84.2 m -111.36 141.58 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.0 pt -101.29 143.99 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.61 136.26 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.49 136.62 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.635 ' HB2' HG23 ' A' ' 226' ' ' VAL . 13.5 mtp180 -99.79 123.09 43.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.867 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 192' ' ' TYR . 36.5 mt -91.49 107.4 19.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.72 133.29 43.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 6.0 m-85 -107.13 164.47 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.22 -7.68 14.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -84.89 9.47 14.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.39 26.39 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -119.14 160.0 22.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.183 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.01 154.2 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -133.98 128.97 35.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.0 tp -73.43 118.62 16.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.952 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.73 132.37 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.8 p -93.45 121.9 44.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -124.61 157.25 35.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 216' ' ' LEU . 36.0 mtp180 -110.4 154.97 42.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.78 -12.09 32.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.66 -36.62 10.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -47.38 168.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 213' ' ' ALA . 24.0 p -110.76 159.57 17.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.541 ' CG2' HD11 ' A' ' 219' ' ' LEU . 68.6 t -61.5 -35.78 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.9 -40.85 89.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -68.36 -38.49 81.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 111.123 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.7 tp -55.59 -46.6 77.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 6.2 mtpp -65.11 -42.05 94.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.8 t -71.02 -28.17 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.591 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.09 -48.14 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.952 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 7.7 m-85 -100.04 -43.65 6.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 24.3 m-85 -107.47 80.74 0.95 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.665 0.745 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 192' ' ' TYR . 53.7 Cg_endo -69.77 127.07 14.07 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.321 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.454 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.1 -41.96 1.83 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.55 39.43 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 37.8 mp0 -85.22 -36.55 20.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.3 t -64.06 -22.96 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.29 -34.61 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -79.35 85.24 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -88.24 134.45 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 13.5 mt -104.11 141.27 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.13 122.78 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 62.0 t80 -117.32 122.43 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.575 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.2 mm-40 53.46 48.61 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.15 33.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.55 142.15 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.441 ' N ' ' HD3' ' A' ' 207' ' ' ARG . 35.1 tp -87.68 121.94 30.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.8 mt -75.75 50.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.425 ' CG ' HD23 ' A' ' 208' ' ' LEU . 73.6 mt-30 -53.1 -71.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 16.5 t0 -42.23 102.57 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.846 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.5 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 184' ' ' THR . . . -107.11 -33.15 7.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -39.98 114.27 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.9 p -61.5 143.37 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -57.56 -31.84 66.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.6 p -64.74 -46.93 80.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.8 t -65.05 -32.32 73.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.541 HD11 ' CG2' ' A' ' 185' ' ' VAL . 48.5 mt -77.14 4.97 9.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.88 30.36 16.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 221' ' ' ILE . 55.2 mt -86.53 95.84 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.7 p -99.75 -175.13 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -74.79 159.79 31.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 62.27 28.88 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.85 157.1 20.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.6 p -119.68 133.68 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 35.2 mt -112.6 116.03 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.93 139.38 57.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.59 144.04 44.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 2.1 m80 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.954 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 26.5 pt -93.75 145.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 111.124 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -89.49 129.76 35.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 179' ' ' ALA . 22.0 t -123.58 138.5 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.7 mtp180 -103.14 117.68 35.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.837 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.832 HD11 ' CD2' ' A' ' 192' ' ' TYR . 46.1 mt -85.21 108.1 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -99.03 129.5 45.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.2 m-85 -107.65 157.17 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.9 mt -63.55 -7.78 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -83.21 17.09 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 62.18 29.03 17.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 169' ' ' PHE . 11.5 t -123.79 167.12 14.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -139.65 153.23 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.25 131.0 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.8 tp -77.42 117.92 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 1.061 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -139.12 135.55 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.9 p -94.8 123.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 165' ' ' VAL . . . -124.08 157.65 34.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -111.46 152.09 43.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.879 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.0 Cg_endo -69.74 -2.55 10.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.341 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.54 -38.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.14 172.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.6 p -114.45 164.57 13.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 209' ' ' LEU . 43.2 t -64.72 -40.41 88.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.89 -42.18 99.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.15 -47.01 82.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 193' ' ' PHE . 21.1 mtpt -63.66 -44.06 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.414 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 39.7 t -70.87 -28.21 64.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.593 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.12 -48.2 74.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.919 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 1.061 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 8.6 m-85 -99.94 -43.91 6.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 4.9 m-85 -112.66 78.63 2.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 131.7 21.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.46 -42.27 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -71.6 1.91 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.414 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 9.7 mt-10 -55.19 -14.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -64.41 -58.28 6.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 201' ' ' LYS . 6.1 pt20 -84.28 -37.2 21.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.459 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -52.6 85.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 199' ' ' GLN . 19.5 mttp -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 17.4 mt -93.67 137.07 33.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.94 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -129.08 122.89 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.7 t80 -114.86 119.75 37.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.4 mm100 54.39 48.45 20.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.73 41.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -102.61 139.08 38.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.64 HD23 ' HG3' ' A' ' 210' ' ' GLN . 41.0 tp -87.39 123.17 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.451 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.5 mt -79.09 47.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.64 ' HG3' HD23 ' A' ' 208' ' ' LEU . 12.3 mt-30 -50.38 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.79 103.29 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.597 0.713 . . . . 0.0 110.842 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.34 6.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.58 22.52 14.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -94.32 105.09 17.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.9 p -50.64 142.95 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.6 mt -62.26 -32.67 73.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.7 t -64.57 -45.94 84.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.1 m -65.08 -31.32 72.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.64 4.48 18.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.0 34.22 11.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 221' ' ' ILE . 57.5 mt -90.83 93.56 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 76.2 p -98.76 -176.66 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -69.39 150.64 47.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 72.44 33.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.2 t -113.39 149.88 33.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.7 p -116.12 134.51 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.0 mt -114.47 122.14 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -79.08 135.74 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -115.82 127.55 55.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.0 m80 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -97.99 151.53 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -101.12 139.12 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.29 132.31 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.458 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.8 mtm180 -94.38 117.58 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.726 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 38.6 mt -85.14 107.34 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -98.73 128.61 45.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 5.3 m-85 -107.32 157.26 18.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.08 -9.97 5.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 173' ' ' THR . 55.7 t30 -81.23 14.59 2.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 62.33 34.05 16.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 171' ' ' ASN . 5.1 t -130.53 157.43 42.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -128.16 153.5 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -134.32 136.25 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.51 116.69 18.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.794 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.65 116.56 10.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.9 t -82.4 121.86 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.079 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.441 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -122.36 158.13 30.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 216' ' ' LEU . 54.5 mtm-85 -110.54 152.85 43.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.56 0.695 . . . . 0.0 110.924 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.4 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -105.02 -36.82 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -49.59 169.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -111.65 160.1 17.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 202' ' ' LEU . 69.4 t -65.1 -44.11 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.59 88.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.53 -43.22 66.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 11.4 tp -55.36 -47.18 76.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.4 mtpt -58.63 -48.24 81.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.7 p -70.76 -27.97 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.587 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -65.19 -47.87 75.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.794 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 48.0 m-85 -99.95 -44.31 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.726 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 7.7 m-85 -111.84 77.44 1.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.689 0.757 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 128.02 15.38 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.24 -14.95 4.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -94.52 -12.49 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.727 0.299 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -48.56 -20.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m -61.54 -49.79 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 201' ' ' LYS . 29.3 mt-30 -91.97 -45.24 8.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -52.14 85.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.779 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.9 ttmm -91.55 120.52 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.06 134.89 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.3 mt -129.13 123.46 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.9 t80 -115.45 116.5 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.1 mt-30 58.13 38.1 26.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.68 7.29 87.27 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -107.05 135.17 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.795 HD23 ' HG3' ' A' ' 210' ' ' GLN . 10.1 tp -80.15 127.03 31.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.4 mt -84.16 26.2 0.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.795 ' HG3' HD23 ' A' ' 208' ' ' LEU . 5.5 mt-30 -34.33 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.58 100.12 0.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 0.79 5.09 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.288 . . . . 0.0 112.36 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.88 16.01 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -89.5 112.83 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -57.92 137.19 56.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.7 mt -57.07 -34.7 68.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.3 t -61.37 -44.31 97.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.5 m -67.05 -35.94 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 mt -75.62 4.37 7.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.64 38.86 11.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 221' ' ' ILE . 52.5 mt -94.04 90.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.7 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.8 157.6 7.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 61.96 37.76 14.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 t -114.46 143.74 44.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.7 p -109.44 134.75 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.431 HG21 ' HB3' ' A' ' 202' ' ' LEU . 41.5 mt -115.45 129.93 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -83.66 127.36 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 1.8 t -111.14 122.42 47.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 19.2 pt -100.97 144.99 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.16 134.32 34.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.21 135.43 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HB2' HG23 ' A' ' 226' ' ' VAL . 17.2 mtm180 -100.68 118.19 36.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.69 HD11 ' CD2' ' A' ' 192' ' ' TYR . 30.4 mt -85.15 110.73 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -98.77 128.56 45.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.7 m-85 -107.69 158.5 17.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.41 -7.81 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -85.31 23.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 55.81 27.54 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -123.75 164.23 19.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.03 153.95 51.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -132.83 133.41 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.71 124.74 28.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 1.027 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.58 142.74 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.19 121.76 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.01 158.21 38.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 216' ' ' LEU . 32.5 mtm180 -115.86 154.18 48.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.85 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -4.86 14.85 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.05 -37.93 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.525 ' OD2' HG21 ' A' ' 187' ' ' THR . 0.9 OUTLIER -51.77 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.0 p -115.01 164.29 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.143 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 209' ' ' LEU . 50.0 t -57.06 -44.02 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.71 -36.62 90.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.525 HG21 ' OD2' ' A' ' 183' ' ' ASP . 3.0 m -71.36 -39.58 71.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.1 tp -55.52 -47.17 76.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 29.4 mttt -58.99 -47.92 83.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -70.12 -28.05 65.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.906 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.528 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -64.53 -48.14 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 1.027 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 4.0 m-85 -100.32 -44.58 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.9 m-85 -111.51 83.13 4.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.17 7.0 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.444 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.74 -26.88 2.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -79.84 -3.88 49.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 2.8 mp0 -52.11 -21.06 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.8 m -60.47 -51.66 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -93.3 -44.09 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.97 95.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -103.77 134.3 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.541 HD13 HD23 ' A' ' 188' ' ' LEU . 11.5 mt -101.06 138.94 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.486 ' CD1' ' CE1' ' A' ' 230' ' ' HIS . 45.1 mt -129.24 122.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.571 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 68.1 t80 -115.21 125.68 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 12.4 mm-40 52.72 46.09 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.3 2.23 40.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 203' ' ' ILE . 5.2 ttp-105 -102.78 144.94 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 25.6 tp -88.28 124.47 33.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.575 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.7 mt -75.71 48.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -51.44 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m-20 -42.31 102.48 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.615 0.722 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.2 Cg_endo -69.82 3.09 3.0 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -118.31 19.42 13.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -86.76 101.16 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 p -48.36 135.42 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -58.97 -37.6 77.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.4 t -59.59 -43.48 93.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -36.04 81.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 HH22 ' A' ' 207' ' ' ARG . 75.7 mt -76.67 5.12 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 63.02 32.94 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 221' ' ' ILE . 48.4 mt -85.54 89.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.5 p -95.73 179.66 5.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 157.96 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 63.6 39.53 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.2 149.49 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 226' ' ' VAL . 1.7 p -114.85 123.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 30.9 mt -105.99 124.02 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -74.4 130.77 40.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 88.6 m -103.81 149.41 25.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.7 pt -95.97 138.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.168 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -87.31 143.62 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.27 138.64 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.5 mtm180 -97.75 116.59 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 58.7 mt -85.18 109.19 18.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' CYS . 1.6 tmtm? -98.95 133.67 42.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.86 ' HB2' HG22 ' A' ' 173' ' ' THR . 1.9 m-85 -108.57 162.89 13.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 230' ' ' HIS . 19.0 mt -61.61 -22.74 65.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 173' ' ' THR . 11.2 p-10 -82.96 34.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 43.19 54.82 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.86 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -128.33 171.59 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.62 147.4 31.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.98 129.48 25.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 tp -77.39 117.82 19.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.8 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.96 140.31 34.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 178' ' ' VAL . 13.1 p -99.05 121.84 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -125.01 157.65 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 76.7 mtm-85 -110.83 152.08 43.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.82 0.22 6.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.59 -43.85 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.63 161.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 213' ' ' ALA . 20.0 p -103.28 164.25 11.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.89 -42.39 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.98 98.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -66.17 -38.01 87.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 111.198 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.9 tp -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.7 mtpt -66.67 -42.05 87.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -70.83 -28.2 64.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.583 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.02 -48.35 74.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 6.7 m-85 -99.98 -44.01 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.669 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 8.0 m-85 -109.98 78.89 1.38 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 131.33 20.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.455 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.79 -41.59 1.72 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.455 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -84.57 35.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.455 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 32.7 mp0 -83.42 -31.4 26.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.5 m -64.7 -19.73 65.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 230' ' ' HIS . 34.5 mt-30 -104.17 -45.02 4.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.77 85.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -88.51 122.21 31.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.95 137.54 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.404 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.3 mt -129.15 122.68 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.563 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 64.0 t80 -116.1 113.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.9 mt-30 62.93 43.55 6.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.32 4.61 60.72 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -106.83 131.62 53.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.425 HD23 ' HG3' ' A' ' 210' ' ' GLN . 39.8 tp -79.95 125.27 29.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.0 46.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.425 ' HG3' HD23 ' A' ' 208' ' ' LEU . 23.7 mt-30 -45.49 -67.84 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 19.6 t0 -44.61 103.93 0.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 52.9 Cg_endo -69.84 2.55 3.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.659 2.239 . . . . 0.0 112.286 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 184' ' ' THR . . . -106.92 -30.53 8.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -41.47 123.3 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.3 p -70.29 150.39 46.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -64.45 -35.63 81.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.0 p -63.55 -46.07 87.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -63.72 -34.45 77.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 59.3 mt -77.84 4.49 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 67.0 29.34 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 84.8 mt -87.02 92.05 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.0 p -101.77 -175.73 2.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -70.24 154.46 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 62.45 38.3 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.92 146.29 47.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.2 p -107.32 142.22 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.68 119.56 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -66.18 137.66 57.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 168' ' ' LYS . 83.1 m -120.26 146.72 45.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 170' ' ' LEU . 4.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.4 pt -120.07 138.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.806 0.336 . . . . 0.0 111.144 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -87.96 143.2 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 179' ' ' ALA . 16.3 t -131.7 137.47 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.408 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtm180 -100.59 117.55 34.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.615 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.0 mt -86.67 107.88 18.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -98.88 128.32 45.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 173' ' ' THR . 1.6 m-85 -107.5 160.23 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 230' ' ' HIS . 70.4 mt -66.71 -6.24 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -84.83 16.37 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 63.0 26.93 15.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.622 HG23 ' CD1' ' A' ' 169' ' ' PHE . 6.1 t -120.84 168.26 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -144.48 149.9 36.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -135.77 129.18 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -73.27 120.29 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 1.031 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.14 125.96 24.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.451 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 6.2 p -86.57 123.07 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -126.31 157.97 37.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -111.96 153.49 44.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -5.61 16.61 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.375 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.76 -38.41 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -51.36 173.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 41.5 p -118.91 164.36 15.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 209' ' ' LEU . 54.2 t -64.37 -43.99 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.78 83.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -44.59 63.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.167 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.1 tp -55.14 -47.12 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HD2' HG12 ' A' ' 185' ' ' VAL . 33.6 mtpt -57.98 -48.57 79.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 94.0 p -70.93 -27.92 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.66 -47.55 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 1.031 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 86.4 m-85 -98.7 -44.44 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.615 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.3 m-85 -113.65 79.14 4.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 134.31 27.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.04 -44.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -68.77 -1.46 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.738 0.304 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.438 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 13.2 mt-10 -51.56 -20.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.7 t -58.83 -59.29 5.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 201' ' ' LYS . 0.0 OUTLIER -82.92 -42.2 17.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.461 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -45.14 91.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.857 ' HG2' HD11 ' A' ' 208' ' ' LEU . 17.8 ttmt -105.29 117.94 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.614 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.72 137.12 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.27 122.9 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.449 ' HB3' HD21 ' A' ' 209' ' ' LEU . 63.5 t80 -116.14 111.9 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 57.97 51.51 8.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.59 5.87 39.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.73 136.55 43.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.857 HD11 ' HG2' ' A' ' 201' ' ' LYS . 12.1 tp -85.32 121.07 27.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.652 ' HB3' HG21 ' A' ' 185' ' ' VAL . 7.2 mt -79.46 44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.959 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -52.14 -72.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 214' ' ' ARG . 9.2 t70 -42.24 102.5 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.698 . . . . 0.0 110.896 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.02 3.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.51 8.66 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.455 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 8.4 mmm-85 -82.33 105.81 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 17.6 p -51.36 142.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.2 mt -62.09 -31.74 72.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 85.8 p -63.3 -44.35 95.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -35.4 79.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.97 5.0 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.65 26.07 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 221' ' ' ILE . 51.6 mt -81.18 93.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.3 p -96.31 -175.58 3.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.95 158.18 33.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 62.91 29.18 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.9 t -110.22 154.82 22.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.9 p -117.11 138.98 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.7 mt -116.15 122.78 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -73.53 134.09 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 60.3 m -120.14 133.9 55.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.409 ' CE1' HD11 ' A' ' 170' ' ' LEU . 4.6 m170 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.6 pt -95.96 144.81 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.28 134.63 34.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.508 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtp180 -96.79 117.06 30.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.4 mt -85.67 107.14 17.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -99.06 127.87 45.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.45 ' CD1' HG23 ' A' ' 173' ' ' THR . 4.0 m-85 -105.42 161.48 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 229' ' ' CYS . 5.3 mp -67.47 -7.71 27.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.11 16.23 2.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.8 t70 63.29 30.15 15.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.45 HG23 ' CD1' ' A' ' 169' ' ' PHE . 14.7 t -125.15 174.91 7.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -148.22 150.14 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -130.23 134.13 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.6 tp -80.87 122.5 27.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.947 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 141.24 33.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.88 121.91 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -126.48 157.91 37.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 216' ' ' LEU . 70.8 mtt180 -113.95 154.51 45.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.72 8.95 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.363 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.26 -39.21 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.11 170.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.7 p -112.76 161.99 16.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 209' ' ' LEU . 66.9 t -64.24 -40.18 88.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.12 97.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.8 m -67.04 -36.28 81.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -56.12 -46.69 79.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 17.6 mttp -64.76 -41.79 95.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.405 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 74.4 p -70.6 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.69 -48.69 73.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.947 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 10.3 m-85 -100.33 -43.58 6.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 20.2 m-85 -110.83 80.47 2.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.18 14.18 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.78 -39.99 1.81 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -84.11 28.68 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 5.1 mt-10 -80.13 -18.72 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.8 t -75.71 -24.15 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.67 -44.3 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.65 86.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.89 121.15 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.69 HD23 HG21 ' A' ' 227' ' ' ILE . 6.8 mp -96.88 139.13 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.1 mt -129.05 122.97 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 74.4 t80 -114.06 111.78 22.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 56.4 mt-30 63.31 42.36 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.77 0.77 64.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.04 131.99 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 tp -81.5 122.36 27.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.8 mt -76.21 53.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.46 -71.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -42.03 102.3 0.27 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.72 . . . . 0.0 110.929 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.74 2.43 3.53 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.385 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.47 14.25 19.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -89.1 101.2 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.1 p -47.8 143.22 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -59.59 -39.99 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.3 p -58.72 -44.77 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -63.92 -34.05 77.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.848 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 78.9 mt -77.91 4.69 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 62.52 36.44 13.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 221' ' ' ILE . 53.8 mt -90.88 94.48 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.2 p -100.32 173.75 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.1 153.42 37.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.4 t30 69.37 38.44 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 t -120.55 151.42 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.5 p -115.11 136.29 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.69 HG21 HD23 ' A' ' 202' ' ' LEU . 28.9 mt -115.37 130.04 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -83.4 127.08 33.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.584 ' O ' HD12 ' A' ' 170' ' ' LEU . 58.0 m -109.02 136.13 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.51 ' ND1' HD11 ' A' ' 170' ' ' LEU . 7.6 m80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.68 HG22 ' HB3' ' A' ' 223' ' ' ASN . 13.0 pt -108.19 145.38 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.91 138.84 32.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.43 137.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.896 ' HB2' HG23 ' A' ' 226' ' ' VAL . 9.1 mtt180 -98.07 125.23 42.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.506 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.1 mt -92.53 104.52 16.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.73 133.69 42.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 173' ' ' THR . 3.9 m-85 -107.27 166.33 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 230' ' ' HIS . 14.4 mt -70.6 -14.21 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 173' ' ' THR . 3.0 p30 -78.15 4.12 13.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.2 t70 73.97 47.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.548 HG22 ' OD1' ' A' ' 171' ' ' ASN . 1.3 t -135.46 171.82 13.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -142.96 153.94 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.55 130.44 23.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.79 117.82 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 1.044 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.1 123.48 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.57 123.76 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -127.18 157.67 39.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 216' ' ' LEU . 73.7 mtm-85 -107.99 153.6 41.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.75 -1.15 7.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.26 -33.22 6.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -50.18 173.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 2.6 p -117.21 159.09 23.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.96 -40.19 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.58 -37.32 94.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -70.44 -42.5 71.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.168 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.34 -47.27 75.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 26.4 mtpt -58.87 -48.11 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.447 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.7 t -70.57 -27.99 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.557 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.5 tmmm? -65.02 -48.06 75.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 1.044 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 54.9 m-85 -100.01 -44.48 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.07 77.23 2.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 134.72 28.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.349 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.08 -42.42 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.29 -9.87 50.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.447 ' OE2' ' CB ' ' A' ' 190' ' ' SER . 13.1 mt-10 -45.51 -22.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.6 t -55.92 -61.24 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -84.19 -42.61 15.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -44.83 113.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -126.3 122.28 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.83 141.21 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.9 mt -129.13 122.81 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 61.2 t80 -116.33 110.94 19.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.446 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 67.2 mt-30 62.38 53.37 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.92 3.74 11.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -104.88 136.47 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.8 tp -84.42 125.39 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -79.99 54.43 1.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -54.96 -73.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.414 ' HB2' ' CG ' ' A' ' 214' ' ' ARG . 28.5 m-20 -43.34 103.15 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.88 7.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.3 23.13 13.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.414 ' CG ' ' HB2' ' A' ' 211' ' ' ASP . 18.0 mmt180 -91.94 108.33 19.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.5 p -52.8 138.41 29.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.8 mt -57.8 -32.22 67.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.4 t -64.75 -42.6 95.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 34.5 t -67.67 -35.41 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.6 mt -76.47 1.77 15.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.2 m120 67.17 28.87 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 221' ' ' ILE . 53.5 mt -84.45 96.08 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.5 p -100.46 -175.71 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.68 ' HB3' HG22 ' A' ' 163' ' ' ILE . 7.0 p30 -76.04 148.6 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 74.2 27.15 1.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.65 158.87 17.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -121.67 131.69 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.42 124.14 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.75 138.98 39.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 39.3 m -120.68 138.55 53.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 170' ' ' LEU . 9.3 m170 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 19.6 pt -99.87 152.39 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.367 . . . . 0.0 111.081 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.07 141.94 30.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.97 137.12 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -101.6 115.79 31.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.652 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 35.6 mt -85.74 106.05 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 229' ' ' CYS . 2.4 tmmm? -98.77 134.23 41.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.66 165.55 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.506 HD11 ' CD2' ' A' ' 230' ' ' HIS . 76.6 mt -68.57 -6.98 28.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -87.05 13.34 9.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.67 35.91 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -128.66 156.57 43.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -129.62 149.9 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -130.54 132.42 45.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.77 118.95 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.776 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -143.27 120.35 11.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 178' ' ' VAL . 12.6 p -88.36 121.85 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.25 158.16 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.408 ' HB3' ' CD ' ' A' ' 182' ' ' GLU . 62.0 mtm180 -111.45 152.6 44.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.11 3.82 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.701 2.267 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 14.2 pm0 -113.32 -23.94 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.82 179.66 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.2 p -119.75 158.65 26.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 214' ' ' ARG . 93.5 t -62.57 -43.42 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.77 96.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -69.68 -31.72 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 111.122 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -66.91 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 193' ' ' PHE . 7.4 mtpp -70.02 -38.6 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.9 t -72.28 -29.89 64.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.86 -47.09 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.776 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 65.1 m-85 -94.72 -21.26 18.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 5.1 m-85 -135.02 74.55 62.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 125.06 11.7 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.42 3.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' SER . 27.6 mt-30 -86.59 -15.69 39.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -42.61 -23.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLN . 75.1 p -59.38 -52.54 65.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -88.89 -36.41 15.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -62.15 100.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -107.93 121.62 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.483 ' HG ' ' HZ2' ' A' ' 189' ' ' LYS . 23.9 mt -94.01 136.98 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.2 122.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.6 t80 -113.48 119.98 39.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 4.9 mm100 55.45 44.2 27.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.24 2.45 59.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 32.3 ttm-85 -102.27 137.69 40.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.838 0.351 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.88 120.54 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.4 mt -75.98 53.87 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -53.34 -73.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -46.23 104.59 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 1.74 4.15 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.707 2.272 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.08 20.81 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.1 mmt-85 -90.42 107.16 18.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 p -52.39 141.49 19.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.779 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -62.01 -31.96 72.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 p -65.34 -43.11 91.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.8 t -67.65 -34.71 77.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.92 5.0 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 63.27 37.0 11.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 221' ' ' ILE . 58.1 mt -92.56 95.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.0 p -96.75 -174.98 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.19 142.43 52.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 73.72 24.98 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.54 140.02 30.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -105.16 133.37 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.8 mt -116.35 122.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -72.49 139.43 47.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' LYS . 60.6 m -116.3 145.25 43.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.506 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.4 m170 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.4 pt -95.19 144.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 111.183 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.535 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 2.5 m-20 -93.47 139.48 30.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.9 t -129.41 134.63 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 226' ' ' VAL . 18.2 mtp180 -99.55 118.72 36.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.529 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 28.3 mt -85.12 107.07 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -98.72 128.26 44.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.0 m-85 -107.24 161.49 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.29 -5.01 12.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -82.38 7.28 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.9 t0 70.86 31.23 2.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -129.64 170.57 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.85 155.71 46.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -136.39 137.68 40.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 14.9 tp -75.48 120.62 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.847 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.98 115.55 8.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.44 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 90.4 t -87.73 122.12 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.05 158.12 34.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -108.9 153.4 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 0.42 5.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.47 -33.17 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.63 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.6 p -124.43 157.39 35.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 209' ' ' LEU . 70.8 t -61.53 -41.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.32 93.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.4 m -71.61 -40.15 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.42 -47.09 76.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' PHE . 31.3 mttt -58.66 -48.06 82.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.4 p -70.71 -28.11 64.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.2 tmmm? -65.44 -47.73 75.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.847 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 73.0 m-85 -99.8 -44.46 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.2 m-85 -113.32 79.23 3.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 110.843 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 126.03 12.87 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 2.25 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.403 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.57 -20.94 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -87.59 -13.5 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 189' ' ' LYS . 5.4 mp0 -46.0 -22.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.9 m -60.89 -52.08 66.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -92.43 -38.51 11.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.27 89.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -96.65 133.86 40.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.28 137.15 40.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.579 ' CD1' ' CE1' ' A' ' 230' ' ' HIS . 19.8 mt -129.22 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.447 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 67.3 t80 -114.08 113.93 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.4 mt-30 62.45 44.62 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.01 0.31 50.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -102.23 133.13 47.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.7 tp -80.52 126.15 30.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 185' ' ' VAL . 7.1 mt -76.86 48.19 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -47.81 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.31 105.24 0.47 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.705 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 2.97 3.09 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.628 2.219 . . . . 0.0 112.366 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.61 -27.64 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.9 mmt-85 -44.87 102.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 48.2 p -54.18 150.65 8.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.813 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.67 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.2 p -64.93 -43.55 92.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.0 m -68.59 -35.26 77.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.4 mt -75.76 4.76 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.3 37.87 10.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 221' ' ' ILE . 50.6 mt -92.61 102.54 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -106.65 -174.3 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 20.4 t-20 -69.45 152.15 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.8 m120 64.18 31.99 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.62 143.83 32.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.3 p -110.95 134.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.8 mt -116.02 126.98 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -78.46 130.89 36.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 98.7 m -103.21 152.21 21.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.579 ' CE1' ' CD1' ' A' ' 203' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.4 pt -96.36 140.16 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.28 138.78 31.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.4 t -128.59 138.04 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.789 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.4 mtm-85 -97.59 122.7 40.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.534 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 65.0 mt -93.14 104.84 17.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -98.66 130.17 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.5 m-85 -107.6 158.35 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 230' ' ' HIS . 52.1 mt -63.41 -7.87 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.27 19.8 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.67 35.0 24.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.9 t -129.91 175.15 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -144.89 154.69 42.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -136.29 129.01 30.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.31 121.32 21.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 1.156 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.91 138.75 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 178' ' ' VAL . 11.2 p -99.91 121.93 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.28 157.76 34.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.083 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 216' ' ' LEU . 18.4 mtt180 -113.4 152.89 45.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.1 Cg_endo -69.71 -0.9 7.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -109.59 -38.98 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.69 173.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.8 p -116.78 162.29 17.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 209' ' ' LEU . 26.1 t -60.16 -42.48 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.181 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.36 -41.91 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 m -66.95 -41.68 86.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 179' ' ' ALA . 13.2 tp -57.68 -45.54 85.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.3 mtpt -65.39 -44.61 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.8 t -70.67 -28.03 64.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.582 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.43 -48.74 74.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 1.156 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 14.6 m-85 -100.48 -43.41 6.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.8 m-85 -110.67 80.59 2.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 128.04 15.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.67 -40.36 1.81 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -83.81 31.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.936 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -83.04 -20.73 34.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 5.3 t -74.57 -26.1 59.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.82 -41.82 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.64 97.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.818 ' HG2' HD11 ' A' ' 208' ' ' LEU . 0.8 OUTLIER -97.89 118.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.1 mp -93.75 137.89 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mt -129.0 122.74 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.532 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 84.6 t80 -114.81 118.65 34.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.532 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 11.3 mm-40 53.14 32.95 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.968 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.88 82.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -106.12 131.15 53.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.818 HD11 ' HG2' ' A' ' 201' ' ' LYS . 9.5 tp -80.95 121.9 26.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.629 ' HB3' HG21 ' A' ' 185' ' ' VAL . 4.5 mt -81.56 40.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -47.58 -67.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 0.9 OUTLIER -44.35 104.32 0.38 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.77 2.77 3.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.618 2.212 . . . . 0.0 112.378 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.6 -10.22 14.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -61.22 117.13 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.5 p -67.08 141.14 57.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.12 -33.98 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -64.02 -44.85 91.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 m -65.3 -33.1 75.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.3 mt -77.78 3.46 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 30.7 t30 65.95 28.44 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.93 104.84 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.2 p -105.7 -174.76 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.41 150.04 43.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t30 69.27 26.32 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -102.32 140.47 36.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.1 p -105.45 140.37 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.424 HG21 HD23 ' A' ' 202' ' ' LEU . 20.6 mt -121.54 129.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -83.07 126.47 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 55.8 m -112.06 127.58 55.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.709 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.1 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 9.8 pt -108.5 143.18 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.68 141.77 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.8 t -134.39 137.39 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 226' ' ' VAL . 56.1 mtp180 -101.97 110.68 22.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.28 108.69 17.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 0.7 OUTLIER -98.78 131.6 44.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' CD1' HG23 ' A' ' 173' ' ' THR . 7.8 m-85 -107.62 166.04 10.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.65 -2.47 11.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.53 14.35 13.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t0 64.37 28.14 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.0 t -117.11 174.76 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 173' ' ' THR . 5.2 mp0 -147.98 147.78 30.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -138.29 128.99 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 177' ' ' ALA . 2.1 tm? -77.01 131.1 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 132.01 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.446 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 96.9 t -82.23 121.76 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -129.84 158.18 40.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 216' ' ' LEU . 27.9 mtm180 -117.11 152.47 48.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 0.0 110.847 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.79 9.04 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -108.5 -33.71 6.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.4 168.61 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 p -110.38 161.35 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.097 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.449 HG12 ' HD2' ' A' ' 189' ' ' LYS . 69.1 t -64.56 -44.11 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.82 78.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -72.1 -43.7 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.3 -47.35 75.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 9.3 mtpp -60.48 -46.99 88.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 27.7 t -70.56 -27.75 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.84 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.4 tmmm? -66.02 -47.62 73.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.971 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 63.3 m-85 -99.59 -44.46 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 7.9 m-85 -111.91 81.97 3.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 130.41 19.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.238 . . . . 0.0 112.343 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.74 -44.31 1.75 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -63.22 -6.87 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.944 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.3 mt-10 -49.6 -18.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 48.0 t -68.9 -46.54 68.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 201' ' ' LYS . 40.1 mt-30 -92.51 -46.11 7.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.71 85.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' GLN . 6.0 mtmp? -95.64 123.14 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 9.1 mt -93.32 138.36 31.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.0 mt -129.46 122.68 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 82.6 t80 -115.78 121.65 43.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.586 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 14.0 mm-40 55.87 47.52 19.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.58 57.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 16.4 ttm105 -111.05 134.19 52.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 24.9 tp -81.36 124.67 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.43 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.9 mt -78.33 45.35 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -47.15 -73.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -49.07 105.98 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.643 0.735 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 1.3 4.57 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.86 31.9 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -104.64 101.63 11.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 40.5 p -48.83 141.73 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.3 mt -60.48 -36.09 77.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.8 t -60.47 -41.24 93.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.7 t -70.7 -30.44 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.493 ' O ' ' CE2' ' A' ' 204' ' ' TYR . 36.5 mt -81.42 5.02 18.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 62.03 32.46 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 221' ' ' ILE . 43.1 mt -86.15 92.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.4 p -103.23 160.71 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -47.96 149.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 9.2 t30 72.49 32.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.3 t -113.69 145.26 41.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.8 p -110.35 130.78 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 10.0 mt -111.55 125.8 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -80.93 133.82 35.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.42 128.72 56.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 1.8 m80 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.461 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 16.7 pt -112.84 143.47 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 111.175 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.37 143.67 28.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 t -134.12 137.88 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.2 mtm180 -100.51 108.85 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 mt -85.15 109.69 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -98.82 133.49 43.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.0 m-85 -107.65 166.26 10.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.1 mt -70.92 -11.59 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HB2' HG22 ' A' ' 173' ' ' THR . 63.4 m-20 -85.16 18.08 2.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 63.47 25.01 14.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 4.0 t -113.46 162.46 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -138.32 148.12 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.6 128.76 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.537 ' C ' HD13 ' A' ' 176' ' ' LEU . 3.4 tm? -76.51 125.26 28.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.977 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -138.73 120.86 15.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 178' ' ' VAL . 11.9 p -81.99 121.44 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.538 ' HB1' ' OD2' ' A' ' 183' ' ' ASP . . . -129.91 158.66 38.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -107.94 154.05 41.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.845 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.6 Cg_endo -69.81 3.93 2.51 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.02 -25.78 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.552 ' OD2' HD11 ' A' ' 216' ' ' LEU . 1.0 OUTLIER -58.25 159.65 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 71.4 p -103.33 151.35 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 202' ' ' LEU . 88.5 t -57.02 -42.55 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.71 86.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -72.08 -42.9 65.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.115 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 179' ' ' ALA . 12.2 tp -55.0 -47.29 74.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 30.5 mttt -58.86 -47.87 83.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.416 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 45.2 t -70.73 -27.94 64.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.3 tmmm? -65.51 -47.63 75.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.977 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 50.0 m-85 -99.74 -44.47 6.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' LYS . 12.0 m-85 -110.46 82.07 2.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 123.71 10.37 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.09 -36.1 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.93 5.76 4.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 7.9 mt-10 -60.68 -9.58 4.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.5 t -75.89 -45.03 37.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' LYS . 36.1 mm-40 -92.07 -43.87 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.24 88.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 199' ' ' GLN . 39.6 mttp -99.28 121.49 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 185' ' ' VAL . 9.8 mt -93.9 139.06 31.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -129.42 123.07 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.501 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.2 t80 -117.23 113.78 22.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.501 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 29.1 mt-30 62.14 49.68 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.26 1.36 13.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -103.37 134.38 46.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.471 HD23 ' HG2' ' A' ' 210' ' ' GLN . 34.1 tp -80.8 124.89 29.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.7 mt -75.87 50.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.471 ' HG2' HD23 ' A' ' 208' ' ' LEU . 11.3 mm-40 -54.51 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 44.9 m-20 -44.68 103.91 0.36 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.76 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.36 14.48 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.083 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -82.94 98.09 9.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 p -47.24 139.92 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 216' ' ' LEU . 2.2 mt -57.52 -36.21 71.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.7 t -58.01 -42.58 85.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 t -71.73 -29.19 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.52 5.07 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.13 25.12 15.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 221' ' ' ILE . 28.7 mt -78.71 96.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.3 p -102.92 -176.72 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 154.23 40.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 63.52 36.2 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 2.0 t -116.51 151.5 35.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -111.84 136.27 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 mt -115.33 118.29 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.31 136.3 53.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 168' ' ' LYS . 5.8 m -117.24 143.32 46.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 2.0 m80 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 38.4 pt -97.12 140.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.405 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 5.2 m-20 -86.68 141.7 28.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.2 t -133.74 137.51 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HB2' HG23 ' A' ' 226' ' ' VAL . 19.2 mtm180 -98.63 118.58 35.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.1 mt -87.76 107.09 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -98.67 128.6 45.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.608 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.1 m-85 -107.76 158.91 16.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 230' ' ' HIS . 12.3 mt -62.01 -9.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -85.46 23.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 54.3 29.61 11.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.4 t -121.91 160.15 25.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -134.32 150.96 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -133.3 133.95 43.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp -77.37 117.57 18.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 1.008 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.75 125.69 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.434 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 93.9 t -91.66 123.68 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.4 158.18 33.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 216' ' ' LEU . 6.5 mpt_? -106.96 152.66 41.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.73 -10.34 28.33 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.727 2.285 . . . . 0.0 112.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 180' ' ' ARG . 17.0 pm0 -99.78 -33.49 10.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.95 166.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 32.0 p -107.82 162.33 14.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.625 HG13 HD12 ' A' ' 202' ' ' LEU . 94.2 t -64.82 -43.75 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -57.84 -34.89 72.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.5 m -72.18 -43.11 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.7 -47.3 77.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.9 mtpp -59.91 -47.1 87.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.444 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.4 t -70.79 -27.95 64.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.44 -48.09 71.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 1.008 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.2 m-85 -97.99 -44.07 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.1 m-85 -111.78 83.22 4.44 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 125.51 12.24 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.685 2.256 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.72 -41.17 1.89 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -66.54 -3.88 7.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.932 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 189' ' ' LYS . 18.2 mt-10 -52.24 -16.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 17.9 m -70.04 -46.5 64.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.63 -47.21 8.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.447 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -50.26 97.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.835 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.4 ttmt -104.63 119.03 38.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 185' ' ' VAL . 14.3 mt -93.57 135.15 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.38 123.01 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.566 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.4 t80 -117.0 120.86 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.566 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 86.2 mt-30 54.71 35.24 23.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.76 4.51 90.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -102.55 134.37 46.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.835 HD11 ' HG2' ' A' ' 201' ' ' LYS . 11.3 tp -80.06 119.65 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.68 45.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -52.75 -69.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -43.64 103.31 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.65 2.66 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.57 9.05 16.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -79.27 101.48 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.8 p -47.23 135.06 10.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.21 -31.35 65.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.4 t -64.11 -42.2 96.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 66.7 m -69.1 -35.6 76.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 76.2 mt -75.05 4.98 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.44 34.99 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 221' ' ' ILE . 54.2 mt -92.08 96.76 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 p -104.14 -177.83 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 224' ' ' ASN . 33.8 t-20 -67.87 153.16 44.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 223' ' ' ASN . 4.4 m120 64.1 46.9 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.65 148.21 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.1 p -110.33 141.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.19 121.06 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -68.11 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 14.4 m -118.25 131.21 56.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.437 ' CE1' HD11 ' A' ' 170' ' ' LEU . 6.1 m170 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -117.96 138.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.099 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.78 143.39 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.91 137.46 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.503 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.5 mtm180 -101.66 113.51 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 31.3 mt -85.18 111.19 19.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.86 131.67 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 173' ' ' THR . 10.1 m-85 -106.6 163.01 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 mt -66.29 -9.44 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.71 21.76 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 56.24 44.03 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 169' ' ' PHE . 14.5 t -131.98 165.29 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -139.56 144.54 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -131.14 128.92 41.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.96 118.42 16.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.79 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.07 121.3 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.7 123.39 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.66 158.13 39.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -112.51 154.23 44.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 2.92 3.08 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.354 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -109.25 -38.63 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -48.04 170.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 213' ' ' ALA . 3.3 p -110.96 158.32 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.183 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 214' ' ' ARG . 84.7 t -61.52 -43.96 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.6 94.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.7 -32.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -64.77 -47.08 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 193' ' ' PHE . 2.6 mtpm? -70.73 -39.84 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.407 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 9.5 t -72.43 -29.4 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.77 -47.41 59.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.79 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.5 m-85 -94.64 -22.47 18.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.6 m-85 -135.05 84.22 37.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.652 0.739 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 123.99 10.63 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.58 -42.31 1.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -9.68 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.407 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.0 mt-10 -49.29 -18.64 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -67.75 -48.29 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 230' ' ' HIS . 46.1 mt-30 -92.62 -45.13 8.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.887 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -57.04 90.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -101.14 120.73 40.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 28.1 mt -93.26 135.22 34.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 207' ' ' ARG . 17.9 mt -129.02 122.88 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.567 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 73.4 t80 -112.9 111.32 21.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.567 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 53.4 mt-30 64.15 50.14 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.7 3.19 26.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 203' ' ' ILE . 59.1 ttt180 -105.72 131.75 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 210' ' ' GLN . 32.2 tp -80.8 126.9 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.597 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.7 mt -78.08 46.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.574 ' HG3' HD23 ' A' ' 208' ' ' LEU . 27.4 mt-30 -48.36 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.33 103.06 0.3 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 2.55 3.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.721 2.28 . . . . 0.0 112.334 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.59 -27.94 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 185' ' ' VAL . 8.2 mmp_? -49.03 114.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.1 p -63.06 149.33 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.42 -31.81 71.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -65.38 -45.22 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 m -63.2 -33.45 75.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 185' ' ' VAL . 64.6 mt -79.99 3.81 18.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 m120 63.65 33.89 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 221' ' ' ILE . 55.7 mt -86.55 92.1 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.7 p -97.08 -176.01 3.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 224' ' ' ASN . 1.7 t30 -70.91 150.71 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.44 ' HB2' ' ND2' ' A' ' 223' ' ' ASN . 10.9 t-20 69.64 32.89 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.4 t -110.7 143.99 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -109.1 132.25 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 23.9 mt -111.04 125.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -79.76 132.57 36.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -113.13 127.64 56.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 199' ' ' GLN . 2.1 m80 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 14.8 pt -107.85 141.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.04 143.14 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 179' ' ' ALA . 24.5 t -131.57 134.1 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.468 ' HB2' HG23 ' A' ' 226' ' ' VAL . 34.5 mtm180 -100.82 115.35 30.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.4 mt -85.18 105.06 15.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -98.56 127.35 44.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.451 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.2 m-85 -106.53 163.46 12.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.42 -10.38 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.552 ' HB3' HG22 ' A' ' 173' ' ' THR . 51.8 t30 -84.86 30.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 2.1 p30 49.85 25.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 171' ' ' ASN . 6.9 t -118.51 161.11 20.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -141.09 149.15 41.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -132.42 128.73 38.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 177' ' ' ALA . 1.2 tt -73.66 125.1 27.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.712 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.82 128.29 20.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 178' ' ' VAL . 11.2 p -90.5 122.14 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.61 158.0 35.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.47 ' CZ ' ' OD2' ' A' ' 183' ' ' ASP . 11.9 mtm105 -112.84 154.52 44.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.641 0.734 . . . . 0.0 110.809 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -4.94 15.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 215' ' ' THR . 0.7 OUTLIER -103.75 -41.17 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.47 ' OD2' ' CZ ' ' A' ' 180' ' ' ARG . 1.4 m-20 -50.34 160.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.7 p -103.3 156.33 17.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.442 HG12 ' HD2' ' A' ' 189' ' ' LYS . 74.3 t -58.73 -41.65 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.165 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.05 93.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -69.02 -42.98 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.341 . . . . 0.0 111.18 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.32 -47.22 75.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.3 mtpt -57.79 -49.13 77.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 t -70.5 -28.06 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.78 -47.67 77.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.712 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.2 m-85 -100.25 -44.46 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 11.9 m-85 -107.77 80.96 1.06 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 123.63 10.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.48 ' CA ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.2 -30.83 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.487 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -82.96 19.74 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.743 0.306 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.48 ' OE1' ' CA ' ' A' ' 195' ' ' GLY . 28.3 mp0 -74.1 2.47 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 91.1 p -86.34 -48.48 8.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 201' ' ' LYS . 2.8 pt20 -89.52 -34.0 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -55.29 85.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.695 ' HG2' HD11 ' A' ' 208' ' ' LEU . 10.2 tttt -97.78 113.18 24.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 202' ' ' LEU . 1.0 OUTLIER -95.12 137.66 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.1 mt -129.31 122.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.501 ' HB3' HD21 ' A' ' 209' ' ' LEU . 66.4 t80 -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 57.74 50.56 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.08 3.0 9.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -104.03 132.44 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 201' ' ' LYS . 14.9 tp -79.76 128.84 33.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 204' ' ' TYR . 3.3 mt -84.72 35.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.515 ' HG2' HD23 ' A' ' 208' ' ' LEU . 7.6 mm100 -39.68 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -40.14 101.23 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.826 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 3.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.89 21.45 12.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -92.6 107.57 19.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.3 p -48.97 135.12 16.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.151 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.33 -31.71 65.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 92.7 p -63.17 -46.0 89.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.5 t -65.1 -33.66 76.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 26.6 mt -77.47 4.92 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 65.12 27.31 12.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.9 mt -83.55 104.2 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 56.1 p -108.73 -177.26 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.418 ' HB3' HG22 ' A' ' 163' ' ' ILE . 2.2 p30 -76.51 151.99 36.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.1 t30 74.01 25.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.81 162.77 13.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -123.62 133.6 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.432 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.7 mt -112.43 119.59 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -72.22 126.15 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.43 127.03 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 223' ' ' ASN . 20.5 pt -111.61 141.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.06 139.51 30.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.93 132.16 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.57 ' HB2' HG23 ' A' ' 226' ' ' VAL . 24.0 mtp180 -94.27 112.07 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 77.7 mt -85.32 104.57 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 2.4 tmmm? -98.57 134.73 41.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.431 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 44.3 m-85 -107.6 165.14 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.0 mt -67.42 -12.3 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 173' ' ' THR . 38.5 m-80 -83.59 18.76 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.52 27.06 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 5.0 t -115.55 160.51 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.7 150.59 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.79 129.09 34.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.77 119.56 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.54 119.66 12.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.445 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 84.7 t -89.59 121.74 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.98 158.12 32.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -110.94 154.84 43.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 217' ' ' SER . 53.7 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.363 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 215' ' ' THR . 14.8 pt-20 -111.24 -41.36 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -44.96 170.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 77.7 p -113.85 160.18 19.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 209' ' ' LEU . 89.4 t -63.36 -44.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.09 -42.2 96.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -70.25 -31.18 68.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -65.45 -47.35 76.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 193' ' ' PHE . 11.5 mtpt -67.3 -39.15 85.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 21.4 t -72.33 -31.92 66.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -70.71 -47.83 57.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.733 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 90.5 m-85 -91.23 -25.27 19.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 189' ' ' LYS . 23.5 m-85 -135.01 85.75 33.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.359 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 -39.15 2.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -65.57 -4.98 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 19.1 mt-10 -49.89 -18.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 11.4 m -63.03 -53.72 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 201' ' ' LYS . 11.0 mm-40 -86.91 -45.72 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.465 ' HG2' ' CG ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -49.26 87.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.735 ' HG2' HD11 ' A' ' 208' ' ' LEU . 1.8 ttmp? -103.94 116.56 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 227' ' ' ILE . 6.6 mp -93.48 137.51 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mt -129.29 122.45 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 70.9 t80 -114.98 113.8 24.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.3 mt-30 60.17 42.13 15.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.05 5.56 62.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -105.11 134.09 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.365 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.735 HD11 ' HG2' ' A' ' 201' ' ' LYS . 7.7 tp -79.8 130.39 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.49 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.5 mt -84.04 26.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 209' ' ' LEU . 19.4 mt-30 -34.69 -73.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 7.7 m-20 -37.05 99.36 0.18 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.46 -15.98 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -57.26 118.16 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.5 p -67.89 142.29 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -59.57 -31.54 69.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 181' ' ' PRO . 5.6 t -62.04 -47.05 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.3 t -67.49 -31.63 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.91 4.54 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.82 40.61 15.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 221' ' ' ILE . 53.6 mt -96.41 98.4 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -102.01 179.18 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 163' ' ' ILE . 1.5 p-10 -68.5 150.52 47.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.74 34.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.88 143.41 45.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -107.06 136.98 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.742 HG21 HD23 ' A' ' 202' ' ' LEU . 14.5 mt -117.83 120.49 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -72.11 128.8 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.82 132.5 56.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.4 pt -108.25 138.34 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.55 138.41 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.5 t -127.72 133.51 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -96.43 116.83 29.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 51.8 mt -85.07 106.99 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 226' ' ' VAL . 3.1 tmtm? -98.6 128.55 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' A' ' 173' ' ' THR . 3.7 m-85 -107.78 158.98 16.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.18 -7.56 6.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 25.9 t30 -83.52 17.99 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 60.15 27.41 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.531 HG23 ' CD1' ' A' ' 169' ' ' PHE . 13.9 t -121.17 172.71 7.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -143.58 152.39 41.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -133.85 135.23 43.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.93 119.6 20.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.87 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -143.27 120.0 11.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.45 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 94.1 t -89.52 121.93 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -120.68 158.16 28.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.514 ' O ' HD12 ' A' ' 216' ' ' LEU . 30.2 mtm180 -110.48 153.44 43.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.4 23.51 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -98.81 -39.9 8.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.19 165.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 213' ' ' ALA . 11.6 p -108.36 162.35 14.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 214' ' ' ARG . 98.8 t -63.77 -41.12 91.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.98 -36.58 93.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -70.71 -41.33 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.152 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.2 -47.26 75.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 193' ' ' PHE . 23.1 mttp -58.29 -48.41 80.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -70.7 -27.89 64.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.06 -47.75 73.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.903 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 192' ' ' TYR . . . . . 0.87 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.1 m-85 -99.16 -44.55 6.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.8 m-85 -112.88 76.06 2.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 128.07 15.49 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.58 -21.24 3.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -92.04 -5.21 53.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 13.2 mp0 -51.26 -18.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.3 m -62.87 -58.19 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -86.36 -36.56 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -59.94 90.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -103.54 125.05 49.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.6 mp -100.53 139.94 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.496 HG23 ' C ' ' A' ' 207' ' ' ARG . 19.4 mt -129.17 123.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.463 ' HB3' HD21 ' A' ' 209' ' ' LEU . 77.4 t80 -111.42 114.39 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 35.9 mt-30 62.2 48.52 4.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.8 2.43 29.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ARG . . . . . 0.496 ' C ' HG23 ' A' ' 203' ' ' ILE . 9.1 ttt180 -105.55 134.83 48.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.07 125.92 31.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.8 mt -76.56 47.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -50.13 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 12.3 m-20 -41.36 101.9 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.6 0.715 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.0 Cg_endo -69.75 -0.49 6.99 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 0.0 112.353 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.03 -24.45 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.5 mmt-85 -51.7 115.24 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 9.4 p -63.52 151.06 42.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.175 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.776 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.37 -34.61 78.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.1 t -63.97 -46.65 83.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.4 m -62.72 -35.71 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.9 mt -76.81 4.54 9.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 m120 62.94 39.08 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 221' ' ' ILE . 45.2 mt -92.68 89.0 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 62.6 p -95.15 170.23 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.77 157.65 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.89 38.89 8.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 144.52 48.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.5 p -109.63 141.3 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.522 HG21 HD23 ' A' ' 202' ' ' LEU . 28.4 mt -119.21 127.29 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -77.4 131.33 37.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 54.6 m -113.17 138.81 49.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -134.48 158.62 43.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 110.878 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.9 p -172.57 151.32 2.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.24 77.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.7 m -102.33 99.04 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.3 t -134.26 143.28 47.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.59 17.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 17.0 pt -104.91 143.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -92.68 138.64 31.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 179' ' ' ALA . 5.0 t -128.31 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HB2' HG23 ' A' ' 226' ' ' VAL . 31.7 mtm180 -99.97 118.44 36.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 42.3 mt -87.02 112.0 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -99.31 130.3 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.8 m-85 -107.72 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.1 mt -59.6 -10.76 3.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.51 15.51 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 62.87 31.63 16.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -123.59 174.31 7.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -142.77 157.39 44.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.07 132.29 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.9 tp -75.74 118.48 18.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.949 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.67 125.62 17.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 178' ' ' VAL . 12.1 p -91.93 121.83 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.06 157.59 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -112.11 153.17 44.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.85 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.54 -29.77 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -54.91 172.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.0 p -116.59 158.08 24.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.118 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.533 HG12 ' HD2' ' A' ' 189' ' ' LYS . 86.5 t -61.88 -43.72 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.01 -41.64 94.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.22 -45.56 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.0 tp -55.48 -47.12 76.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.533 ' HD2' HG12 ' A' ' 185' ' ' VAL . 24.9 mtpt -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -70.74 -28.1 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.98 -47.82 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.949 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 51.6 m-85 -99.93 -44.42 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 9.9 m-85 -109.71 79.52 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.5 28.12 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.46 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 74.74 -45.25 1.58 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.46 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -82.47 39.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 38.5 mp0 -85.53 -28.98 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 15.9 m -72.19 -13.59 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -110.83 -47.69 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.04 85.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.78 ' NZ ' HD21 ' A' ' 208' ' ' LEU . 11.7 mmtp -89.81 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.608 ' HB2' HD12 ' A' ' 209' ' ' LEU . 12.4 mt -106.26 141.25 37.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.7 mt -129.16 122.82 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.498 ' CB ' HD21 ' A' ' 209' ' ' LEU . 57.8 t80 -119.93 112.39 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 62.24 44.05 7.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.15 1.0 55.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -101.97 140.3 36.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.78 HD21 ' NZ ' ' A' ' 201' ' ' LYS . 15.0 tp -86.21 125.3 33.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.755 HD22 HD13 ' A' ' 219' ' ' LEU . 6.4 mt -83.25 20.79 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -34.62 -53.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.46 ' HB3' ' CG ' ' A' ' 214' ' ' ARG . 12.6 t0 -48.49 105.73 0.53 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.714 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -4.04 13.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.691 2.26 . . . . 0.0 112.384 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.13 -28.73 10.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.5 mmt180 -46.21 109.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.59 148.87 44.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -63.03 -31.5 72.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 t -64.59 -44.26 91.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 52.4 m -66.46 -35.99 81.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.755 HD13 HD22 ' A' ' 209' ' ' LEU . 95.4 mt -75.86 1.97 13.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 10.6 m120 67.05 25.04 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 216' ' ' LEU . 32.8 mt -77.97 103.65 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.2 p -103.52 -177.85 3.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 224' ' ' ASN . 1.0 OUTLIER -72.29 170.95 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 223' ' ' ASN . 4.4 p-10 47.71 30.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.9 t -107.97 159.57 16.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -119.2 138.72 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.8 mt -119.1 119.59 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -70.53 133.37 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 91.7 m -107.96 148.35 29.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -129.54 138.41 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 231' ' ' ARG . 21.3 ttm105 -113.21 126.7 55.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 154.44 40.3 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.682 0.754 . . . . 0.0 110.873 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 148.92 66.13 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.754 2.302 . . . . 0.0 112.318 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 99.83 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.341 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -97.91 31.89 7.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.12 148.99 43.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -119.16 37.22 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.01 140.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.3 t -151.63 127.35 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.831 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -169.98 146.08 9.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.22 8.39 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.329 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.9 m -62.15 126.74 28.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -102.08 142.27 33.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 61.4 p -117.28 102.59 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.9 p -147.03 134.05 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 106.02 85.49 1.82 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 165.5 30.69 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.364 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.5 m -151.54 113.23 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 55.4 m -127.74 110.54 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.53 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.6 m -82.47 141.22 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.813 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.8 m -122.27 101.67 7.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.856 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 44.56 88.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.2 m -102.06 101.31 11.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.824 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 t -110.82 90.88 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.24 -170.34 43.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.463 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 21.0 pt -110.33 138.84 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.34 137.13 32.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 179' ' ' ALA . 13.3 t -126.63 133.28 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.432 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.5 mtm180 -95.91 115.55 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.6 mt -86.48 106.55 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -98.78 133.96 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.853 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' THR . 6.0 m-85 -107.61 164.57 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.95 -11.79 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 32.9 t30 -85.36 16.32 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 62.41 30.17 17.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 169' ' ' PHE . 7.6 t -113.2 169.96 8.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -142.82 149.21 38.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -135.65 137.32 41.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.21 118.77 20.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.744 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -142.77 113.9 7.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.1 t -83.9 121.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.653 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -122.04 158.09 29.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -109.25 151.09 41.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.622 0.725 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.5 Cg_endo -69.75 -1.67 8.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.298 . . . . 0.0 112.319 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 17.1 pm0 -112.67 -17.07 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.89 -177.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.9 p -127.14 149.48 49.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.465 HG12 ' HD2' ' A' ' 189' ' ' LYS . 88.4 t -57.22 -39.57 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -63.19 -42.01 99.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.37 -44.79 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.57 -47.04 77.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.4 mtpt -58.38 -48.38 80.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 t -70.78 -27.99 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.7 tmmm? -65.05 -47.8 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.744 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 51.4 m-85 -99.82 -44.29 6.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 16.4 m-85 -108.64 75.99 0.65 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.641 0.734 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.68 28.5 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 0.0 112.33 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.456 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.51 -41.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -90.67 42.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 27.8 mp0 -88.11 -32.5 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.5 t -67.43 -24.91 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -98.57 -38.18 9.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -71.41 85.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -91.02 134.79 34.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.896 HD23 HG21 ' A' ' 227' ' ' ILE . 7.4 mp -109.55 141.65 41.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.14 122.89 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.5 t80 -115.42 113.0 23.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.461 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 68.3 mt-30 62.99 44.08 6.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.53 -0.27 43.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -102.68 131.29 49.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 33.5 tp -79.98 127.6 32.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 209' ' ' LEU . 4.4 mt -80.5 46.02 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -44.2 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -45.08 104.09 0.37 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.584 0.707 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 0.0 112.312 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.93 -17.73 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -54.3 117.98 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.1 p -65.71 147.01 54.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.49 -32.14 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 p -64.98 -46.9 79.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 p -61.59 -35.95 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.82 5.0 10.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.0 m120 62.2 34.22 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 221' ' ' ILE . 58.5 mt -87.29 93.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -98.21 -178.31 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.8 52.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.9 t30 73.59 37.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.1 t -119.0 145.86 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.6 p -110.54 141.36 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.896 HG21 HD23 ' A' ' 202' ' ' LEU . 23.0 mt -119.92 120.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -70.89 134.24 47.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 84.2 m -111.36 141.58 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -121.77 130.84 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -107.02 119.92 40.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.0 t -96.89 144.5 27.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.682 0.753 . . . . 0.0 110.831 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.54 63.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.726 2.284 . . . . 0.0 112.351 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 154.35 67.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.629 2.22 . . . . 0.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -112.96 -35.99 1.58 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.87 173.41 11.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 238' ' ' VAL . . . -115.15 127.87 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 237' ' ' ALA . 14.5 m 35.93 54.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 t -126.34 138.9 53.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 127.56 145.21 6.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 129.38 17.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.324 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.1 m -143.83 123.38 13.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -154.81 131.04 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.7 t -145.5 108.63 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.1 t -155.23 148.77 25.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.53 83.41 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 166.58 27.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 2.242 . . . . 0.0 112.349 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.0 t 68.43 35.64 3.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.6 m -117.92 -47.47 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.9 p -86.46 107.66 18.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.3 p -85.74 135.1 33.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.822 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -76.55 -125.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.6 m -145.34 163.19 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.4 p -55.41 154.69 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.97 -178.95 38.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.0 pt -101.29 143.99 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.61 136.26 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.49 136.62 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.635 ' HB2' HG23 ' A' ' 226' ' ' VAL . 13.5 mtp180 -99.79 123.09 43.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.867 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 192' ' ' TYR . 36.5 mt -91.49 107.4 19.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.72 133.29 43.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 6.0 m-85 -107.13 164.47 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.22 -7.68 14.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -84.89 9.47 14.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.39 26.39 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -119.14 160.0 22.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.183 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.01 154.2 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -133.98 128.97 35.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.0 tp -73.43 118.62 16.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.952 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.73 132.37 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.8 p -93.45 121.9 44.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -124.61 157.25 35.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 216' ' ' LEU . 36.0 mtp180 -110.4 154.97 42.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.78 -12.09 32.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.66 -36.62 10.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -47.38 168.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 213' ' ' ALA . 24.0 p -110.76 159.57 17.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.541 ' CG2' HD11 ' A' ' 219' ' ' LEU . 68.6 t -61.5 -35.78 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.9 -40.85 89.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -68.36 -38.49 81.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 111.123 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.7 tp -55.59 -46.6 77.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 6.2 mtpp -65.11 -42.05 94.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.8 t -71.02 -28.17 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.591 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.09 -48.14 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.952 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 7.7 m-85 -100.04 -43.65 6.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 24.3 m-85 -107.47 80.74 0.95 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.665 0.745 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 192' ' ' TYR . 53.7 Cg_endo -69.77 127.07 14.07 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.321 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.454 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.1 -41.96 1.83 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.55 39.43 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 37.8 mp0 -85.22 -36.55 20.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.3 t -64.06 -22.96 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.29 -34.61 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -79.35 85.24 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -88.24 134.45 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 13.5 mt -104.11 141.27 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.13 122.78 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 62.0 t80 -117.32 122.43 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.575 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.2 mm-40 53.46 48.61 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.15 33.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.55 142.15 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.441 ' N ' ' HD3' ' A' ' 207' ' ' ARG . 35.1 tp -87.68 121.94 30.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.8 mt -75.75 50.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.425 ' CG ' HD23 ' A' ' 208' ' ' LEU . 73.6 mt-30 -53.1 -71.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 16.5 t0 -42.23 102.57 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.846 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.5 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 184' ' ' THR . . . -107.11 -33.15 7.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -39.98 114.27 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.9 p -61.5 143.37 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -57.56 -31.84 66.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.6 p -64.74 -46.93 80.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.8 t -65.05 -32.32 73.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.541 HD11 ' CG2' ' A' ' 185' ' ' VAL . 48.5 mt -77.14 4.97 9.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.88 30.36 16.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.496 HG22 ' O ' ' A' ' 221' ' ' ILE . 55.2 mt -86.53 95.84 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.7 p -99.75 -175.13 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -74.79 159.79 31.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 62.27 28.88 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.85 157.1 20.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.6 p -119.68 133.68 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 35.2 mt -112.6 116.03 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.93 139.38 57.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.59 144.04 44.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -131.7 128.38 38.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -102.5 125.46 49.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.2 m -97.69 154.33 37.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 0.0 110.832 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 142.48 48.12 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 143.54 51.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.252 . . . . 0.0 112.37 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.89 -52.22 3.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -147.84 155.9 42.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.48 144.35 53.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.071 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.13 123.88 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.2 t -164.24 -179.59 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.85 147.21 4.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.538 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -45.0 1.72 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.661 2.241 . . . . 0.0 112.309 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.9 m 63.7 35.19 11.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -142.76 112.62 6.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 m -131.33 178.8 6.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.6 p -67.71 152.72 45.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.74 148.15 17.5 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 151.8 69.35 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.349 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 m -145.82 174.85 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 75.4 p -110.5 135.62 50.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.461 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.2 t -68.42 -61.38 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.0 t -77.42 108.03 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.63 71.72 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 t -69.91 -52.31 25.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.86 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 26.0 p -53.75 128.4 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.15 154.08 10.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 26.5 pt -93.75 145.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 111.124 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -89.49 129.76 35.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 179' ' ' ALA . 22.0 t -123.58 138.5 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.7 mtp180 -103.14 117.68 35.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.837 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.832 HD11 ' CD2' ' A' ' 192' ' ' TYR . 46.1 mt -85.21 108.1 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -99.03 129.5 45.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.2 m-85 -107.65 157.17 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.9 mt -63.55 -7.78 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -83.21 17.09 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 62.18 29.03 17.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 169' ' ' PHE . 11.5 t -123.79 167.12 14.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -139.65 153.23 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.25 131.0 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.8 tp -77.42 117.92 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.061 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -139.12 135.55 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 178' ' ' VAL . 14.9 p -94.8 123.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 165' ' ' VAL . . . -124.08 157.65 34.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -111.46 152.09 43.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.879 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.0 Cg_endo -69.74 -2.55 10.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.341 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.54 -38.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.14 172.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.6 p -114.45 164.57 13.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 209' ' ' LEU . 43.2 t -64.72 -40.41 88.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.89 -42.18 99.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.15 -47.01 82.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 193' ' ' PHE . 21.1 mtpt -63.66 -44.06 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.414 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 39.7 t -70.87 -28.21 64.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.593 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.12 -48.2 74.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.919 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 1.061 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 8.6 m-85 -99.94 -43.91 6.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 4.9 m-85 -112.66 78.63 2.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 131.7 21.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.46 -42.27 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -71.6 1.91 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.414 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 9.7 mt-10 -55.19 -14.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -64.41 -58.28 6.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 201' ' ' LYS . 6.1 pt20 -84.28 -37.2 21.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.459 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -52.6 85.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 199' ' ' GLN . 19.5 mttp -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 17.4 mt -93.67 137.07 33.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.94 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -129.08 122.89 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.7 t80 -114.86 119.75 37.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.4 mm100 54.39 48.45 20.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.73 41.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -102.61 139.08 38.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.64 HD23 ' HG3' ' A' ' 210' ' ' GLN . 41.0 tp -87.39 123.17 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.451 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.5 mt -79.09 47.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.64 ' HG3' HD23 ' A' ' 208' ' ' LEU . 12.3 mt-30 -50.38 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.79 103.29 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.597 0.713 . . . . 0.0 110.842 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.34 6.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.58 22.52 14.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -94.32 105.09 17.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.9 p -50.64 142.95 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.6 mt -62.26 -32.67 73.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.7 t -64.57 -45.94 84.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.1 m -65.08 -31.32 72.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.64 4.48 18.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.0 34.22 11.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 221' ' ' ILE . 57.5 mt -90.83 93.56 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 76.2 p -98.76 -176.66 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -69.39 150.64 47.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 72.44 33.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.2 t -113.39 149.88 33.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.7 p -116.12 134.51 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.0 mt -114.47 122.14 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -79.08 135.74 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -115.82 127.55 55.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -100.45 123.15 44.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -108.58 113.28 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -89.15 143.81 31.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 0.0 110.84 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 148.83 65.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 157.71 59.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.727 2.284 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -147.27 37.78 1.13 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.445 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.97 162.47 35.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 238' ' ' VAL . . . -115.12 99.57 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 237' ' ' ALA . 12.5 m 34.49 50.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.3 t -156.29 134.4 11.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -153.47 148.26 18.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.446 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -23.93 30.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 2.1 t 43.45 40.1 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -117.09 145.89 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.077 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t -153.05 174.27 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.3 p -130.94 174.24 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.47 16.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 150.62 68.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 72.7 m -78.77 82.74 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 47.3 p -118.59 84.5 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -85.71 141.81 29.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 t -60.45 115.14 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 77.95 77.08 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.4 m -69.81 170.62 10.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 110.883 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.6 m 50.4 38.23 17.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.52 173.26 22.39 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -97.99 151.53 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -101.12 139.12 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.29 132.31 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.458 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.8 mtm180 -94.38 117.58 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.726 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 38.6 mt -85.14 107.34 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -98.73 128.61 45.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 5.3 m-85 -107.32 157.26 18.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.08 -9.97 5.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 173' ' ' THR . 55.7 t30 -81.23 14.59 2.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 62.33 34.05 16.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 171' ' ' ASN . 5.1 t -130.53 157.43 42.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -128.16 153.5 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -134.32 136.25 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.51 116.69 18.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.794 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.65 116.56 10.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.9 t -82.4 121.86 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.079 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.441 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -122.36 158.13 30.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 216' ' ' LEU . 54.5 mtm-85 -110.54 152.85 43.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.56 0.695 . . . . 0.0 110.924 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.4 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -105.02 -36.82 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -49.59 169.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -111.65 160.1 17.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 202' ' ' LEU . 69.4 t -65.1 -44.11 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.59 88.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.53 -43.22 66.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 11.4 tp -55.36 -47.18 76.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.4 mtpt -58.63 -48.24 81.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.7 p -70.76 -27.97 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.587 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -65.19 -47.87 75.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.794 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 48.0 m-85 -99.95 -44.31 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.726 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 7.7 m-85 -111.84 77.44 1.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.689 0.757 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 128.02 15.38 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.24 -14.95 4.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -94.52 -12.49 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.727 0.299 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -48.56 -20.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m -61.54 -49.79 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 201' ' ' LYS . 29.3 mt-30 -91.97 -45.24 8.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.501 ' HE1' ' HG3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -52.14 85.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.779 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.9 ttmm -91.55 120.52 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.06 134.89 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.3 mt -129.13 123.46 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.9 t80 -115.45 116.5 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.1 mt-30 58.13 38.1 26.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.68 7.29 87.27 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -107.05 135.17 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.795 HD23 ' HG3' ' A' ' 210' ' ' GLN . 10.1 tp -80.15 127.03 31.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.4 mt -84.16 26.2 0.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.795 ' HG3' HD23 ' A' ' 208' ' ' LEU . 5.5 mt-30 -34.33 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.58 100.12 0.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 0.79 5.09 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.288 . . . . 0.0 112.36 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.88 16.01 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -89.5 112.83 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -57.92 137.19 56.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.7 mt -57.07 -34.7 68.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.3 t -61.37 -44.31 97.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.5 m -67.05 -35.94 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 mt -75.62 4.37 7.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.64 38.86 11.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 221' ' ' ILE . 52.5 mt -94.04 90.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.7 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.8 157.6 7.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 61.96 37.76 14.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 t -114.46 143.74 44.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.7 p -109.44 134.75 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.431 HG21 ' HB3' ' A' ' 202' ' ' LEU . 41.5 mt -115.45 129.93 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -83.66 127.36 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 1.8 t -111.14 122.42 47.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -99.83 130.26 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.501 ' HG3' ' HE1' ' A' ' 200' ' ' MET . 16.3 ttm180 -113.01 112.93 24.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 41.4 t -81.95 144.12 50.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.676 0.751 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 145.41 56.84 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 235' ' ' GLY . 53.9 Cg_endo -69.73 102.86 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.381 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -34.51 -59.23 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -141.68 155.24 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.14 90.5 6.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.02 -8.52 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 36.4 m -115.76 166.31 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -101.73 -164.88 27.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -17.46 37.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.8 p -42.84 156.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -126.9 118.5 24.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.086 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.0 t -97.73 137.47 36.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.4 t -170.56 151.15 3.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.8 67.51 0.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 142.1 46.92 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.324 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 249' ' ' SER . 12.1 t -63.95 152.36 40.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 248' ' ' SER . 52.6 p -36.54 147.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -47.55 142.68 4.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.818 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.4 t -89.14 151.26 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -179.14 47.24 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.502 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.7 t -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 p -73.16 167.05 21.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.817 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 138.09 167.05 10.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.507 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 19.2 pt -100.97 144.99 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.16 134.32 34.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.21 135.43 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HB2' HG23 ' A' ' 226' ' ' VAL . 17.2 mtm180 -100.68 118.19 36.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.69 HD11 ' CD2' ' A' ' 192' ' ' TYR . 30.4 mt -85.15 110.73 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -98.77 128.56 45.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.7 m-85 -107.69 158.5 17.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.41 -7.81 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -85.31 23.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 55.81 27.54 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -123.75 164.23 19.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.03 153.95 51.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -132.83 133.41 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.71 124.74 28.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.027 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.58 142.74 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.19 121.76 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.01 158.21 38.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 216' ' ' LEU . 32.5 mtm180 -115.86 154.18 48.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.85 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -4.86 14.85 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.05 -37.93 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.525 ' OD2' HG21 ' A' ' 187' ' ' THR . 0.9 OUTLIER -51.77 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.0 p -115.01 164.29 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.143 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 209' ' ' LEU . 50.0 t -57.06 -44.02 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.71 -36.62 90.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.525 HG21 ' OD2' ' A' ' 183' ' ' ASP . 3.0 m -71.36 -39.58 71.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.1 tp -55.52 -47.17 76.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 29.4 mttt -58.99 -47.92 83.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -70.12 -28.05 65.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.906 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.528 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -64.53 -48.14 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 1.027 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 4.0 m-85 -100.32 -44.58 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.9 m-85 -111.51 83.13 4.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.17 7.0 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.444 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.74 -26.88 2.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -79.84 -3.88 49.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 2.8 mp0 -52.11 -21.06 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.8 m -60.47 -51.66 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -93.3 -44.09 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.97 95.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -103.77 134.3 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.541 HD13 HD23 ' A' ' 188' ' ' LEU . 11.5 mt -101.06 138.94 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.486 ' CD1' ' CE1' ' A' ' 230' ' ' HIS . 45.1 mt -129.24 122.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.571 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 68.1 t80 -115.21 125.68 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 12.4 mm-40 52.72 46.09 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.3 2.23 40.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 203' ' ' ILE . 5.2 ttp-105 -102.78 144.94 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 25.6 tp -88.28 124.47 33.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.575 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.7 mt -75.71 48.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -51.44 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m-20 -42.31 102.48 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.615 0.722 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.2 Cg_endo -69.82 3.09 3.0 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -118.31 19.42 13.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -86.76 101.16 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 p -48.36 135.42 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -58.97 -37.6 77.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.4 t -59.59 -43.48 93.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -36.04 81.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 HH22 ' A' ' 207' ' ' ARG . 75.7 mt -76.67 5.12 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 63.02 32.94 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 221' ' ' ILE . 48.4 mt -85.54 89.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.5 p -95.73 179.66 5.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 157.96 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 63.6 39.53 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.2 149.49 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 226' ' ' VAL . 1.7 p -114.85 123.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 30.9 mt -105.99 124.02 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -74.4 130.77 40.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 88.6 m -103.81 149.41 25.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 203' ' ' ILE . 0.3 OUTLIER -127.24 127.1 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -113.2 112.75 24.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -90.36 143.05 28.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 147.27 62.28 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 0.0 112.359 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 157.51 60.13 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -105.01 -33.88 3.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.45 162.38 35.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.318 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.58 42.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.95 -15.44 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.4 t -56.11 100.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.888 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 84.78 146.92 8.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.493 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -29.81 23.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 23.7 m -140.7 178.86 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -106.97 94.09 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.0 m -64.6 108.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.0 m -96.7 103.31 15.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 165.47 167.98 26.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 151.73 69.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.252 . . . . 0.0 112.382 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 60.0 p -157.51 127.55 6.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 61.0 p -53.45 166.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.5 m -139.79 144.55 37.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.383 . . . . 0.0 110.85 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -134.17 131.54 38.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.879 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.39 162.18 11.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.0 m -165.29 154.75 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 0.0 110.872 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.7 p -97.79 142.96 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.28 164.37 14.31 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.7 pt -95.97 138.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.168 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -87.31 143.62 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.27 138.64 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.5 mtm180 -97.75 116.59 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 58.7 mt -85.18 109.19 18.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' CYS . 1.6 tmtm? -98.95 133.67 42.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.86 ' HB2' HG22 ' A' ' 173' ' ' THR . 1.9 m-85 -108.57 162.89 13.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 230' ' ' HIS . 19.0 mt -61.61 -22.74 65.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 173' ' ' THR . 11.2 p-10 -82.96 34.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 43.19 54.82 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.86 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -128.33 171.59 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.62 147.4 31.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.98 129.48 25.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 tp -77.39 117.82 19.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.8 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.96 140.31 34.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 178' ' ' VAL . 13.1 p -99.05 121.84 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -125.01 157.65 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 76.7 mtm-85 -110.83 152.08 43.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.82 0.22 6.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.59 -43.85 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.63 161.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 213' ' ' ALA . 20.0 p -103.28 164.25 11.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.89 -42.39 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.98 98.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -66.17 -38.01 87.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 111.198 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.9 tp -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.7 mtpt -66.67 -42.05 87.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -70.83 -28.2 64.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.583 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.02 -48.35 74.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 6.7 m-85 -99.98 -44.01 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.669 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 8.0 m-85 -109.98 78.89 1.38 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 131.33 20.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.455 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.79 -41.59 1.72 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.455 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -84.57 35.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.455 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 32.7 mp0 -83.42 -31.4 26.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.5 m -64.7 -19.73 65.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 230' ' ' HIS . 34.5 mt-30 -104.17 -45.02 4.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.77 85.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -88.51 122.21 31.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.95 137.54 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.404 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.3 mt -129.15 122.68 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.563 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 64.0 t80 -116.1 113.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.9 mt-30 62.93 43.55 6.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.32 4.61 60.72 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -106.83 131.62 53.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.425 HD23 ' HG3' ' A' ' 210' ' ' GLN . 39.8 tp -79.95 125.27 29.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.0 46.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.425 ' HG3' HD23 ' A' ' 208' ' ' LEU . 23.7 mt-30 -45.49 -67.84 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 19.6 t0 -44.61 103.93 0.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 52.9 Cg_endo -69.84 2.55 3.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.659 2.239 . . . . 0.0 112.286 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 184' ' ' THR . . . -106.92 -30.53 8.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -41.47 123.3 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.3 p -70.29 150.39 46.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -64.45 -35.63 81.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.0 p -63.55 -46.07 87.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -63.72 -34.45 77.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 59.3 mt -77.84 4.49 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 67.0 29.34 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 84.8 mt -87.02 92.05 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.0 p -101.77 -175.73 2.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -70.24 154.46 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 62.45 38.3 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.92 146.29 47.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.2 p -107.32 142.22 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.68 119.56 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -66.18 137.66 57.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 168' ' ' LYS . 83.1 m -120.26 146.72 45.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 170' ' ' LEU . 4.2 m-70 -127.28 141.57 51.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.417 ' HD2' ' C ' ' A' ' 231' ' ' ARG . 2.7 tmm_? -112.3 123.78 51.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 72.1 m -92.19 143.37 27.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.655 0.74 . . . . 0.0 110.824 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 146.55 60.54 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 235' ' ' GLY . 53.9 Cg_endo -69.72 98.19 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.702 2.268 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -34.82 -46.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.75 155.25 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.1 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.26 141.47 35.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.05 170.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 52.1 p -127.08 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 75.36 141.63 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 242' ' ' SER . 53.5 Cg_endo -69.77 170.92 15.45 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.737 2.291 . . . . 0.0 112.301 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' PRO . 26.0 p -37.11 137.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.7 151.96 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.2 t -94.49 -47.9 6.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.5 t 56.6 42.59 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.4 73.1 0.26 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 98.41 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.6 t -92.19 153.86 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 2.3 t -161.67 137.25 7.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 85.4 p -95.6 176.62 6.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.898 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.0 m -84.4 132.72 34.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.68 55.6 2.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.0 m -49.79 -48.15 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.877 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.6 t -124.07 103.04 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.83 30.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.4 pt -120.07 138.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.806 0.336 . . . . 0.0 111.144 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -87.96 143.2 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 179' ' ' ALA . 16.3 t -131.7 137.47 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.408 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtm180 -100.59 117.55 34.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.615 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.0 mt -86.67 107.88 18.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -98.88 128.32 45.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 173' ' ' THR . 1.6 m-85 -107.5 160.23 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 230' ' ' HIS . 70.4 mt -66.71 -6.24 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -84.83 16.37 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 63.0 26.93 15.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.622 HG23 ' CD1' ' A' ' 169' ' ' PHE . 6.1 t -120.84 168.26 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -144.48 149.9 36.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -135.77 129.18 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -73.27 120.29 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.031 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.14 125.96 24.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.451 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 6.2 p -86.57 123.07 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -126.31 157.97 37.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -111.96 153.49 44.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -5.61 16.61 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.375 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.76 -38.41 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -51.36 173.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 41.5 p -118.91 164.36 15.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 209' ' ' LEU . 54.2 t -64.37 -43.99 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.78 83.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -44.59 63.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.167 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.1 tp -55.14 -47.12 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HD2' HG12 ' A' ' 185' ' ' VAL . 33.6 mtpt -57.98 -48.57 79.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 94.0 p -70.93 -27.92 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.66 -47.55 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 1.031 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 86.4 m-85 -98.7 -44.44 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.615 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.3 m-85 -113.65 79.14 4.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 134.31 27.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.04 -44.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -68.77 -1.46 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.738 0.304 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.438 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 13.2 mt-10 -51.56 -20.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.7 t -58.83 -59.29 5.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 201' ' ' LYS . 0.0 OUTLIER -82.92 -42.2 17.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.461 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -45.14 91.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.857 ' HG2' HD11 ' A' ' 208' ' ' LEU . 17.8 ttmt -105.29 117.94 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.614 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.72 137.12 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.27 122.9 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.449 ' HB3' HD21 ' A' ' 209' ' ' LEU . 63.5 t80 -116.14 111.9 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 57.97 51.51 8.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.59 5.87 39.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.73 136.55 43.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.857 HD11 ' HG2' ' A' ' 201' ' ' LYS . 12.1 tp -85.32 121.07 27.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.652 ' HB3' HG21 ' A' ' 185' ' ' VAL . 7.2 mt -79.46 44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.959 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -52.14 -72.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 214' ' ' ARG . 9.2 t70 -42.24 102.5 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.698 . . . . 0.0 110.896 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.02 3.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.51 8.66 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.455 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 8.4 mmm-85 -82.33 105.81 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 17.6 p -51.36 142.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.2 mt -62.09 -31.74 72.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 85.8 p -63.3 -44.35 95.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -35.4 79.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.97 5.0 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.65 26.07 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.547 HG22 ' O ' ' A' ' 221' ' ' ILE . 51.6 mt -81.18 93.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.3 p -96.31 -175.58 3.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.95 158.18 33.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 62.91 29.18 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.9 t -110.22 154.82 22.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.9 p -117.11 138.98 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.7 mt -116.15 122.78 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -73.53 134.09 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 60.3 m -120.14 133.9 55.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.409 ' CE1' HD11 ' A' ' 170' ' ' LEU . 4.6 m170 -111.07 127.3 55.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -113.32 112.95 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.3 t -102.33 143.13 25.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 138.25 37.36 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.317 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 128.16 15.6 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -42.71 -75.4 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.488 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.4 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -40.12 114.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.5 m -40.1 140.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -152.7 119.1 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.36 95.94 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.474 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 80.34 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 88.0 p -160.64 150.26 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -165.43 169.13 15.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 77.8 p -62.2 177.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 35.0 t -53.17 96.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 150.2 146.71 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.452 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -177.42 1.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.731 2.287 . . . . 0.0 112.32 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.9 m -148.73 144.92 27.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 42.9 m -65.02 -49.77 68.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.0 t -50.86 -44.15 59.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.827 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.0 m -64.15 -60.12 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.12 153.7 41.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.5 m -60.09 -50.99 71.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.835 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.4 m -153.73 129.56 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.39 -179.6 9.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.6 pt -95.96 144.81 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.28 134.63 34.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.508 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtp180 -96.79 117.06 30.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.4 mt -85.67 107.14 17.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -99.06 127.87 45.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.45 ' CD1' HG23 ' A' ' 173' ' ' THR . 4.0 m-85 -105.42 161.48 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 229' ' ' CYS . 5.3 mp -67.47 -7.71 27.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.11 16.23 2.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.8 t70 63.29 30.15 15.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.45 HG23 ' CD1' ' A' ' 169' ' ' PHE . 14.7 t -125.15 174.91 7.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -148.22 150.14 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -130.23 134.13 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.6 tp -80.87 122.5 27.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.947 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 141.24 33.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.88 121.91 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -126.48 157.91 37.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 216' ' ' LEU . 70.8 mtt180 -113.95 154.51 45.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.72 8.95 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.363 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.26 -39.21 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.11 170.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.7 p -112.76 161.99 16.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 209' ' ' LEU . 66.9 t -64.24 -40.18 88.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.12 97.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.8 m -67.04 -36.28 81.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -56.12 -46.69 79.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 17.6 mttp -64.76 -41.79 95.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.405 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 74.4 p -70.6 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.69 -48.69 73.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.947 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 10.3 m-85 -100.33 -43.58 6.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 20.2 m-85 -110.83 80.47 2.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.18 14.18 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.78 -39.99 1.81 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -84.11 28.68 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 5.1 mt-10 -80.13 -18.72 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.8 t -75.71 -24.15 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.67 -44.3 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.65 86.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.89 121.15 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.69 HD23 HG21 ' A' ' 227' ' ' ILE . 6.8 mp -96.88 139.13 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.1 mt -129.05 122.97 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 74.4 t80 -114.06 111.78 22.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 56.4 mt-30 63.31 42.36 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.77 0.77 64.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.04 131.99 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 tp -81.5 122.36 27.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.8 mt -76.21 53.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.46 -71.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -42.03 102.3 0.27 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.72 . . . . 0.0 110.929 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.74 2.43 3.53 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.385 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.47 14.25 19.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -89.1 101.2 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.1 p -47.8 143.22 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -59.59 -39.99 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.3 p -58.72 -44.77 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -63.92 -34.05 77.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.848 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 78.9 mt -77.91 4.69 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 62.52 36.44 13.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 221' ' ' ILE . 53.8 mt -90.88 94.48 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.2 p -100.32 173.75 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.1 153.42 37.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.4 t30 69.37 38.44 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 t -120.55 151.42 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.5 p -115.11 136.29 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.69 HG21 HD23 ' A' ' 202' ' ' LEU . 28.9 mt -115.37 130.04 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -83.4 127.08 33.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.584 ' O ' HD12 ' A' ' 170' ' ' LEU . 58.0 m -109.02 136.13 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.51 ' ND1' HD11 ' A' ' 170' ' ' LEU . 7.6 m80 -112.66 131.72 55.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.86 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HG3' ' HE1' ' A' ' 200' ' ' MET . 49.6 ttm-85 -110.16 128.67 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.0 t -115.65 139.44 24.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 0.0 110.859 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 126.71 13.65 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.682 2.255 . . . . 0.0 112.404 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 79.96 0.91 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.718 2.279 . . . . 0.0 112.345 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.24 -90.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -174.87 122.75 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.074 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.87 165.34 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.92 144.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.19 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 44.6 t -51.1 115.75 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -171.59 153.31 19.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 163.83 36.8 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.312 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.0 t -124.25 -59.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -148.36 141.22 24.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.073 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 t -95.57 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 29.0 p -107.03 41.65 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.24 -75.94 0.49 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 1.75 4.16 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.312 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.7 t -67.35 109.67 3.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 96.3 p -98.59 152.73 19.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 m -55.11 125.29 19.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.0 p -127.22 146.37 50.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.8 42.04 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 42.0 t -157.41 147.12 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.6 m -59.56 169.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.14 179.15 30.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.68 HG22 ' HB3' ' A' ' 223' ' ' ASN . 13.0 pt -108.19 145.38 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.91 138.84 32.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.43 137.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.896 ' HB2' HG23 ' A' ' 226' ' ' VAL . 9.1 mtt180 -98.07 125.23 42.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.506 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.1 mt -92.53 104.52 16.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.73 133.69 42.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 173' ' ' THR . 3.9 m-85 -107.27 166.33 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 230' ' ' HIS . 14.4 mt -70.6 -14.21 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 173' ' ' THR . 3.0 p30 -78.15 4.12 13.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.2 t70 73.97 47.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.548 HG22 ' OD1' ' A' ' 171' ' ' ASN . 1.3 t -135.46 171.82 13.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -142.96 153.94 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.55 130.44 23.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.79 117.82 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.044 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.1 123.48 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.57 123.76 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -127.18 157.67 39.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 216' ' ' LEU . 73.7 mtm-85 -107.99 153.6 41.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.75 -1.15 7.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.26 -33.22 6.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -50.18 173.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 2.6 p -117.21 159.09 23.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.96 -40.19 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.58 -37.32 94.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -70.44 -42.5 71.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.168 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.34 -47.27 75.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 26.4 mtpt -58.87 -48.11 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.447 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.7 t -70.57 -27.99 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.557 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.5 tmmm? -65.02 -48.06 75.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 1.044 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 54.9 m-85 -100.01 -44.48 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.07 77.23 2.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 134.72 28.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.349 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.08 -42.42 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.29 -9.87 50.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.447 ' OE2' ' CB ' ' A' ' 190' ' ' SER . 13.1 mt-10 -45.51 -22.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.6 t -55.92 -61.24 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -84.19 -42.61 15.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -44.83 113.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -126.3 122.28 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.83 141.21 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.9 mt -129.13 122.81 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 61.2 t80 -116.33 110.94 19.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.446 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 67.2 mt-30 62.38 53.37 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.92 3.74 11.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -104.88 136.47 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.8 tp -84.42 125.39 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -79.99 54.43 1.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -54.96 -73.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.414 ' HB2' ' CG ' ' A' ' 214' ' ' ARG . 28.5 m-20 -43.34 103.15 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.88 7.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.3 23.13 13.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.414 ' CG ' ' HB2' ' A' ' 211' ' ' ASP . 18.0 mmt180 -91.94 108.33 19.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.5 p -52.8 138.41 29.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.8 mt -57.8 -32.22 67.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.4 t -64.75 -42.6 95.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 34.5 t -67.67 -35.41 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.6 mt -76.47 1.77 15.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.2 m120 67.17 28.87 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 221' ' ' ILE . 53.5 mt -84.45 96.08 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.5 p -100.46 -175.71 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.68 ' HB3' HG22 ' A' ' 163' ' ' ILE . 7.0 p30 -76.04 148.6 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 74.2 27.15 1.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.65 158.87 17.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -121.67 131.69 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.42 124.14 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.75 138.98 39.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 39.3 m -120.68 138.55 53.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 170' ' ' LEU . 9.3 m170 -119.68 122.78 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -99.67 113.88 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.6 m -78.68 149.81 75.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.19 62.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.07 34.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -129.39 76.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . 44.79 45.54 8.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.079 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.1 122.38 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.071 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 239' ' ' SER . 14.8 p -133.64 155.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.443 ' N ' HG22 ' A' ' 238' ' ' VAL . 78.3 p -151.42 138.35 19.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -97.35 -121.42 4.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 107.0 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.711 2.274 . . . . 0.0 112.311 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 8.1 t -101.74 92.08 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 60.71 38.2 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 94.0 p -124.63 142.87 51.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.0 m 44.78 47.44 8.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.53 84.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.72 68.36 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.693 2.262 . . . . 0.0 112.312 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.1 t -126.24 -41.59 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 77.5 p -117.77 42.24 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 t -171.76 137.69 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.824 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.9 p -76.29 164.86 25.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.66 -122.03 28.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.5 m -164.7 164.85 21.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 t -56.05 -62.07 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.815 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.88 20.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 19.6 pt -99.87 152.39 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.367 . . . . 0.0 111.081 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.07 141.94 30.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.97 137.12 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -101.6 115.79 31.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.652 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 35.6 mt -85.74 106.05 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 229' ' ' CYS . 2.4 tmmm? -98.77 134.23 41.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.66 165.55 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.506 HD11 ' CD2' ' A' ' 230' ' ' HIS . 76.6 mt -68.57 -6.98 28.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -87.05 13.34 9.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.67 35.91 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -128.66 156.57 43.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -129.62 149.9 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -130.54 132.42 45.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.77 118.95 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.776 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -143.27 120.35 11.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 178' ' ' VAL . 12.6 p -88.36 121.85 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.25 158.16 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.408 ' HB3' ' CD ' ' A' ' 182' ' ' GLU . 62.0 mtm180 -111.45 152.6 44.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.11 3.82 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.701 2.267 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 182' ' ' GLU . 14.2 pm0 -113.32 -23.94 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.82 179.66 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.2 p -119.75 158.65 26.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 214' ' ' ARG . 93.5 t -62.57 -43.42 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.77 96.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -69.68 -31.72 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 111.122 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -66.91 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 193' ' ' PHE . 7.4 mtpp -70.02 -38.6 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.9 t -72.28 -29.89 64.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.86 -47.09 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.776 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 65.1 m-85 -94.72 -21.26 18.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 5.1 m-85 -135.02 74.55 62.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 125.06 11.7 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.42 3.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' SER . 27.6 mt-30 -86.59 -15.69 39.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -42.61 -23.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLN . 75.1 p -59.38 -52.54 65.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -88.89 -36.41 15.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -62.15 100.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -107.93 121.62 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.483 ' HG ' ' HZ2' ' A' ' 189' ' ' LYS . 23.9 mt -94.01 136.98 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.2 122.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.6 t80 -113.48 119.98 39.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 4.9 mm100 55.45 44.2 27.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.24 2.45 59.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 32.3 ttm-85 -102.27 137.69 40.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.838 0.351 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.88 120.54 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.4 mt -75.98 53.87 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -53.34 -73.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -46.23 104.59 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 1.74 4.15 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.707 2.272 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.08 20.81 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.1 mmt-85 -90.42 107.16 18.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 p -52.39 141.49 19.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.779 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -62.01 -31.96 72.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 p -65.34 -43.11 91.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.8 t -67.65 -34.71 77.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.92 5.0 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 63.27 37.0 11.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 221' ' ' ILE . 58.1 mt -92.56 95.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.0 p -96.75 -174.98 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.19 142.43 52.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 73.72 24.98 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.54 140.02 30.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -105.16 133.37 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.8 mt -116.35 122.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -72.49 139.43 47.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' LYS . 60.6 m -116.3 145.25 43.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.506 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.4 m170 -123.32 123.88 41.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.418 ' HD2' ' C ' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -109.14 120.76 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.843 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.3 t -98.23 148.23 34.22 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.704 0.764 . . . . 0.0 110.866 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 148.55 65.18 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.636 2.224 . . . . 0.0 112.377 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 119.93 6.8 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.634 2.222 . . . . 0.0 112.344 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.53 -42.17 99.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -137.96 119.75 15.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.92 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.18 134.55 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 m -61.61 136.66 58.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -151.3 150.32 22.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -8.9 24.78 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.7 m -68.07 71.43 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 244' ' ' SER . . . -119.41 140.67 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 243' ' ' ALA . 4.3 m -35.21 145.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 26.3 t -122.89 105.18 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.72 82.82 1.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 93.51 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.686 2.258 . . . . 0.0 112.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 t 62.64 38.51 12.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 6.8 t -162.94 143.57 9.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.9 m -110.16 124.49 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -99.26 137.69 37.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.85 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.32 -61.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.1 m -89.4 106.13 18.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.865 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.2 p -97.41 161.63 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.08 173.99 37.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.4 pt -95.19 144.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 111.183 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.535 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 2.5 m-20 -93.47 139.48 30.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.9 t -129.41 134.63 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 226' ' ' VAL . 18.2 mtp180 -99.55 118.72 36.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.529 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 28.3 mt -85.12 107.07 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -98.72 128.26 44.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.0 m-85 -107.24 161.49 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.29 -5.01 12.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -82.38 7.28 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.9 t0 70.86 31.23 2.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -129.64 170.57 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.85 155.71 46.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -136.39 137.68 40.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 14.9 tp -75.48 120.62 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.847 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.98 115.55 8.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.44 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 90.4 t -87.73 122.12 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.05 158.12 34.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -108.9 153.4 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 0.42 5.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.47 -33.17 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.63 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.6 p -124.43 157.39 35.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 209' ' ' LEU . 70.8 t -61.53 -41.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.32 93.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.4 m -71.61 -40.15 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.42 -47.09 76.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' PHE . 31.3 mttt -58.66 -48.06 82.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.4 p -70.71 -28.11 64.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.2 tmmm? -65.44 -47.73 75.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.847 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 73.0 m-85 -99.8 -44.46 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.2 m-85 -113.32 79.23 3.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 110.843 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 126.03 12.87 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 2.25 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.403 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.57 -20.94 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -87.59 -13.5 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 189' ' ' LYS . 5.4 mp0 -46.0 -22.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.9 m -60.89 -52.08 66.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -92.43 -38.51 11.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.27 89.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -96.65 133.86 40.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.28 137.15 40.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.579 ' CD1' ' CE1' ' A' ' 230' ' ' HIS . 19.8 mt -129.22 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.447 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 67.3 t80 -114.08 113.93 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.4 mt-30 62.45 44.62 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.01 0.31 50.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -102.23 133.13 47.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.7 tp -80.52 126.15 30.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 185' ' ' VAL . 7.1 mt -76.86 48.19 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -47.81 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.31 105.24 0.47 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.705 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 2.97 3.09 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.628 2.219 . . . . 0.0 112.366 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.61 -27.64 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.9 mmt-85 -44.87 102.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 48.2 p -54.18 150.65 8.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.813 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.67 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.2 p -64.93 -43.55 92.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.0 m -68.59 -35.26 77.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.4 mt -75.76 4.76 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.3 37.87 10.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 221' ' ' ILE . 50.6 mt -92.61 102.54 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -106.65 -174.3 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 20.4 t-20 -69.45 152.15 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.8 m120 64.18 31.99 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.62 143.83 32.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.3 p -110.95 134.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.8 mt -116.02 126.98 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -78.46 130.89 36.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 98.7 m -103.21 152.21 21.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.579 ' CE1' ' CD1' ' A' ' 203' ' ' ILE . 1.0 OUTLIER -128.54 124.92 37.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -108.01 123.85 49.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.1 t -108.67 143.66 27.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.682 0.753 . . . . 0.0 110.852 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 147.83 64.06 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.1 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.722 2.282 . . . . 0.0 112.312 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 140.81 48.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -152.01 158.86 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.82 -179.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.47 136.86 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.2 t -142.12 150.8 41.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -178.47 155.22 16.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 167.02 25.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.9 p -76.31 155.29 34.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.76 51.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 66.1 m -155.43 124.8 6.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 246' ' ' GLY . 58.1 m -129.77 139.15 51.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 245' ' ' SER . . . -32.05 95.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.443 ' N ' ' O ' ' A' ' 245' ' ' SER . 53.4 Cg_endo -69.74 119.73 6.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 94.1 p -150.95 135.21 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 36.3 m -40.77 -62.45 0.8 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.869 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 m -86.77 161.97 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.4 t -112.87 98.38 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.78 -153.4 6.96 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.9 t 62.59 42.61 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 110.867 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 m -140.17 152.37 45.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.23 159.24 10.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.4 pt -96.36 140.16 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.28 138.78 31.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.4 t -128.59 138.04 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.789 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.4 mtm-85 -97.59 122.7 40.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.534 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 65.0 mt -93.14 104.84 17.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -98.66 130.17 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.5 m-85 -107.6 158.35 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 230' ' ' HIS . 52.1 mt -63.41 -7.87 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -83.27 19.8 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.67 35.0 24.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.9 t -129.91 175.15 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -144.89 154.69 42.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -136.29 129.01 30.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.31 121.32 21.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.156 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.91 138.75 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.523 ' O ' HG13 ' A' ' 178' ' ' VAL . 11.2 p -99.91 121.93 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.28 157.76 34.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.083 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 216' ' ' LEU . 18.4 mtt180 -113.4 152.89 45.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.1 Cg_endo -69.71 -0.9 7.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -109.59 -38.98 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.69 173.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.8 p -116.78 162.29 17.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 209' ' ' LEU . 26.1 t -60.16 -42.48 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.181 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.36 -41.91 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 m -66.95 -41.68 86.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 179' ' ' ALA . 13.2 tp -57.68 -45.54 85.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.3 mtpt -65.39 -44.61 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.8 t -70.67 -28.03 64.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.582 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.43 -48.74 74.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 1.156 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 14.6 m-85 -100.48 -43.41 6.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.8 m-85 -110.67 80.59 2.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 128.04 15.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.67 -40.36 1.81 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -83.81 31.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.936 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -83.04 -20.73 34.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 5.3 t -74.57 -26.1 59.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.82 -41.82 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.64 97.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.818 ' HG2' HD11 ' A' ' 208' ' ' LEU . 0.8 OUTLIER -97.89 118.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.1 mp -93.75 137.89 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mt -129.0 122.74 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.532 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 84.6 t80 -114.81 118.65 34.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.532 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 11.3 mm-40 53.14 32.95 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.968 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.88 82.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -106.12 131.15 53.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.818 HD11 ' HG2' ' A' ' 201' ' ' LYS . 9.5 tp -80.95 121.9 26.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.629 ' HB3' HG21 ' A' ' 185' ' ' VAL . 4.5 mt -81.56 40.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -47.58 -67.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 0.9 OUTLIER -44.35 104.32 0.38 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.77 2.77 3.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.618 2.212 . . . . 0.0 112.378 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.6 -10.22 14.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -61.22 117.13 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.5 p -67.08 141.14 57.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.12 -33.98 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -64.02 -44.85 91.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 m -65.3 -33.1 75.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.3 mt -77.78 3.46 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 30.7 t30 65.95 28.44 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.93 104.84 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.2 p -105.7 -174.76 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.41 150.04 43.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t30 69.27 26.32 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -102.32 140.47 36.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.1 p -105.45 140.37 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.424 HG21 HD23 ' A' ' 202' ' ' LEU . 20.6 mt -121.54 129.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -83.07 126.47 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 55.8 m -112.06 127.58 55.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.709 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.1 m170 -105.91 136.97 44.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -106.15 128.84 54.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.6 143.72 30.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.688 0.756 . . . . 0.0 110.864 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.85 52.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.694 2.263 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 139.03 39.37 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.373 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -89.22 -38.38 6.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -169.15 155.59 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.86 123.18 26.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.5 m -69.47 157.4 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 42.9 p -164.22 156.2 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 168.59 147.58 5.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 150.04 67.95 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.1 t -131.06 143.74 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -157.47 120.15 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 44.9 t -90.89 155.32 18.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 60.1 p -174.15 163.4 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -68.76 173.26 34.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -48.35 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.714 2.276 . . . . 0.0 112.338 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 249' ' ' SER . 7.3 t -66.28 146.85 54.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 248' ' ' SER . 27.7 t -36.92 -46.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.818 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.492 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.3 m -90.87 121.87 33.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.875 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.1 m -48.74 -54.33 15.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.2 128.22 7.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.7 p -135.79 119.97 17.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 110.836 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.6 p -113.11 106.71 14.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.16 -177.32 43.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 9.8 pt -108.5 143.18 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -86.68 141.77 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.8 t -134.39 137.39 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 226' ' ' VAL . 56.1 mtp180 -101.97 110.68 22.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.28 108.69 17.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 0.7 OUTLIER -98.78 131.6 44.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' CD1' HG23 ' A' ' 173' ' ' THR . 7.8 m-85 -107.62 166.04 10.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.65 -2.47 11.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.53 14.35 13.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t0 64.37 28.14 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.0 t -117.11 174.76 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 173' ' ' THR . 5.2 mp0 -147.98 147.78 30.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -138.29 128.99 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 177' ' ' ALA . 2.1 tm? -77.01 131.1 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 132.01 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.446 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 96.9 t -82.23 121.76 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -129.84 158.18 40.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 216' ' ' LEU . 27.9 mtm180 -117.11 152.47 48.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 0.0 110.847 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.79 9.04 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -108.5 -33.71 6.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.4 168.61 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 p -110.38 161.35 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.097 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.449 HG12 ' HD2' ' A' ' 189' ' ' LYS . 69.1 t -64.56 -44.11 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.82 78.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -72.1 -43.7 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.3 -47.35 75.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 9.3 mtpp -60.48 -46.99 88.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 27.7 t -70.56 -27.75 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.84 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.4 tmmm? -66.02 -47.62 73.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.971 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 63.3 m-85 -99.59 -44.46 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 7.9 m-85 -111.91 81.97 3.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 130.41 19.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.238 . . . . 0.0 112.343 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.74 -44.31 1.75 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -63.22 -6.87 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.944 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.3 mt-10 -49.6 -18.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 48.0 t -68.9 -46.54 68.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 201' ' ' LYS . 40.1 mt-30 -92.51 -46.11 7.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.71 85.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' GLN . 6.0 mtmp? -95.64 123.14 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 9.1 mt -93.32 138.36 31.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 29.0 mt -129.46 122.68 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 82.6 t80 -115.78 121.65 43.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.586 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 14.0 mm-40 55.87 47.52 19.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.58 57.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 16.4 ttm105 -111.05 134.19 52.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 24.9 tp -81.36 124.67 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.43 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.9 mt -78.33 45.35 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -47.15 -73.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -49.07 105.98 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.643 0.735 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 1.3 4.57 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.86 31.9 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -104.64 101.63 11.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 40.5 p -48.83 141.73 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.3 mt -60.48 -36.09 77.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.8 t -60.47 -41.24 93.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.7 t -70.7 -30.44 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.493 ' O ' ' CE2' ' A' ' 204' ' ' TYR . 36.5 mt -81.42 5.02 18.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 62.03 32.46 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 221' ' ' ILE . 43.1 mt -86.15 92.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.4 p -103.23 160.71 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -47.96 149.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 9.2 t30 72.49 32.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.3 t -113.69 145.26 41.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.8 p -110.35 130.78 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 10.0 mt -111.55 125.8 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -80.93 133.82 35.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.42 128.72 56.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -99.73 127.86 45.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -113.33 124.97 53.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 17.2 t -102.54 145.33 30.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.674 0.749 . . . . 0.0 110.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 154.93 67.27 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 81.76 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -45.14 -44.33 9.58 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -137.93 176.78 8.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -125.36 91.66 3.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.44 164.29 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 70.0 m -59.8 122.31 13.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.825 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.84 -173.37 48.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 137.6 35.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.2 m -145.35 117.88 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -163.62 167.23 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 74.5 m -107.16 84.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.5 p -117.74 81.66 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.55 67.41 0.49 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.82 29.67 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.381 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 m -160.98 162.8 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.9 t -55.38 150.06 12.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.2 p -114.09 -44.67 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.8 t -110.09 156.02 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -88.32 140.84 16.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 m -88.22 39.09 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -131.29 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.55 175.96 14.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.463 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.461 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 16.7 pt -112.84 143.47 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 111.175 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.37 143.67 28.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 t -134.12 137.88 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.2 mtm180 -100.51 108.85 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 mt -85.15 109.69 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -98.82 133.49 43.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.0 m-85 -107.65 166.26 10.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.1 mt -70.92 -11.59 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HB2' HG22 ' A' ' 173' ' ' THR . 63.4 m-20 -85.16 18.08 2.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 63.47 25.01 14.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 4.0 t -113.46 162.46 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -138.32 148.12 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.6 128.76 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.537 ' C ' HD13 ' A' ' 176' ' ' LEU . 3.4 tm? -76.51 125.26 28.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.977 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -138.73 120.86 15.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 178' ' ' VAL . 11.9 p -81.99 121.44 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.538 ' HB1' ' OD2' ' A' ' 183' ' ' ASP . . . -129.91 158.66 38.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -107.94 154.05 41.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.845 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.6 Cg_endo -69.81 3.93 2.51 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.02 -25.78 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.552 ' OD2' HD11 ' A' ' 216' ' ' LEU . 1.0 OUTLIER -58.25 159.65 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 71.4 p -103.33 151.35 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 202' ' ' LEU . 88.5 t -57.02 -42.55 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.71 86.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -72.08 -42.9 65.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.115 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 179' ' ' ALA . 12.2 tp -55.0 -47.29 74.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 30.5 mttt -58.86 -47.87 83.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.416 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 45.2 t -70.73 -27.94 64.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.3 tmmm? -65.51 -47.63 75.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.977 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 50.0 m-85 -99.74 -44.47 6.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' LYS . 12.0 m-85 -110.46 82.07 2.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 123.71 10.37 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.09 -36.1 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.93 5.76 4.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 7.9 mt-10 -60.68 -9.58 4.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.5 t -75.89 -45.03 37.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' LYS . 36.1 mm-40 -92.07 -43.87 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.437 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.24 88.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 199' ' ' GLN . 39.6 mttp -99.28 121.49 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 185' ' ' VAL . 9.8 mt -93.9 139.06 31.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 17.8 mt -129.42 123.07 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.501 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.2 t80 -117.23 113.78 22.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.501 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 29.1 mt-30 62.14 49.68 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.26 1.36 13.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -103.37 134.38 46.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.471 HD23 ' HG2' ' A' ' 210' ' ' GLN . 34.1 tp -80.8 124.89 29.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.7 mt -75.87 50.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.471 ' HG2' HD23 ' A' ' 208' ' ' LEU . 11.3 mm-40 -54.51 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 44.9 m-20 -44.68 103.91 0.36 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.76 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.36 14.48 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.083 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -82.94 98.09 9.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 p -47.24 139.92 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 216' ' ' LEU . 2.2 mt -57.52 -36.21 71.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.7 t -58.01 -42.58 85.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 t -71.73 -29.19 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.52 5.07 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.13 25.12 15.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 221' ' ' ILE . 28.7 mt -78.71 96.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.3 p -102.92 -176.72 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.72 154.23 40.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 63.52 36.2 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 2.0 t -116.51 151.5 35.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -111.84 136.27 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 mt -115.33 118.29 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.31 136.3 53.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 168' ' ' LYS . 5.8 m -117.24 143.32 46.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -121.15 122.46 40.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -113.14 119.32 37.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 3.8 t -108.67 140.49 21.87 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 0.0 110.879 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 148.29 64.83 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.665 2.243 . . . . 0.0 112.328 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 156.93 62.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 0.0 112.361 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -74.15 -71.33 1.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -122.0 116.55 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -43.16 113.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 92.9 t -78.6 116.1 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 33.9 t -137.27 135.27 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -156.37 152.41 23.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 129.63 17.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.9 t -151.04 159.06 44.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -139.62 124.95 19.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -90.16 117.2 28.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.7 p -51.13 -57.7 8.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 139.39 83.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 248' ' ' SER . 53.1 Cg_endo -69.82 -32.07 19.01 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 247' ' ' PRO . 9.1 t -37.89 121.0 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 17.6 t -101.3 101.43 12.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.7 p -127.81 154.89 44.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 0.0 110.855 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.0 m -89.96 126.19 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.2 -100.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 m -120.48 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 0.0 110.825 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.5 m -122.48 141.29 51.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.4 159.4 29.39 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 38.4 pt -97.12 140.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.405 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 5.2 m-20 -86.68 141.7 28.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.2 t -133.74 137.51 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HB2' HG23 ' A' ' 226' ' ' VAL . 19.2 mtm180 -98.63 118.58 35.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.1 mt -87.76 107.09 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -98.67 128.6 45.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.608 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.1 m-85 -107.76 158.91 16.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 230' ' ' HIS . 12.3 mt -62.01 -9.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -85.46 23.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 54.3 29.61 11.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.4 t -121.91 160.15 25.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -134.32 150.96 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -133.3 133.95 43.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp -77.37 117.57 18.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 1.008 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.75 125.69 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.434 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 93.9 t -91.66 123.68 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.4 158.18 33.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 216' ' ' LEU . 6.5 mpt_? -106.96 152.66 41.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.73 -10.34 28.33 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.727 2.285 . . . . 0.0 112.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 180' ' ' ARG . 17.0 pm0 -99.78 -33.49 10.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.95 166.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 32.0 p -107.82 162.33 14.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.625 HG13 HD12 ' A' ' 202' ' ' LEU . 94.2 t -64.82 -43.75 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -57.84 -34.89 72.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.5 m -72.18 -43.11 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.7 -47.3 77.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.9 mtpp -59.91 -47.1 87.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.444 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.4 t -70.79 -27.95 64.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.44 -48.09 71.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 1.008 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.2 m-85 -97.99 -44.07 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.1 m-85 -111.78 83.22 4.44 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 125.51 12.24 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.685 2.256 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.72 -41.17 1.89 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -66.54 -3.88 7.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.932 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 189' ' ' LYS . 18.2 mt-10 -52.24 -16.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 17.9 m -70.04 -46.5 64.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.63 -47.21 8.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.447 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -50.26 97.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.835 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.4 ttmt -104.63 119.03 38.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 185' ' ' VAL . 14.3 mt -93.57 135.15 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.38 123.01 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.566 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.4 t80 -117.0 120.86 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.566 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 86.2 mt-30 54.71 35.24 23.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.76 4.51 90.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -102.55 134.37 46.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.835 HD11 ' HG2' ' A' ' 201' ' ' LYS . 11.3 tp -80.06 119.65 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.68 45.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -52.75 -69.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -43.64 103.31 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.65 2.66 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.57 9.05 16.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -79.27 101.48 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.8 p -47.23 135.06 10.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.21 -31.35 65.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.4 t -64.11 -42.2 96.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 66.7 m -69.1 -35.6 76.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 76.2 mt -75.05 4.98 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.44 34.99 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 221' ' ' ILE . 54.2 mt -92.08 96.76 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 p -104.14 -177.83 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 224' ' ' ASN . 33.8 t-20 -67.87 153.16 44.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 223' ' ' ASN . 4.4 m120 64.1 46.9 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.65 148.21 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.1 p -110.33 141.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.19 121.06 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -68.11 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 14.4 m -118.25 131.21 56.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.437 ' CE1' HD11 ' A' ' 170' ' ' LEU . 6.1 m170 -117.66 146.92 43.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -112.85 112.59 24.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -80.61 135.17 53.13 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.649 0.738 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.74 66.05 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.742 2.294 . . . . 0.0 112.362 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 176.56 6.58 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.695 2.264 . . . . 0.0 112.374 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -130.78 -28.57 0.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.3 32.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 111.083 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.75 97.34 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.68 145.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.8 p -110.3 159.36 17.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 77.58 149.58 3.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 152.64 69.57 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.734 2.289 . . . . 0.0 112.319 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 78.2 p -104.92 85.78 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 58.49 44.86 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -106.57 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 59.9 p -92.92 175.03 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.865 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -68.57 146.38 45.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 169.75 18.18 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.2 m -131.08 -44.85 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.8 p -103.96 97.56 7.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.5 m -147.45 146.72 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -129.45 161.0 31.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.92 177.72 1.44 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 96.3 p -78.37 -46.79 19.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.892 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -61.83 152.67 30.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 133.49 -169.57 22.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -117.96 138.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.099 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.78 143.39 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.91 137.46 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.503 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.5 mtm180 -101.66 113.51 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 31.3 mt -85.18 111.19 19.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.86 131.67 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 173' ' ' THR . 10.1 m-85 -106.6 163.01 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.597 HD12 ' H ' ' A' ' 231' ' ' ARG . 51.5 mt -66.29 -9.44 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.71 21.76 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 56.24 44.03 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 169' ' ' PHE . 14.5 t -131.98 165.29 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -139.56 144.54 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -131.14 128.92 41.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.96 118.42 16.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.79 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.07 121.3 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.7 123.39 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.66 158.13 39.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -112.51 154.23 44.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 2.92 3.08 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.354 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -109.25 -38.63 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -48.04 170.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 213' ' ' ALA . 3.3 p -110.96 158.32 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.183 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 214' ' ' ARG . 84.7 t -61.52 -43.96 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.6 94.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.7 -32.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -64.77 -47.08 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 193' ' ' PHE . 2.6 mtpm? -70.73 -39.84 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.407 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 9.5 t -72.43 -29.4 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.77 -47.41 59.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.79 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.5 m-85 -94.64 -22.47 18.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.6 m-85 -135.05 84.22 37.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.652 0.739 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 123.99 10.63 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.58 -42.31 1.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -9.68 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.407 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.0 mt-10 -49.29 -18.64 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -67.75 -48.29 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 230' ' ' HIS . 46.1 mt-30 -92.62 -45.13 8.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.887 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -57.04 90.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -101.14 120.73 40.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 28.1 mt -93.26 135.22 34.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 207' ' ' ARG . 17.9 mt -129.02 122.88 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.567 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 73.4 t80 -112.9 111.32 21.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.567 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 53.4 mt-30 64.15 50.14 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.7 3.19 26.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 203' ' ' ILE . 59.1 ttt180 -105.72 131.75 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 210' ' ' GLN . 32.2 tp -80.8 126.9 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.597 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.7 mt -78.08 46.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.574 ' HG3' HD23 ' A' ' 208' ' ' LEU . 27.4 mt-30 -48.36 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.33 103.06 0.3 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 2.55 3.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.721 2.28 . . . . 0.0 112.334 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.59 -27.94 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 185' ' ' VAL . 8.2 mmp_? -49.03 114.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.1 p -63.06 149.33 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.42 -31.81 71.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -65.38 -45.22 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 m -63.2 -33.45 75.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 185' ' ' VAL . 64.6 mt -79.99 3.81 18.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.2 m120 63.65 33.89 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 221' ' ' ILE . 55.7 mt -86.55 92.1 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.7 p -97.08 -176.01 3.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 224' ' ' ASN . 1.7 t30 -70.91 150.71 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.44 ' HB2' ' ND2' ' A' ' 223' ' ' ASN . 10.9 t-20 69.64 32.89 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.4 t -110.7 143.99 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -109.1 132.25 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 23.9 mt -111.04 125.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -79.76 132.57 36.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -113.13 127.64 56.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' A' ' 199' ' ' GLN . 2.1 m80 -100.06 129.05 46.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.597 ' H ' HD12 ' A' ' 170' ' ' LEU . 14.9 ttp85 -113.05 119.98 39.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 5.5 t -116.87 124.54 29.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 147.88 63.71 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.667 2.245 . . . . 0.0 112.324 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 140.72 43.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.695 2.263 . . . . 0.0 112.339 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -95.82 -41.46 3.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -108.29 37.56 2.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 41.28 40.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.5 t -74.93 -20.77 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.8 t -91.28 74.49 6.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -66.27 -155.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.491 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.11 59.25 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.366 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 52.4 p -98.81 -47.9 5.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 55.61 42.27 29.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 m -94.06 -55.83 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t 66.25 41.11 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -112.58 86.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 127.31 14.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.314 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 60.0 p -67.78 105.59 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 73.3 m -89.22 -55.14 3.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.1 p -69.33 168.89 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.852 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 m -163.6 143.86 8.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 -179.85 2.38 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.449 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.0 m -108.41 97.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.1 m -127.0 168.36 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.0 175.46 29.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 14.8 pt -107.85 141.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.04 143.14 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 179' ' ' ALA . 24.5 t -131.57 134.1 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.468 ' HB2' HG23 ' A' ' 226' ' ' VAL . 34.5 mtm180 -100.82 115.35 30.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.4 mt -85.18 105.06 15.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -98.56 127.35 44.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.451 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.2 m-85 -106.53 163.46 12.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.42 -10.38 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.552 ' HB3' HG22 ' A' ' 173' ' ' THR . 51.8 t30 -84.86 30.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 2.1 p30 49.85 25.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 171' ' ' ASN . 6.9 t -118.51 161.11 20.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -141.09 149.15 41.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -132.42 128.73 38.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 177' ' ' ALA . 1.2 tt -73.66 125.1 27.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.712 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.82 128.29 20.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 178' ' ' VAL . 11.2 p -90.5 122.14 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.61 158.0 35.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.47 ' CZ ' ' OD2' ' A' ' 183' ' ' ASP . 11.9 mtm105 -112.84 154.52 44.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.641 0.734 . . . . 0.0 110.809 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -4.94 15.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 215' ' ' THR . 0.7 OUTLIER -103.75 -41.17 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.47 ' OD2' ' CZ ' ' A' ' 180' ' ' ARG . 1.4 m-20 -50.34 160.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.7 p -103.3 156.33 17.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.442 HG12 ' HD2' ' A' ' 189' ' ' LYS . 74.3 t -58.73 -41.65 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.165 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.05 93.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -69.02 -42.98 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.341 . . . . 0.0 111.18 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.32 -47.22 75.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.3 mtpt -57.79 -49.13 77.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 t -70.5 -28.06 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.78 -47.67 77.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.712 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.2 m-85 -100.25 -44.46 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 11.9 m-85 -107.77 80.96 1.06 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 123.63 10.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.48 ' CA ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.2 -30.83 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.487 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -82.96 19.74 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.743 0.306 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.48 ' OE1' ' CA ' ' A' ' 195' ' ' GLY . 28.3 mp0 -74.1 2.47 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 91.1 p -86.34 -48.48 8.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 201' ' ' LYS . 2.8 pt20 -89.52 -34.0 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -55.29 85.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.695 ' HG2' HD11 ' A' ' 208' ' ' LEU . 10.2 tttt -97.78 113.18 24.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 202' ' ' LEU . 1.0 OUTLIER -95.12 137.66 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.1 mt -129.31 122.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.501 ' HB3' HD21 ' A' ' 209' ' ' LEU . 66.4 t80 -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 57.74 50.56 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.08 3.0 9.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -104.03 132.44 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 201' ' ' LYS . 14.9 tp -79.76 128.84 33.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 204' ' ' TYR . 3.3 mt -84.72 35.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.515 ' HG2' HD23 ' A' ' 208' ' ' LEU . 7.6 mm100 -39.68 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -40.14 101.23 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.826 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 3.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.89 21.45 12.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -92.6 107.57 19.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.3 p -48.97 135.12 16.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.151 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.33 -31.71 65.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 92.7 p -63.17 -46.0 89.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.5 t -65.1 -33.66 76.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 26.6 mt -77.47 4.92 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 65.12 27.31 12.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.9 mt -83.55 104.2 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 56.1 p -108.73 -177.26 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.418 ' HB3' HG22 ' A' ' 163' ' ' ILE . 2.2 p30 -76.51 151.99 36.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.1 t30 74.01 25.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.81 162.77 13.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -123.62 133.6 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.432 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.7 mt -112.43 119.59 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -72.22 126.15 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.43 127.03 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -101.89 123.83 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -112.26 128.84 56.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -117.51 143.7 32.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 0.0 110.902 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -175.49 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.83 -53.87 3.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -117.65 96.65 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.49 53.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.91 -10.04 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.2 t -163.58 176.07 10.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -153.82 146.58 14.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 242' ' ' SER . 53.5 Cg_endo -69.8 -8.75 24.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 243' ' ' ALA . 31.0 p -37.9 -41.59 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 242' ' ' SER . . . -34.56 -62.73 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 245' ' ' SER . 24.3 p -45.98 -47.62 16.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 244' ' ' SER . 3.6 t -35.43 131.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -104.64 -158.34 23.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 102.91 1.08 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -84.23 -38.19 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 37.0 m -59.66 104.34 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.476 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.9 t -89.8 -59.85 2.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 t -112.27 153.41 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.05 -46.01 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.6 p -53.93 -46.53 71.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 6.9 p -62.32 -11.98 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -126.78 -173.5 13.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 223' ' ' ASN . 20.5 pt -111.61 141.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.06 139.51 30.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.93 132.16 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.57 ' HB2' HG23 ' A' ' 226' ' ' VAL . 24.0 mtp180 -94.27 112.07 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 77.7 mt -85.32 104.57 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 168' ' ' LYS . 2.4 tmmm? -98.57 134.73 41.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.431 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 44.3 m-85 -107.6 165.14 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.0 mt -67.42 -12.3 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 173' ' ' THR . 38.5 m-80 -83.59 18.76 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.52 27.06 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 5.0 t -115.55 160.51 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.7 150.59 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.79 129.09 34.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.77 119.56 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.54 119.66 12.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.445 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 84.7 t -89.59 121.74 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.98 158.12 32.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -110.94 154.84 43.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 217' ' ' SER . 53.7 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.363 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 215' ' ' THR . 14.8 pt-20 -111.24 -41.36 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -44.96 170.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 77.7 p -113.85 160.18 19.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 209' ' ' LEU . 89.4 t -63.36 -44.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.09 -42.2 96.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -70.25 -31.18 68.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -65.45 -47.35 76.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 193' ' ' PHE . 11.5 mtpt -67.3 -39.15 85.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 21.4 t -72.33 -31.92 66.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -70.71 -47.83 57.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.733 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 90.5 m-85 -91.23 -25.27 19.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 189' ' ' LYS . 23.5 m-85 -135.01 85.75 33.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.359 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 -39.15 2.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -65.57 -4.98 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 19.1 mt-10 -49.89 -18.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 11.4 m -63.03 -53.72 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 201' ' ' LYS . 11.0 mm-40 -86.91 -45.72 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.465 ' HG2' ' CG ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -49.26 87.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.735 ' HG2' HD11 ' A' ' 208' ' ' LEU . 1.8 ttmp? -103.94 116.56 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 227' ' ' ILE . 6.6 mp -93.48 137.51 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mt -129.29 122.45 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 70.9 t80 -114.98 113.8 24.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.3 mt-30 60.17 42.13 15.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.05 5.56 62.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -105.11 134.09 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.365 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.735 HD11 ' HG2' ' A' ' 201' ' ' LYS . 7.7 tp -79.8 130.39 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.49 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.5 mt -84.04 26.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 209' ' ' LEU . 19.4 mt-30 -34.69 -73.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 7.7 m-20 -37.05 99.36 0.18 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.46 -15.98 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -57.26 118.16 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.5 p -67.89 142.29 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -59.57 -31.54 69.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 181' ' ' PRO . 5.6 t -62.04 -47.05 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.3 t -67.49 -31.63 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.91 4.54 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.82 40.61 15.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 221' ' ' ILE . 53.6 mt -96.41 98.4 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -102.01 179.18 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 163' ' ' ILE . 1.5 p-10 -68.5 150.52 47.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.74 34.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.88 143.41 45.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -107.06 136.98 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.742 HG21 HD23 ' A' ' 202' ' ' LEU . 14.5 mt -117.83 120.49 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -72.11 128.8 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.82 132.5 56.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -99.76 124.58 45.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -112.24 127.45 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.2 t -127.91 143.6 48.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.827 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 144.32 53.77 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.653 2.236 . . . . 0.0 112.326 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.43 40.15 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -137.08 80.44 0.3 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.487 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -135.53 168.74 18.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.2 40.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.27 143.73 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.2 t -167.84 125.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.6 146.82 4.42 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 174.54 9.37 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.3 m -165.82 123.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -119.32 152.97 35.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -165.24 153.63 11.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.3 t -122.37 173.98 7.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.06 82.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 105.9 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.6 t -77.76 -43.95 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 34.7 t -68.32 -48.86 63.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.463 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.1 p -81.43 135.11 35.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.842 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -58.53 -63.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 139.94 -69.41 0.47 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.1 m -146.32 132.36 19.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.805 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -167.95 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.51 -175.17 15.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.4 pt -108.25 138.34 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.55 138.41 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.5 t -127.72 133.51 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -96.43 116.83 29.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 51.8 mt -85.07 106.99 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 226' ' ' VAL . 3.1 tmtm? -98.6 128.55 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' A' ' 173' ' ' THR . 3.7 m-85 -107.78 158.98 16.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.18 -7.56 6.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 25.9 t30 -83.52 17.99 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 60.15 27.41 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.531 HG23 ' CD1' ' A' ' 169' ' ' PHE . 13.9 t -121.17 172.71 7.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -143.58 152.39 41.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -133.85 135.23 43.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.93 119.6 20.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.87 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -143.27 120.0 11.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.45 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 94.1 t -89.52 121.93 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -120.68 158.16 28.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.514 ' O ' HD12 ' A' ' 216' ' ' LEU . 30.2 mtm180 -110.48 153.44 43.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.4 23.51 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -98.81 -39.9 8.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.19 165.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 213' ' ' ALA . 11.6 p -108.36 162.35 14.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 214' ' ' ARG . 98.8 t -63.77 -41.12 91.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.98 -36.58 93.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -70.71 -41.33 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.152 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.2 -47.26 75.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 193' ' ' PHE . 23.1 mttp -58.29 -48.41 80.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -70.7 -27.89 64.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.06 -47.75 73.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.903 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' TYR . . . . . 0.87 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.1 m-85 -99.16 -44.55 6.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.8 m-85 -112.88 76.06 2.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 128.07 15.49 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.58 -21.24 3.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -92.04 -5.21 53.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 13.2 mp0 -51.26 -18.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.3 m -62.87 -58.19 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -86.36 -36.56 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -59.94 90.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -103.54 125.05 49.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.6 mp -100.53 139.94 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.496 HG23 ' C ' ' A' ' 207' ' ' ARG . 19.4 mt -129.17 123.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.463 ' HB3' HD21 ' A' ' 209' ' ' LEU . 77.4 t80 -111.42 114.39 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 35.9 mt-30 62.2 48.52 4.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.8 2.43 29.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ARG . . . . . 0.496 ' C ' HG23 ' A' ' 203' ' ' ILE . 9.1 ttt180 -105.55 134.83 48.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.07 125.92 31.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.8 mt -76.56 47.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -50.13 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 12.3 m-20 -41.36 101.9 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.6 0.715 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.0 Cg_endo -69.75 -0.49 6.99 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 0.0 112.353 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.03 -24.45 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.5 mmt-85 -51.7 115.24 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 9.4 p -63.52 151.06 42.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.175 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.776 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.37 -34.61 78.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.1 t -63.97 -46.65 83.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.4 m -62.72 -35.71 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.9 mt -76.81 4.54 9.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 m120 62.94 39.08 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 221' ' ' ILE . 45.2 mt -92.68 89.0 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 62.6 p -95.15 170.23 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.77 157.65 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.89 38.89 8.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 144.52 48.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.5 p -109.63 141.3 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.522 HG21 HD23 ' A' ' 202' ' ' LEU . 28.4 mt -119.21 127.29 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -77.4 131.33 37.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 54.6 m -113.17 138.81 49.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -111.78 122.48 47.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 -100.83 124.35 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.8 m -113.82 141.39 26.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.643 0.735 . . . . 0.0 110.848 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 126.73 13.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.73 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -99.1 -76.51 1.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -145.28 135.05 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -121.41 119.72 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.98 -11.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.8 t -91.13 -53.33 4.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 84.33 -114.25 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.443 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.681 2.254 . . . . 0.0 112.355 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.83 141.59 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -91.43 167.58 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.6 m -116.46 -59.01 2.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 t -46.85 148.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.822 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -155.55 -93.43 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 150.88 69.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.338 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 54.1 p -117.51 139.0 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 31.2 t -120.72 135.5 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 17.0 pt -104.91 143.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -92.68 138.64 31.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 179' ' ' ALA . 5.0 t -128.31 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HB2' HG23 ' A' ' 226' ' ' VAL . 31.7 mtm180 -99.97 118.44 36.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 42.3 mt -87.02 112.0 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -99.31 130.3 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.8 m-85 -107.72 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.1 mt -59.6 -10.76 3.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.51 15.51 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 62.87 31.63 16.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -123.59 174.31 7.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -142.77 157.39 44.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.07 132.29 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.9 tp -75.74 118.48 18.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.949 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.67 125.62 17.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 178' ' ' VAL . 12.1 p -91.93 121.83 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.06 157.59 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -112.11 153.17 44.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.85 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.54 -29.77 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -54.91 172.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.0 p -116.59 158.08 24.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.118 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.533 HG12 ' HD2' ' A' ' 189' ' ' LYS . 86.5 t -61.88 -43.72 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.01 -41.64 94.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.22 -45.56 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.0 tp -55.48 -47.12 76.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.533 ' HD2' HG12 ' A' ' 185' ' ' VAL . 24.9 mtpt -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -70.74 -28.1 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.98 -47.82 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.949 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 51.6 m-85 -99.93 -44.42 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 9.9 m-85 -109.71 79.52 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.5 28.12 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.46 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 74.74 -45.25 1.58 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.46 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -82.47 39.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 38.5 mp0 -85.53 -28.98 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 15.9 m -72.19 -13.59 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -110.83 -47.69 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.04 85.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.78 ' NZ ' HD21 ' A' ' 208' ' ' LEU . 11.7 mmtp -89.81 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.608 ' HB2' HD12 ' A' ' 209' ' ' LEU . 12.4 mt -106.26 141.25 37.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.508 HD12 ' CD2' ' A' ' 230' ' ' HIS . 54.7 mt -129.16 122.82 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.498 ' CB ' HD21 ' A' ' 209' ' ' LEU . 57.8 t80 -119.93 112.39 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 62.24 44.05 7.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.15 1.0 55.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -101.97 140.3 36.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.78 HD21 ' NZ ' ' A' ' 201' ' ' LYS . 15.0 tp -86.21 125.3 33.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.755 HD22 HD13 ' A' ' 219' ' ' LEU . 6.4 mt -83.25 20.79 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -34.62 -53.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.46 ' HB3' ' CG ' ' A' ' 214' ' ' ARG . 12.6 t0 -48.49 105.73 0.53 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.714 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -4.04 13.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.691 2.26 . . . . 0.0 112.384 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.13 -28.73 10.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.5 mmt180 -46.21 109.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.59 148.87 44.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -63.03 -31.5 72.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 t -64.59 -44.26 91.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 52.4 m -66.46 -35.99 81.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.755 HD13 HD22 ' A' ' 209' ' ' LEU . 95.4 mt -75.86 1.97 13.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 10.6 m120 67.05 25.04 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 216' ' ' LEU . 32.8 mt -77.97 103.65 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.2 p -103.52 -177.85 3.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 224' ' ' ASN . 1.0 OUTLIER -72.29 170.95 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 223' ' ' ASN . 4.4 p-10 47.71 30.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.9 t -107.97 159.57 16.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -119.2 138.72 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.8 mt -119.1 119.59 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -70.53 133.37 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 91.7 m -107.96 148.35 29.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.508 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.3 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 21.0 pt -110.33 138.84 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.34 137.13 32.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 179' ' ' ALA . 13.3 t -126.63 133.28 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.432 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.5 mtm180 -95.91 115.55 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.6 mt -86.48 106.55 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -98.78 133.96 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.853 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' THR . 6.0 m-85 -107.61 164.57 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.95 -11.79 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 32.9 t30 -85.36 16.32 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 62.41 30.17 17.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 169' ' ' PHE . 7.6 t -113.2 169.96 8.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -142.82 149.21 38.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -135.65 137.32 41.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.21 118.77 20.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.744 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -142.77 113.9 7.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.1 t -83.9 121.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.653 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -122.04 158.09 29.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -109.25 151.09 41.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.622 0.725 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.5 Cg_endo -69.75 -1.67 8.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.298 . . . . 0.0 112.319 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 182' ' ' GLU . 17.1 pm0 -112.67 -17.07 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.89 -177.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.9 p -127.14 149.48 49.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.465 HG12 ' HD2' ' A' ' 189' ' ' LYS . 88.4 t -57.22 -39.57 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -63.19 -42.01 99.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.37 -44.79 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.57 -47.04 77.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.4 mtpt -58.38 -48.38 80.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 t -70.78 -27.99 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.7 tmmm? -65.05 -47.8 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.744 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 51.4 m-85 -99.82 -44.29 6.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 16.4 m-85 -108.64 75.99 0.65 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.641 0.734 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.68 28.5 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 0.0 112.33 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.456 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.51 -41.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -90.67 42.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 27.8 mp0 -88.11 -32.5 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.5 t -67.43 -24.91 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -98.57 -38.18 9.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -71.41 85.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -91.02 134.79 34.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.896 HD23 HG21 ' A' ' 227' ' ' ILE . 7.4 mp -109.55 141.65 41.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.14 122.89 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.5 t80 -115.42 113.0 23.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.461 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 68.3 mt-30 62.99 44.08 6.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.53 -0.27 43.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -102.68 131.29 49.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 33.5 tp -79.98 127.6 32.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 209' ' ' LEU . 4.4 mt -80.5 46.02 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -44.2 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -45.08 104.09 0.37 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.584 0.707 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 0.0 112.312 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.93 -17.73 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -54.3 117.98 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.1 p -65.71 147.01 54.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.49 -32.14 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 p -64.98 -46.9 79.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 p -61.59 -35.95 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.82 5.0 10.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 220' ' ' ASN . 1.8 m-80 62.2 34.22 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 221' ' ' ILE . 58.5 mt -87.29 93.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -98.21 -178.31 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.8 52.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.9 t30 73.59 37.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.1 t -119.0 145.86 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.6 p -110.54 141.36 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.896 HG21 HD23 ' A' ' 202' ' ' LEU . 23.0 mt -119.92 120.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -70.89 134.24 47.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 84.2 m -111.36 141.58 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.0 pt -101.29 143.99 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.61 136.26 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.49 136.62 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.635 ' HB2' HG23 ' A' ' 226' ' ' VAL . 13.5 mtp180 -99.79 123.09 43.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.867 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 192' ' ' TYR . 36.5 mt -91.49 107.4 19.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.72 133.29 43.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 6.0 m-85 -107.13 164.47 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.22 -7.68 14.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -84.89 9.47 14.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.39 26.39 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -119.14 160.0 22.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.183 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.01 154.2 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -133.98 128.97 35.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.0 tp -73.43 118.62 16.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.952 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.73 132.37 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 178' ' ' VAL . 14.8 p -93.45 121.9 44.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -124.61 157.25 35.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 216' ' ' LEU . 36.0 mtp180 -110.4 154.97 42.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.78 -12.09 32.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.66 -36.62 10.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -47.38 168.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 213' ' ' ALA . 24.0 p -110.76 159.57 17.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.541 ' CG2' HD11 ' A' ' 219' ' ' LEU . 68.6 t -61.5 -35.78 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.9 -40.85 89.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -68.36 -38.49 81.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 111.123 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.7 tp -55.59 -46.6 77.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 6.2 mtpp -65.11 -42.05 94.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.8 t -71.02 -28.17 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.591 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.09 -48.14 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.952 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 7.7 m-85 -100.04 -43.65 6.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 24.3 m-85 -107.47 80.74 0.95 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.665 0.745 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 192' ' ' TYR . 53.7 Cg_endo -69.77 127.07 14.07 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.321 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.454 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.1 -41.96 1.83 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.55 39.43 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 37.8 mp0 -85.22 -36.55 20.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.3 t -64.06 -22.96 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.29 -34.61 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -79.35 85.24 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -88.24 134.45 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 13.5 mt -104.11 141.27 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.13 122.78 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 62.0 t80 -117.32 122.43 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.575 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.2 mm-40 53.46 48.61 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.15 33.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.55 142.15 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.441 ' N ' ' HD3' ' A' ' 207' ' ' ARG . 35.1 tp -87.68 121.94 30.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.8 mt -75.75 50.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.425 ' CG ' HD23 ' A' ' 208' ' ' LEU . 73.6 mt-30 -53.1 -71.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 16.5 t0 -42.23 102.57 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.846 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.5 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 184' ' ' THR . . . -107.11 -33.15 7.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -39.98 114.27 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.9 p -61.5 143.37 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -57.56 -31.84 66.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.6 p -64.74 -46.93 80.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.8 t -65.05 -32.32 73.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.541 HD11 ' CG2' ' A' ' 185' ' ' VAL . 48.5 mt -77.14 4.97 9.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.88 30.36 16.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 221' ' ' ILE . 55.2 mt -86.53 95.84 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.7 p -99.75 -175.13 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -74.79 159.79 31.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 62.27 28.88 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.85 157.1 20.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.6 p -119.68 133.68 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 35.2 mt -112.6 116.03 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.93 139.38 57.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.59 144.04 44.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 8.2 m170 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.954 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 26.5 pt -93.75 145.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 111.124 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -89.49 129.76 35.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 179' ' ' ALA . 22.0 t -123.58 138.5 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.7 mtp180 -103.14 117.68 35.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.837 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.832 HD11 ' CD2' ' A' ' 192' ' ' TYR . 46.1 mt -85.21 108.1 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -99.03 129.5 45.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.2 m-85 -107.65 157.17 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.9 mt -63.55 -7.78 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -83.21 17.09 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 62.18 29.03 17.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 169' ' ' PHE . 11.5 t -123.79 167.12 14.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -139.65 153.23 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.25 131.0 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.8 tp -77.42 117.92 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 1.061 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -139.12 135.55 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 178' ' ' VAL . 14.9 p -94.8 123.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 165' ' ' VAL . . . -124.08 157.65 34.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -111.46 152.09 43.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.879 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.0 Cg_endo -69.74 -2.55 10.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.341 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.54 -38.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.14 172.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.6 p -114.45 164.57 13.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 209' ' ' LEU . 43.2 t -64.72 -40.41 88.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.89 -42.18 99.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.15 -47.01 82.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 193' ' ' PHE . 21.1 mtpt -63.66 -44.06 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.414 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 39.7 t -70.87 -28.21 64.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.593 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.12 -48.2 74.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.919 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 1.061 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 8.6 m-85 -99.94 -43.91 6.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 4.9 m-85 -112.66 78.63 2.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 131.7 21.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.46 -42.27 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -71.6 1.91 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.414 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 9.7 mt-10 -55.19 -14.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -64.41 -58.28 6.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 201' ' ' LYS . 6.1 pt20 -84.28 -37.2 21.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.459 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -52.6 85.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 199' ' ' GLN . 19.5 mttp -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 17.4 mt -93.67 137.07 33.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.94 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -129.08 122.89 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.7 t80 -114.86 119.75 37.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.4 mm100 54.39 48.45 20.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.73 41.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -102.61 139.08 38.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.64 HD23 ' HG3' ' A' ' 210' ' ' GLN . 41.0 tp -87.39 123.17 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.451 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.5 mt -79.09 47.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.64 ' HG3' HD23 ' A' ' 208' ' ' LEU . 12.3 mt-30 -50.38 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.79 103.29 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.597 0.713 . . . . 0.0 110.842 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.34 6.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.58 22.52 14.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -94.32 105.09 17.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.9 p -50.64 142.95 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.6 mt -62.26 -32.67 73.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.7 t -64.57 -45.94 84.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.1 m -65.08 -31.32 72.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.64 4.48 18.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.0 34.22 11.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 221' ' ' ILE . 57.5 mt -90.83 93.56 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 76.2 p -98.76 -176.66 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -69.39 150.64 47.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 72.44 33.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.2 t -113.39 149.88 33.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.7 p -116.12 134.51 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.0 mt -114.47 122.14 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -79.08 135.74 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -115.82 127.55 55.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.932 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -97.99 151.53 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -101.12 139.12 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.29 132.31 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.458 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.8 mtm180 -94.38 117.58 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.726 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 38.6 mt -85.14 107.34 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -98.73 128.61 45.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 5.3 m-85 -107.32 157.26 18.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.08 -9.97 5.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 173' ' ' THR . 55.7 t30 -81.23 14.59 2.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 62.33 34.05 16.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 171' ' ' ASN . 5.1 t -130.53 157.43 42.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -128.16 153.5 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -134.32 136.25 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.51 116.69 18.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.794 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.65 116.56 10.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.9 t -82.4 121.86 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.079 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.441 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -122.36 158.13 30.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 216' ' ' LEU . 54.5 mtm-85 -110.54 152.85 43.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.56 0.695 . . . . 0.0 110.924 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.4 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -105.02 -36.82 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -49.59 169.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -111.65 160.1 17.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 202' ' ' LEU . 69.4 t -65.1 -44.11 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.59 88.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.53 -43.22 66.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 11.4 tp -55.36 -47.18 76.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.4 mtpt -58.63 -48.24 81.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.7 p -70.76 -27.97 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.587 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -65.19 -47.87 75.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.794 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 48.0 m-85 -99.95 -44.31 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.726 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 7.7 m-85 -111.84 77.44 1.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.689 0.757 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 128.02 15.38 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.24 -14.95 4.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -94.52 -12.49 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.727 0.299 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -48.56 -20.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m -61.54 -49.79 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 201' ' ' LYS . 29.3 mt-30 -91.97 -45.24 8.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -52.14 85.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.779 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.9 ttmm -91.55 120.52 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.06 134.89 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.3 mt -129.13 123.46 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.9 t80 -115.45 116.5 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.1 mt-30 58.13 38.1 26.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.68 7.29 87.27 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -107.05 135.17 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.795 HD23 ' HG3' ' A' ' 210' ' ' GLN . 10.1 tp -80.15 127.03 31.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.4 mt -84.16 26.2 0.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.795 ' HG3' HD23 ' A' ' 208' ' ' LEU . 21.1 mt-30 -34.33 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.58 100.12 0.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 0.79 5.09 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.288 . . . . 0.0 112.36 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.88 16.01 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -89.5 112.83 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -57.92 137.19 56.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.7 mt -57.07 -34.7 68.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.3 t -61.37 -44.31 97.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.5 m -67.05 -35.94 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 mt -75.62 4.37 7.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.64 38.86 11.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 221' ' ' ILE . 52.5 mt -94.04 90.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.7 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.8 157.6 7.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 61.96 37.76 14.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 t -114.46 143.74 44.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.7 p -109.44 134.75 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.431 HG21 ' HB3' ' A' ' 202' ' ' LEU . 41.5 mt -115.45 129.93 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -83.66 127.36 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 1.8 t -111.14 122.42 47.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 19.2 pt -100.97 144.99 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.16 134.32 34.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.21 135.43 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HB2' HG23 ' A' ' 226' ' ' VAL . 17.2 mtm180 -100.68 118.19 36.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.69 HD11 ' CD2' ' A' ' 192' ' ' TYR . 30.4 mt -85.15 110.73 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -98.77 128.56 45.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.7 m-85 -107.69 158.5 17.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.41 -7.81 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -85.31 23.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 55.81 27.54 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -123.75 164.23 19.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.03 153.95 51.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -132.83 133.41 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.71 124.74 28.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 1.027 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.58 142.74 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.19 121.76 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.01 158.21 38.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 216' ' ' LEU . 32.5 mtm180 -115.86 154.18 48.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.85 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -4.86 14.85 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.05 -37.93 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.525 ' OD2' HG21 ' A' ' 187' ' ' THR . 0.9 OUTLIER -51.77 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.0 p -115.01 164.29 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.143 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 209' ' ' LEU . 50.0 t -57.06 -44.02 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.71 -36.62 90.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.525 HG21 ' OD2' ' A' ' 183' ' ' ASP . 3.0 m -71.36 -39.58 71.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.1 tp -55.52 -47.17 76.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 29.4 mttt -58.99 -47.92 83.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -70.12 -28.05 65.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.906 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.528 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -64.53 -48.14 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 1.027 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 4.0 m-85 -100.32 -44.58 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.9 m-85 -111.51 83.13 4.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.17 7.0 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.444 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.74 -26.88 2.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -79.84 -3.88 49.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 2.8 mp0 -52.11 -21.06 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.8 m -60.47 -51.66 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -93.3 -44.09 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.97 95.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -103.77 134.3 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.541 HD13 HD23 ' A' ' 188' ' ' LEU . 11.5 mt -101.06 138.94 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.565 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.1 mt -129.24 122.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.571 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 68.1 t80 -115.21 125.68 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 12.4 mm-40 52.72 46.09 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.3 2.23 40.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 203' ' ' ILE . 5.2 ttp-105 -102.78 144.94 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 25.6 tp -88.28 124.47 33.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.575 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.7 mt -75.71 48.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -51.44 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m-20 -42.31 102.48 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.615 0.722 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.2 Cg_endo -69.82 3.09 3.0 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -118.31 19.42 13.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -86.76 101.16 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 p -48.36 135.42 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -58.97 -37.6 77.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.4 t -59.59 -43.48 93.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -36.04 81.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 HH22 ' A' ' 207' ' ' ARG . 75.7 mt -76.67 5.12 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 63.02 32.94 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 221' ' ' ILE . 48.4 mt -85.54 89.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.5 p -95.73 179.66 5.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 157.96 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 63.6 39.53 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.2 149.49 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 226' ' ' VAL . 1.7 p -114.85 123.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 30.9 mt -105.99 124.02 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -74.4 130.77 40.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 88.6 m -103.81 149.41 25.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.565 ' CD2' HD12 ' A' ' 203' ' ' ILE . 4.0 m170 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.536 -0.225 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.7 pt -95.97 138.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.168 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -87.31 143.62 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.27 138.64 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.5 mtm180 -97.75 116.59 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 58.7 mt -85.18 109.19 18.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' CYS . 1.6 tmtm? -98.95 133.67 42.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.86 ' HB2' HG22 ' A' ' 173' ' ' THR . 1.9 m-85 -108.57 162.89 13.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 230' ' ' HIS . 19.0 mt -61.61 -22.74 65.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 173' ' ' THR . 11.2 p-10 -82.96 34.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 43.19 54.82 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.86 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -128.33 171.59 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.62 147.4 31.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.98 129.48 25.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 tp -77.39 117.82 19.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.8 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.96 140.31 34.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 178' ' ' VAL . 13.1 p -99.05 121.84 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -125.01 157.65 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 76.7 mtm-85 -110.83 152.08 43.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.82 0.22 6.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.59 -43.85 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.63 161.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 213' ' ' ALA . 20.0 p -103.28 164.25 11.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.89 -42.39 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.98 98.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -66.17 -38.01 87.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 111.198 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.9 tp -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.7 mtpt -66.67 -42.05 87.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -70.83 -28.2 64.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.583 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.02 -48.35 74.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 6.7 m-85 -99.98 -44.01 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.669 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 8.0 m-85 -109.98 78.89 1.38 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 131.33 20.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.455 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.79 -41.59 1.72 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.455 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -84.57 35.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.455 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 32.7 mp0 -83.42 -31.4 26.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.5 m -64.7 -19.73 65.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 230' ' ' HIS . 34.5 mt-30 -104.17 -45.02 4.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.77 85.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -88.51 122.21 31.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.95 137.54 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.404 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.3 mt -129.15 122.68 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.563 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 64.0 t80 -116.1 113.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.9 mt-30 62.93 43.55 6.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.32 4.61 60.72 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -106.83 131.62 53.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.425 HD23 ' HG3' ' A' ' 210' ' ' GLN . 39.8 tp -79.95 125.27 29.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.0 46.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.425 ' HG3' HD23 ' A' ' 208' ' ' LEU . 23.7 mt-30 -45.49 -67.84 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 19.6 t0 -44.61 103.93 0.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 52.9 Cg_endo -69.84 2.55 3.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.659 2.239 . . . . 0.0 112.286 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 184' ' ' THR . . . -106.92 -30.53 8.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -41.47 123.3 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.3 p -70.29 150.39 46.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -64.45 -35.63 81.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.0 p -63.55 -46.07 87.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -63.72 -34.45 77.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 59.3 mt -77.84 4.49 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 67.0 29.34 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 84.8 mt -87.02 92.05 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.0 p -101.77 -175.73 2.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -70.24 154.46 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 62.45 38.3 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.92 146.29 47.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.2 p -107.32 142.22 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.68 119.56 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -66.18 137.66 57.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 168' ' ' LYS . 83.1 m -120.26 146.72 45.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 170' ' ' LEU . 4.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.4 pt -120.07 138.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.806 0.336 . . . . 0.0 111.144 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -87.96 143.2 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 179' ' ' ALA . 16.3 t -131.7 137.47 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.408 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtm180 -100.59 117.55 34.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.615 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.0 mt -86.67 107.88 18.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -98.88 128.32 45.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 173' ' ' THR . 1.6 m-85 -107.5 160.23 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 230' ' ' HIS . 70.4 mt -66.71 -6.24 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -84.83 16.37 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 63.0 26.93 15.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.622 HG23 ' CD1' ' A' ' 169' ' ' PHE . 6.1 t -120.84 168.26 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -144.48 149.9 36.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -135.77 129.18 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -73.27 120.29 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 1.031 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.14 125.96 24.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.451 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 6.2 p -86.57 123.07 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -126.31 157.97 37.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -111.96 153.49 44.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -5.61 16.61 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.375 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.76 -38.41 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -51.36 173.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 41.5 p -118.91 164.36 15.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 209' ' ' LEU . 54.2 t -64.37 -43.99 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.78 83.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -44.59 63.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.167 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.1 tp -55.14 -47.12 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HD2' HG12 ' A' ' 185' ' ' VAL . 33.6 mtpt -57.98 -48.57 79.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 94.0 p -70.93 -27.92 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.66 -47.55 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 1.031 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 86.4 m-85 -98.7 -44.44 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.615 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.3 m-85 -113.65 79.14 4.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 134.31 27.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.04 -44.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -68.77 -1.46 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.738 0.304 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.438 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 13.2 mt-10 -51.56 -20.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.7 t -58.83 -59.29 5.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 201' ' ' LYS . 0.0 OUTLIER -82.92 -42.2 17.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.461 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -45.14 91.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.857 ' HG2' HD11 ' A' ' 208' ' ' LEU . 17.8 ttmt -105.29 117.94 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.614 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.72 137.12 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.27 122.9 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.449 ' HB3' HD21 ' A' ' 209' ' ' LEU . 63.5 t80 -116.14 111.9 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 57.97 51.51 8.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.59 5.87 39.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.73 136.55 43.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.857 HD11 ' HG2' ' A' ' 201' ' ' LYS . 12.1 tp -85.32 121.07 27.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.652 ' HB3' HG21 ' A' ' 185' ' ' VAL . 7.2 mt -79.46 44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.959 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -52.14 -72.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 214' ' ' ARG . 9.2 t70 -42.24 102.5 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.698 . . . . 0.0 110.896 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.02 3.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.51 8.66 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.455 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 8.4 mmm-85 -82.33 105.81 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 17.6 p -51.36 142.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.2 mt -62.09 -31.74 72.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 85.8 p -63.3 -44.35 95.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -35.4 79.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.97 5.0 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.65 26.07 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.547 ' O ' HG22 ' A' ' 221' ' ' ILE . 51.6 mt -81.18 93.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.3 p -96.31 -175.58 3.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.5 OUTLIER -74.95 158.18 33.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 56.4 m-20 62.91 29.18 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.9 t -110.22 154.82 22.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.9 p -117.11 138.98 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.7 mt -116.15 122.78 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -73.53 134.09 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 60.3 m -120.14 133.9 55.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.409 ' CE1' HD11 ' A' ' 170' ' ' LEU . 4.6 m170 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.6 pt -95.96 144.81 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.28 134.63 34.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.508 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtp180 -96.79 117.06 30.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.4 mt -85.67 107.14 17.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -99.06 127.87 45.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.45 ' CD1' HG23 ' A' ' 173' ' ' THR . 4.0 m-85 -105.42 161.48 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.71 HD11 ' CD2' ' A' ' 230' ' ' HIS . 5.3 mp -67.47 -7.71 27.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.11 16.23 2.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.8 t70 63.29 30.15 15.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.45 HG23 ' CD1' ' A' ' 169' ' ' PHE . 14.7 t -125.15 174.91 7.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -148.22 150.14 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -130.23 134.13 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.6 tp -80.87 122.5 27.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.947 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 141.24 33.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.88 121.91 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -126.48 157.91 37.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 216' ' ' LEU . 70.8 mtt180 -113.95 154.51 45.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.72 8.95 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.363 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.26 -39.21 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.11 170.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.7 p -112.76 161.99 16.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 209' ' ' LEU . 66.9 t -64.24 -40.18 88.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.12 97.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.8 m -67.04 -36.28 81.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -56.12 -46.69 79.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 17.6 mttp -64.76 -41.79 95.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.405 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 74.4 p -70.6 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.69 -48.69 73.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.947 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 10.3 m-85 -100.33 -43.58 6.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 20.2 m-85 -110.83 80.47 2.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.18 14.18 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.78 -39.99 1.81 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -84.11 28.68 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 5.1 mt-10 -80.13 -18.72 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.8 t -75.71 -24.15 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.67 -44.3 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.65 86.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.89 121.15 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.69 HD23 HG21 ' A' ' 227' ' ' ILE . 6.8 mp -96.88 139.13 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.1 mt -129.05 122.97 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 74.4 t80 -114.06 111.78 22.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 26.5 mt-30 63.31 42.36 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.77 0.77 64.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.04 131.99 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 tp -81.5 122.36 27.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.8 mt -76.21 53.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.46 -71.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -42.03 102.3 0.27 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.72 . . . . 0.0 110.929 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.74 2.43 3.53 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.385 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.47 14.25 19.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -89.1 101.2 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.1 p -47.8 143.22 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -59.59 -39.99 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.3 p -58.72 -44.77 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -63.92 -34.05 77.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.848 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 78.9 mt -77.91 4.69 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 62.52 36.44 13.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 221' ' ' ILE . 53.8 mt -90.88 94.48 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.2 p -100.32 173.75 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.1 153.42 37.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.4 t30 69.37 38.44 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 t -120.55 151.42 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.5 p -115.11 136.29 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.69 HG21 HD23 ' A' ' 202' ' ' LEU . 28.9 mt -115.37 130.04 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -83.4 127.08 33.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.584 ' O ' HD12 ' A' ' 170' ' ' LEU . 58.0 m -109.02 136.13 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.71 ' CD2' HD11 ' A' ' 170' ' ' LEU . 5.8 m-70 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.68 HG22 ' HB3' ' A' ' 223' ' ' ASN . 13.0 pt -108.19 145.38 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.91 138.84 32.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.43 137.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.896 ' HB2' HG23 ' A' ' 226' ' ' VAL . 9.1 mtt180 -98.07 125.23 42.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.506 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.1 mt -92.53 104.52 16.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.73 133.69 42.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 173' ' ' THR . 3.9 m-85 -107.27 166.33 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 230' ' ' HIS . 14.4 mt -70.6 -14.21 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 173' ' ' THR . 3.0 p30 -78.15 4.12 13.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.2 t70 73.97 47.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.548 HG22 ' OD1' ' A' ' 171' ' ' ASN . 1.3 t -135.46 171.82 13.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -142.96 153.94 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.55 130.44 23.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.79 117.82 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 1.044 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.1 123.48 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.57 123.76 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -127.18 157.67 39.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 216' ' ' LEU . 73.7 mtm-85 -107.99 153.6 41.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.75 -1.15 7.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.26 -33.22 6.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -50.18 173.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 2.6 p -117.21 159.09 23.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.96 -40.19 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.58 -37.32 94.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -70.44 -42.5 71.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.168 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.34 -47.27 75.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 26.4 mtpt -58.87 -48.11 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.447 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.7 t -70.57 -27.99 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.557 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.5 tmmm? -65.02 -48.06 75.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 1.044 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 54.9 m-85 -100.01 -44.48 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.07 77.23 2.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 134.72 28.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.349 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.08 -42.42 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.29 -9.87 50.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.447 ' OE2' ' CB ' ' A' ' 190' ' ' SER . 13.1 mt-10 -45.51 -22.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.6 t -55.92 -61.24 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -84.19 -42.61 15.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -44.83 113.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -126.3 122.28 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.83 141.21 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.9 mt -129.13 122.81 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 61.2 t80 -116.33 110.94 19.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.446 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 67.2 mt-30 62.38 53.37 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.92 3.74 11.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -104.88 136.47 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.8 tp -84.42 125.39 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -79.99 54.43 1.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -54.96 -73.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.414 ' HB2' ' CG ' ' A' ' 214' ' ' ARG . 28.5 m-20 -43.34 103.15 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.88 7.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.3 23.13 13.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.414 ' CG ' ' HB2' ' A' ' 211' ' ' ASP . 18.0 mmt180 -91.94 108.33 19.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.5 p -52.8 138.41 29.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.8 mt -57.8 -32.22 67.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.4 t -64.75 -42.6 95.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 34.5 t -67.67 -35.41 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.6 mt -76.47 1.77 15.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.2 m120 67.17 28.87 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 221' ' ' ILE . 53.5 mt -84.45 96.08 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.5 p -100.46 -175.71 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.68 ' HB3' HG22 ' A' ' 163' ' ' ILE . 7.0 p30 -76.04 148.6 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 74.2 27.15 1.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.65 158.87 17.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -121.67 131.69 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.42 124.14 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.75 138.98 39.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 39.3 m -120.68 138.55 53.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 170' ' ' LEU . 9.3 m170 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 19.6 pt -99.87 152.39 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.367 . . . . 0.0 111.081 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.07 141.94 30.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.97 137.12 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -101.6 115.79 31.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.652 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 35.6 mt -85.74 106.05 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 229' ' ' CYS . 2.4 tmmm? -98.77 134.23 41.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.66 165.55 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.506 HD11 ' CD2' ' A' ' 230' ' ' HIS . 76.6 mt -68.57 -6.98 28.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -87.05 13.34 9.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.67 35.91 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -128.66 156.57 43.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -129.62 149.9 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -130.54 132.42 45.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.77 118.95 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.776 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -143.27 120.35 11.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 178' ' ' VAL . 12.6 p -88.36 121.85 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.25 158.16 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.408 ' HB3' ' CD ' ' A' ' 182' ' ' GLU . 62.0 mtm180 -111.45 152.6 44.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.11 3.82 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.701 2.267 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 182' ' ' GLU . 14.2 pm0 -113.32 -23.94 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.82 179.66 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.2 p -119.75 158.65 26.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 214' ' ' ARG . 93.5 t -62.57 -43.42 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.77 96.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -69.68 -31.72 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 111.122 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -66.91 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 193' ' ' PHE . 7.4 mtpp -70.02 -38.6 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.9 t -72.28 -29.89 64.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.86 -47.09 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.776 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 65.1 m-85 -94.72 -21.26 18.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 5.1 m-85 -135.02 74.55 62.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 125.06 11.7 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.42 3.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' SER . 27.6 mt-30 -86.59 -15.69 39.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -42.61 -23.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLN . 75.1 p -59.38 -52.54 65.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -88.89 -36.41 15.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -62.15 100.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -107.93 121.62 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.483 ' HG ' ' HZ2' ' A' ' 189' ' ' LYS . 23.9 mt -94.01 136.98 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.2 122.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.6 t80 -113.48 119.98 39.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 4.9 mm100 55.45 44.2 27.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.24 2.45 59.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 32.3 ttm-85 -102.27 137.69 40.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.838 0.351 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.88 120.54 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.4 mt -75.98 53.87 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -53.34 -73.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -46.23 104.59 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 1.74 4.15 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.707 2.272 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.08 20.81 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.1 mmt-85 -90.42 107.16 18.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 p -52.39 141.49 19.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.779 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -62.01 -31.96 72.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 p -65.34 -43.11 91.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.8 t -67.65 -34.71 77.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.92 5.0 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 63.27 37.0 11.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 221' ' ' ILE . 58.1 mt -92.56 95.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.0 p -96.75 -174.98 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.19 142.43 52.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 73.72 24.98 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.54 140.02 30.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -105.16 133.37 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.8 mt -116.35 122.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -72.49 139.43 47.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' LYS . 60.6 m -116.3 145.25 43.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.506 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.4 m170 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.4 pt -95.19 144.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 111.183 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.535 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 2.5 m-20 -93.47 139.48 30.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.9 t -129.41 134.63 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 226' ' ' VAL . 18.2 mtp180 -99.55 118.72 36.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.529 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 28.3 mt -85.12 107.07 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -98.72 128.26 44.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.0 m-85 -107.24 161.49 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.29 -5.01 12.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -82.38 7.28 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.9 t0 70.86 31.23 2.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -129.64 170.57 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.85 155.71 46.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -136.39 137.68 40.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 14.9 tp -75.48 120.62 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.847 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.98 115.55 8.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.44 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 90.4 t -87.73 122.12 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.05 158.12 34.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -108.9 153.4 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 0.42 5.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.47 -33.17 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.63 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.6 p -124.43 157.39 35.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 209' ' ' LEU . 70.8 t -61.53 -41.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.32 93.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.4 m -71.61 -40.15 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.42 -47.09 76.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' PHE . 31.3 mttt -58.66 -48.06 82.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.4 p -70.71 -28.11 64.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.2 tmmm? -65.44 -47.73 75.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.847 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 73.0 m-85 -99.8 -44.46 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.2 m-85 -113.32 79.23 3.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 110.843 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 126.03 12.87 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 2.25 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.403 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.57 -20.94 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -87.59 -13.5 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 189' ' ' LYS . 5.4 mp0 -46.0 -22.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.9 m -60.89 -52.08 66.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -92.43 -38.51 11.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.27 89.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -96.65 133.86 40.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.28 137.15 40.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.706 HD12 ' CD2' ' A' ' 230' ' ' HIS . 19.8 mt -129.22 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.447 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 67.3 t80 -114.08 113.93 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 22.0 mt-30 62.45 44.62 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.01 0.31 50.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -102.23 133.13 47.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.7 tp -80.52 126.15 30.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 185' ' ' VAL . 7.1 mt -76.86 48.19 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -47.81 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.31 105.24 0.47 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.705 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 2.97 3.09 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.628 2.219 . . . . 0.0 112.366 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.61 -27.64 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.9 mmt-85 -44.87 102.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 48.2 p -54.18 150.65 8.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.813 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.67 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.2 p -64.93 -43.55 92.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.0 m -68.59 -35.26 77.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.4 mt -75.76 4.76 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.3 37.87 10.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 221' ' ' ILE . 50.6 mt -92.61 102.54 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -106.65 -174.3 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 20.4 t-20 -69.45 152.15 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.8 m120 64.18 31.99 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.62 143.83 32.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.3 p -110.95 134.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.8 mt -116.02 126.98 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -78.46 130.89 36.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 98.7 m -103.21 152.21 21.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.706 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.8 m170 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.4 pt -96.36 140.16 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.28 138.78 31.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.4 t -128.59 138.04 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.789 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.4 mtm-85 -97.59 122.7 40.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.534 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 65.0 mt -93.14 104.84 17.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -98.66 130.17 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.5 m-85 -107.6 158.35 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 230' ' ' HIS . 52.1 mt -63.41 -7.87 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.27 19.8 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.67 35.0 24.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.9 t -129.91 175.15 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -144.89 154.69 42.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -136.29 129.01 30.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.31 121.32 21.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 1.156 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.91 138.75 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 178' ' ' VAL . 11.2 p -99.91 121.93 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.28 157.76 34.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.083 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 216' ' ' LEU . 18.4 mtt180 -113.4 152.89 45.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.1 Cg_endo -69.71 -0.9 7.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -109.59 -38.98 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.69 173.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.8 p -116.78 162.29 17.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 209' ' ' LEU . 26.1 t -60.16 -42.48 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.181 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.36 -41.91 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 m -66.95 -41.68 86.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 179' ' ' ALA . 13.2 tp -57.68 -45.54 85.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.3 mtpt -65.39 -44.61 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.8 t -70.67 -28.03 64.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.582 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.43 -48.74 74.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 1.156 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 14.6 m-85 -100.48 -43.41 6.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 4.8 m-85 -110.67 80.59 2.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 128.04 15.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.67 -40.36 1.81 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -83.81 31.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.936 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -83.04 -20.73 34.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 5.3 t -74.57 -26.1 59.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.82 -41.82 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.466 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.64 97.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.818 ' HG2' HD11 ' A' ' 208' ' ' LEU . 0.8 OUTLIER -97.89 118.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.1 mp -93.75 137.89 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mt -129.0 122.74 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.532 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 84.6 t80 -114.81 118.65 34.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.532 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 11.3 mm-40 53.14 32.95 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.968 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.88 82.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -106.12 131.15 53.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.818 HD11 ' HG2' ' A' ' 201' ' ' LYS . 9.5 tp -80.95 121.9 26.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.629 ' HB3' HG21 ' A' ' 185' ' ' VAL . 4.5 mt -81.56 40.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -47.58 -67.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 0.9 OUTLIER -44.35 104.32 0.38 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.77 2.77 3.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.618 2.212 . . . . 0.0 112.378 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.6 -10.22 14.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -61.22 117.13 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.5 p -67.08 141.14 57.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.12 -33.98 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -64.02 -44.85 91.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 m -65.3 -33.1 75.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.3 mt -77.78 3.46 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 30.7 t30 65.95 28.44 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.93 104.84 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.2 p -105.7 -174.76 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.41 150.04 43.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t30 69.27 26.32 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -102.32 140.47 36.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.1 p -105.45 140.37 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.424 HG21 HD23 ' A' ' 202' ' ' LEU . 20.6 mt -121.54 129.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -83.07 126.47 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 55.8 m -112.06 127.58 55.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.709 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.1 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 9.8 pt -108.5 143.18 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.68 141.77 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.8 t -134.39 137.39 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 226' ' ' VAL . 56.1 mtp180 -101.97 110.68 22.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.28 108.69 17.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 168' ' ' LYS . 0.7 OUTLIER -98.78 131.6 44.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' CD1' HG23 ' A' ' 173' ' ' THR . 7.8 m-85 -107.62 166.04 10.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.65 -2.47 11.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.53 14.35 13.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t0 64.37 28.14 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.0 t -117.11 174.76 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 173' ' ' THR . 5.2 mp0 -147.98 147.78 30.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -138.29 128.99 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 177' ' ' ALA . 2.1 tm? -77.01 131.1 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 132.01 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.446 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 96.9 t -82.23 121.76 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -129.84 158.18 40.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 216' ' ' LEU . 27.9 mtm180 -117.11 152.47 48.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 0.0 110.847 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.79 9.04 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -108.5 -33.71 6.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.4 168.61 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 p -110.38 161.35 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.097 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.449 HG12 ' HD2' ' A' ' 189' ' ' LYS . 69.1 t -64.56 -44.11 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.82 78.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -72.1 -43.7 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.3 -47.35 75.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 9.3 mtpp -60.48 -46.99 88.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 27.7 t -70.56 -27.75 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.84 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.4 tmmm? -66.02 -47.62 73.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.971 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 63.3 m-85 -99.59 -44.46 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 7.9 m-85 -111.91 81.97 3.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 130.41 19.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.238 . . . . 0.0 112.343 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.74 -44.31 1.75 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -63.22 -6.87 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.944 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.3 mt-10 -49.6 -18.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 48.0 t -68.9 -46.54 68.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 201' ' ' LYS . 40.1 mt-30 -92.51 -46.11 7.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.71 85.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' GLN . 6.0 mtmp? -95.64 123.14 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 9.1 mt -93.32 138.36 31.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 230' ' ' HIS . 29.0 mt -129.46 122.68 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 82.6 t80 -115.78 121.65 43.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.586 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 14.0 mm-40 55.87 47.52 19.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.58 57.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 16.4 ttm105 -111.05 134.19 52.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 24.9 tp -81.36 124.67 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.43 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.9 mt -78.33 45.35 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -47.15 -73.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -49.07 105.98 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.643 0.735 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 1.3 4.57 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.86 31.9 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -104.64 101.63 11.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 40.5 p -48.83 141.73 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.3 mt -60.48 -36.09 77.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.8 t -60.47 -41.24 93.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.7 t -70.7 -30.44 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.493 ' O ' ' CE2' ' A' ' 204' ' ' TYR . 36.5 mt -81.42 5.02 18.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 62.03 32.46 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 221' ' ' ILE . 43.1 mt -86.15 92.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.4 p -103.23 160.71 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -47.96 149.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 9.2 t30 72.49 32.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.3 t -113.69 145.26 41.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.8 p -110.35 130.78 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 10.0 mt -111.55 125.8 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -80.93 133.82 35.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.42 128.72 56.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.435 ' CD2' HD12 ' A' ' 203' ' ' ILE . 4.1 m-70 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.461 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 16.7 pt -112.84 143.47 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 111.175 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.37 143.67 28.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 t -134.12 137.88 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.2 mtm180 -100.51 108.85 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 mt -85.15 109.69 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -98.82 133.49 43.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.0 m-85 -107.65 166.26 10.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.1 mt -70.92 -11.59 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HB2' HG22 ' A' ' 173' ' ' THR . 63.4 m-20 -85.16 18.08 2.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 63.47 25.01 14.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 4.0 t -113.46 162.46 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -138.32 148.12 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.6 128.76 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 176' ' ' LEU . 3.4 tm? -76.51 125.26 28.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.977 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -138.73 120.86 15.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 178' ' ' VAL . 11.9 p -81.99 121.44 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.538 ' HB1' ' OD2' ' A' ' 183' ' ' ASP . . . -129.91 158.66 38.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -107.94 154.05 41.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.845 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.6 Cg_endo -69.81 3.93 2.51 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.02 -25.78 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.552 ' OD2' HD11 ' A' ' 216' ' ' LEU . 1.0 OUTLIER -58.25 159.65 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 71.4 p -103.33 151.35 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 202' ' ' LEU . 88.5 t -57.02 -42.55 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.71 86.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -72.08 -42.9 65.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.115 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 179' ' ' ALA . 12.2 tp -55.0 -47.29 74.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 30.5 mttt -58.86 -47.87 83.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.416 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 45.2 t -70.73 -27.94 64.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.3 tmmm? -65.51 -47.63 75.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.977 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 50.0 m-85 -99.74 -44.47 6.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' LYS . 12.0 m-85 -110.46 82.07 2.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 123.71 10.37 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.09 -36.1 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.93 5.76 4.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 7.9 mt-10 -60.68 -9.58 4.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.5 t -75.89 -45.03 37.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' LYS . 36.1 mm-40 -92.07 -43.87 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.24 88.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 199' ' ' GLN . 39.6 mttp -99.28 121.49 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 185' ' ' VAL . 9.8 mt -93.9 139.06 31.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.541 HD12 ' CD2' ' A' ' 230' ' ' HIS . 17.8 mt -129.42 123.07 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.501 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.2 t80 -117.23 113.78 22.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.501 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 29.1 mt-30 62.14 49.68 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.26 1.36 13.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -103.37 134.38 46.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.471 HD23 ' HG2' ' A' ' 210' ' ' GLN . 34.1 tp -80.8 124.89 29.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.7 mt -75.87 50.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.471 ' HG2' HD23 ' A' ' 208' ' ' LEU . 11.3 mm-40 -54.51 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 44.9 m-20 -44.68 103.91 0.36 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.76 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.36 14.48 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.083 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -82.94 98.09 9.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 p -47.24 139.92 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 216' ' ' LEU . 2.2 mt -57.52 -36.21 71.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.7 t -58.01 -42.58 85.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 t -71.73 -29.19 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.52 5.07 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.13 25.12 15.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 221' ' ' ILE . 28.7 mt -78.71 96.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.3 p -102.92 -176.72 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.8 OUTLIER -72.72 154.23 40.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 25.7 m-20 63.52 36.2 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 2.0 t -116.51 151.5 35.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -111.84 136.27 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 mt -115.33 118.29 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.31 136.3 53.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 168' ' ' LYS . 5.8 m -117.24 143.32 46.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.541 ' CD2' HD12 ' A' ' 203' ' ' ILE . 4.4 m-70 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 38.4 pt -97.12 140.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.405 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 5.2 m-20 -86.68 141.7 28.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.2 t -133.74 137.51 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HB2' HG23 ' A' ' 226' ' ' VAL . 19.2 mtm180 -98.63 118.58 35.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.1 mt -87.76 107.09 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -98.67 128.6 45.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.608 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.1 m-85 -107.76 158.91 16.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 230' ' ' HIS . 12.3 mt -62.01 -9.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -85.46 23.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 54.3 29.61 11.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.4 t -121.91 160.15 25.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -134.32 150.96 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -133.3 133.95 43.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp -77.37 117.57 18.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 1.008 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.75 125.69 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.434 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 93.9 t -91.66 123.68 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.4 158.18 33.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 216' ' ' LEU . 6.5 mpt_? -106.96 152.66 41.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.73 -10.34 28.33 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.727 2.285 . . . . 0.0 112.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 180' ' ' ARG . 17.0 pm0 -99.78 -33.49 10.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.95 166.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 32.0 p -107.82 162.33 14.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.625 HG13 HD12 ' A' ' 202' ' ' LEU . 94.2 t -64.82 -43.75 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -57.84 -34.89 72.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.5 m -72.18 -43.11 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.7 -47.3 77.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.9 mtpp -59.91 -47.1 87.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.444 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.4 t -70.79 -27.95 64.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.44 -48.09 71.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 1.008 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.2 m-85 -97.99 -44.07 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.1 m-85 -111.78 83.22 4.44 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 125.51 12.24 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.685 2.256 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.72 -41.17 1.89 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -66.54 -3.88 7.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.932 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 189' ' ' LYS . 18.2 mt-10 -52.24 -16.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 17.9 m -70.04 -46.5 64.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.63 -47.21 8.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.447 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -50.26 97.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.835 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.4 ttmt -104.63 119.03 38.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 185' ' ' VAL . 14.3 mt -93.57 135.15 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.38 123.01 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.566 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.4 t80 -117.0 120.86 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.566 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 86.2 mt-30 54.71 35.24 23.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.76 4.51 90.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -102.55 134.37 46.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.835 HD11 ' HG2' ' A' ' 201' ' ' LYS . 11.3 tp -80.06 119.65 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.68 45.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -52.75 -69.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -43.64 103.31 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.65 2.66 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.57 9.05 16.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -79.27 101.48 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.8 p -47.23 135.06 10.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.21 -31.35 65.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.4 t -64.11 -42.2 96.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 66.7 m -69.1 -35.6 76.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 76.2 mt -75.05 4.98 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.44 34.99 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 221' ' ' ILE . 54.2 mt -92.08 96.76 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 p -104.14 -177.83 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 224' ' ' ASN . 33.8 t-20 -67.87 153.16 44.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 223' ' ' ASN . 4.4 m120 64.1 46.9 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.65 148.21 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.1 p -110.33 141.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.19 121.06 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -68.11 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 14.4 m -118.25 131.21 56.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.437 ' CE1' HD11 ' A' ' 170' ' ' LEU . 6.1 m170 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -117.96 138.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.099 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.78 143.39 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.91 137.46 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.503 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.5 mtm180 -101.66 113.51 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 31.3 mt -85.18 111.19 19.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.86 131.67 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 173' ' ' THR . 10.1 m-85 -106.6 163.01 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 51.5 mt -66.29 -9.44 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.71 21.76 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 56.24 44.03 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 169' ' ' PHE . 14.5 t -131.98 165.29 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -139.56 144.54 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -131.14 128.92 41.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.96 118.42 16.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.79 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.07 121.3 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.7 123.39 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.66 158.13 39.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -112.51 154.23 44.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 2.92 3.08 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.354 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -109.25 -38.63 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -48.04 170.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 213' ' ' ALA . 3.3 p -110.96 158.32 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.183 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 214' ' ' ARG . 84.7 t -61.52 -43.96 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.6 94.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.7 -32.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -64.77 -47.08 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 193' ' ' PHE . 2.6 mtpm? -70.73 -39.84 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.407 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 9.5 t -72.43 -29.4 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.77 -47.41 59.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.79 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.5 m-85 -94.64 -22.47 18.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.6 m-85 -135.05 84.22 37.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.652 0.739 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 123.99 10.63 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.58 -42.31 1.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -9.68 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.407 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.0 mt-10 -49.29 -18.64 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -67.75 -48.29 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 230' ' ' HIS . 26.2 mt-30 -92.62 -45.13 8.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.887 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -57.04 90.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -101.14 120.73 40.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 28.1 mt -93.26 135.22 34.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 207' ' ' ARG . 17.9 mt -129.02 122.88 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.567 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 73.4 t80 -112.9 111.32 21.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.567 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 53.4 mt-30 64.15 50.14 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.7 3.19 26.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 203' ' ' ILE . 59.1 ttt180 -105.72 131.75 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 210' ' ' GLN . 32.2 tp -80.8 126.9 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.597 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.7 mt -78.08 46.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.574 ' HG3' HD23 ' A' ' 208' ' ' LEU . 27.4 mt-30 -48.36 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.33 103.06 0.3 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 2.55 3.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.721 2.28 . . . . 0.0 112.334 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.59 -27.94 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 185' ' ' VAL . 8.2 mmp_? -49.03 114.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.1 p -63.06 149.33 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.42 -31.81 71.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -65.38 -45.22 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 m -63.2 -33.45 75.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 185' ' ' VAL . 64.6 mt -79.99 3.81 18.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.65 33.89 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 221' ' ' ILE . 55.7 mt -86.55 92.1 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.7 p -97.08 -176.01 3.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 224' ' ' ASN . 1.7 t30 -70.91 150.71 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.44 ' HB2' ' ND2' ' A' ' 223' ' ' ASN . 10.9 t-20 69.64 32.89 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.4 t -110.7 143.99 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -109.1 132.25 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 23.9 mt -111.04 125.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -79.76 132.57 36.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -113.13 127.64 56.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . 0.425 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.8 m-70 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 14.8 pt -107.85 141.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.04 143.14 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 179' ' ' ALA . 24.5 t -131.57 134.1 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.468 ' HB2' HG23 ' A' ' 226' ' ' VAL . 34.5 mtm180 -100.82 115.35 30.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.4 mt -85.18 105.06 15.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -98.56 127.35 44.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.451 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.2 m-85 -106.53 163.46 12.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.42 -10.38 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.552 ' HB3' HG22 ' A' ' 173' ' ' THR . 51.8 t30 -84.86 30.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 2.1 p30 49.85 25.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 171' ' ' ASN . 6.9 t -118.51 161.11 20.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -141.09 149.15 41.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -132.42 128.73 38.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 177' ' ' ALA . 1.2 tt -73.66 125.1 27.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.712 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.82 128.29 20.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 178' ' ' VAL . 11.2 p -90.5 122.14 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.61 158.0 35.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.47 ' CZ ' ' OD2' ' A' ' 183' ' ' ASP . 11.9 mtm105 -112.84 154.52 44.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.641 0.734 . . . . 0.0 110.809 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -4.94 15.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 215' ' ' THR . 0.7 OUTLIER -103.75 -41.17 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.47 ' OD2' ' CZ ' ' A' ' 180' ' ' ARG . 1.4 m-20 -50.34 160.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.7 p -103.3 156.33 17.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.442 HG12 ' HD2' ' A' ' 189' ' ' LYS . 74.3 t -58.73 -41.65 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.165 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.05 93.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -69.02 -42.98 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.341 . . . . 0.0 111.18 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.32 -47.22 75.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.3 mtpt -57.79 -49.13 77.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 t -70.5 -28.06 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.78 -47.67 77.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.712 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.2 m-85 -100.25 -44.46 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 11.9 m-85 -107.77 80.96 1.06 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 123.63 10.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.48 ' CA ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.2 -30.83 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.487 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -82.96 19.74 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.743 0.306 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.48 ' OE1' ' CA ' ' A' ' 195' ' ' GLY . 28.3 mp0 -74.1 2.47 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 91.1 p -86.34 -48.48 8.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 201' ' ' LYS . 2.8 pt20 -89.52 -34.0 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -55.29 85.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.695 ' HG2' HD11 ' A' ' 208' ' ' LEU . 10.2 tttt -97.78 113.18 24.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 202' ' ' LEU . 1.0 OUTLIER -95.12 137.66 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.1 mt -129.31 122.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.501 ' HB3' HD21 ' A' ' 209' ' ' LEU . 66.4 t80 -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 57.74 50.56 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.08 3.0 9.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -104.03 132.44 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 201' ' ' LYS . 14.9 tp -79.76 128.84 33.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 204' ' ' TYR . 3.3 mt -84.72 35.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.515 ' HG2' HD23 ' A' ' 208' ' ' LEU . 7.6 mm100 -39.68 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -40.14 101.23 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.826 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 3.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.89 21.45 12.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -92.6 107.57 19.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.3 p -48.97 135.12 16.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.151 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.33 -31.71 65.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 92.7 p -63.17 -46.0 89.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.5 t -65.1 -33.66 76.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 26.6 mt -77.47 4.92 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 65.12 27.31 12.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.9 mt -83.55 104.2 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 56.1 p -108.73 -177.26 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.418 ' HB3' HG22 ' A' ' 163' ' ' ILE . 2.2 p30 -76.51 151.99 36.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.1 t30 74.01 25.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.81 162.77 13.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -123.62 133.6 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.432 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.7 mt -112.43 119.59 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -72.22 126.15 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.43 127.03 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 223' ' ' ASN . 20.5 pt -111.61 141.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.06 139.51 30.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.93 132.16 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.57 ' HB2' HG23 ' A' ' 226' ' ' VAL . 24.0 mtp180 -94.27 112.07 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 77.7 mt -85.32 104.57 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 168' ' ' LYS . 2.4 tmmm? -98.57 134.73 41.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.431 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 44.3 m-85 -107.6 165.14 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.0 mt -67.42 -12.3 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 173' ' ' THR . 38.5 m-80 -83.59 18.76 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.52 27.06 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 5.0 t -115.55 160.51 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.7 150.59 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.79 129.09 34.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.77 119.56 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.54 119.66 12.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.445 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 84.7 t -89.59 121.74 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.98 158.12 32.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -110.94 154.84 43.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 217' ' ' SER . 53.7 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.363 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 215' ' ' THR . 14.8 pt-20 -111.24 -41.36 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -44.96 170.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 77.7 p -113.85 160.18 19.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 209' ' ' LEU . 89.4 t -63.36 -44.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.09 -42.2 96.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -70.25 -31.18 68.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -65.45 -47.35 76.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 193' ' ' PHE . 11.5 mtpt -67.3 -39.15 85.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 21.4 t -72.33 -31.92 66.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -70.71 -47.83 57.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.733 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 90.5 m-85 -91.23 -25.27 19.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 189' ' ' LYS . 23.5 m-85 -135.01 85.75 33.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.359 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 -39.15 2.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -65.57 -4.98 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 19.1 mt-10 -49.89 -18.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 11.4 m -63.03 -53.72 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 201' ' ' LYS . 11.0 mm-40 -86.91 -45.72 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.465 ' HG2' ' CG ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -49.26 87.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.735 ' HG2' HD11 ' A' ' 208' ' ' LEU . 1.8 ttmp? -103.94 116.56 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 227' ' ' ILE . 6.6 mp -93.48 137.51 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mt -129.29 122.45 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 70.9 t80 -114.98 113.8 24.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.3 mt-30 60.17 42.13 15.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.05 5.56 62.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -105.11 134.09 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.365 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.735 HD11 ' HG2' ' A' ' 201' ' ' LYS . 7.7 tp -79.8 130.39 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.49 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.5 mt -84.04 26.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 209' ' ' LEU . 19.4 mt-30 -34.69 -73.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 7.7 m-20 -37.05 99.36 0.18 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.46 -15.98 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -57.26 118.16 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.5 p -67.89 142.29 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -59.57 -31.54 69.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 181' ' ' PRO . 5.6 t -62.04 -47.05 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.3 t -67.49 -31.63 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.91 4.54 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.82 40.61 15.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.44 ' O ' HG22 ' A' ' 221' ' ' ILE . 53.6 mt -96.41 98.4 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -102.01 179.18 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 163' ' ' ILE . 1.5 p-10 -68.5 150.52 47.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.74 34.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.88 143.41 45.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -107.06 136.98 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.742 HG21 HD23 ' A' ' 202' ' ' LEU . 14.5 mt -117.83 120.49 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -72.11 128.8 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.82 132.5 56.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.4 pt -108.25 138.34 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.55 138.41 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.5 t -127.72 133.51 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -96.43 116.83 29.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 51.8 mt -85.07 106.99 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 226' ' ' VAL . 3.1 tmtm? -98.6 128.55 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' A' ' 173' ' ' THR . 3.7 m-85 -107.78 158.98 16.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.18 -7.56 6.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 25.9 t30 -83.52 17.99 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 60.15 27.41 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.531 HG23 ' CD1' ' A' ' 169' ' ' PHE . 13.9 t -121.17 172.71 7.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -143.58 152.39 41.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -133.85 135.23 43.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.93 119.6 20.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.87 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -143.27 120.0 11.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.45 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 94.1 t -89.52 121.93 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -120.68 158.16 28.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.514 ' O ' HD12 ' A' ' 216' ' ' LEU . 30.2 mtm180 -110.48 153.44 43.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.4 23.51 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -98.81 -39.9 8.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.19 165.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 213' ' ' ALA . 11.6 p -108.36 162.35 14.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 214' ' ' ARG . 98.8 t -63.77 -41.12 91.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.98 -36.58 93.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -70.71 -41.33 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.152 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.2 -47.26 75.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 193' ' ' PHE . 23.1 mttp -58.29 -48.41 80.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -70.7 -27.89 64.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.06 -47.75 73.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.903 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' TYR . . . . . 0.87 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.1 m-85 -99.16 -44.55 6.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.8 m-85 -112.88 76.06 2.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 128.07 15.49 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.58 -21.24 3.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -92.04 -5.21 53.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 13.2 mp0 -51.26 -18.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.3 m -62.87 -58.19 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -86.36 -36.56 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -59.94 90.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -103.54 125.05 49.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.6 mp -100.53 139.94 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.496 HG23 ' C ' ' A' ' 207' ' ' ARG . 19.4 mt -129.17 123.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.463 ' HB3' HD21 ' A' ' 209' ' ' LEU . 77.4 t80 -111.42 114.39 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 35.9 mt-30 62.2 48.52 4.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.8 2.43 29.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ARG . . . . . 0.496 ' C ' HG23 ' A' ' 203' ' ' ILE . 9.1 ttt180 -105.55 134.83 48.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.07 125.92 31.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.8 mt -76.56 47.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -50.13 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 12.3 m-20 -41.36 101.9 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.6 0.715 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.0 Cg_endo -69.75 -0.49 6.99 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 0.0 112.353 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.03 -24.45 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.5 mmt-85 -51.7 115.24 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 9.4 p -63.52 151.06 42.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.175 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.776 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.37 -34.61 78.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.1 t -63.97 -46.65 83.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.4 m -62.72 -35.71 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.9 mt -76.81 4.54 9.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 m120 62.94 39.08 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.618 ' O ' HG22 ' A' ' 221' ' ' ILE . 45.2 mt -92.68 89.0 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 62.6 p -95.15 170.23 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.77 157.65 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.89 38.89 8.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 144.52 48.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.5 p -109.63 141.3 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.522 HG21 HD23 ' A' ' 202' ' ' LEU . 28.4 mt -119.21 127.29 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -77.4 131.33 37.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 54.6 m -113.17 138.81 49.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.4 m -134.48 158.62 43.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 110.878 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.9 p -172.57 151.32 2.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.24 77.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 67.7 m -102.33 99.04 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.3 t -134.26 143.28 47.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.828 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 114.49 -177.59 17.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 17.0 pt -104.91 143.65 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -92.68 138.64 31.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 179' ' ' ALA . 5.0 t -128.31 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HB2' HG23 ' A' ' 226' ' ' VAL . 31.7 mtm180 -99.97 118.44 36.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.681 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 42.3 mt -87.02 112.0 21.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -99.31 130.3 45.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 1.8 m-85 -107.72 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 21.1 mt -59.6 -10.76 3.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -81.51 15.51 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 62.87 31.63 16.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 8.9 t -123.59 174.31 7.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -142.77 157.39 44.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -140.07 132.29 28.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.9 tp -75.74 118.48 18.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.949 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.67 125.62 17.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.152 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 178' ' ' VAL . 12.1 p -91.93 121.83 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.06 157.59 32.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.1 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 19.9 mtm180 -112.11 153.17 44.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.85 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -111.54 -29.77 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -54.91 172.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.0 p -116.59 158.08 24.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.118 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.533 HG12 ' HD2' ' A' ' 189' ' ' LYS . 86.5 t -61.88 -43.72 97.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.01 -41.64 94.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.22 -45.56 76.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 111.104 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.441 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.0 tp -55.48 -47.12 76.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.533 ' HD2' HG12 ' A' ' 185' ' ' VAL . 24.9 mtpt -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.6 t -70.74 -28.1 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.839 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.98 -47.82 76.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.949 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 51.6 m-85 -99.93 -44.42 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 9.9 m-85 -109.71 79.52 1.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.644 0.735 . . . . 0.0 110.838 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 134.5 28.12 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.678 2.252 . . . . 0.0 112.39 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.46 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 74.74 -45.25 1.58 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.46 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -82.47 39.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 38.5 mp0 -85.53 -28.98 24.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 15.9 m -72.19 -13.59 61.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -110.83 -47.69 3.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.436 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.04 85.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.78 ' NZ ' HD21 ' A' ' 208' ' ' LEU . 11.7 mmtp -89.81 138.24 31.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.608 ' HB2' HD12 ' A' ' 209' ' ' LEU . 12.4 mt -106.26 141.25 37.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.508 HD12 ' CD2' ' A' ' 230' ' ' HIS . 54.7 mt -129.16 122.82 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.498 ' CB ' HD21 ' A' ' 209' ' ' LEU . 57.8 t80 -119.93 112.39 19.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 62.24 44.05 7.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.15 1.0 55.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.9 ttm-85 -101.97 140.3 36.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.78 HD21 ' NZ ' ' A' ' 201' ' ' LYS . 15.0 tp -86.21 125.3 33.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.755 HD22 HD13 ' A' ' 219' ' ' LEU . 6.4 mt -83.25 20.79 1.22 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 209' ' ' LEU . 1.0 OUTLIER -34.62 -53.06 0.53 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.46 ' HB3' ' CG ' ' A' ' 214' ' ' ARG . 12.6 t0 -48.49 105.73 0.53 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.714 . . . . 0.0 110.865 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -4.04 13.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.691 2.26 . . . . 0.0 112.384 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.13 -28.73 10.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.5 mmt180 -46.21 109.11 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.846 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.59 148.87 44.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.822 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -63.03 -31.5 72.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.868 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 t -64.59 -44.26 91.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 52.4 m -66.46 -35.99 81.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.865 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.755 HD13 HD22 ' A' ' 209' ' ' LEU . 95.4 mt -75.86 1.97 13.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 10.6 m120 67.05 25.04 9.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 216' ' ' LEU . 32.8 mt -77.97 103.65 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.112 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.2 p -103.52 -177.85 3.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.091 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 224' ' ' ASN . 1.0 OUTLIER -72.29 170.95 13.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.44 ' CG ' ' O ' ' A' ' 223' ' ' ASN . 4.4 p-10 47.71 30.04 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 3.9 t -107.97 159.57 16.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -119.2 138.72 48.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.105 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.8 mt -119.1 119.59 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -70.53 133.37 46.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 91.7 m -107.96 148.35 29.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.508 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.3 m-70 -129.54 138.41 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 231' ' ' ARG . 21.3 ttm105 -113.21 126.7 55.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 154.44 40.3 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.682 0.754 . . . . 0.0 110.873 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 148.92 66.13 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.754 2.302 . . . . 0.0 112.318 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 99.83 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.709 2.273 . . . . 0.0 112.341 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -97.91 31.89 7.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.12 148.99 43.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 111.097 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -119.16 37.22 4.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.01 140.28 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.165 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 10.3 t -151.63 127.35 10.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.831 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -169.98 146.08 9.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.22 8.39 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.329 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 70.9 m -62.15 126.74 28.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -102.08 142.27 33.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 61.4 p -117.28 102.59 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 83.9 p -147.03 134.05 20.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 106.02 85.49 1.82 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.468 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 165.5 30.69 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.688 2.259 . . . . 0.0 112.364 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.5 m -151.54 113.23 4.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 55.4 m -127.74 110.54 12.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.797 -0.715 . . . . 0.0 112.53 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 32.6 m -82.47 141.22 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 110.813 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.8 m -122.27 101.67 7.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.856 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 44.56 88.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.2 m -102.06 101.31 11.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.883 0.373 . . . . 0.0 110.824 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 t -110.82 90.88 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.24 -170.34 43.21 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.463 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 21.0 pt -110.33 138.84 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.34 137.13 32.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 179' ' ' ALA . 13.3 t -126.63 133.28 68.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.088 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.432 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.5 mtm180 -95.91 115.55 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.846 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.58 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.6 mt -86.48 106.55 17.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.5 tmmm? -98.78 133.96 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.853 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 173' ' ' THR . 6.0 m-85 -107.61 164.57 12.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.95 -11.79 42.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 32.9 t30 -85.36 16.32 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.9 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 62.41 30.17 17.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 169' ' ' PHE . 7.6 t -113.2 169.96 8.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -142.82 149.21 38.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -135.65 137.32 41.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.857 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 13.0 tp -77.21 118.77 20.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.927 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.744 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -142.77 113.9 7.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 84.1 t -83.9 121.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.653 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -122.04 158.09 29.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.098 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.6 mtm-85 -109.25 151.09 41.85 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.622 0.725 . . . . 0.0 110.892 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.5 Cg_endo -69.75 -1.67 8.85 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.746 2.298 . . . . 0.0 112.319 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' N ' ' OE1' ' A' ' 182' ' ' GLU . 17.1 pm0 -112.67 -17.07 12.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.89 -177.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.9 p -127.14 149.48 49.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.465 HG12 ' HD2' ' A' ' 189' ' ' LYS . 88.4 t -57.22 -39.57 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -63.19 -42.01 99.5 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -67.37 -44.79 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.794 0.33 . . . . 0.0 111.131 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 10.9 tp -55.57 -47.04 77.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.4 mtpt -58.38 -48.38 80.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.888 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 27.5 t -70.78 -27.99 64.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.584 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.7 tmmm? -65.05 -47.8 76.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.744 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 51.4 m-85 -99.82 -44.29 6.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.58 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 16.4 m-85 -108.64 75.99 0.65 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.641 0.734 . . . . 0.0 110.837 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.68 28.5 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.67 2.247 . . . . 0.0 112.33 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.456 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.51 -41.02 1.59 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -90.67 42.75 1.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.792 0.329 . . . . 0.0 110.925 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.456 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 27.8 mp0 -88.11 -32.5 18.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.5 t -67.43 -24.91 65.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -98.57 -38.18 9.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -71.41 85.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -91.02 134.79 34.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.896 HD23 HG21 ' A' ' 227' ' ' ILE . 7.4 mp -109.55 141.65 41.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.96 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.14 122.89 57.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.5 t80 -115.42 113.0 23.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.461 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 68.3 mt-30 62.99 44.08 6.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.53 -0.27 43.39 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.9 ttp-105 -102.68 131.29 49.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.817 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 33.5 tp -79.98 127.6 32.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 209' ' ' LEU . 4.4 mt -80.5 46.02 0.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -44.2 -73.82 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -45.08 104.09 0.37 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.584 0.707 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 3.04 3.0 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.28 . . . . 0.0 112.312 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.93 -17.73 14.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -54.3 117.98 3.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 16.1 p -65.71 147.01 54.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.103 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.49 -32.14 72.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 6.3 p -64.98 -46.9 79.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.0 p -61.59 -35.95 79.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.82 5.0 10.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.424 HD22 ' N ' ' A' ' 220' ' ' ASN . 1.8 m-80 62.2 34.22 16.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 221' ' ' ILE . 58.5 mt -87.29 93.24 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.2 p -98.21 -178.31 4.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.8 52.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 60.9 t30 73.59 37.15 0.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.1 t -119.0 145.86 45.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.432 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.6 p -110.54 141.36 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.103 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.896 HG21 HD23 ' A' ' 202' ' ' LEU . 23.0 mt -119.92 120.08 62.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -70.89 134.24 47.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 84.2 m -111.36 141.58 44.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -121.77 130.84 53.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -107.02 119.92 40.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 33.0 t -96.89 144.5 27.96 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.682 0.753 . . . . 0.0 110.831 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 147.54 63.18 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.726 2.284 . . . . 0.0 112.351 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 154.35 67.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.629 2.22 . . . . 0.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -112.96 -35.99 1.58 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.416 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.87 173.41 11.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 238' ' ' VAL . . . -115.15 127.87 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.132 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 237' ' ' ALA . 14.5 m 35.93 54.02 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.9 t -126.34 138.9 53.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 127.56 145.21 6.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 129.38 17.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.666 2.244 . . . . 0.0 112.324 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.1 m -143.83 123.38 13.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.86 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -154.81 131.04 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.7 t -145.5 108.63 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.1 t -155.23 148.77 25.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -142.53 83.41 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 166.58 27.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 2.242 . . . . 0.0 112.349 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.0 t 68.43 35.64 3.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.6 m -117.92 -47.47 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.9 p -86.46 107.66 18.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.36 . . . . 0.0 110.883 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.3 p -85.74 135.1 33.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.822 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -76.55 -125.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.523 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.6 m -145.34 163.19 35.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.858 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 71.4 p -55.41 154.69 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.97 -178.95 38.5 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.417 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.0 pt -101.29 143.99 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.61 136.26 33.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.2 t -131.49 136.62 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.635 ' HB2' HG23 ' A' ' 226' ' ' VAL . 13.5 mtp180 -99.79 123.09 43.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.867 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 192' ' ' TYR . 36.5 mt -91.49 107.4 19.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -98.72 133.29 43.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 6.0 m-85 -107.13 164.47 12.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.3 mt -65.22 -7.68 14.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -84.89 9.47 14.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 69.39 26.39 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 9.0 t -119.14 160.0 22.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.183 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -131.01 154.2 48.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -133.98 128.97 35.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.0 tp -73.43 118.62 16.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.952 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.73 132.37 23.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.087 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 178' ' ' VAL . 14.8 p -93.45 121.9 44.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -124.61 157.25 35.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.529 ' O ' HD12 ' A' ' 216' ' ' LEU . 36.0 mtp180 -110.4 154.97 42.74 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.622 0.725 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.78 -12.09 32.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.319 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.66 -36.62 10.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -47.38 168.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 213' ' ' ALA . 24.0 p -110.76 159.57 17.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.541 ' CG2' HD11 ' A' ' 219' ' ' LEU . 68.6 t -61.5 -35.78 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.16 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -67.9 -40.85 89.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.464 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.5 m -68.36 -38.49 81.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.771 0.32 . . . . 0.0 111.123 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.7 tp -55.59 -46.6 77.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 6.2 mtpp -65.11 -42.05 94.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.8 t -71.02 -28.17 64.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.591 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.09 -48.14 74.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.858 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.952 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 7.7 m-85 -100.04 -43.65 6.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 24.3 m-85 -107.47 80.74 0.95 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.665 0.745 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 192' ' ' TYR . 53.7 Cg_endo -69.77 127.07 14.07 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.321 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.454 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.1 -41.96 1.83 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.481 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -83.55 39.43 0.67 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.741 0.305 . . . . 0.0 110.887 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 37.8 mp0 -85.22 -36.55 20.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 4.3 t -64.06 -22.96 67.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -100.29 -34.61 9.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.905 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -79.35 85.24 5.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -88.24 134.45 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 13.5 mt -104.11 141.27 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.917 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.13 122.78 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 62.0 t80 -117.32 122.43 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.575 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.2 mm-40 53.46 48.61 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.03 4.15 33.55 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.451 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.441 ' HD3' ' N ' ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.55 142.15 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.862 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.441 ' N ' ' HD3' ' A' ' 207' ' ' ARG . 35.1 tp -87.68 121.94 30.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.485 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.8 mt -75.75 50.1 0.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.425 ' CG ' HD23 ' A' ' 208' ' ' LEU . 73.6 mt-30 -53.1 -71.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 16.5 t0 -42.23 102.57 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.846 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.5 Cg_endo -69.81 3.02 3.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 184' ' ' THR . . . -107.11 -33.15 7.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -39.98 114.27 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.9 p -61.5 143.37 56.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.129 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.717 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -57.56 -31.84 66.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 77.6 p -64.74 -46.93 80.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.8 t -65.05 -32.32 73.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.541 HD11 ' CG2' ' A' ' 185' ' ' VAL . 48.5 mt -77.14 4.97 9.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 62.88 30.36 16.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 221' ' ' ILE . 55.2 mt -86.53 95.84 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.7 p -99.75 -175.13 2.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.152 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -74.79 159.79 31.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 62.27 28.88 17.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -110.85 157.1 20.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.635 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.6 p -119.68 133.68 65.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 35.2 mt -112.6 116.03 51.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -66.93 139.38 57.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 99.2 m -115.59 144.04 44.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -131.7 128.38 38.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -102.5 125.46 49.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 2.2 m -97.69 154.33 37.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.641 0.734 . . . . 0.0 110.832 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 142.48 48.12 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.338 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 143.54 51.08 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.252 . . . . 0.0 112.37 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.89 -52.22 3.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -147.84 155.9 42.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.103 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.48 144.35 53.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.071 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 6.0 p -60.13 123.88 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.2 t -164.24 -179.59 6.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 143.85 147.21 4.66 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.538 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -45.0 1.72 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.661 2.241 . . . . 0.0 112.309 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.9 m 63.7 35.19 11.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.85 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -142.76 112.62 6.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.9 m -131.33 178.8 6.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.6 p -67.71 152.72 45.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.74 148.15 17.5 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 151.8 69.35 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.73 2.287 . . . . 0.0 112.349 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 m -145.82 174.85 10.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.828 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 75.4 p -110.5 135.62 50.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.461 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.2 t -68.42 -61.38 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.0 t -77.42 108.03 10.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.63 71.72 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.515 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 t -69.91 -52.31 25.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.92 0.39 . . . . 0.0 110.86 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 26.0 p -53.75 128.4 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.15 154.08 10.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.507 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 26.5 pt -93.75 145.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 111.124 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -89.49 129.76 35.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 179' ' ' ALA . 22.0 t -123.58 138.5 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.7 mtp180 -103.14 117.68 35.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.837 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.832 HD11 ' CD2' ' A' ' 192' ' ' TYR . 46.1 mt -85.21 108.1 17.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -99.03 129.5 45.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.2 m-85 -107.65 157.17 18.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.9 mt -63.55 -7.78 7.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -83.21 17.09 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 62.18 29.03 17.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.43 HG23 ' CD1' ' A' ' 169' ' ' PHE . 11.5 t -123.79 167.12 14.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -139.65 153.23 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.25 131.0 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 44.8 tp -77.42 117.92 19.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.061 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -139.12 135.55 34.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.11 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 178' ' ' VAL . 14.9 p -94.8 123.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.114 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.447 ' HB3' ' CG2' ' A' ' 165' ' ' VAL . . . -124.08 157.65 34.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -111.46 152.09 43.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.601 0.715 . . . . 0.0 110.879 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.0 Cg_endo -69.74 -2.55 10.35 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.341 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.54 -38.56 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.14 172.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.6 p -114.45 164.57 13.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.172 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 209' ' ' LEU . 43.2 t -64.72 -40.41 88.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.121 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.89 -42.18 99.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -66.54 -38.75 87.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.183 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.15 -47.01 82.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.888 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 193' ' ' PHE . 21.1 mtpt -63.66 -44.06 94.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.414 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 39.7 t -70.87 -28.21 64.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.593 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.12 -48.2 74.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.919 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 1.061 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 8.6 m-85 -99.94 -43.91 6.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 4.9 m-85 -112.66 78.63 2.85 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 131.7 21.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.336 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.46 -42.27 1.7 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -71.6 1.91 5.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.907 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.414 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 9.7 mt-10 -55.19 -14.38 1.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.863 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 49.8 m -64.41 -58.28 6.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 201' ' ' LYS . 6.1 pt20 -84.28 -37.2 21.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.459 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -52.6 85.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 199' ' ' GLN . 19.5 mttp -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.466 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 17.4 mt -93.67 137.07 33.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.94 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 24.9 mt -129.08 122.89 57.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.123 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.7 t80 -114.86 119.75 37.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 10.4 mm100 54.39 48.45 20.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.73 41.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -102.61 139.08 38.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.869 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.64 HD23 ' HG3' ' A' ' 210' ' ' GLN . 41.0 tp -87.39 123.17 32.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.451 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.5 mt -79.09 47.01 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.64 ' HG3' HD23 ' A' ' 208' ' ' LEU . 12.3 mt-30 -50.38 -73.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -43.79 103.29 0.32 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.597 0.713 . . . . 0.0 110.842 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -0.34 6.78 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 0.0 112.373 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.58 22.52 14.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -94.32 105.09 17.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.9 p -50.64 142.95 10.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.6 mt -62.26 -32.67 73.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 15.7 t -64.57 -45.94 84.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.1 m -65.08 -31.32 72.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.64 4.48 18.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.0 34.22 11.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.518 ' O ' HG22 ' A' ' 221' ' ' ILE . 57.5 mt -90.83 93.56 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 76.2 p -98.76 -176.66 3.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.168 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -69.39 150.64 47.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 72.44 33.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.2 t -113.39 149.88 33.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.7 p -116.12 134.51 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.466 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.0 mt -114.47 122.14 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -79.08 135.74 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.906 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -115.82 127.55 55.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.878 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -100.45 123.15 44.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -108.58 113.28 26.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -89.15 143.81 31.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.64 0.733 . . . . 0.0 110.84 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 148.83 65.73 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.682 2.254 . . . . 0.0 112.325 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 157.71 59.53 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.727 2.284 . . . . 0.0 112.352 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -147.27 37.78 1.13 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.445 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.97 162.47 35.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.351 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.437 ' O ' ' C ' ' A' ' 238' ' ' VAL . . . -115.12 99.57 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 237' ' ' ALA . 12.5 m 34.49 50.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.3 t -156.29 134.4 11.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -153.47 148.26 18.75 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.446 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -23.93 30.45 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.706 2.271 . . . . 0.0 112.382 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 2.1 t 43.45 40.1 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -117.09 145.89 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.077 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 8.2 t -153.05 174.27 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.3 p -130.94 174.24 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.47 16.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 150.62 68.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 0.0 112.376 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 72.7 m -78.77 82.74 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.834 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 47.3 p -118.59 84.5 2.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -85.71 141.81 29.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.848 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.2 t -60.45 115.14 3.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 77.95 77.08 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.461 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.4 m -69.81 170.62 10.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.858 0.361 . . . . 0.0 110.883 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 50.6 m 50.4 38.23 17.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.835 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.52 173.26 22.39 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -97.99 151.53 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 0.0 111.166 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -101.12 139.12 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.29 132.31 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.458 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.8 mtm180 -94.38 117.58 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.726 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 38.6 mt -85.14 107.34 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -98.73 128.61 45.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 5.3 m-85 -107.32 157.26 18.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.08 -9.97 5.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HB3' HG22 ' A' ' 173' ' ' THR . 55.7 t30 -81.23 14.59 2.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 62.33 34.05 16.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 171' ' ' ASN . 5.1 t -130.53 157.43 42.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -128.16 153.5 46.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -134.32 136.25 43.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.9 tp -77.51 116.69 18.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.794 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.65 116.56 10.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.149 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.9 t -82.4 121.86 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.079 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.441 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -122.36 158.13 30.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 216' ' ' LEU . 54.5 mtm-85 -110.54 152.85 43.63 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.56 0.695 . . . . 0.0 110.924 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.4 Cg_endo -69.77 -5.0 15.17 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -105.02 -36.82 7.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -49.59 169.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.5 p -111.65 160.1 17.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 202' ' ' LEU . 69.4 t -65.1 -44.11 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.59 88.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.53 -43.22 66.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 111.121 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 11.4 tp -55.36 -47.18 76.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.4 mtpt -58.63 -48.24 81.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 90.7 p -70.76 -27.97 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.587 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.6 tmmm? -65.19 -47.87 75.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.794 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 48.0 m-85 -99.95 -44.31 6.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.927 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.726 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 7.7 m-85 -111.84 77.44 1.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.689 0.757 . . . . 0.0 110.843 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 128.02 15.38 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.675 2.25 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.24 -14.95 4.62 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -94.52 -12.49 27.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.727 0.299 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -48.56 -20.93 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.2 m -61.54 -49.79 75.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 201' ' ' LYS . 29.3 mt-30 -91.97 -45.24 8.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.501 ' HE1' ' HG3' ' A' ' 231' ' ' ARG . 0.0 OUTLIER -52.14 85.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.779 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.9 ttmm -91.55 120.52 32.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.06 134.89 34.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.3 mt -129.13 123.46 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.435 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 78.9 t80 -115.45 116.5 28.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.93 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 60.1 mt-30 58.13 38.1 26.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 77.68 7.29 87.27 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -107.05 135.17 49.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.795 HD23 ' HG3' ' A' ' 210' ' ' GLN . 10.1 tp -80.15 127.03 31.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.455 ' HB3' HG21 ' A' ' 185' ' ' VAL . 5.4 mt -84.16 26.2 0.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.795 ' HG3' HD23 ' A' ' 208' ' ' LEU . 21.1 mt-30 -34.33 -74.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.58 100.12 0.2 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.89 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 0.79 5.09 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.733 2.288 . . . . 0.0 112.36 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.88 16.01 20.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -89.5 112.83 24.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.1 p -57.92 137.19 56.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.703 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.7 mt -57.07 -34.7 68.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.3 t -61.37 -44.31 97.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.812 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 74.5 m -67.05 -35.94 80.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.876 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 48.2 mt -75.62 4.37 7.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.901 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.64 38.86 11.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 221' ' ' ILE . 52.5 mt -94.04 90.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.134 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 73.7 p -95.81 171.76 8.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -57.8 157.6 7.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.873 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 61.96 37.76 14.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 t -114.46 143.74 44.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.7 p -109.44 134.75 50.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.431 HG21 ' HB3' ' A' ' 202' ' ' LEU . 41.5 mt -115.45 129.93 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -83.66 127.36 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 1.8 t -111.14 122.42 47.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -99.83 130.26 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.849 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.501 ' HG3' ' HE1' ' A' ' 200' ' ' MET . 16.3 ttm180 -113.01 112.93 24.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 41.4 t -81.95 144.12 50.92 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.676 0.751 . . . . 0.0 110.852 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 145.41 56.84 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.347 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 235' ' ' GLY . 53.9 Cg_endo -69.73 102.86 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.381 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -34.51 -59.23 0.67 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -141.68 155.24 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.14 90.5 6.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.08 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.02 -8.52 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.165 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 36.4 m -115.76 166.31 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -101.73 -164.88 27.09 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -17.46 37.64 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.683 2.255 . . . . 0.0 112.348 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 16.8 p -42.84 156.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -126.9 118.5 24.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.086 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.0 t -97.73 137.47 36.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.4 t -170.56 151.15 3.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -173.8 67.51 0.11 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 142.1 46.92 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.748 2.299 . . . . 0.0 112.324 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 249' ' ' SER . 12.1 t -63.95 152.36 40.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 248' ' ' SER . 52.6 p -36.54 147.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.476 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.0 m -47.55 142.68 4.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 110.818 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.4 t -89.14 151.26 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.827 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -179.14 47.24 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.502 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.7 t -44.69 144.75 1.04 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.3 p -73.16 167.05 21.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.817 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 138.09 167.05 10.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.507 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.411 ' CD1' ' O ' ' A' ' 221' ' ' ILE . 19.2 pt -100.97 144.99 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 0.0 111.08 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -91.16 134.32 34.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.21 135.43 61.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.454 ' HB2' HG23 ' A' ' 226' ' ' VAL . 17.2 mtm180 -100.68 118.19 36.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.69 HD11 ' CD2' ' A' ' 192' ' ' TYR . 30.4 mt -85.15 110.73 19.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -98.77 128.56 45.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.7 m-85 -107.69 158.5 17.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 5.1 mp -64.41 -7.81 11.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -85.31 23.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 55.81 27.54 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 15.3 t -123.75 164.23 19.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.03 153.95 51.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -132.83 133.41 43.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.6 tp -78.71 124.74 28.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.027 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.58 142.74 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.19 121.76 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.01 158.21 38.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.477 ' O ' HD12 ' A' ' 216' ' ' LEU . 32.5 mtm180 -115.86 154.18 48.2 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.85 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 -4.86 14.85 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.372 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.05 -37.93 7.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.525 ' OD2' HG21 ' A' ' 187' ' ' THR . 0.9 OUTLIER -51.77 168.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 70.0 p -115.01 164.29 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.143 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 209' ' ' LEU . 50.0 t -57.06 -44.02 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.187 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.71 -36.62 90.37 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.511 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.525 HG21 ' OD2' ' A' ' 183' ' ' ASP . 3.0 m -71.36 -39.58 71.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.126 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.1 tp -55.52 -47.17 76.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 29.4 mttt -58.99 -47.92 83.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -70.12 -28.05 65.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.906 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.528 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -64.53 -48.14 76.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 1.027 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 4.0 m-85 -100.32 -44.58 5.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.9 m-85 -111.51 83.13 4.07 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.73 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 120.17 7.0 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.655 2.237 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.444 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.74 -26.88 2.66 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -79.84 -3.88 49.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 0.0 110.929 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 2.8 mp0 -52.11 -21.06 2.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 52.8 m -60.47 -51.66 68.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -93.3 -44.09 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.97 95.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -103.77 134.3 47.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.541 HD13 HD23 ' A' ' 188' ' ' LEU . 11.5 mt -101.06 138.94 37.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.565 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.1 mt -129.24 122.9 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.125 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.571 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 68.1 t80 -115.21 125.68 53.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.963 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 12.4 mm-40 52.72 46.09 27.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 70.3 2.23 40.05 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 203' ' ' ILE . 5.2 ttp-105 -102.78 144.94 30.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 25.6 tp -88.28 124.47 33.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.575 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.7 mt -75.71 48.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -51.44 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m-20 -42.31 102.48 0.27 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.615 0.722 . . . . 0.0 110.84 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.2 Cg_endo -69.82 3.09 3.0 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.654 2.236 . . . . 0.0 112.345 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -118.31 19.42 13.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -86.76 101.16 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 p -48.36 135.42 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -58.97 -37.6 77.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 47.4 t -59.59 -43.48 93.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -36.04 81.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.847 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.435 HD22 HH22 ' A' ' 207' ' ' ARG . 75.7 mt -76.67 5.12 8.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 63.02 32.94 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 221' ' ' ILE . 48.4 mt -85.54 89.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.5 p -95.73 179.66 5.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 157.96 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 63.6 39.53 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -116.2 149.49 39.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' A' ' 226' ' ' VAL . 1.7 p -114.85 123.79 70.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 30.9 mt -105.99 124.02 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -74.4 130.77 40.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 88.6 m -103.81 149.41 25.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.565 ' CD2' HD12 ' A' ' 203' ' ' ILE . 4.0 m170 -127.24 127.1 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -113.2 112.75 24.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.5 t -90.36 143.05 28.85 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.654 0.74 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 147.27 62.28 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 0.0 112.359 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 157.51 60.13 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -105.01 -33.88 3.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -139.45 162.38 35.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.769 0.318 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -104.58 42.58 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.95 -15.44 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.123 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 8.4 t -56.11 100.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.888 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 84.78 146.92 8.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.493 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -29.81 23.48 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.699 2.266 . . . . 0.0 112.352 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 23.7 m -140.7 178.86 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -106.97 94.09 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.136 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.0 m -64.6 108.7 1.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.0 m -96.7 103.31 15.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.864 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 165.47 167.98 26.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 151.73 69.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.252 . . . . 0.0 112.382 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 60.0 p -157.51 127.55 6.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 61.0 p -53.45 166.61 0.27 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.865 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.5 m -139.79 144.55 37.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.383 . . . . 0.0 110.85 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 44.3 t -134.17 131.54 38.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.879 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.39 162.18 11.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.447 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 10.0 m -165.29 154.75 12.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 0.0 110.872 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.7 p -97.79 142.96 28.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.28 164.37 14.31 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.536 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.7 pt -95.97 138.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 0.0 111.168 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -87.31 143.62 27.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.27 138.64 49.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.5 mtm180 -97.75 116.59 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.669 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 58.7 mt -85.18 109.19 18.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 229' ' ' CYS . 1.6 tmtm? -98.95 133.67 42.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.86 ' HB2' HG22 ' A' ' 173' ' ' THR . 1.9 m-85 -108.57 162.89 13.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 230' ' ' HIS . 19.0 mt -61.61 -22.74 65.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' A' ' 173' ' ' THR . 11.2 p-10 -82.96 34.47 0.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 43.19 54.82 4.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.86 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.8 OUTLIER -128.33 171.59 11.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.159 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.62 147.4 31.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.98 129.48 25.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.7 tp -77.39 117.82 19.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.8 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.96 140.31 34.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.088 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 178' ' ' VAL . 13.1 p -99.05 121.84 50.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.601 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -125.01 157.65 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 76.7 mtm-85 -110.83 152.08 43.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.587 0.708 . . . . 0.0 110.931 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.1 Cg_endo -69.82 0.22 6.0 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.659 2.239 . . . . 0.0 112.31 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.59 -43.85 4.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.63 161.67 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.772 HG22 ' O ' ' A' ' 213' ' ' ALA . 20.0 p -103.28 164.25 11.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.4 t -59.89 -42.39 89.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.158 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.98 98.87 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.498 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -66.17 -38.01 87.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 111.198 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.9 tp -57.14 -46.86 82.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 18.7 mtpt -66.67 -42.05 87.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.3 t -70.83 -28.2 64.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.583 ' HD2' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -65.02 -48.35 74.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 6.7 m-85 -99.98 -44.01 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.955 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.669 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 8.0 m-85 -109.98 78.89 1.38 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.673 0.749 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.84 131.33 20.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.455 ' C ' ' OE1' ' A' ' 197' ' ' GLU . . . 76.79 -41.59 1.72 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.455 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -84.57 35.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.79 0.329 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.455 ' OE1' ' C ' ' A' ' 195' ' ' GLY . 32.7 mp0 -83.42 -31.4 26.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.5 m -64.7 -19.73 65.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 230' ' ' HIS . 34.5 mt-30 -104.17 -45.02 4.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.446 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.77 85.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mtmt -88.51 122.21 31.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 31.8 mt -93.95 137.54 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.404 HD12 ' CD2' ' A' ' 230' ' ' HIS . 45.3 mt -129.15 122.68 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.563 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 64.0 t80 -116.1 113.8 23.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.9 mt-30 62.93 43.55 6.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.32 4.61 60.72 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.497 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -106.83 131.62 53.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.425 HD23 ' HG3' ' A' ' 210' ' ' GLN . 39.8 tp -79.95 125.27 29.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.3 mt -78.0 46.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.425 ' HG3' HD23 ' A' ' 208' ' ' LEU . 23.7 mt-30 -45.49 -67.84 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 19.6 t0 -44.61 103.93 0.36 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 52.9 Cg_endo -69.84 2.55 3.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.659 2.239 . . . . 0.0 112.286 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 184' ' ' THR . . . -106.92 -30.53 8.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.115 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -41.47 123.3 2.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.3 p -70.29 150.39 46.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -64.45 -35.63 81.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 90.0 p -63.55 -46.07 87.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 4.3 m -63.72 -34.45 77.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 59.3 mt -77.84 4.49 11.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 67.0 29.34 8.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.87 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 84.8 mt -87.02 92.05 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.0 p -101.77 -175.73 2.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -70.24 154.46 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 62.45 38.3 12.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -122.92 146.29 47.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.2 p -107.32 142.22 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.119 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 25.5 mt -120.68 119.56 59.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -66.18 137.66 57.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.837 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.492 ' N ' ' O ' ' A' ' 168' ' ' LYS . 83.1 m -120.26 146.72 45.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 170' ' ' LEU . 4.2 m-70 -127.28 141.57 51.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.417 ' C ' ' HD2' ' A' ' 231' ' ' ARG . 2.7 tmm_? -112.3 123.78 51.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 72.1 m -92.19 143.37 27.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.655 0.74 . . . . 0.0 110.824 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 146.55 60.54 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.354 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 235' ' ' GLY . 53.9 Cg_endo -69.72 98.19 0.67 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.702 2.268 . . . . 0.0 112.329 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 234' ' ' PRO . . . -34.82 -46.49 0.61 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -165.75 155.25 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.787 0.327 . . . . 0.0 111.1 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.26 141.47 35.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.05 170.12 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 52.1 p -127.08 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 75.36 141.63 0.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.513 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 242' ' ' SER . 53.5 Cg_endo -69.77 170.92 15.45 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.737 2.291 . . . . 0.0 112.301 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 241' ' ' PRO . 26.0 p -37.11 137.66 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -123.7 151.96 42.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.2 t -94.49 -47.9 6.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 1.5 t 56.6 42.59 26.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -153.4 73.1 0.26 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.475 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 98.41 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.632 2.222 . . . . 0.0 112.344 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.6 t -92.19 153.86 19.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.837 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 2.3 t -161.67 137.25 7.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.847 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.471 -179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 85.4 p -95.6 176.62 6.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 0.0 110.898 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.0 m -84.4 132.72 34.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 85.68 55.6 2.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 65.0 m -49.79 -48.15 50.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.877 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.6 t -124.07 103.04 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.854 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.83 30.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 29.4 pt -120.07 138.85 49.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.806 0.336 . . . . 0.0 111.144 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -87.96 143.2 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 179' ' ' ALA . 16.3 t -131.7 137.47 55.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.408 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtm180 -100.59 117.55 34.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.615 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.0 mt -86.67 107.88 18.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -98.88 128.32 45.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.622 ' CD1' HG23 ' A' ' 173' ' ' THR . 1.6 m-85 -107.5 160.23 15.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.409 HD11 ' CE1' ' A' ' 230' ' ' HIS . 70.4 mt -66.71 -6.24 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -84.83 16.37 3.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 63.0 26.93 15.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.622 HG23 ' CD1' ' A' ' 169' ' ' PHE . 6.1 t -120.84 168.26 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -144.48 149.9 36.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -135.77 129.18 32.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 177' ' ' ALA . 0.8 OUTLIER -73.27 120.29 18.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.031 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.14 125.96 24.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.053 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.451 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 6.2 p -86.57 123.07 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -126.31 157.97 37.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -111.96 153.49 44.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.619 0.723 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -5.61 16.61 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.251 . . . . 0.0 112.375 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -101.76 -38.41 7.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -51.36 173.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.891 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 41.5 p -118.91 164.36 15.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.652 HG21 ' HB3' ' A' ' 209' ' ' LEU . 54.2 t -64.37 -43.99 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.13 -36.78 83.63 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -71.97 -44.59 63.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 111.167 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 179' ' ' ALA . 10.1 tp -55.14 -47.12 75.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.539 ' HD2' HG12 ' A' ' 185' ' ' VAL . 33.6 mtpt -57.98 -48.57 79.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.903 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 94.0 p -70.93 -27.92 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.66 -47.55 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 1.031 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 86.4 m-85 -98.7 -44.44 6.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.615 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.3 m-85 -113.65 79.14 4.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.667 0.746 . . . . 0.0 110.833 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 134.31 27.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.684 2.256 . . . . 0.0 112.344 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.04 -44.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -68.77 -1.46 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.738 0.304 . . . . 0.0 110.88 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.438 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 13.2 mt-10 -51.56 -20.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.885 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.7 t -58.83 -59.29 5.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 201' ' ' LYS . 0.0 OUTLIER -82.92 -42.2 17.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.461 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -45.14 91.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.857 ' HG2' HD11 ' A' ' 208' ' ' LEU . 17.8 ttmt -105.29 117.94 35.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.614 HD12 HG13 ' A' ' 185' ' ' VAL . 15.0 mt -93.72 137.12 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.27 122.9 57.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.152 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.449 ' HB3' HD21 ' A' ' 209' ' ' LEU . 63.5 t80 -116.14 111.9 20.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 57.97 51.51 8.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.59 5.87 39.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.73 136.55 43.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 110.914 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.857 HD11 ' HG2' ' A' ' 201' ' ' LYS . 12.1 tp -85.32 121.07 27.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.652 ' HB3' HG21 ' A' ' 185' ' ' VAL . 7.2 mt -79.46 44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.959 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -52.14 -72.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 214' ' ' ARG . 9.2 t70 -42.24 102.5 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.567 0.698 . . . . 0.0 110.896 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.02 3.02 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.51 8.66 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.105 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.455 ' N ' ' OD1' ' A' ' 211' ' ' ASP . 8.4 mmm-85 -82.33 105.81 13.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.867 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 17.6 p -51.36 142.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.163 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.75 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.2 mt -62.09 -31.74 72.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 85.8 p -63.3 -44.35 95.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 m -67.25 -35.4 79.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.97 5.0 5.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.65 26.07 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.547 ' O ' HG22 ' A' ' 221' ' ' ILE . 51.6 mt -81.18 93.67 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 41.3 p -96.31 -175.58 3.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.5 OUTLIER -74.95 158.18 33.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 56.4 m-20 62.91 29.18 16.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.9 t -110.22 154.82 22.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 166' ' ' ARG . 4.9 p -117.11 138.98 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 37.7 mt -116.15 122.78 70.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -73.53 134.09 43.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 60.3 m -120.14 133.9 55.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.409 ' CE1' HD11 ' A' ' 170' ' ' LEU . 4.6 m170 -111.07 127.3 55.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -113.32 112.95 24.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.3 t -102.33 143.13 25.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.648 0.737 . . . . 0.0 110.851 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 138.25 37.36 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 0.0 112.317 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 128.16 15.6 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -42.71 -75.4 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.488 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -163.2 156.4 19.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -40.12 114.0 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.062 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.5 m -40.1 140.06 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.8 t -152.7 119.1 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 164.36 95.94 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.474 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 80.34 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 88.0 p -160.64 150.26 17.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -165.43 169.13 15.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.098 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 77.8 p -62.2 177.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 35.0 t -53.17 96.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 150.2 146.71 4.38 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.452 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -177.42 1.87 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.731 2.287 . . . . 0.0 112.32 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.9 m -148.73 144.92 27.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 42.9 m -65.02 -49.77 68.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.839 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.482 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.0 t -50.86 -44.15 59.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.0 110.827 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.0 m -64.15 -60.12 3.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -62.12 153.7 41.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.5 m -60.09 -50.99 71.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.835 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.4 m -153.73 129.56 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 65.39 -179.6 9.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.6 pt -95.96 144.81 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.28 134.63 34.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.39 130.93 70.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.508 ' HB2' HG23 ' A' ' 226' ' ' VAL . 28.4 mtp180 -96.79 117.06 30.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.4 mt -85.67 107.14 17.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -99.06 127.87 45.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.45 ' CD1' HG23 ' A' ' 173' ' ' THR . 4.0 m-85 -105.42 161.48 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.71 HD11 ' CD2' ' A' ' 230' ' ' HIS . 5.3 mp -67.47 -7.71 27.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -82.11 16.23 2.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.8 t70 63.29 30.15 15.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.45 HG23 ' CD1' ' A' ' 169' ' ' PHE . 14.7 t -125.15 174.91 7.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.7 mp0 -148.22 150.14 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -130.23 134.13 47.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.6 tp -80.87 122.5 27.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.947 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 141.24 33.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.111 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.88 121.91 52.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -126.48 157.91 37.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.142 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 216' ' ' LEU . 70.8 mtt180 -113.95 154.51 45.98 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.602 0.715 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -1.72 8.95 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.635 2.223 . . . . 0.0 112.363 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.26 -39.21 6.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -46.11 170.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 46.7 p -112.76 161.99 16.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.15 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.474 HG11 ' O ' ' A' ' 209' ' ' LEU . 66.9 t -64.24 -40.18 88.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.128 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.82 -44.12 97.94 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.8 m -67.04 -36.28 81.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.352 . . . . 0.0 111.169 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -56.12 -46.69 79.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 193' ' ' PHE . 17.6 mttp -64.76 -41.79 95.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.405 ' HB3' ' CD ' ' A' ' 197' ' ' GLU . 74.4 p -70.6 -28.24 64.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.69 -48.69 73.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.947 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 10.3 m-85 -100.33 -43.58 6.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 189' ' ' LYS . 20.2 m-85 -110.83 80.47 2.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.18 14.18 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 0.0 112.322 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.78 -39.99 1.81 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.476 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -84.11 28.68 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.746 0.308 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.405 ' CD ' ' HB3' ' A' ' 190' ' ' SER . 5.1 mt-10 -80.13 -18.72 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 22.8 t -75.71 -24.15 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -100.67 -44.3 5.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.65 86.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 29.4 mtmt -88.89 121.15 30.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.69 HD23 HG21 ' A' ' 227' ' ' ILE . 6.8 mp -96.88 139.13 33.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.1 mt -129.05 122.97 57.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.518 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 74.4 t80 -114.06 111.78 22.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 26.5 mt-30 63.31 42.36 6.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 75.77 0.77 64.89 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.04 131.99 48.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 tp -81.5 122.36 27.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.474 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.8 mt -76.21 53.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.46 -71.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -42.03 102.3 0.27 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.72 . . . . 0.0 110.929 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.74 2.43 3.53 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.639 2.226 . . . . 0.0 112.385 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.47 14.25 19.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -89.1 101.2 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 10.1 p -47.8 143.22 4.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.5 mt -59.59 -39.99 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 36.3 p -58.72 -44.77 90.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.837 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.1 m -63.92 -34.05 77.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.848 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 78.9 mt -77.91 4.69 11.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 62.52 36.44 13.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.517 ' O ' HG22 ' A' ' 221' ' ' ILE . 53.8 mt -90.88 94.48 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 78.2 p -100.32 173.75 6.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.193 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -64.1 153.42 37.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 40.4 t30 69.37 38.44 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 t -120.55 151.42 39.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.5 p -115.11 136.29 52.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.103 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.69 HG21 HD23 ' A' ' 202' ' ' LEU . 28.9 mt -115.37 130.04 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -83.4 127.08 33.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.828 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.584 ' O ' HD12 ' A' ' 170' ' ' LEU . 58.0 m -109.02 136.13 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.891 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.71 ' CD2' HD11 ' A' ' 170' ' ' LEU . 5.8 m-70 -112.66 131.72 55.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.86 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HG3' ' HE1' ' A' ' 200' ' ' MET . 49.6 ttm-85 -110.16 128.67 55.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 24.0 t -115.65 139.44 24.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 0.0 110.859 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 126.71 13.65 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.682 2.255 . . . . 0.0 112.404 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 79.96 0.91 Allowed 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.718 2.279 . . . . 0.0 112.345 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 59.24 -90.19 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.526 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -174.87 122.75 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.074 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -144.87 165.34 28.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.92 144.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.19 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 44.6 t -51.1 115.75 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -171.59 153.31 19.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.519 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 163.83 36.8 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.312 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.0 t -124.25 -59.73 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -148.36 141.22 24.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.073 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.7 t -95.57 134.58 38.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 29.0 p -107.03 41.65 1.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.24 -75.94 0.49 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 1.75 4.16 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.711 2.274 . . . . 0.0 112.312 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 28.7 t -67.35 109.67 3.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 96.3 p -98.59 152.73 19.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.0 m -55.11 125.29 19.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.0 p -127.22 146.37 50.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.8 42.04 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 42.0 t -157.41 147.12 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 48.6 m -59.56 169.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.14 179.15 30.96 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.68 HG22 ' HB3' ' A' ' 223' ' ' ASN . 13.0 pt -108.19 145.38 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.91 138.84 32.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 89.2 t -130.43 137.43 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.896 ' HB2' HG23 ' A' ' 226' ' ' VAL . 9.1 mtt180 -98.07 125.23 42.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.506 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 40.1 mt -92.53 104.52 16.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.73 133.69 42.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.934 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 173' ' ' THR . 3.9 m-85 -107.27 166.33 10.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.451 HD11 ' CE1' ' A' ' 230' ' ' HIS . 14.4 mt -70.6 -14.21 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.889 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.548 ' OD1' HG22 ' A' ' 173' ' ' THR . 3.0 p30 -78.15 4.12 13.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.861 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.2 t70 73.97 47.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.548 HG22 ' OD1' ' A' ' 171' ' ' ASN . 1.3 t -135.46 171.82 13.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -142.96 153.94 43.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.55 130.44 23.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.79 117.82 14.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.044 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.1 123.48 17.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.57 123.76 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -127.18 157.67 39.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.454 ' O ' HD12 ' A' ' 216' ' ' LEU . 73.7 mtm-85 -107.99 153.6 41.61 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 0.0 110.889 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.75 -1.15 7.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.674 2.249 . . . . 0.0 112.33 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -109.26 -33.22 6.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -50.18 173.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 2.6 p -117.21 159.09 23.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.121 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.96 -40.19 88.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.58 -37.32 94.54 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.488 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -70.44 -42.5 71.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 111.168 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.2 tp -55.34 -47.27 75.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.938 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 193' ' ' PHE . 26.4 mtpt -58.87 -48.11 82.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.447 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.7 t -70.57 -27.99 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.557 ' CE ' ' CZ ' ' A' ' 192' ' ' TYR . 1.5 tmmm? -65.02 -48.06 75.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 1.044 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 54.9 m-85 -100.01 -44.48 6.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 189' ' ' LYS . 4.9 m-85 -112.07 77.23 2.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 134.72 28.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.657 2.238 . . . . 0.0 112.349 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.08 -42.42 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.461 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -68.29 -9.87 50.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.723 0.297 . . . . 0.0 110.899 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.447 ' OE2' ' CB ' ' A' ' 190' ' ' SER . 13.1 mt-10 -45.51 -22.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 8.6 t -55.92 -61.24 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -84.19 -42.61 15.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.91 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.405 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -44.83 113.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.92 179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -126.3 122.28 35.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 14.5 mt -93.83 141.21 28.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 30.9 mt -129.13 122.81 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.446 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 61.2 t80 -116.33 110.94 19.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.446 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 67.2 mt-30 62.38 53.37 2.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.92 3.74 11.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 22.1 ttt85 -104.88 136.47 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 21.8 tp -84.42 125.39 32.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 209' ' ' LEU . 5.8 mt -79.99 54.43 1.9 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.907 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -54.96 -73.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.414 ' HB2' ' CG ' ' A' ' 214' ' ' ARG . 28.5 m-20 -43.34 103.15 0.3 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.619 0.723 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.88 7.56 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.3 23.13 13.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.414 ' CG ' ' HB2' ' A' ' 211' ' ' ASP . 18.0 mmt180 -91.94 108.33 19.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 11.5 p -52.8 138.41 29.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.68 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.8 mt -57.8 -32.22 67.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.4 t -64.75 -42.6 95.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.838 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 34.5 t -67.67 -35.41 78.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 89.6 mt -76.47 1.77 15.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.2 m120 67.17 28.87 8.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.492 ' O ' HG22 ' A' ' 221' ' ' ILE . 53.5 mt -84.45 96.08 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.156 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.5 p -100.46 -175.71 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.159 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.68 ' HB3' HG22 ' A' ' 163' ' ' ILE . 7.0 p30 -76.04 148.6 37.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 74.2 27.15 1.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.65 158.87 17.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -121.67 131.69 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.0 mt -111.42 124.14 67.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -77.75 138.98 39.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.861 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 39.3 m -120.68 138.55 53.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 170' ' ' LEU . 9.3 m170 -119.68 122.78 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -99.67 113.88 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.6 m -78.68 149.81 75.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 110.868 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.19 62.3 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.336 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 137.07 34.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.347 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -129.39 76.06 0.41 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.502 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . 44.79 45.54 8.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.079 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -105.1 122.38 45.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.071 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 239' ' ' SER . 14.8 p -133.64 155.95 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.443 ' N ' HG22 ' A' ' 238' ' ' VAL . 78.3 p -151.42 138.35 19.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.831 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -97.35 -121.42 4.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 107.0 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.711 2.274 . . . . 0.0 112.311 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 8.1 t -101.74 92.08 4.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 60.71 38.2 18.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 94.0 p -124.63 142.87 51.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.0 m 44.78 47.44 8.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.53 84.93 0.36 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 153.72 68.36 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.693 2.262 . . . . 0.0 112.312 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.1 t -126.24 -41.59 1.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 77.5 p -117.77 42.24 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 t -171.76 137.69 1.03 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.881 0.372 . . . . 0.0 110.824 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 77.9 p -76.29 164.86 25.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.893 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 58.66 -122.03 28.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.5 m -164.7 164.85 21.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 110.889 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 t -56.05 -62.07 1.96 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.815 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.88 20.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.422 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 19.6 pt -99.87 152.39 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.872 0.367 . . . . 0.0 111.081 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -98.07 141.94 30.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 44.2 t -130.97 137.12 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -101.6 115.79 31.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.652 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 35.6 mt -85.74 106.05 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 229' ' ' CYS . 2.4 tmmm? -98.77 134.23 41.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.932 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -107.66 165.55 11.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.506 HD11 ' CD2' ' A' ' 230' ' ' HIS . 76.6 mt -68.57 -6.98 28.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -87.05 13.34 9.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 65.67 35.91 6.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 5.2 t -128.66 156.57 43.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -129.62 149.9 51.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.3 tp10 -130.54 132.42 45.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 19.0 tp -72.77 118.95 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.776 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -143.27 120.35 11.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 178' ' ' VAL . 12.6 p -88.36 121.85 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.25 158.16 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.072 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.408 ' HB3' ' CD ' ' A' ' 182' ' ' GLU . 62.0 mtm180 -111.45 152.6 44.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.6 0.714 . . . . 0.0 110.89 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.11 3.82 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.701 2.267 . . . . 0.0 112.332 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 182' ' ' GLU . 14.2 pm0 -113.32 -23.94 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -60.82 179.66 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 22.2 p -119.75 158.65 26.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 214' ' ' ARG . 93.5 t -62.57 -43.42 98.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.52 -38.77 96.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -69.68 -31.72 69.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.0 111.122 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -66.91 -47.08 72.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 193' ' ' PHE . 7.4 mtpp -70.02 -38.6 75.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.9 t -72.28 -29.89 64.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.482 ' HD2' ' CZ ' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.86 -47.09 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.776 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 65.1 m-85 -94.72 -21.26 18.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 5.1 m-85 -135.02 74.55 62.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 125.06 11.7 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.712 2.275 . . . . 0.0 112.311 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.42 3.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.442 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 198' ' ' SER . 27.6 mt-30 -86.59 -15.69 39.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -42.61 -23.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLN . 75.1 p -59.38 -52.54 65.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -88.89 -36.41 15.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -62.15 100.15 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.846 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -107.93 121.62 45.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.483 ' HG ' ' HZ2' ' A' ' 189' ' ' LYS . 23.9 mt -94.01 136.98 33.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 27.1 mt -129.2 122.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 75.6 t80 -113.48 119.98 39.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.57 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 4.9 mm100 55.45 44.2 27.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.24 2.45 59.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 32.3 ttm-85 -102.27 137.69 40.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.838 0.351 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 39.5 tp -84.88 120.54 26.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.462 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.4 mt -75.98 53.87 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -53.34 -73.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -46.23 104.59 0.41 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 1.74 4.15 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.707 2.272 . . . . 0.0 112.334 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.08 20.81 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.073 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 185' ' ' VAL . 33.1 mmt-85 -90.42 107.16 18.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.927 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 p -52.39 141.49 19.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.779 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.0 OUTLIER -62.01 -31.96 72.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 p -65.34 -43.11 91.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.872 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 36.8 t -67.65 -34.71 77.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 79.5 mt -75.92 5.0 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 63.27 37.0 11.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 221' ' ' ILE . 58.1 mt -92.56 95.72 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.0 p -96.75 -174.98 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -70.19 142.43 52.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 73.72 24.98 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.6 m -94.54 140.02 30.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 1.5 p -105.16 133.37 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 13.8 mt -116.35 122.59 70.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -72.49 139.43 47.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' LYS . 60.6 m -116.3 145.25 43.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.506 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.4 m170 -123.32 123.88 41.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.418 ' C ' ' HD2' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -109.14 120.76 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.843 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 6.3 t -98.23 148.23 34.22 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.704 0.764 . . . . 0.0 110.866 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 148.55 65.18 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.636 2.224 . . . . 0.0 112.377 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 119.93 6.8 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.634 2.222 . . . . 0.0 112.344 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.53 -42.17 99.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -137.96 119.75 15.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.759 0.314 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.92 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.077 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 80.4 t -127.18 134.55 65.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.125 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.7 m -61.61 136.66 58.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.866 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -151.3 150.32 22.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -8.9 24.78 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 6.7 m -68.07 71.43 0.16 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.43 ' O ' ' C ' ' A' ' 244' ' ' SER . . . -119.41 140.67 50.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.166 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 243' ' ' ALA . 4.3 m -35.21 145.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 26.3 t -122.89 105.18 9.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.72 82.82 1.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.463 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 93.51 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.686 2.258 . . . . 0.0 112.373 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 t 62.64 38.51 12.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 6.8 t -162.94 143.57 9.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.495 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.9 m -110.16 124.49 51.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.7 m -99.26 137.69 37.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.85 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.32 -61.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.499 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.1 m -89.4 106.13 18.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.865 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.2 p -97.41 161.63 13.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.08 173.99 37.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.448 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 24.4 pt -95.19 144.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 111.183 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.535 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 2.5 m-20 -93.47 139.48 30.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.9 t -129.41 134.63 63.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 226' ' ' VAL . 18.2 mtp180 -99.55 118.72 36.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.865 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.529 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 28.3 mt -85.12 107.07 17.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -98.72 128.26 44.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 3.0 m-85 -107.24 161.49 14.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 10.7 mt -67.29 -5.01 12.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.939 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -82.38 7.28 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.9 t0 70.86 31.23 2.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 2.2 t -129.64 170.57 13.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.85 155.71 46.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -136.39 137.68 40.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 14.9 tp -75.48 120.62 21.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.847 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -142.98 115.55 8.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.44 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 90.4 t -87.73 122.12 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.152 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.05 158.12 34.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.081 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.8 mtm-85 -108.9 153.4 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.582 0.706 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 0.42 5.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.724 2.283 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.47 -33.17 6.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -50.63 -179.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 20.6 p -124.43 157.39 35.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.149 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.604 HG11 ' HB3' ' A' ' 209' ' ' LEU . 70.8 t -61.53 -41.86 91.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -62.98 -36.32 93.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.4 m -71.61 -40.15 70.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.42 -47.09 76.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 193' ' ' PHE . 31.3 mttt -58.66 -48.06 82.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.4 p -70.71 -28.11 64.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.2 tmmm? -65.44 -47.73 75.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.847 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 73.0 m-85 -99.8 -44.46 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 189' ' ' LYS . 8.2 m-85 -113.32 79.23 3.78 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.655 0.74 . . . . 0.0 110.843 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 126.03 12.87 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.676 2.25 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.403 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.57 -20.94 3.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.492 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -87.59 -13.5 42.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' A' ' 189' ' ' LYS . 5.4 mp0 -46.0 -22.49 0.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.926 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.9 m -60.89 -52.08 66.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -92.43 -38.51 11.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.935 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.425 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -63.27 89.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -96.65 133.86 40.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.28 137.15 40.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.706 HD12 ' CD2' ' A' ' 230' ' ' HIS . 19.8 mt -129.22 122.91 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.447 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 67.3 t80 -114.08 113.93 25.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.447 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 22.0 mt-30 62.45 44.62 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 73.01 0.31 50.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 13.4 tpp85 -102.23 133.13 47.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 27.7 tp -80.52 126.15 30.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 185' ' ' VAL . 7.1 mt -76.86 48.19 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -47.81 -71.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -47.31 105.24 0.47 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.705 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 2.97 3.09 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.628 2.219 . . . . 0.0 112.366 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.61 -27.64 10.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.082 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.558 ' O ' HG23 ' A' ' 185' ' ' VAL . 15.9 mmt-85 -44.87 102.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 48.2 p -54.18 150.65 8.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.813 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.67 -31.29 72.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 13.2 p -64.93 -43.55 92.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.0 m -68.59 -35.26 77.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 67.4 mt -75.76 4.76 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 63.3 37.87 10.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 221' ' ' ILE . 50.6 mt -92.61 102.54 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -106.65 -174.3 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.535 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 20.4 t-20 -69.45 152.15 45.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.8 m120 64.18 31.99 12.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.62 143.83 32.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.3 p -110.95 134.14 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.8 mt -116.02 126.98 73.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.101 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -78.46 130.89 36.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 98.7 m -103.21 152.21 21.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.706 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.8 m170 -128.54 124.92 37.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.831 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -108.01 123.85 49.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.1 t -108.67 143.66 27.99 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.682 0.753 . . . . 0.0 110.852 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 147.83 64.06 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.699 2.266 . . . . 0.0 112.351 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -170.1 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.722 2.282 . . . . 0.0 112.312 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 140.81 48.77 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -152.01 158.86 43.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.82 -179.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 14.6 p -159.47 136.86 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.2 t -142.12 150.8 41.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -178.47 155.22 16.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.471 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 167.02 25.6 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.244 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 46.9 p -76.31 155.29 34.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.76 51.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 66.1 m -155.43 124.8 6.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 246' ' ' GLY . 58.1 m -129.77 139.15 51.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 245' ' ' SER . . . -32.05 95.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.443 ' N ' ' O ' ' A' ' 245' ' ' SER . 53.4 Cg_endo -69.74 119.73 6.63 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 94.1 p -150.95 135.21 16.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 36.3 m -40.77 -62.45 0.8 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.869 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.531 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.7 m -86.77 161.97 18.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 110.879 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.4 t -112.87 98.38 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.78 -153.4 6.96 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.499 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 26.9 t 62.59 42.61 8.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.866 0.365 . . . . 0.0 110.867 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.9 m -140.17 152.37 45.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.23 159.24 10.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 26.4 pt -96.36 140.16 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.857 0.361 . . . . 0.0 111.124 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.28 138.78 31.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.4 t -128.59 138.04 55.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.789 ' HB2' HG23 ' A' ' 226' ' ' VAL . 26.4 mtm-85 -97.59 122.7 40.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.534 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 65.0 mt -93.14 104.84 17.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -98.66 130.17 45.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.5 m-85 -107.6 158.35 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.709 HD11 ' CD2' ' A' ' 230' ' ' HIS . 52.1 mt -63.41 -7.87 7.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -83.27 19.8 1.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.67 35.0 24.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 1.9 t -129.91 175.15 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.114 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -144.89 154.69 42.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -136.29 129.01 30.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 29.0 tp -74.31 121.32 21.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.926 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.156 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.91 138.75 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.104 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 178' ' ' VAL . 11.2 p -99.91 121.93 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.593 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -124.28 157.76 34.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.083 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.432 ' O ' HD12 ' A' ' 216' ' ' LEU . 18.4 mtt180 -113.4 152.89 45.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.6 0.714 . . . . 0.0 110.886 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.1 Cg_endo -69.71 -0.9 7.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -109.59 -38.98 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.69 173.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 76.8 p -116.78 162.29 17.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.629 HG21 ' HB3' ' A' ' 209' ' ' LEU . 26.1 t -60.16 -42.48 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.181 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.36 -41.91 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.473 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 m -66.95 -41.68 86.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 179' ' ' ALA . 13.2 tp -57.68 -45.54 85.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.3 mtpt -65.39 -44.61 86.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.8 t -70.67 -28.03 64.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.582 ' HD3' ' CD1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -64.43 -48.74 74.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 1.156 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 14.6 m-85 -100.48 -43.41 6.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.534 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 4.8 m-85 -110.67 80.59 2.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 128.04 15.41 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.67 -40.36 1.81 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -83.81 31.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.936 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -83.04 -20.73 34.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 5.3 t -74.57 -26.1 59.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -96.82 -41.82 8.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.937 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.466 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -64.64 97.02 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.818 ' HG2' HD11 ' A' ' 208' ' ' LEU . 0.8 OUTLIER -97.89 118.58 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.1 mp -93.75 137.89 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 34.2 mt -129.0 122.74 57.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.164 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.532 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 84.6 t80 -114.81 118.65 34.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.915 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.532 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 11.3 mm-40 53.14 32.95 14.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.968 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.88 82.16 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -106.12 131.15 53.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.817 0.342 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.818 HD11 ' HG2' ' A' ' 201' ' ' LYS . 9.5 tp -80.95 121.9 26.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.904 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.629 ' HB3' HG21 ' A' ' 185' ' ' VAL . 4.5 mt -81.56 40.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -47.58 -67.15 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.433 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 0.9 OUTLIER -44.35 104.32 0.38 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.625 0.726 . . . . 0.0 110.856 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.1 Cg_endo -69.77 2.77 3.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.618 2.212 . . . . 0.0 112.378 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.6 -10.22 14.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -61.22 117.13 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.5 p -67.08 141.14 57.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.12 -33.98 67.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.0 t -64.02 -44.85 91.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.9 m -65.3 -33.1 75.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 33.3 mt -77.78 3.46 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 30.7 t30 65.95 28.44 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.93 104.84 12.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.2 p -105.7 -174.76 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.179 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -72.41 150.04 43.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t30 69.27 26.32 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.5 m -102.32 140.47 36.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.1 p -105.45 140.37 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.424 HG21 HD23 ' A' ' 202' ' ' LEU . 20.6 mt -121.54 129.79 75.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.137 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -83.07 126.47 32.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 55.8 m -112.06 127.58 55.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.709 ' CD2' HD11 ' A' ' 170' ' ' LEU . 4.1 m170 -105.91 136.97 44.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -106.15 128.84 54.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.6 143.72 30.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.688 0.756 . . . . 0.0 110.864 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.85 52.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.694 2.263 . . . . 0.0 112.351 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 139.03 39.37 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.373 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -89.22 -38.38 6.77 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -169.15 155.59 6.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -77.86 123.18 26.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 25.5 m -69.47 157.4 6.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 42.9 p -164.22 156.2 16.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 168.59 147.58 5.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 150.04 67.95 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.241 . . . . 0.0 112.342 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.1 t -131.06 143.74 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.873 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -157.47 120.15 3.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 44.9 t -90.89 155.32 18.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 60.1 p -174.15 163.4 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -68.76 173.26 34.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -48.35 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.714 2.276 . . . . 0.0 112.338 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 249' ' ' SER . 7.3 t -66.28 146.85 54.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 248' ' ' SER . 27.7 t -36.92 -46.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.818 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.492 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 69.3 m -90.87 121.87 33.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.875 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.1 m -48.74 -54.33 15.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -116.2 128.22 7.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 52.7 p -135.79 119.97 17.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 110.836 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.6 p -113.11 106.71 14.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 170.16 -177.32 43.53 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.513 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 9.8 pt -108.5 143.18 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.839 0.352 . . . . 0.0 111.102 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.68 141.77 28.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 20.8 t -134.39 137.39 51.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 226' ' ' VAL . 56.1 mtp180 -101.97 110.68 22.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.28 108.69 17.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.423 ' HD2' ' C ' ' A' ' 168' ' ' LYS . 0.7 OUTLIER -98.78 131.6 44.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' CD1' HG23 ' A' ' 173' ' ' THR . 7.8 m-85 -107.62 166.04 10.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.65 -2.47 11.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.972 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -90.53 14.35 13.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t0 64.37 28.14 13.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.0 t -117.11 174.76 5.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.431 ' OE2' ' C ' ' A' ' 173' ' ' THR . 5.2 mp0 -147.98 147.78 30.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -138.29 128.99 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 177' ' ' ALA . 2.1 tm? -77.01 131.1 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.971 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.69 132.01 25.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.446 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 96.9 t -82.23 121.76 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.165 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -129.84 158.18 40.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.522 ' O ' HD12 ' A' ' 216' ' ' LEU . 27.9 mtm180 -117.11 152.47 48.95 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.637 0.732 . . . . 0.0 110.847 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -1.79 9.04 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -108.5 -33.71 6.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.4 168.61 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 40.3 p -110.38 161.35 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.097 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.449 HG12 ' HD2' ' A' ' 189' ' ' LYS . 69.1 t -64.56 -44.11 96.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -58.67 -34.82 78.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.509 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.4 m -72.1 -43.7 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.803 0.335 . . . . 0.0 111.124 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.8 tp -55.3 -47.35 75.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.892 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 193' ' ' PHE . 9.3 mtpp -60.48 -46.99 88.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 27.7 t -70.56 -27.75 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.84 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.54 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.4 tmmm? -66.02 -47.62 73.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.971 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 63.3 m-85 -99.59 -44.46 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' LYS . 7.9 m-85 -111.91 81.97 3.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 130.41 19.27 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.238 . . . . 0.0 112.343 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 75.74 -44.31 1.75 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.472 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -63.22 -6.87 4.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.76 0.314 . . . . 0.0 110.944 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.3 mt-10 -49.6 -18.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 48.0 t -68.9 -46.54 68.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 201' ' ' LYS . 40.1 mt-30 -92.51 -46.11 7.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.71 85.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' GLN . 6.0 mtmp? -95.64 123.14 39.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 9.1 mt -93.32 138.36 31.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.435 HD12 ' CD2' ' A' ' 230' ' ' HIS . 29.0 mt -129.46 122.68 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 82.6 t80 -115.78 121.65 43.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.586 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 14.0 mm-40 55.87 47.52 19.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.58 57.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.49 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.445 ' HB2' ' NH1' ' A' ' 207' ' ' ARG . 16.4 ttm105 -111.05 134.19 52.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 24.9 tp -81.36 124.67 29.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.43 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.9 mt -78.33 45.35 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.966 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -47.15 -73.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -49.07 105.98 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.643 0.735 . . . . 0.0 110.872 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 1.3 4.57 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.723 2.282 . . . . 0.0 112.326 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.86 31.9 5.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.089 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -104.64 101.63 11.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 40.5 p -48.83 141.73 7.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.704 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.3 mt -60.48 -36.09 77.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 25.8 t -60.47 -41.24 93.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 31.7 t -70.7 -30.44 67.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.493 ' O ' ' CE2' ' A' ' 204' ' ' TYR . 36.5 mt -81.42 5.02 18.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 62.03 32.46 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 221' ' ' ILE . 43.1 mt -86.15 92.27 3.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.4 p -103.23 160.71 14.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.148 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -47.96 149.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 9.2 t30 72.49 32.88 1.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.3 t -113.69 145.26 41.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.529 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.8 p -110.35 130.78 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.159 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 10.0 mt -111.55 125.8 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -80.93 133.82 35.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.42 128.72 56.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.435 ' CD2' HD12 ' A' ' 203' ' ' ILE . 4.1 m-70 -99.73 127.86 45.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -113.33 124.97 53.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 17.2 t -102.54 145.33 30.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.674 0.749 . . . . 0.0 110.893 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 154.93 67.27 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.714 2.276 . . . . 0.0 112.321 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 81.76 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -45.14 -44.33 9.58 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -137.93 176.78 8.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 111.089 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -125.36 91.66 3.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.44 164.29 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 70.0 m -59.8 122.31 13.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.825 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -81.84 -173.37 48.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.517 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 137.6 35.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 3.2 m -145.35 117.88 8.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -163.62 167.23 21.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 74.5 m -107.16 84.4 1.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 93.5 p -117.74 81.66 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.814 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -140.55 67.41 0.49 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.488 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.82 29.67 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.678 2.252 . . . . 0.0 112.381 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.3 m -160.98 162.8 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.828 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 8.9 t -55.38 150.06 12.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.483 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.2 p -114.09 -44.67 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.8 t -110.09 156.02 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.86 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -88.32 140.84 16.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.0 m -88.22 39.09 0.88 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 110.865 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -131.29 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.55 175.96 14.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.463 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.461 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 16.7 pt -112.84 143.47 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 0.0 111.175 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -85.37 143.67 28.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 7.1 t -134.12 137.88 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.2 mtm180 -100.51 108.85 20.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 mt -85.15 109.69 18.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -98.82 133.49 43.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 169' ' ' PHE . 2.0 m-85 -107.65 166.26 10.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 60.1 mt -70.92 -11.59 61.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HB2' HG22 ' A' ' 173' ' ' THR . 63.4 m-20 -85.16 18.08 2.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.868 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 6.5 t70 63.47 25.01 14.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 4.0 t -113.46 162.46 16.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -138.32 148.12 44.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.849 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.6 128.76 27.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 176' ' ' LEU . 3.4 tm? -76.51 125.26 28.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.977 ' HB1' ' CE2' ' A' ' 192' ' ' TYR . . . -138.73 120.86 15.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 178' ' ' VAL . 11.9 p -81.99 121.44 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.538 ' HB1' ' OD2' ' A' ' 183' ' ' ASP . . . -129.91 158.66 38.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 24.3 mtt180 -107.94 154.05 41.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.603 0.716 . . . . 0.0 110.845 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.421 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 53.6 Cg_endo -69.81 3.93 2.51 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -116.02 -25.78 7.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.552 ' OD2' HD11 ' A' ' 216' ' ' LEU . 1.0 OUTLIER -58.25 159.65 5.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 71.4 p -103.33 151.35 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.655 HG13 HD12 ' A' ' 202' ' ' LEU . 88.5 t -57.02 -42.55 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.64 -35.71 86.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -72.08 -42.9 65.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.781 0.324 . . . . 0.0 111.115 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 179' ' ' ALA . 12.2 tp -55.0 -47.29 74.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 30.5 mttt -58.86 -47.87 83.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.416 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 45.2 t -70.73 -27.94 64.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.827 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.585 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 1.3 tmmm? -65.51 -47.63 75.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.977 ' CE2' ' HB1' ' A' ' 177' ' ' ALA . 50.0 m-85 -99.74 -44.47 6.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 189' ' ' LYS . 12.0 m-85 -110.46 82.07 2.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 123.71 10.37 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.671 2.247 . . . . 0.0 112.355 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.09 -36.1 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.524 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.93 5.76 4.78 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 110.929 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.416 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 7.9 mt-10 -60.68 -9.58 4.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.5 t -75.89 -45.03 37.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.832 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.402 ' O ' ' N ' ' A' ' 201' ' ' LYS . 36.1 mm-40 -92.07 -43.87 9.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.437 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -55.24 88.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.862 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 199' ' ' GLN . 39.6 mttp -99.28 121.49 41.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.655 HD12 HG13 ' A' ' 185' ' ' VAL . 9.8 mt -93.9 139.06 31.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.541 HD12 ' CD2' ' A' ' 230' ' ' HIS . 17.8 mt -129.42 123.07 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.133 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.501 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.2 t80 -117.23 113.78 22.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.501 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 29.1 mt-30 62.14 49.68 4.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.26 1.36 13.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.497 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -103.37 134.38 46.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.471 HD23 ' HG2' ' A' ' 210' ' ' GLN . 34.1 tp -80.8 124.89 29.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 204' ' ' TYR . 5.7 mt -75.87 50.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.471 ' HG2' HD23 ' A' ' 208' ' ' LEU . 11.3 mm-40 -54.51 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 44.9 m-20 -44.68 103.91 0.36 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.76 -0.83 7.48 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.305 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -113.36 14.48 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.083 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -82.94 98.09 9.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 p -47.24 139.92 5.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.11 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 216' ' ' LEU . 2.2 mt -57.52 -36.21 71.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.7 t -58.01 -42.58 85.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.2 t -71.73 -29.19 64.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.52 5.07 19.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.13 25.12 15.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 221' ' ' ILE . 28.7 mt -78.71 96.43 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.3 p -102.92 -176.72 3.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' A' ' 224' ' ' ASN . 0.8 OUTLIER -72.72 154.23 40.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 223' ' ' ASN . 25.7 m-20 63.52 36.2 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 2.0 t -116.51 151.5 35.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 166' ' ' ARG . 2.0 p -111.84 136.27 48.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 mt -115.33 118.29 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.108 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -68.31 136.3 53.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.819 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.411 ' N ' ' O ' ' A' ' 168' ' ' LYS . 5.8 m -117.24 143.32 46.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.541 ' CD2' HD12 ' A' ' 203' ' ' ILE . 4.4 m-70 -121.15 122.46 40.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -113.14 119.32 37.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 3.8 t -108.67 140.49 21.87 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.604 0.716 . . . . 0.0 110.879 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 148.29 64.83 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.665 2.243 . . . . 0.0 112.328 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 156.93 62.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 0.0 112.361 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -74.15 -71.33 1.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.502 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -122.0 116.55 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.351 . . . . 0.0 111.088 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -43.16 113.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 92.9 t -78.6 116.1 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.167 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 33.9 t -137.27 135.27 37.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -156.37 152.41 23.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.515 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 129.63 17.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.646 2.231 . . . . 0.0 112.354 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 25.9 t -151.04 159.06 44.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -139.62 124.95 19.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -90.16 117.2 28.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.7 p -51.13 -57.7 8.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 139.39 83.0 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 248' ' ' SER . 53.1 Cg_endo -69.82 -32.07 19.01 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 247' ' ' PRO . 9.1 t -37.89 121.0 0.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 17.6 t -101.3 101.43 12.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.469 -179.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 28.7 p -127.81 154.89 44.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.361 . . . . 0.0 110.855 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.0 m -89.96 126.19 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.824 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.2 -100.39 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 4.1 m -120.48 94.58 4.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 0.0 110.825 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.5 m -122.48 141.29 51.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -173.4 159.4 29.39 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 38.4 pt -97.12 140.38 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.82 0.343 . . . . 0.0 111.158 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.405 ' H ' ' ND2' ' A' ' 223' ' ' ASN . 5.2 m-20 -86.68 141.7 28.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 25.2 t -133.74 137.51 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.439 ' HB2' HG23 ' A' ' 226' ' ' VAL . 19.2 mtm180 -98.63 118.58 35.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 51.1 mt -87.76 107.09 18.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -98.67 128.6 45.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.608 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.1 m-85 -107.76 158.91 16.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 230' ' ' HIS . 12.3 mt -62.01 -9.15 6.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -85.46 23.78 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 54.3 29.61 11.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.608 HG23 ' CD1' ' A' ' 169' ' ' PHE . 9.4 t -121.91 160.15 25.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 mp0 -134.32 150.96 51.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -133.3 133.95 43.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 50.1 tp -77.37 117.57 18.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.929 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 1.008 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -140.75 125.69 18.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.434 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 93.9 t -91.66 123.68 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.425 ' O ' ' CG1' ' A' ' 163' ' ' ILE . . . -124.4 158.18 33.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.484 ' O ' HD12 ' A' ' 216' ' ' LEU . 6.5 mpt_? -106.96 152.66 41.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.579 0.704 . . . . 0.0 110.895 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' A' ' 216' ' ' LEU . 54.2 Cg_endo -69.73 -10.34 28.33 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.727 2.285 . . . . 0.0 112.324 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CD ' ' HB3' ' A' ' 180' ' ' ARG . 17.0 pm0 -99.78 -33.49 10.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.916 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.95 166.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.896 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 32.0 p -107.82 162.33 14.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.14 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.625 HG13 HD12 ' A' ' 202' ' ' LEU . 94.2 t -64.82 -43.75 96.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.118 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -57.84 -34.89 72.69 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.5 m -72.18 -43.11 65.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.809 0.337 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 14.8 tp -55.7 -47.3 77.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 193' ' ' PHE . 10.9 mtpp -59.91 -47.1 87.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.444 ' CB ' ' OE2' ' A' ' 197' ' ' GLU . 7.4 t -70.79 -27.95 64.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.56 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.44 -48.09 71.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.897 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 1.008 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.2 m-85 -97.99 -44.07 6.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' A' ' 189' ' ' LYS . 19.1 m-85 -111.78 83.22 4.44 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 0.0 110.854 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 125.51 12.24 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.685 2.256 . . . . 0.0 112.365 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.72 -41.17 1.89 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.446 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -66.54 -3.88 7.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.301 . . . . 0.0 110.932 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.464 ' HG2' ' CB ' ' A' ' 189' ' ' LYS . 18.2 mt-10 -52.24 -16.02 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 17.9 m -70.04 -46.5 64.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -89.63 -47.21 8.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.447 ' O ' ' NZ ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -50.26 97.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.835 ' HG2' HD11 ' A' ' 208' ' ' LEU . 5.4 ttmt -104.63 119.03 38.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.625 HD12 HG13 ' A' ' 185' ' ' VAL . 14.3 mt -93.57 135.15 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.38 123.01 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.154 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.566 ' CE1' ' HG3' ' A' ' 205' ' ' GLN . 59.4 t80 -117.0 120.86 39.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.566 ' HG3' ' CE1' ' A' ' 204' ' ' TYR . 86.2 mt-30 54.71 35.24 23.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 80.76 4.51 90.32 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.47 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -102.55 134.37 46.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.835 HD11 ' HG2' ' A' ' 201' ' ' LYS . 11.3 tp -80.06 119.65 23.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mt -78.68 45.07 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -52.75 -69.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -43.64 103.31 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.711 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.65 2.66 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.57 9.05 16.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -79.27 101.48 8.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 4.8 p -47.23 135.06 10.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.21 -31.35 65.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.932 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 17.4 t -64.11 -42.2 96.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 66.7 m -69.1 -35.6 76.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 76.2 mt -75.05 4.98 5.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.894 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.44 34.99 12.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 221' ' ' ILE . 54.2 mt -92.08 96.76 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 37.6 p -104.14 -177.83 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 224' ' ' ASN . 33.8 t-20 -67.87 153.16 44.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 223' ' ' ASN . 4.4 m120 64.1 46.9 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.65 148.21 52.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 166' ' ' ARG . 5.1 p -110.33 141.45 25.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.19 121.06 66.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.136 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -68.11 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 201' ' ' LYS . 14.4 m -118.25 131.21 56.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.866 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.437 ' CE1' HD11 ' A' ' 170' ' ' LEU . 6.1 m170 -117.66 146.92 43.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -112.85 112.59 24.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -80.61 135.17 53.13 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.649 0.738 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 148.74 66.05 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.742 2.294 . . . . 0.0 112.362 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 176.56 6.58 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.695 2.264 . . . . 0.0 112.374 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -130.78 -28.57 0.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -135.66 129.3 32.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.841 0.353 . . . . 0.0 111.083 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.75 97.34 8.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 9.3 p -89.68 145.76 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.8 p -110.3 159.36 17.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 77.58 149.58 3.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.454 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 152.64 69.57 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.734 2.289 . . . . 0.0 112.319 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 78.2 p -104.92 85.78 2.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 58.49 44.86 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.5 t -106.57 116.59 32.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 59.9 p -92.92 175.03 6.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.865 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -68.57 146.38 45.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 169.75 18.18 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.712 2.275 . . . . 0.0 112.325 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.2 m -131.08 -44.85 1.03 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 69.8 p -103.96 97.56 7.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.5 m -147.45 146.72 29.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.6 m -129.45 161.0 31.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.833 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -57.92 177.72 1.44 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 96.3 p -78.37 -46.79 19.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.91 0.386 . . . . 0.0 110.892 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -61.83 152.67 30.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 133.49 -169.57 22.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 18.7 pt -117.96 138.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.099 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.78 143.39 27.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 41.2 t -132.91 137.46 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.503 ' HB2' HG23 ' A' ' 226' ' ' VAL . 27.5 mtm180 -101.66 113.51 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.487 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 31.3 mt -85.18 111.19 19.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.86 131.67 46.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.858 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.534 ' HB2' HG22 ' A' ' 173' ' ' THR . 10.1 m-85 -106.6 163.01 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.597 HD12 ' H ' ' A' ' 231' ' ' ARG . 51.5 mt -66.29 -9.44 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.71 21.76 2.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 56.24 44.03 25.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 169' ' ' PHE . 14.5 t -131.98 165.29 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -139.56 144.54 37.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -131.14 128.92 41.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.96 118.42 16.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.79 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -137.07 121.3 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 92.6 t -83.7 123.39 38.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.125 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 188' ' ' LEU . . . -128.66 158.13 39.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 35.5 mtp180 -112.51 154.23 44.67 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 2.92 3.08 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.677 2.251 . . . . 0.0 112.354 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -109.25 -38.63 5.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -48.04 170.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 213' ' ' ALA . 3.3 p -110.96 158.32 18.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.183 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 214' ' ' ARG . 84.7 t -61.52 -43.96 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.116 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.33 -37.6 94.31 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.486 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.0 m -71.7 -32.41 67.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.801 0.334 . . . . 0.0 111.132 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.5 tp -64.77 -47.08 79.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 193' ' ' PHE . 2.6 mtpm? -70.73 -39.84 73.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.407 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 9.5 t -72.43 -29.4 63.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.811 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 192' ' ' TYR . 0.1 OUTLIER -70.77 -47.41 59.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.79 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 80.5 m-85 -94.64 -22.47 18.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 189' ' ' LYS . 9.6 m-85 -135.05 84.22 37.57 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.652 0.739 . . . . 0.0 110.844 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 123.99 10.63 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 77.58 -42.31 1.98 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.473 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -9.68 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.407 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 10.0 mt-10 -49.29 -18.64 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 3.6 t -67.75 -48.29 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.85 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 230' ' ' HIS . 26.2 mt-30 -92.62 -45.13 8.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.887 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -57.04 90.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -101.14 120.73 40.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.468 ' HB3' ' CG2' ' A' ' 227' ' ' ILE . 28.1 mt -93.26 135.22 34.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 207' ' ' ARG . 17.9 mt -129.02 122.88 57.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.091 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.567 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 73.4 t80 -112.9 111.32 21.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.567 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 53.4 mt-30 64.15 50.14 2.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.922 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 67.7 3.19 26.33 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.511 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.452 ' C ' HG23 ' A' ' 203' ' ' ILE . 59.1 ttt180 -105.72 131.75 52.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.849 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.574 HD23 ' HG3' ' A' ' 210' ' ' GLN . 32.2 tp -80.8 126.9 31.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.597 ' HB3' HG11 ' A' ' 185' ' ' VAL . 6.7 mt -78.08 46.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.574 ' HG3' HD23 ' A' ' 208' ' ' LEU . 27.4 mt-30 -48.36 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -43.33 103.06 0.3 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 2.55 3.45 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.721 2.28 . . . . 0.0 112.334 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.59 -27.94 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.12 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 185' ' ' VAL . 8.2 mmp_? -49.03 114.86 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.1 p -63.06 149.33 45.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -61.42 -31.81 71.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 8.1 t -65.38 -45.22 84.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.843 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 40.5 m -63.2 -33.45 75.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 185' ' ' VAL . 64.6 mt -79.99 3.81 18.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.65 33.89 12.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.556 ' O ' HG22 ' A' ' 221' ' ' ILE . 55.7 mt -86.55 92.1 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.7 p -97.08 -176.01 3.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 224' ' ' ASN . 1.7 t30 -70.91 150.71 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.44 ' HB2' ' ND2' ' A' ' 223' ' ' ASN . 10.9 t-20 69.64 32.89 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.4 t -110.7 143.99 40.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.4 p -109.1 132.25 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 23.9 mt -111.04 125.66 68.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -79.76 132.57 36.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -113.13 127.64 56.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . 0.425 ' CD2' HD12 ' A' ' 203' ' ' ILE . 3.8 m-70 -100.06 129.05 46.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.597 ' H ' HD12 ' A' ' 170' ' ' LEU . 14.9 ttp85 -113.05 119.98 39.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.869 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 5.5 t -116.87 124.54 29.15 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 147.88 63.71 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.667 2.245 . . . . 0.0 112.324 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 140.72 43.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.695 2.263 . . . . 0.0 112.339 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -95.82 -41.46 3.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -108.29 37.56 2.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 111.097 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . 41.28 40.0 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.09 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.5 t -74.93 -20.77 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.155 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.8 t -91.28 74.49 6.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -66.27 -155.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.491 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 146.11 59.25 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.366 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 52.4 p -98.81 -47.9 5.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . 55.61 42.27 29.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 23.2 m -94.06 -55.83 3.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t 66.25 41.11 3.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -112.58 86.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 127.31 14.39 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.248 . . . . 0.0 112.314 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 60.0 p -67.78 105.59 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 73.3 m -89.22 -55.14 3.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.488 -179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.1 p -69.33 168.89 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.852 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.5 m -163.6 143.86 8.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -60.39 -179.85 2.38 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.449 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 62.0 m -108.41 97.05 6.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 68.1 m -127.0 168.36 14.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.0 175.46 29.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.528 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 14.8 pt -107.85 141.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -91.04 143.14 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.428 HG21 ' HB3' ' A' ' 179' ' ' ALA . 24.5 t -131.57 134.1 60.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.468 ' HB2' HG23 ' A' ' 226' ' ' VAL . 34.5 mtm180 -100.82 115.35 30.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 37.4 mt -85.18 105.06 15.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -98.56 127.35 44.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.451 ' CD1' HG23 ' A' ' 173' ' ' THR . 2.2 m-85 -106.53 163.46 12.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.7 mt -67.42 -10.38 50.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.937 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.552 ' HB3' HG22 ' A' ' 173' ' ' THR . 51.8 t30 -84.86 30.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.404 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 2.1 p30 49.85 25.28 1.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 171' ' ' ASN . 6.9 t -118.51 161.11 20.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -141.09 149.15 41.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -132.42 128.73 38.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 177' ' ' ALA . 1.2 tt -73.66 125.1 27.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.966 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.712 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.82 128.29 20.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 178' ' ' VAL . 11.2 p -90.5 122.14 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.505 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -125.61 158.0 35.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.47 ' CZ ' ' OD2' ' A' ' 183' ' ' ASP . 11.9 mtm105 -112.84 154.52 44.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.641 0.734 . . . . 0.0 110.809 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -4.94 15.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.669 2.246 . . . . 0.0 112.346 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 215' ' ' THR . 0.7 OUTLIER -103.75 -41.17 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.47 ' OD2' ' CZ ' ' A' ' 180' ' ' ARG . 1.4 m-20 -50.34 160.45 0.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 68.7 p -103.3 156.33 17.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.442 HG12 ' HD2' ' A' ' 189' ' ' LYS . 74.3 t -58.73 -41.65 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.165 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.05 93.65 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -69.02 -42.98 75.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.341 . . . . 0.0 111.18 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 12.6 tp -55.32 -47.22 75.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 193' ' ' PHE . 13.3 mtpt -57.79 -49.13 77.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.1 t -70.5 -28.06 64.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.851 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.539 ' HE3' ' CZ ' ' A' ' 192' ' ' TYR . 1.6 tmmm? -64.78 -47.67 77.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.912 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.712 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.2 m-85 -100.25 -44.46 5.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 11.9 m-85 -107.77 80.96 1.06 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.692 0.758 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 123.63 10.28 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.323 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.48 ' CA ' ' OE1' ' A' ' 197' ' ' GLU . . . 79.2 -30.83 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.487 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -82.96 19.74 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.743 0.306 . . . . 0.0 110.869 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.48 ' OE1' ' CA ' ' A' ' 195' ' ' GLY . 28.3 mp0 -74.1 2.47 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 91.1 p -86.34 -48.48 8.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.878 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 201' ' ' LYS . 2.8 pt20 -89.52 -34.0 16.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -55.29 85.41 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.695 ' HG2' HD11 ' A' ' 208' ' ' LEU . 10.2 tttt -97.78 113.18 24.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 202' ' ' LEU . 1.0 OUTLIER -95.12 137.66 33.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.1 mt -129.31 122.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.501 ' HB3' HD21 ' A' ' 209' ' ' LEU . 66.4 t80 -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 57.74 50.56 10.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 65.08 3.0 9.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -104.03 132.44 50.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.864 0.364 . . . . 0.0 110.873 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 201' ' ' LYS . 14.9 tp -79.76 128.84 33.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 204' ' ' TYR . 3.3 mt -84.72 35.74 0.58 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.948 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.515 ' HG2' HD23 ' A' ' 208' ' ' LEU . 7.6 mm100 -39.68 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -40.14 101.23 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.64 0.733 . . . . 0.0 110.826 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 3.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.89 21.45 12.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -92.6 107.57 19.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.818 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.3 p -48.97 135.12 16.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.151 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.725 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.4 mt -57.33 -31.71 65.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.952 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 92.7 p -63.17 -46.0 89.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.5 t -65.1 -33.66 76.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 26.6 mt -77.47 4.92 9.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 65.12 27.31 12.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 51.9 mt -83.55 104.2 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.144 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 56.1 p -108.73 -177.26 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.169 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.418 ' HB3' HG22 ' A' ' 163' ' ' ILE . 2.2 p30 -76.51 151.99 36.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.1 t30 74.01 25.46 1.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.847 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 1.8 t -108.81 162.77 13.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.468 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -123.62 133.6 68.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.432 ' CG2' ' HB3' ' A' ' 202' ' ' LEU . 20.7 mt -112.43 119.59 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.079 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -72.22 126.15 29.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.43 127.03 55.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -101.89 123.83 46.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -112.26 128.84 56.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.1 t -117.51 143.7 32.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 0.0 110.902 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 128.55 16.2 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.686 2.257 . . . . 0.0 112.367 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -175.49 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.328 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -82.83 -53.87 3.4 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -117.65 96.65 5.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 0.0 111.105 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -102.49 53.43 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.067 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 33.1 m -68.91 -10.04 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 1.2 t -163.58 176.07 10.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . -153.82 146.58 14.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.462 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 242' ' ' SER . 53.5 Cg_endo -69.8 -8.75 24.4 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.259 . . . . 0.0 112.342 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 243' ' ' ALA . 31.0 p -37.9 -41.59 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 242' ' ' SER . . . -34.56 -62.73 0.33 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 245' ' ' SER . 24.3 p -45.98 -47.62 16.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 244' ' ' SER . 3.6 t -35.43 131.18 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -104.64 -158.34 23.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 102.91 1.08 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.718 2.279 . . . . 0.0 112.325 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -84.23 -38.19 20.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 37.0 m -59.66 104.34 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.476 179.98 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 39.9 t -89.8 -59.85 2.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.853 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.5 t -112.27 153.41 27.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.05 -46.01 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.513 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 57.6 p -53.93 -46.53 71.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 6.9 p -62.32 -11.98 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -126.78 -173.5 13.55 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.524 HG22 ' HB3' ' A' ' 223' ' ' ASN . 20.5 pt -111.61 141.57 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.847 0.356 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.06 139.51 30.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.93 132.16 70.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.104 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.57 ' HB2' HG23 ' A' ' 226' ' ' VAL . 24.0 mtp180 -94.27 112.07 23.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 77.7 mt -85.32 104.57 15.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 168' ' ' LYS . 2.4 tmmm? -98.57 134.73 41.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.865 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.431 ' HB2' ' CG2' ' A' ' 173' ' ' THR . 44.3 m-85 -107.6 165.14 11.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 75.0 mt -67.42 -12.3 59.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.43 ' HB2' HG22 ' A' ' 173' ' ' THR . 38.5 m-80 -83.59 18.76 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 61.52 27.06 16.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 169' ' ' PHE . 5.0 t -115.55 160.51 19.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -130.7 150.59 51.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -134.79 129.09 34.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.899 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 28.7 tp -72.77 119.56 17.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.733 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -141.54 119.66 12.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.445 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 84.7 t -89.59 121.74 40.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.155 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -123.98 158.12 32.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -110.94 154.84 43.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 217' ' ' SER . 53.7 Cg_endo -69.78 2.15 3.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.363 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 215' ' ' THR . 14.8 pt-20 -111.24 -41.36 4.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 182' ' ' GLU . 0.8 OUTLIER -44.96 170.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 77.7 p -113.85 160.18 19.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.49 HG11 ' O ' ' A' ' 209' ' ' LEU . 89.4 t -63.36 -44.25 98.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -59.09 -42.2 96.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -70.25 -31.18 68.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 179' ' ' ALA . 14.8 tp -65.45 -47.35 76.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 193' ' ' PHE . 11.5 mtpt -67.3 -39.15 85.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.415 ' HB2' ' CD ' ' A' ' 197' ' ' GLU . 21.4 t -72.33 -31.92 66.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.574 ' HE3' ' CE1' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -70.71 -47.83 57.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.866 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.733 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 90.5 m-85 -91.23 -25.27 19.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 189' ' ' LYS . 23.5 m-85 -135.01 85.75 33.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.615 0.721 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.359 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 79.22 -39.15 2.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -65.57 -4.98 6.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.753 0.311 . . . . 0.0 110.9 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.415 ' CD ' ' HB2' ' A' ' 190' ' ' SER . 19.1 mt-10 -49.89 -18.12 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 11.4 m -63.03 -53.72 49.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.498 ' O ' ' N ' ' A' ' 201' ' ' LYS . 11.0 mm-40 -86.91 -45.72 10.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.465 ' HG2' ' CG ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -49.26 87.45 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.735 ' HG2' HD11 ' A' ' 208' ' ' LEU . 1.8 ttmp? -103.94 116.56 32.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.742 HD23 HG21 ' A' ' 227' ' ' ILE . 6.6 mp -93.48 137.51 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 19.7 mt -129.29 122.45 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.543 ' CE2' ' HG3' ' A' ' 205' ' ' GLN . 70.9 t80 -114.98 113.8 24.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.958 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.543 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 20.3 mt-30 60.17 42.13 15.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.921 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.05 5.56 62.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.509 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -105.11 134.09 48.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.365 . . . . 0.0 110.848 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.735 HD11 ' HG2' ' A' ' 201' ' ' LYS . 7.7 tp -79.8 130.39 35.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.49 ' O ' HG11 ' A' ' 185' ' ' VAL . 5.5 mt -84.04 26.69 0.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 209' ' ' LEU . 19.4 mt-30 -34.69 -73.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 7.7 m-20 -37.05 99.36 0.18 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 53.6 Cg_endo -69.73 3.49 2.73 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.688 2.259 . . . . 0.0 112.348 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.46 -15.98 12.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -57.26 118.16 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 182' ' ' GLU . 1.5 p -67.89 142.29 56.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.777 HD23 ' N ' ' A' ' 216' ' ' LEU . 1.1 mt -59.57 -31.54 69.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 181' ' ' PRO . 5.6 t -62.04 -47.05 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 3.3 t -67.49 -31.63 71.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 43.8 mt -78.91 4.54 13.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 60.82 40.61 15.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.44 ' O ' HG22 ' A' ' 221' ' ' ILE . 53.6 mt -96.41 98.4 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -102.01 179.18 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.524 ' HB3' HG22 ' A' ' 163' ' ' ILE . 1.5 p-10 -68.5 150.52 47.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.74 34.62 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.88 143.41 45.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.57 HG23 ' HB2' ' A' ' 166' ' ' ARG . 1.5 p -107.06 136.98 40.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.742 HG21 HD23 ' A' ' 202' ' ' LEU . 14.5 mt -117.83 120.49 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -72.11 128.8 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.82 132.5 56.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -99.76 124.58 45.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -112.24 127.45 55.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.2 t -127.91 143.6 48.35 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.671 0.748 . . . . 0.0 110.827 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 144.32 53.77 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.653 2.236 . . . . 0.0 112.326 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 139.43 40.15 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.694 2.263 . . . . 0.0 112.332 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -137.08 80.44 0.3 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.487 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -135.53 168.74 18.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -96.2 40.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.088 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.27 143.73 23.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.119 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 28.2 t -167.84 125.4 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 151.6 146.82 4.42 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 174.54 9.37 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.682 2.255 . . . . 0.0 112.327 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.3 m -165.82 123.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -119.32 152.97 35.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.088 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.2 t -165.24 153.63 11.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.3 t -122.37 173.98 7.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.853 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 174.06 82.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.481 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 105.9 1.56 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.692 2.261 . . . . 0.0 112.362 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.6 t -77.76 -43.95 29.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 34.7 t -68.32 -48.86 63.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.463 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 62.1 p -81.43 135.11 35.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.867 0.365 . . . . 0.0 110.842 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 t -58.53 -63.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 139.94 -69.41 0.47 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.1 m -146.32 132.36 19.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.864 0.364 . . . . 0.0 110.805 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -167.95 110.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.51 -175.17 15.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.456 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.441 ' CG1' ' O ' ' A' ' 179' ' ' ALA . 25.4 pt -108.25 138.34 35.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 0.0 111.14 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.55 138.41 31.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 179' ' ' ALA . 9.5 t -127.72 133.51 67.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.105 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -96.43 116.83 29.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.671 HD13 ' CZ ' ' A' ' 193' ' ' PHE . 51.8 mt -85.07 106.99 16.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.476 ' HB2' ' CG2' ' A' ' 226' ' ' VAL . 3.1 tmtm? -98.6 128.55 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.935 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' CD1' HG23 ' A' ' 173' ' ' THR . 3.7 m-85 -107.78 158.98 16.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 43.6 mt -63.18 -7.56 6.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 171' ' ' ASN . 25.9 t30 -83.52 17.99 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 60.15 27.41 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.531 HG23 ' CD1' ' A' ' 169' ' ' PHE . 13.9 t -121.17 172.71 7.79 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -143.58 152.39 41.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -133.85 135.23 43.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.93 119.6 20.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.87 ' HB1' ' CZ ' ' A' ' 192' ' ' TYR . . . -143.27 120.0 11.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.45 ' N ' ' OH ' ' A' ' 192' ' ' TYR . 94.1 t -89.52 121.93 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 216' ' ' LEU . . . -120.68 158.16 28.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.514 ' O ' HD12 ' A' ' 216' ' ' LEU . 30.2 mtm180 -110.48 153.44 43.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.599 0.714 . . . . 0.0 110.885 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -8.4 23.51 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -98.81 -39.9 8.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.19 165.6 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 213' ' ' ALA . 11.6 p -108.36 162.35 14.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 214' ' ' ARG . 98.8 t -63.77 -41.12 91.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -61.98 -36.58 93.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.3 m -70.71 -41.33 72.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.338 . . . . 0.0 111.152 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.2 -47.26 75.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 193' ' ' PHE . 23.1 mttp -58.29 -48.41 80.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -70.7 -27.89 64.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.572 ' HE3' ' CE2' ' A' ' 192' ' ' TYR . 0.0 OUTLIER -66.06 -47.75 73.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.903 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' TYR . . . . . 0.87 ' CZ ' ' HB1' ' A' ' 177' ' ' ALA . 83.1 m-85 -99.16 -44.55 6.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.934 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.671 ' CZ ' HD13 ' A' ' 167' ' ' LEU . 10.8 m-85 -112.88 76.06 2.12 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 128.07 15.49 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' OE1' ' A' ' 197' ' ' GLU . . . 77.58 -21.24 3.12 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -92.04 -5.21 53.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 195' ' ' GLY . 13.2 mp0 -51.26 -18.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.3 m -62.87 -58.19 8.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -86.36 -36.56 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 200' ' ' MET . 0.0 OUTLIER -59.94 90.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 53.7 mttt -103.54 125.05 49.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 202' ' ' LEU . 5.6 mp -100.53 139.94 35.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.496 HG23 ' C ' ' A' ' 207' ' ' ARG . 19.4 mt -129.17 123.13 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.463 ' HB3' HD21 ' A' ' 209' ' ' LEU . 77.4 t80 -111.42 114.39 27.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.424 ' HG3' ' CE2' ' A' ' 204' ' ' TYR . 35.9 mt-30 62.2 48.52 4.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 68.8 2.43 29.62 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . 0.496 ' C ' HG23 ' A' ' 203' ' ' ILE . 9.1 ttt180 -105.55 134.83 48.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 37.3 tp -82.07 125.92 31.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 204' ' ' TYR . 5.8 mt -76.56 47.94 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -50.13 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.931 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 212' ' ' PRO . 12.3 m-20 -41.36 101.9 0.25 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.6 0.715 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 211' ' ' ASP . 54.0 Cg_endo -69.75 -0.49 6.99 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 0.0 112.353 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 184' ' ' THR . . . -103.03 -24.45 13.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 185' ' ' VAL . 20.5 mmt-85 -51.7 115.24 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.824 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 9.4 p -63.52 151.06 42.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.175 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.776 HD23 ' N ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -64.37 -34.61 78.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 28.1 t -63.97 -46.65 83.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.4 m -62.72 -35.71 80.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 31.9 mt -76.81 4.54 9.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 28.4 m120 62.94 39.08 10.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.618 ' O ' HG22 ' A' ' 221' ' ' ILE . 45.2 mt -92.68 89.0 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 62.6 p -95.15 170.23 9.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.77 157.65 9.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 4.3 m120 63.89 38.89 8.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.32 144.52 48.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.843 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.476 ' CG2' ' HB2' ' A' ' 168' ' ' LYS . 5.5 p -109.63 141.3 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.095 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.522 HG21 HD23 ' A' ' 202' ' ' LEU . 28.4 mt -119.21 127.29 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.098 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -77.4 131.33 37.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.851 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' CYS . . . . . . . . . . . . . 54.6 m -113.17 138.81 49.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -111.78 122.48 47.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.4 ttp85 -100.83 124.35 46.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 1.8 m -113.82 141.39 26.06 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.643 0.735 . . . . 0.0 110.848 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 126.73 13.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -174.73 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.718 2.279 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -99.1 -76.51 1.26 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ALA . . . . . . . . . . . . . . . -145.28 135.05 23.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -121.41 119.72 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.98 -11.17 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.8 t -91.13 -53.33 4.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 84.33 -114.25 3.88 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.443 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 116.65 4.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.681 2.254 . . . . 0.0 112.355 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.83 141.59 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -91.43 167.58 12.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.118 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.6 m -116.46 -59.01 2.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.6 t -46.85 148.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.822 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -155.55 -93.43 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 150.88 69.03 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.338 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 54.1 p -117.51 139.0 51.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 31.2 t -120.72 135.5 55.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.82 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.965 . . . . . . . . 0 0 . 1 stop_ save_